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Background: Colorectal cancer (CRC) survivors are not meeting the recommended physical activity levels
associated with improving their chances of survival and quality of life. Rehabilitation could address
this problem.
Objectives: The aims of the Cardiac Rehabilitation In Bowel cancer study were to assess whether or not
cardiac rehabilitation is a feasible and acceptable model to aid the recovery of people with CRC and to test
the feasibility and acceptability of the protocol design.
Design: Intervention testing and feasibility work (phase 1) and a pilot randomised controlled trial with
embedded qualitative study (phase 2), supplemented with an economic evaluation. Randomisation was to
cardiac rehabilitation or usual care. Outcomes were differences in objective measures of physical activity
and sedentary behaviour, self-reported measures of quality of life, anxiety, depression and fatigue.
Qualitative work involved patients and clinicians from both cancer and cardiac specialties.
Setting: Three colorectal cancer wards and three cardiac rehabilitation facilities.
Participants: Inclusion criteria were those who were aged > 18 years, had primary CRC and were
post surgery.
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Results: Phase 1 (single site) – of 34 patient admissions, 24 (70%) were eligible and 4 (17%) participated
in cardiac rehabilitation. Sixteen clinicians participated in an interview/focus group. Modifications to trial
procedures were made for further testing in phase 2. Additionally, 20 clinicians in all three sites were
trained in cancer and exercise, rating it as excellent. Phase 2 (three sites) – screening, eligibility, consent
and retention rates were 156 (79%), 133 (67%), 41 (31%) and 38 (93%), respectively. Questionnaire
completion rates were 40 (97.5%), 31 (75%) and 25 (61%) at baseline, follow-up 1 and follow-up 2,
respectively. Forty (69%) accelerometer data sets were analysed; 20 (31%) were removed owing to
invalid data.
Qualitative study: CRC and cardiac patients and clinicians were interviewed. Key themes were benefits
and barriers for people with CRC attending cardiac rehabilitation; generic versus disease-specific
rehabilitation; key concerns of the intervention; and barriers to participation (CRC participants only).
Economic evaluation: The average out-of-pocket expenses of attending cardiac rehabilitation were £50.
The costs of cardiac rehabilitation for people with cancer are highly dependent on whether it involves
accommodating additional patients in an already existing service or setting up a completely new service.
Limitations and conclusions: The main limitation is that this is a small feasibility and pilot study. The
main novel finding is that cardiac rehabilitation for cancer and cardiac patients together is feasible and
acceptable, thereby challenging disease-specific rehabilitation models.
Future work: This study highlighted important challenges to doing a full-scale trial of cardiac
rehabilitation but does not, we believe, provide sufficient evidence to reject the possibility of such a future
trial. We recommend that any future trial must specifically address the challenges identified in this study,
such as suboptimal consent, completion, missing data and intervention adherence rates and recruitment
bias, and that an internal pilot trial be conducted. This should have clear ‘stop–proceed’ rules that are
formally reviewed before proceeding to the full-scale trial.
Trial registration: Current Controlled Trials ISRCTN63510637.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Services
and Delivery Research programme and will be published in full in Health Services and Delivery Research;
Vol. 4, No. 24. See the NIHR Journals Library website for further project information.
ABSTRACT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
viii
Contents
List of tables xiii
List of figures xvii
List of boxes xix
List of abbreviations xxi
Plain English summary xxiii
Scientific summary xxv
Chapter 1 Introduction 1
Rationale for cancer rehabilitation 1
Evidence for increasing physical activity 2
Physical activity and survival 2
Physical activity and psychosocial outcomes 5
What kind of cancer rehabilitation could be delivered in the NHS? 6
The importance of feasibility and pilot studies 9
Study aims 12
Chapter 2 Study design and governance 13
Study design 13
Objectives 14
Phase 1: feasibility study objectives 14
Phase 2: pilot study objectives 14
Ethics approval and research governance 14
Trial registration 14
Chapter 3 Phase 1 methods 15
Phase 1 design 15
Participants 15
Colorectal cancer patients 15
Clinicians 16
Recruitment procedures 16
Informed consent 17
Intervention 18
Cardiac rehabilitation 18
Cancer and exercise training 18
Measures 22
Proposed primary outcome 23
Proposed secondary outcomes 24
Proposed process variables 26
Proposed clinical variables 26
Sample size justification 27
Data collection and management 27
Outcome measures 27
Process evaluation 27
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
ix
Analysis 28
Descriptive statistics 28
Thematic analysis 28
Adverse events 29
Chapter 4 Phase 1 results 31
Feasibility and acceptability of main trial components 32
Colorectal cancer patient recruitment rate 32
Participant characteristics 33
Participant and non-participant characteristics 33
Completion rates and missing data 34
Clinicians’ experiences and perceptions of recruitment 35
Feasibility and acceptability of the intervention 37
Cancer and exercise training 37
Cardiac rehabilitation adherence 39
Patients’ and clinicians’ experiences and perceptions of cardiac rehabilitation 40
Chapter 5 Phase 1 discussion and recommendations for phase 2 45
Summary of findings 45
Recommended changes to main trial components 46
Recommended changes to the cardiac rehabilitation 47
Limitations 49
Conclusions 49
Trial procedures 49
Intervention 49
Chapter 6 Phase 2 methods 51
Phase 2 design 51
Participants 51
Inclusion criteria 51
Exclusion criteria 51
Recruitment procedures 52
Informed consent 54
Randomisation, concealment and blinding 54
Treatment group allocation 54
Usual care 54
Intervention 54
Measures 62
Proposed primary outcome 62
Proposed secondary outcomes 62
Proposed process variables 64
Proposed clinical variables 64
Sample size justification 64
Data collection and management 65
Trial procedures 65
Adverse events 66
Outcome measures 66
Analysis 67
Chapter 7 Phase 2 trial results 69
Site recruitment 69
Flow of participants in the trial 69
Screening rate 69
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
x
Eligibility rate 71
Reasons for ineligibility 71
Consent rate 72
Reasons for non-participation 72
Retention rate 74
Completion rates and missing data 74
Number of participants completing the self-reported questionnaires 74
Number of participants providing valid accelerometer data 74
Adverse events 75
Intervention adherence 75
Participant length of time in the study 77
Comparability of characteristics of consenting and non-consenting eligible patients 78
Baseline comparability of demographic and clinical characteristics of intervention and
control group participants 80
Age and gender 80
Colorectal cancer diagnosis 80
Type of surgery and stoma 81
Treatments 82
Baseline physical activity self-efficacy and risk perception 83
Physical activity and sedentary behaviour 84
Moderate to vigorous physical activity 84
Sedentary behaviour 84
Intervention fidelity 87
Chapter 8 Phase 2 discussion 89
Summary 89
Strengths and limitations of phase 2 90
Key trial parameters 90
Eligibility rate 94
Consent rate 99
Retention, completion rates and missing data 100
Accelerometer validation 100
Intervention adherence 101
Sample size calculation for a definitive randomised controlled trial 101
Recommendations for improving trial procedures for a future effectiveness trial 102
Chapter 9 Phase 2 qualitative study 105
Introduction 105
Research team 105
Study design 105
Participant selection 105
Data collection 107
Analysis 108
Findings 108
Number of participants 108
Key themes and subthemes 109
Clinician interviews 109
Colorectal cancer participant interviews 121
Focus groups with people with coronary heart disease 133
Discussion 135
Strengths and limitations 135
Feasibility and acceptability of cardiac rehabilitation for people with colorectal cancer 135
Feasibility and acceptability of trial procedures 138
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xi
Chapter 10 Economic evaluation 141
Economic evaluation 141
Feasibility 141
Cost data 141
Rehabilitation groups 141
Health-care resource use 143
Health-care costs 143
Patient costs 145
Discussion of economic evaluation findings 146
Chapter 11 Patient and public involvement 147
Involvement of Bowel Cancer UK (Scotland) 147
Discussion and recommendations 148
Chapter 12 Discussion and conclusions 149
Results 149
Is cardiac rehabilitation an acceptable and feasible rehabilitation service for people
with colorectal cancer? 149
Are trial procedures acceptable and feasible? 151
Limitations 151
Conclusions 156
Implications for health care 156
Implications for future research 156
Acknowledgements 159
References 161
Appendix 1 Patient information sheet 175
Appendix 2 Screening form 179
Appendix 3 Referral form 187
Appendix 4 Non-participation consent form 189
Appendix 5 Consent form 191
Appendix 6 Training evaluation form 193
Appendix 7 Interview guides 199
Appendix 8 Adverse event log 211
Appendix 9 Accelerometer frequently asked questions sheet 213
Appendix 10 Weekly intervention log questions 215
Appendix 11 Statistical analysis plan 219
Appendix 12 Descriptive data for quality of life 229
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xii
List of tables
TABLE 1 Bowen et al.’s areas of focus for evaluating intervention feasibility 10
TABLE 2 Thabane et al.’s four reasons for conducting pilot studies 11
TABLE 3 A description of cardiac rehabilitation at site 1 19
TABLE 4 Participants and key themes 31
TABLE 5 Characteristics of participants willing to participate (n= 10) 33
TABLE 6 Characteristics of eligible people with CRC willing and unwilling
to participate 33
TABLE 7 Accelerometer wear-time 34
TABLE 8 Evaluation of cancer and exercise training 38
TABLE 9 Number of consenting patients attending cardiac rehabilitation 39
TABLE 10 Attendance at cardiac rehabilitation 39
TABLE 11 Additional information requested 41
TABLE 12 Recommended changes to trial components 46
TABLE 13 Recommended changes to intervention 47
TABLE 14 Site characteristics 51
TABLE 15 Cardiac rehabilitation site 2 55
TABLE 16 Cardiac rehabilitation site 3 58
TABLE 17 Comparison of three cardiac rehabilitation sites 61
TABLE 18 Phase 2 end points 63
TABLE 19 Screening rates 71
TABLE 20 Eligibility rates 71
TABLE 21 Reasons for ineligibility (sites 1 and 2) 71
TABLE 22 Revised estimated and actual admission, eligibility and consent rates in
each site 72
TABLE 23 Reasons for declining to participate (N= 33) 73
TABLE 24 Variation in complete data, by site 74
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xiii
TABLE 25 Reasons for accelerometer data removal from analysis (N= 20) 75
TABLE 26 Reasons for not completing CRC classes (n= 8) 76
TABLE 27 Cardiac rehabilitation attendance (n= 13) 76
TABLE 28 Data collection dates (n= 25) 77
TABLE 29 Characteristics of consenting and not eligible patients who consented
and did not consent 78
TABLE 30 Colorectal cancer diagnosis 80
TABLE 31 Type of surgery and stoma 81
TABLE 32 Treatments 82
TABLE 33 Baseline physical activity self-efficacy and risk perception scores 83
TABLE 34 Minutes per day of moderate to vigorous physical activity 85
TABLE 35 Total sedentary time per day in minutes 86
TABLE 36 Mean time in minutes over 1 week spent in different types of physical
activity (SPAQ) 87
TABLE 37 Comparison of recruitment parameters 91
TABLE 38 Eligibility criteria studies 95
TABLE 39 Minimum criteria for trials of physical activity interventions for
CRC survivors 98
TABLE 40 Reasons why eligible participants do not consent (%) 99
TABLE 41 Intervention adherence 101
TABLE 42 Recommendations for improving trial parameters 102
TABLE 43 Mean duration of interviews 106
TABLE 44 Key topic guide explored with each group 107
TABLE 45 Qualitative participants 108
TABLE 46 Reasons for declining interview 109
TABLE 47 Themes and subthemes 109
TABLE 48 Cost per patient of running rehabilitation group at each trial site 141
TABLE 49 Frequency of health-care contacts by trial arm across the whole period 143
LIST OF TABLES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xiv
TABLE 50 Frequency of health-care contacts by trial arm from baseline to end of
intervention and follow-up 2 144
TABLE 51 NHS unit costs 144
TABLE 52 Mean cost of NHS resource use by trial arm 145
TABLE 53 Mean EQ-5D-5L scores 146
TABLE 54 Feasibility and acceptability of cardiac rehabilitation for people with CRC 149
TABLE 55 Feasibility and acceptability of trial procedures 152
TABLE 56 Functional Assessment of Cancer Therapy – Colorectal: total score 229
TABLE 57 Functional Assessment of Chronic Illness Therapy Fatigue Scale:
total score 231
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xv

List of figures
FIGURE 1 Four phases of cardiac rehabilitation 8
FIGURE 2 Flow chart outlining phase 1 recruitment and follow-up procedures 17
FIGURE 3 Participant flow 32
FIGURE 4 Research and practice cardiac rehabilitation referral pathways 41
FIGURE 5 Flow chart outlining phase 2 recruitment and follow-up procedures 53
FIGURE 6 Phase 2 total recruitment and sample attrition across all three sites 70
FIGURE 7 Total differences between estimated and actual admission, eligibility
and randomisation rates 73
FIGURE 8 Number of participants completing self-reported questionnaires and
valid accelerometer data 75
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xvii

List of boxes
BOX 1 UK physical activity guidance recommendations for adults 3
BOX 2 Metabolic equivalents 3
BOX 3 Cardiac rehabilitation stages 8
BOX 4 Cost of cardiac rehabilitation 142
BOX 5 Patient involvement comment 148
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xix

List of abbreviations
AE adverse event
CABG coronary artery bypass graft
CHD coronary heart disease
CI confidence interval
CNS cancer nurse specialist
CRC colorectal cancer
CRIB Cardiac Rehabilitation in Bowel
cancer
CRP cardiac rehabilitation professional
EQ-5D European Quality of Life-5
Dimensions
EQ-5D-5L European Quality of Life-5
Dimensions-5 Levels
FACIT Functional Assessment of Chronic
Illness Therapy
FACT-C Functional Assessment of Cancer
Therapy – Colorectal
HADS Hospital Anxiety and Depression
Scale
HCPC Health and Care Professions
Council
HR hazard ratio
ICC intraclass correlation coefficient
ICER incremental cost-effectiveness ratio
ID identification
IPAQ International Physical Activity
Questionnaire
MET metabolic equivalent
MRC Medical Research Council
MVPA moderate- to vigorous-intensity
physical activity
NIHR National Institute for Health
Research
PIS participant information sheet
RCT randomised controlled trial
SAE serious adverse event
SD standard deviation
SF-36 Short Form Health Survey-36 items
SPAQ Scottish Physical Activity
Questionnaire
TIDieR Template for Intervention
Description and Replication
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxi

Plain English summary
S tudies have shown a range of benefits of exercise after colorectal cancer surgery. However, oftenpeople in this situation do not know if exercise is something that is safe for them to do.
Cardiac rehabilitation is a programme of exercise and health advice for people recovering from heart
disease. This can lead to improvements in health and well-being. It may also help people who are
recovering from colorectal cancer surgery. This study asked people recovering from colorectal cancer
surgery to go to cardiac rehabilitation, alongside the patients recovering from heart problems.
We aimed to find out:
l Is it possible to deliver a cardiac rehabilitation programme to cancer patients?
l How acceptable would this be for patients and clinicians?
Forty-one patients with colorectal cancer took part and gave us information on how active they were. We
collected information on quality of life and anxiety and depression by using a questionnaire. Patients and
clinicians were also interviewed.
Our results show that using cardiac rehabilitation was possible for those recovering from colorectal cancer
surgery. Cardiac clinicians were happy to involve cancer patients on their cardiac rehabilitation
programmes but needed additional training to better support these patients. Patients diagnosed with
colorectal cancer found various benefits to taking part, including improvements in their motivation and
confidence to exercise after their surgery.
More work is needed to see if such a programme will provide a health benefit for people recovering from
colorectal cancer surgery.
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Scientific summary
Background
Colorectal cancer (CRC) is the fourth most common cancer in the UK, and there are approximately 244,000
CRC survivors. Higher levels of post-diagnosis physical activity are associated with improved CRC outcomes,
in terms of both survival and quality of life. However, CRC survivors are not meeting the recommended
physical activity levels associated with health benefits. A barrier to physical activity interventions becoming
standard NHS cancer care occurs because there are difficulties around implementation. Thus, when
designing this study, particular attention was paid to this issue. This study is novel in that it aims to test an
existing evidence- and theory-based cardiac rehabilitation service for a different patient group, namely
people with CRC. There were four main reasons why cardiac rehabilitation was chosen:
1. Physical activity is the cornerstone of cardiac rehabilitation.
2. Cardiac rehabilitation is evidence based and informed by theories of behaviour change.
3. Cardiac rehabilitation clinicians have the expertise to provide relevant rehabilitation, including
monitored physical activity, to a wide variety of patients, such as those with a CRC diagnosis.
4. Cardiac rehabilitation is widely available throughout the UK.
Objectives
The aims of the Cardiac Rehabilitation In Bowel cancer study were to assess whether or not cardiac
rehabilitation is a feasible and acceptable model of rehabilitation to aid the recovery of CRC survivors (i.e.
examine intervention implementation potential) and to test the feasibility and acceptability of the protocol
design (i.e. examine methodological standard). The study was not designed to measure the effect of
cardiac rehabilitation on health outcomes. Thus, the overall purpose of the study was to assess whether or
not it is appropriate to progress to an effectiveness trial and, if so, to optimise the design and conduct of
any such trial.
Design
We undertook a phased programme of work comprising intervention testing and feasibility work (phase 1)
and a pilot randomised controlled trial (phase 2), which was supplemented with an economic evaluation to
consider resource use of providing the intervention, compared with usual care. There was also a qualitative
study that aimed to explore the views and experiences of all CRC participants, six cardiac patients and
12 clinicians involved in the study.
The intervention was the referral of people with CRC to cardiac rehabilitation, which comprised
approximately 12 exercises classes and cardiac-specific education sessions over 12 weeks, depending on
the site. Cardiac rehabilitation physiotherapists and other cardiac rehabilitation clinicians received training
in cancer and exercise.
The primary outcomes were the difference in measures of physical activity and sedentary behaviour
between the intervention and usual care (control) groups, measured by an accelerometer at 12 weeks post
randomisation. The secondary outcomes were self-reported measures of quality of life, anxiety, depression
and fatigue. In this study, we assessed the feasibility and acceptability of data collection instruments for
these proposed outcomes.
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Interviews were carried out with people with CRC recruited to the study and with cancer and cardiac
clinicians. In addition, focus groups with people with coronary heart disease attending cardiac
rehabilitation were conducted and analysed using thematic analysis.
Setting
The setting was CRC hospital wards and cardiac rehabilitation facilities. Phase 1 was conducted in one site
and phase 2 (a pilot randomised controlled trial) was conducted in three sites.
Participants
In both phases, people with CRC were recruited from hospitals and considered for inclusion if they were
aged ≥ 18 years, diagnosed with primary CRC and in the recovery period post surgery. People with CRC
were excluded if they had advanced disease, had failed clinical/risk assessment for rehabilitation and were
deemed unsafe to participate in exercise classes, had severe cognitive impairment or were unable to
communicate in English, as this is the language used in delivering cardiac rehabilitation. The estimated
sample size was 12 and 66 CRC patients in phases 1 and 2, respectively.
Phase 1
Results
Participants
During phase 1, three CRC patients, three CRC nurse specialists and the cardiac rehabilitation senior
physiotherapist in site 1 were interviewed. In addition, a focus group was conducted in site 2, involving
12 cardiac rehabilitation clinicians (eight physiotherapists/assistants and four nurses).
Feasibility and acceptability of trial components
The feasibility and acceptability of trial components were tested in one site, with the following results.
There were 34 new CRC patient admissions and the 24 (70%) eligible patients were given study
information. Ten (42%) eligible patients were willing to participate in the study (mean age was 71 years,
six were male, eight had undergone open surgery/two had undergone laparoscopic surgery, five were
receiving adjuvant therapy, four had a stoma). Four (17%) patients signed a consent form and were
entered into the study, and six withdrew owing to ill health (n= 3) or travel problems (n= 2), or because
they could not subsequently be contacted (n= 1). Three patients remained in the study. One adverse event
was reported, which was not related to the study.
The characteristics of 10 eligible participants willing to participate and seven eligible participants who
declined to participate were compared. The age range and CRC diagnosis in each group were similar.
There were proportionately more men and more people who had undergone open surgery in the
willingness to participate group.
Participants did not report difficulties wearing an accelerometer. All questionnaires were completed and
there were no missing data. Participants found sections of the questionnaires repetitive, in particular the
questions about quality of life. They also found some questions not relevant; for example, there were
questions about being physically active at work, but most of the participants had retired.
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Nurses did not report difficulties applying exclusion criteria and found that it was feasible and acceptable
to approach patients on the surgical ward about the study. Perceived barriers to participation were:
l travel distance from cardiac rehabilitation facility
l returning to work and therefore unable to attend cardiac rehabilitation
l feeling fit and well and therefore perceiving cardiac rehabilitation as unnecessary
l having ongoing treatment and not feeling well enough to attend cardiac rehabilitation
l poor recovery from surgery.
Feasibility and acceptability of the intervention
The average number of days between a patient indicating his or her willingness to participate in the study
and starting cardiac rehabilitation was 70. Participants were expected to attend 10 consecutive cardiac
rehabilitation exercise classes; the four participants attended 10, 6, 5 and 0 classes, respectively, thereby
bringing a total of three participants remaining in the study.
Themes from the interviews and focus groups were referral pathways to cardiac rehabilitation, importance
of exercise for patients with CRC, cancer and cardiac patients exercising together, and cardiac
rehabilitation education sessions.
Before any CRC patients were recruited, all clinicians (six CRC nurses, 10 cardiac rehabilitation
physiotherapists and four cardiac rehabilitation nurses) in all three sites who were involved in recruitment
or delivering the intervention attended a 1-day cancer and exercise training event. A cancer and exercise
specialist delivered the training face to face in two sites and by video conferencing in one site. Fourteen
evaluation forms were returned. All scaled questions marked highly with a score of 4 or 5, with 5 being
the maximum score.
Conclusions
The feasibility and acceptability of trial components and the intervention were only tested on one site over
a short period of 6 months, including a very small number of patients and clinicians. A decision was
reached among the research team, funder and advisory group to proceed to phase 2 with the following
main modifications to the trial procedures and the intervention.
Trial procedures
l Approach CRC patients about the study on the surgical ward.
l Remove duplication of questions and include a physical activity questionnaire relevant to this
age group.
l Include people with metastatic disease.
Intervention
l Refer CRC patients to cardiac rehabilitation only when they feel ready to begin exercise classes.
l Include on the referral form information about comorbidities, treatments, date of surgery and relevant
previous medical history.
l Modify the intervention so that CRC nurses provide cancer-specific education sessions and lifestyle
advice to CRC patients to supplement the cardiac rehabilitation education sessions.
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Phase 2
Results
Randomised controlled trial
The screening rate was 79%. One hundred and ninety-eight people were admitted to hospital for CRC
surgery and, of these, a CRC nurse assessed 156 for eligibility. The eligibility rate was 67%. Of the 198
people admitted for surgery, 133 met the eligibility criteria. The main reason for excluding a patient was
poor mobility. The consent rate was 31%. Forty-one out of 133 eligible patients gave written consent. The
most common reason given by patients for non-participation was poor recovery from surgery, comorbidity
or receiving adjuvant therapy. The randomisation rate was 100%. No adverse events were reported.
The retention rate was 93%. Three out of 41 participants formally left the study (two control and
one intervention).
There were no significant differences in age, gender and type of surgery (colon or rectal) between
consenting and non-consenting eligible patients, but people with metastatic disease, having open surgery
or who had a stoma were more likely not to participate. However, there was recruitment bias; although
eligible, most participants were already meeting the recommended level for moderate to vigorous physical
activity (i.e. 30 minutes per day).
The completion rate for self-report questionnaires at baseline, follow-up 1 and follow-up 2 was 97.5%
(20 intervention and 20 control), 75.6% (15 intervention and 16 control) and 61% (12 intervention and
13 control), respectively. The completion rate for accelerometers at baseline, follow-up 1 and follow-up 2 was
68% (14 intervention and 14 control), 56% (11 intervention and 12 control) and 34% (six intervention and
eight control), respectively. There was a total of 65 accelerometer device data sets across all three time points.
Twenty out of 65 (31%) accelerometer device data sets were removed from analysis because data were
invalid. The main reason for missing accelerometer data was a participant not wearing the device (35%).
Thirteen out of 21 participants (62%) completed the cardiac rehabilitation programme. Three participants
started cardiac rehabilitation but could not complete all of the classes and five (38%) did not begin
cardiac rehabilitation.
Qualitative study
The qualitative study comprised 38 participants (22 patients with CRC, eight patients with cardiovascular
disease, two CRC nurses and six cardiac rehabilitation clinicians). Key themes (subthemes shown in
parentheses) were benefits for people with CRC attending cardiac rehabilitation (delivered by health
experts, benefits of physical activity, confidence, motivation, peer support, social skills), barriers for people
with CRC attending cardiac rehabilitation (travel and distance, recovery from treatments, stoma), generic
versus disease-specific rehabilitation, key concerns about including people with cancer in cardiac
rehabilitation (capability of clinicians, capacity of cardiac rehabilitation) and barriers to involvement in a
study about cardiac rehabilitation (randomisation, study information, participant burden) (CRC
participants only).
Economic evaluation
Response rates were high for the health service resource use questionnaire and a questionnaire to measure
quality-adjusted life-years. The key resources used to deliver cardiac rehabilitation were staff time,
equipment and room hire. Two sites provided historical data that related to all cardiac rehabilitation costs,
which were £375 and £437, respectively. One site provided an estimated cost per patient for hiring a
physiotherapy assistant to accommodate an additional 24 CRC patients into the cardiac rehabilitation
service; this cost was £198.71. NHS resource use was similar between CRC patients allocated to the
cardiac rehabilitation intervention and the usual care groups. Costs incurred by CRC patients allocated to
the cardiac rehabilitation intervention group specifically related to attending the cardiac rehabilitation
intervention (e.g. travel and clothing) were relatively small (approximately £50).
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Limitations
This feasibility and pilot work, conducted in only three sites, highlights a range of trial design limitations,
including suboptimal eligibility, consent and completion rates, missing data and recruitment bias. It also
highlights limitations of cardiac rehabilitation for patients with cancer, including capacity, costs and
capability issues. To make a full multicentre trial feasible, we recommend an internal pilot with clear
stop–proceed rules, induction training for staff and participant incentives. We also recommend an
embedded process evaluation so that each site’s contextual factors impacting cardiac rehabilitation for
patients with cancer are illuminated.
Conclusions
Implications for health care
The main novel finding is that cardiac rehabilitation for cancer and cardiac patients together is feasible and
acceptable, thereby challenging disease-specific rehabilitation models.
This study suggests that cardiac rehabilitation is an acceptable and feasible rehabilitation service for people
with CRC and their clinical care teams, but the capacity of cardiac rehabilitation to accommodate additional
patients with cancer and the capability of cardiac rehabilitation clinicians to provide cancer-specific
psychosocial support are key concerns. Before UK-wide implementation, it is critical to address these
concerns and then to find out if this model of rehabilitation has a health benefit. A major strength of this
feasibility and pilot study, however, is that we evaluated an already widely available existing rehabilitation
service, namely cardiac rehabilitation. The aim of this study was not to attempt to change and adapt cardiac
rehabilitation, but to find out if it is feasible and acceptable to refer people with CRC to this current service
as it is currently configured. We were successful in achieving this aim.
Implications for future research
Research priorities
To maximise the success of any future effectiveness trial, research priorities include addressing CRC patient
barriers to attending cardiac rehabilitation and consenting to the study (e.g. travel or poor recovery),
gaps in cardiac rehabilitation provision for cancer patients such as cancer-specific psychosocial support,
recruitment bias, missing accelerometer data, retention of control group participants and marginal costs
related to expanding cardiac rehabilitation provision to other patient groups.
To address concerns about capacity, we recommend that additional resources be given to cardiac
rehabilitation (if required) so that they can take more patients. To address concerns about the competence
of cardiac rehabilitation clinicians to address cancer-specific issues, we recommend that the cancer team
address cancer-specific needs and that cardiac rehabilitation attend to generic concerns of patients. To
address travel barriers to attending cardiac rehabilitation, outreach services should be offered. To address
recruitment bias, induction training should be provided to cancer clinicians about cardiac rehabilitation, so
that they refer and offer the service only to patients who need it most, that is, those currently not meeting
the recommended guidelines for physical activity. This training will also point out the ability of cardiac
rehabilitation to support people who, for instance, have a disability or are immobile, thereby encouraging
the referral of patients to the service who are frail, etc. To improve uptake of the service, we recommend
ensuring that patients are part of the decision-making process about the start date for attending cardiac
rehabilitation. This is so that those who wish to begin rehabiliation at the end of all active treatment can
still participate. To improve completion rates, especially for participants allocated to the control arm,
we recommend providing incentives to remain in the study, such as monetary incentives and regular
reminders. To reduce missing accelerometer data, we recommend training researchers so that they
communicate to participants the importance of these data and how to wear the device.
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Next steps
A major strength and advantage of a pragmatic trial is the testing of already existing services in real-world
settings. A pragmatic trial is very different from an explanatory trial, in which the intervention is tightly
controlled and managed by the investigating team. A future multicentre effectiveness trial should
incorporate the recommended protocol modifications and include an internal pilot trial with clear ‘stop–go’
rules that are formally reviewed before proceeding to the full-scale trial.
Trial registration
This trial is registered as ISRCTN63510637.
Funding
Funding for this study was provided by the Health Services and Delivery Research programme of the
National Institute for Health Research.
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Chapter 1 Introduction
In this chapter, the rationale for rehabilitation for people with colorectal cancer (CRC) is provided. Inparticular, evidence of the benefits of physical activity for people with CRC is presented. Arguments are
also presented for the use of cardiac rehabilitation as a rehabilitation model to aid the recovery of people
with CRC. Finally, the importance of conducting feasibility and pilot studies as preparation for large-scale
effectiveness trials is discussed.
Rationale for cancer rehabilitation
Increasing 5- and 10-year survival rates mean that many cancers are now considered chronic diseases.
There are approximately 28 million people living with and beyond cancer in the world1 and many of these
cancer survivors face ongoing challenges from the post-treatment care standpoint. In this report, we use
that term, cancer survivor, to refer to someone who is living with and beyond cancer; we recognise,
however, that not all cancer survivors would identify themselves using the term ‘survivor’.2 In the UK, there
are over 2 million people living with and beyond cancer, a figure which is rising by 3% per annum.3
As such, supporting cancer survivors represents one of the largest UK and global health challenges.
Colorectal cancer is also called bowel cancer and includes large bowel cancer (colon cancer) and cancer of
the back passage (rectal cancer or cancer of the rectum). CRC is the second most frequently diagnosed
cancer in women and the third most frequently diagnosed cancer in men, accounting for 1.23 million
new CRC cases in 2008 worldwide.4 CRC is the fourth most common cancer in the UK and there are
approximately 244,000 people living with and beyond CRC.5 In 2011 in the UK, 41,581 people were
diagnosed with CRC (13% of all cancer cases); 57% of adults who were diagnosed with CRC (56% of
men and 57% of women) in 2010–11 in England and Wales were predicted to survive ≥ 10 years.6
Addressing the post-treatment needs of this group is, therefore, a UK public health priority.
Colorectal cancer survivors report ongoing and persistent physical and psychological impairments.7–9
Physical symptoms include fatigue, physical discomfort and bowel function problems (e.g. diarrhoea,
frequency of bowel movement and incontinence), and these may be present in up to 72% of survivors.9
The clinical rationale for cancer rehabilitation is to support the management of late and long-term effects
of cancer and its treatment, increase chances of survival and improve general health and quality of life.
The American Cancer Society and the World Cancer Research Fund recommend that cancer survivors
would benefit from following lifestyle recommendations for secondary cancer risk reduction (e.g. taking a
nutrient-dense diet, increasing levels of physical activity, ceasing smoking, reducing alcohol intake and
avoiding excess body fat).10,11 The adoption of lifestyle recommendations may also reduce CRC survivors’
risk of other diseases, such as cardiovascular disease, which is a common comorbidity in people diagnosed
with CRC,12 the aetiology of which is also attributed to lifestyle factors.13
However, most CRC survivors are not meeting these lifestyle recommendations.14–18 A study conducted in
Australia, for instance, shows that, at 12 months post diagnosis, approximately 8% of CRC survivors are
smokers, 22% are high-risk drinkers, 62% are insufficiently physically active and 61% are overweight/
obese.14 CRC survivors have been found to have the lowest physical activity rates of any cancer group.19
There is a strong case, therefore, for the provision of rehabilitation for cancer survivors, and, in particular,
for people with CRC. However, at the time the protocol for this current study was written (2012), cancer
rehabilitation was not usual care in the UK or, indeed, elsewhere.20 A challenge facing the NHS, therefore,
is integrating rehabilitation into standardised models of care for cancer survivors.
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The National Institute for Health and Care Excellence guidance, Improving Supportive and Palliative Care
for Adults with Cancer, states that:
Rehabilitation attempts to maximise patients’ ability to function, to promote their independence and
to help them adapt to their condition. It offers a major route to improving their quality of life, no
matter how long or short the timescale. It aims to maximise dignity and reduce the extent to which
cancer interferes with an individual’s physical, psychosocial and economic functioning.21
Cancer rehabilitation is a care specialty that comprises the full spectrum of rehabilitation fields, including
the physical, psychosocial and socioeconomic, and can include physical activity, diet, nutrition and
psychosocial components.22 As we have already pointed out, cancer rehabilitation is an often-neglected
aspect of cancer care in terms of health policy and infrastructure.20 Reasons for this include clinicians
remaining unconvinced or unaware of evidence of patient benefit from rehabilitation, and challenges
around the implementation of rehabilitation in current cancer care pathways. The following section
explains why rehabilitation for people with CRC should include physical activity as a core component.
Evidence for increasing physical activity
Physical activity is a key component of rehabilitation. In order for clinicians to prescribe physical activity,
which is a non-pharmacological adjunctive therapy, for CRC survivors, there needs to be strong evidence
of patient benefit. The clinical rationale for physical activity interventions for CRC survivors is derived from
epidemiological observations of relationships between physical activity and survival, and evidence of cause
and effect derived from randomised controlled trials (RCTs) about the benefits of physical activity on
psychosocial domains, such as quality of life, fatigue, anxiety and depression.23,24 We use the term ‘physical
activity’ throughout this report, although we recognise that the term ‘exercise’ is often used
interchangeably to refer to ‘A potential disruption to homeostasis by muscle activity that is either
exclusively or in combination, concentric, eccentric or isometric’.25
To assist the reader in interpreting the following evidence about associations between physical activity and
clinical endpoints in people with CRC, and, perhaps more importantly, to recognise the level of physical
activity required to achieve a health benefit, we describe current recommended UK guidance for physical
activity for the general population and metabolic equivalents (METs) in Boxes 126 and 2, respectively.27
Physical activity and survival
Three separate meta-analyses23,28,29 including the same six observational studies30–35 were published in
2013–14. Owing to different cut-off values for level of physical activity and different statistical analyses
used, there is slight variation in the results; what is evident, however, is that all three studies show that a
higher level of physical activity is associated with an increase in cancer-specific and overall survival.
A meta-analysis28 reported that three32,34,35 out of the six prospective cohorts assessing post-diagnosis
physical activity found a statistically significant increase in cancer-specific survival among patients with a
high level of physical activity, compared with patients with a low level. Overall, higher post-diagnosis
physical activity was significantly associated with an improved cancer-specific survival [hazard ratio (HR)
cancer-specific survival= 0.61, 95% confidence interval (CI) 0.44 to 0.86; random-effects model;
p< 0.001]. The meta-analysis also found that higher post-diagnosis physical activity level was associated
with a significantly increased overall survival (HR overall survival= 0.62, 95% CI 0.54 to 0.71; fixed-effects
model; p< 0.001). Five31–35 out of the six individual studies assessing the relationship between physical
activity level and overall survival found a statistically significant increase in overall survival among patients
with higher post-diagnosis physical activity levels.
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Pooled relative risks from another meta-analysis23 among CRC survivors showed inverse associations
between post-diagnosis leisure-time physical activity and mortality based on six prospective cohorts.30–35
The authors conducted a meta-analysis for exerciser versus not exerciser, moderate level of physical activity
versus low physical activity, and high level of physical activity versus low physical activity. Low physical
activity (reference group) was defined as 0, < 3 and < 3.5 MET hours per week or sedentary and the
highest category was defined as ≥ 18 and ≥ 8.75 MET hours per week or sufficiently active. All categories
above the reference group were pooled to represent ‘exercisers’. Exercisers had a risk ratio of 0.74
(95% CI 0.58 to 0.95; p= 0.02) for CRC-specific mortality, compared with non-exercisers. The risk ratios of
CRC-specific mortality for moderate versus low physical activity and high versus low physical activity were
0.82 (95% CI 0.61 to 1.10; p= 0.19) and 0.65 (95% CI 0.47 to 0.92; p= 0.01), respectively. Similarly,
exercisers had a risk ratio of 0.68 (95% CI 0.60 to 0.78; p< 0.001) for all-cause mortality, compared with
non-exercisers, and the risk ratios of all-cause mortality for moderate versus low physical activity and high
versus low physical activity were 0.76 (95% CI 0.64 to 0.90; p= 0.001) and 0.61 (95% CI 0.52 to 0.71;
p< 0.001), respectively.
BOX 1 UK physical activity guidance recommendations for adults
At least 150 minutes (2 hours and 30 minutes) of moderate-intensity aerobic activity such as cycling or fast
walking every week, and muscle-strengthening activities on 2 or more days a week that work all major muscle
groups (legs, chest, shoulders, hips, back abdomen, and arms)
OR
75 minutes (1 hour and 15 minutes) of vigorous-intensity aerobic activity such as running or a game of singles
tennis every week, and muscle-strengthening activities on 2 or more days a week that work all major
muscle groups.
OR
An equivalent mix of moderate and vigorous-intensity aerobic activity every week (for example, two 30-minute
runs plus 30 minutes of fast walking), and muscle-strengthening activities on 2 or more days a week that work
all major muscle groups (legs, hips, back, abdomen, chest, shoulders and arms).
Also try to break up long periods of sitting with light activity as sedentary behaviour is now considered an
independent risk factor for ill health, no matter how much exercise you do.26
Reproduced from NHS Choices (www.nhs.uk). Contains public sector information licensed under the Open
Government Licence v 3.0 (www.nationalarchives.gov.uk/doc/open-government-licence/version/3/).
BOX 2 Metabolic equivalents
A metabolic equivalent, or MET, is a unit useful for describing the energy expenditure of a specific activity. A
MET is the ratio of the rate of energy expended during an activity to the rate of energy expended at rest. One
MET is the rate of energy expenditure while at rest. A 4-MET activity expends four times the energy used by the
body at rest.
The health benefits of physical activity demand a range of 500–1000 MET minutes per week.
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The meta-analysis indicated that there may be a threshold ‘dose’ of physical activity that is necessary to
yield a health protective effect.23 In this meta-analysis, those who participated in both moderate amounts
of physical activity and high amounts of physical activity after diagnosis had a 24% and 39% risk
reduction in all-cause mortality, respectively, compared with those who participated in low amounts of
physical activity. Thus, the researchers highlight a clinically relevant finding from the meta-analysis, which is
that a moderate amount of physical activity participation (defined by the researchers as physical activities
between 3 and 18 MET hours per week or between 3 and 8.75 MET hours per week, or between 1 and
150 minutes of physical activity per week) was associated with a 24% risk reduction in all-cause mortality,
whereas previously reported individual studies33,34 had suggested that higher levels of more than 18 or
27 MET hours per week of physical activity participation were associated with favourable survival outcomes
in CRC survivors.23
Another meta-analysis29 of the same studies30–35 also found a dose response. Each 5-, 10-, or 15-MET
hours per week increase in post-diagnosis physical activity was associated with a 15% (95% CI 10% to
19%), 28% (95% CI 20% to 35%) and 38% (95% CI 28% to 47%) lower risk of total mortality,
respectively. The reviewers also found that the apparent protection from total mortality afforded by
physical activity was not modified by tumour stage, cancer treatment, smoking or adiposity.
A study published after the above meta-analysis36 found that spending ≥ 7 hours per week in leisure time
physical activity after a diagnosis of CRC was associated with a 31% lower risk of death (from any cause)
than doing no leisure time physical activity (HR= 0.69, 95% CI 0.49 to 0.98; p for trend= 0.01; adjusted
for pre-diagnosis leisure-time physical activity). Looking at specific causes of death, spending ≥ 7 hours in
leisure time physical activity after diagnosis, compared with none, probably reduces risk of death from CRC
(HR 0.53, 95% CI 0.27 to 1.03; p for trend= 0.04) but not death from cardiovascular disease (HR 0.89,
95% CI 0.42 to 1.86; p for trend= 0.38).
Only one of the studies included in the above meta-analyses reported on sedentary time and mortality
among people with CRC31 and found that sitting for ≥ 6 hours per day compared with sitting for < 3 hours
per day after diagnosis was associated with a 27% increased mortality risk (95% CI 0.99 to 1.64). This
specific study has added to the growing literature on the health risks of sedentary time, which is defined
as waking activities performed in a seated or reclining posture that require very low energy expenditure
(< 1.5 METs).37–40 For this reason, our study is designed to assess the feasibility and acceptability of
obtaining objective measures of both sedentary time and physical activity among people with CRC.
Another recent meta-analysis adopted a slightly different approach from the three described above.41
Rather than focusing on assessing the amount or categories of physical activity at one point of time with
cancer outcome, the focus was on the impact of actual changes of physical activity over time. Physical
activity was required to be assessed at least twice, before and after diagnosis, or during two follow-up
periods after diagnosis. Patients who increased their physical activity level or remained active throughout
the diagnosis and treatment phases had significantly higher quality-of-life scores than patients with
reduced physical activity levels after treatment. Pooled analysis from two studies30,35 found a significant
association between increases in physical activity in the post-diagnosis period and reduced CRC death, but
increases from pre diagnosis to 5 months post diagnosis were not significant. However, the overall pooled
HR estimate of 0.70 (95% CI 0.55 to 0.85) indicated that the change was significant. A similar pattern
was observed for overall mortality (pooled HR 0.75, 95% CI 0.62 to 0.87). Pooled analysis from three
studies42–44 revealed that, compared with decreased physical activity post diagnosis and/or post treatment,
increased physical activity was associated with significantly higher quality-of-life scores [standardised mean
difference (SMD) 0.74, 95% CI 0.66 to 0.82]. The impact of physical activity on quality of life for people
with CRC is discussed further in the following section.
INTRODUCTION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
4
Physical activity and psychosocial outcomes
Recent systematic reviews and meta-analyses of multiple cancer types provide evidence that physical
activity interventions can help to address the psychosocial effects of cancer and associated treatments.45–47
These reviews have been chosen for this report because they have been published recently (i.e. since 2010)
and therefore include most recent evidence. Below we summarise the results of these reviews relating
specifically to our outcomes of interest (i.e. level of physical activity, quality of life, fatigue, anxiety and
depression). In addition, any results and conclusions about the moderating influence of intervention
characteristics are described. Signs of effect sizes described below are set so that negative effect sizes for
fatigue, anxiety and depression and positive effect sizes for quality of life and level of physical activity
indicate improvements in favour of intervention participants.
A meta-analysis of 82 unique studies of interventions (not conducted in a physical therapy setting or
delivered by a physical therapist) concluded that there is a small to moderate effect on physical activity
level (weighted mean effect size 0.38, 95% CI 0.22 to 0.54; p= 0.0001), overall quality of life (weighted
mean effect size 0.29, 95% CI 0.03 to 0.54; p= 0.03), and fatigue (weighted mean effect size –0.54,
95% CI –0.90 to 0.19; p= 0.003) in post-treatment interventions, and a small to moderate effect on
functional quality of life (weighted mean effect size 0.28, 95% CI 0.02 to 0.54; p= 0.04) and anxiety
(weighted mean effect size –0.21, 95% CI –0.39 to –0.03; p= 0.02) during treatment interventions.45 No
significant effect of physical activity interventions on depression was found (18 studies assessed depressive
symptoms). Although intervention characteristics are described, no analyses of moderating effects
are reported.
A meta-analysis of 15 RCTs of moderate-intensity physical activity programmes found a small but significant
effect on depression under a random-effects model [effect size reported as mean change scores (Cohen’s d)
–0.2, 95% CI –0.43 to –0.009; p= 0.04].46 Characteristics of physical activity interventions were found to
be significant. Home-based exercise was associated with increased depressive symptoms [effect size
reported as mean change scores (Cohen’s d) 0.16, 95% CI –0.15 to 0.47], compared with an improvement
in depressive symptoms from interventions in other locations (e.g. community facilities, laboratories and
gyms) [effect size reported as mean change scores (Cohen’s d) –0.45, 95% CI –0.77 to –0.14] and was
significant (p= 0.04). Supervised and partially supervised exercise produced reductions in depressive
symptoms, whereas non-supervised activity was associated with a small increase in depressive symptoms
[supervised: effect size reported as mean change scores (Cohen’s d) –0.67, 95% CI –1.11 to –0.23; mixed
supervision: effect size reported as mean change scores (Cohen’s d) –0.32, 95% CI –0.50 to –0.14; and
unsupervised: effect size reported as mean change scores (Cohen’s d) 0.25, 95% CI –0.01 to 0.50] and was
significant (p= 0.01). Exercise bout durations of > 30 minutes had larger effects on depression than exercise
bouts of ≤ 30 minutes [> 30 minutes’ bout: effect size reported as mean change scores (Cohen’s d) –0.57,
95% CI –0.91 to –0.23; ≤ 30 minutes’ bout: effect size reported as mean change scores (Cohen’s d) 0.01,
95% CI –0.20 to 0.22] and this was significant (p= 0.02).
A meta-analysis of 34 studies of physical activity interventions for patients after they had completed their
main treatment (it was possible that patients were still undergoing hormonal treatment) found effects on
fatigue, depression and quality of life.47 Measured by the revised Piper Fatigue Scale, physical activity was
associated with slightly reduced fatigue (mean difference −1.0, 95% CI −1.8 to −0.1; p= 0.03) in three
comparisons from two studies on breast cancer, compared with the control. In survivors of mixed types of
cancer, physical activity was associated with reduced depression (mean difference −4.1, 95% CI −6.5 to
−1.8; p< 0.01) as measured by the Beck Depression Inventory. In survivors of mixed types of cancer,
physical activity improved the Short Form Health Survey 36 items (SF-36) physical function (mean difference
3.0, 95% CI 0.7 to 5.3; p= 0.01), social function (mean difference 3.4, 95% CI 0.4 to 6.4; p= 0.03) and
mental health scores (mean difference 2.4, 95% CI 0.7 to 4.1; p= 0.01) compared with the control group.
Although intervention characteristics were described, no analyses of moderating effects were reported.
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These meta-analyses suggest that physical activity interventions have a small to moderate effect for level
of physical activity, quality of life, fatigue, anxiety and depression. Although these reviews demonstrate
patient benefit, a note of caution is required because most of the studies included in these reviews involve
people diagnosed with breast cancer (e.g. 83% of all studies in the review by Speck et al.45 involved
people with breast cancer) and the results of these studies cannot be automatically generalised to people
with CRC. This is because people with CRC, relative to people with a diagnosis of breast cancer (i.e. the
patient group most represented in the controlled trials of physical activity), are likely to present with more
advanced disease, have different treatments and side effects, tend to be older and include equal numbers
of men and women.
However, a 2014 systematic review and meta-analysis of physical activity interventions for people with
CRC suggests that, with appropriate support, people with CRC can increase physical activity levels, with
subsequent health-related benefits.24 Only three RCTs were included in the meta-analysis:44,48,49 a pilot RCT
involving 18 participants who had recently undergone surgery and completed chemotherapy treatment
for CRC, randomised to either a 12-week programme of twice-weekly supervised exercise sessions for
6 weeks followed by 6 weeks’ home-based exercise and dietary advice or standard treatment;48 a RCT
involving 102 CRC survivors randomised to either an exercise group where they were specifically advised
to perform moderate-intensity exercise 3–5 times per week or a control group who were requested not
to exercise;44 and a RCT involving 46 people who had completed treatment for CRC and who were
randomised to either 3 months of telephone counselling to support home-based physical activity or a
contact telephone call.49 The meta-analysis found no evidence for effects on quality of life (standardised
mean difference 0.18, 95% CI –0.39 to 0.76; p= 0.53) or fatigue (standardised mean difference 0.18,
95% CI –0.22 to 0.59; p= 0.26). There was, however, evidence for improvements in physical fitness
(standardised mean difference 0.59, 95% CI 0.25 to 0.93; p< 0.01). Analysis of moderating effects of
intervention characteristics was not possible. The authors acknowledged that the review comprised only
three studies with a total sample size of 166 participants and therefore concluded that further studies on
physical activity for people with CRC are warranted.
At the time this current study was being developed (2012), two large-scale trials featuring people diagnosed
with CRC were in progress.50,51 The multinational, multicentre Colon Health and Life-Long Exercise
Change trial (CHALLENGE) will determine the effects of a 3-year structured physical activity intervention on
disease-free survival in 962 survivors of stage II or III colon cancer.50 The 3-year intervention, modelled on
the theory of planned behaviour, will consist of a behavioural support programme (n= 48 sessions in total),
focusing on strategies to promote the adoption and long-term maintenance of physical activity and
supervised physical activity sessions (n= 48 in total, one to one or in group format), designed to address
physical activity techniques and intensity and safety, both delivered by a physical activity consultant
(professional discipline not stated). The CanChange trial, drawing theoretically on cognitive–behavioural
approaches for telephone-based health coaching sessions, recently reported significant intervention effects
for moderate physical activity (28.5 minutes per week; p= 0.023).51
What kind of cancer rehabilitation could be delivered in
the NHS?
Given the increasing number of studies showing the safety and benefits of physical activity, it should be
part of standard care for all cancer survivors. One barrier to physical activity becoming standard care is
difficulties around implementation. Thus, when designing this study, we paid particular attention to this
issue. We wanted a physical activity intervention that was effective, sustainable, cost-effective and capable
of being integrated into the routine care of cancer survivors. As far as we know, this study is novel in that
it aims to test an existing, evidence-based and theory-driven cardiac rehabilitation service for people with
CRC. Should this model of rehabilitation prove to be clinically effective and cost-effective in a large-scale
definitive trial, referral pathways could be adapted to ensure that the model is integrated into existing
cancer service frameworks.
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One of the reasons cardiac rehabilitation may be a suitable model for CRC survivors is that cardiac
rehabilitation multiprofessional teams have the expertise required to provide relevant rehabilitation,
including monitored physical activity, to a wide variety of patients, such as those with a CRC diagnosis.
Second, a comparison of studies of coronary heart disease (CHD) and the post-treatment needs of people
with CRC suggests that there is reasonable justification for referring CRC patients to cardiac rehabilitation
and running mixed classes involving people with CHD and people with cancer. Four qualitative studies of
patients’ experiences of needs after coronary artery bypass graft (CABG),52–55 one case note review of
needs of 521 patients surgically treated for CRC cancer56 and one population-based cohort study including
522 people with CRC57 all indicate that people with CHD and people diagnosed with CRC experience
similar problems, including pain, fatigue, anxiety and depression, worry, appetite loss, sexual problems,
sleep disturbance, and work and financial-related difficulties, and express a need for information about
medication and self-management. Thus, the rehabilitation needs of people with CHD and those of people
with CRC are likely to be similar, suggesting that a common rehabilitation programme may be appropriate.
Moreover, cardiac rehabilitation may be particularly relevant for people with CRC because the estimated
prevalence of cardiovascular disease is 59% at 5 months post diagnosis, and, 16% develop de novo
cardiovascular disease within 36 months of completion of treatment.58 In addition, common comorbid
conditions in CRC survivors include congestive heart failure, diabetes mellitus and chronic obstructive
pulmonary disease,59 which, again, may be managed by rehabilitation.
Pointing out the similarities in post-treatment experiences is not to deny that there are, of course,
disease-related differences among different patient groups. For example, people diagnosed with, and
treated for, CRC can experience physical discomfort, bowel function problems and urinary tract infections
and need advice about abdominal pain and stoma care,9 problems almost certainly not experienced by
those with CHD unless they have comorbidities. There is a need, however, to meet the long-term
rehabilitation needs of cancer survivors as well as a need to identify cost-effective and sustainable models
of rehabilitation. This is why researching the effectiveness of rehabilitation to mixed classes of people with
CHD and people with CRC is justifiable.
A further reason why it is worthwhile finding out if cardiac rehabilitation is a feasible, acceptable and
effective model for CRC survivors is that cardiac rehabilitation is standard clinical care for patients after a
cardiac event and is widely available throughout the UK. Comprehensive cardiac rehabilitation consists of
supervised exercise, behavioural change, lifestyle risk factor management, education and psychological
support.60,61 In 2010–11 there were 276 cardiac rehabilitation centres in England, Northern Ireland and
Wales62 and 37 in Scotland.63
Cardiac rehabilitation is defined as:
The coordinated sum of activities required to influence favourably the underlying cause of
cardiovascular disease, as well as to provide the best possible physical, mental and social conditions, so
that the patients may, by their own efforts, preserve or resume optimal functioning in their community
and through improved health behaviour, slow or reverse progression of disease.61
Traditionally, the provision of cardiac rehabilitation has been described using phases 1–4, as mentioned in
the National Service Framework for CHD.64 Figure 1 summarises each phase.
A more recent approach in the Department of Health’s commissioning pack on cardiac rehabilitation65
describes cardiac rehabilitation along a best practice care pathway, using stages 0–6 to reflect core stages
in the cardiac rehabilitation pathway, as shown in Box 3.
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
7
Another reason why cardiac rehabilitation may be a good model for cancer rehabilitation is that supervised
exercise is the cornerstone of cardiac rehabilitation.60,61 Although phase 3 cardiac rehabilitation varies
across the UK, exercise classes are usually offered to patients once-weekly for 6–10 weeks. There are
13 rehabilitation standards for cardiac rehabilitation physical activity and exercise.66 These provide a
benchmark for all cardiac rehabilitation programmes delivered throughout the UK and include standards
about initial screening and assessment, goal planning, exercise programmes and health and safety. A recent
audit found that at 12 months after participation in cardiac rehabilitation there was a 14 percentage point
increase in the number of people exercising five or more times a week for 30 minutes and a 23 percentage
point reduction in those who rarely/never took exercise.62 These changes in levels of physical activity
represent important milestones for achieving recommended physical activity levels associated with disease
prevention.26 There is no obvious reason why the observed increases in the amount of physical activity among
people with CHD could not also be found among people with cancer attending cardiac rehabilitation.
Cardiac event/surgical intervention
Patient discharge
Structured programme begins
Long-term maintenance
Reassurance/education/mobilisationInpatient care
4–6 weeks post discharge
Phase 1
Phase 2
Phase 4
Phase 3
Follow-up/heart manual/education
Long-term changes in
 behaviour/activity levels
Exercise/education/
risk factor modification
Community/home
Community/home
FIGURE 1 Four phases of cardiac rehabilitation.
BOX 3 Cardiac rehabilitation stages
Stage 0: identify and refer patient.
Stage 1: manage referral and recruit patient to cardiac rehabilitation programme.
Stage 2: assess patient for cardiac rehabilitation.
Stage 3: develop patient care plan.
Stage 4: deliver comprehensive cardiac rehabilitation programme.
Stage 5: conduct final assessment.
Stage 6: discharge and transition to long-term management.
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Until the publication in 2012 of a study contesting the benefits of cardiac rehabilitation,67 the consensus had
been that cardiac rehabilitation decreases mortality rates in people with CHD. After we had started our
study, however, the Rehabilitation After Myocardial Infarction Trial67 involving 1813 patients was published,
which reported that there were no significant differences between patients referred to rehabilitation and
controls in mortality at 2 years (risk ratio 0.98, 95% CI 0.74 to 1.30) or after 7–9 years (0.99, 95% CI 0.85
to 1.15), cardiac events, quality of life or psychological general well-being.67 Its publication has caused
considerable debate in those providing cardiac rehabilitation services,61,68 not least as the results seem to
contradict a 2011 Cochrane systematic review and meta-analysis, which included 47 studies with over
10,000 patients and showed that cardiac rehabilitation reduces death from any cause by 13% and cardiac
deaths by 26%.69 Our study, therefore, took place at a time when there was a degree of controversy about
the health benefits of cardiac rehabilitation for people with CHD.
The importance of feasibility and pilot studies
Conducting a full-scale RCT and economic evaluation of cardiac rehabilitation versus usual care for CRC
survivors requires the involvement of many sites and is likely to be resource intensive. As there are
uncertainties regarding rates of eligibility, consent, recruitment, retention and participation in the
intervention and uncertainties about the feasibility and acceptability of the intervention for patients and
clinicians, it is important in the first instance to conduct feasibility and pilot work. Findings from feasibility
and pilot work can then be used to optimise the design and conduct of any subsequent large-scale trial or,
indeed, be used to judge whether or not it is even appropriate and ethical to proceed to such a trial.
Conducting pilot studies to iron out methodological bias in advance of a large-scale trial is critical if that
larger trial is to become part of an evidence base that is then used for recommending policy and changing
cancer care practice. The importance of addressing methodological bias was highlighted in a recent
meta-analysis of 33 RCTs of physical activity interventions for people with breast cancer.70 The meta-analysis
found that RCTs rated at high risk of selection bias with the absence of random sequence generation, or at
high risk of attrition bias with large attrition rate or the absence of intention-to-treat analysis, resulted in
greater efficacy of physical activity on quality of life, anxiety or depression at the end of intervention in
experimental group versus control. The reviewers call for exacting methodological standards in future trials
to increase confidence in evidence about the benefits of physical activity for cancer survivors. A pilot trial in
advance of a larger-scale trial may be one useful approach to improve methodological rigor and standards.
The Medical Research Council’s (MRC) recommended framework for the evaluation of complex
interventions includes feasibility and piloting phases.71 Currently, however, there are no internationally
agreed definitions of feasibility and pilot work.72 One definition of feasibility study and its differentiation
from pilot study comes from the UK’s National Institute for Health Research (NIHR) Evaluation, Trials and
Studies Coordination Centre:73
Feasibility Studies are pieces of research done before a main study in order to answer the question
‘Can this study be done?’ They are used to estimate important parameters that are needed to design
the main study.
Pilot studies are a version of the main study that is run in miniature to test whether the components of
the main study can all work together. It is focused on the processes of the main study, for example to
ensure recruitment, randomisation, treatment, and follow-up assessments all run smoothly. It will
therefore resemble the main study in many respects, including an assessment of the primary outcome.
Reproduced with permission from NIHR
Thus, whereas a feasibility study may examine a specific part of a trial, a pilot study is a dummy run,
examining the trial as a whole in order to see if all of the parts work together as planned.
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
9
In a review of 54 pilot and feasibility studies,74 researchers found that pilot studies tend to have more
rigorous methodological components, such as sample size estimation, randomisation and control group
selection, and are more likely include a greater number of methodological components for testing than
studies labelled as ‘feasibility’. Nevertheless, the reviewers drew the conclusion that the distinction
between the two is not clear-cut.74
Irrespective of what researchers actually call preliminary studies, it is important that they clarify why pilot
and feasibility work is being carried out. Feasibility and pilot work can be conducted to evaluate the
operational feasibility and acceptability of the intervention itself and the feasibility and acceptability of a
trial’s protocol design. There seems little point in running large-scale (and therefore presumably expensive)
trials of interventions – even those suggesting promise of effect – if these interventions are unlikely to ever
see the light of day and be implemented in practice. Likewise, if a trial is unworkable, then results about
effectiveness will not be forthcoming. Thus, for our study we explored the twin pillars of feasibility and
pilot work by examining intervention implementation and trial methodology parameters.
Bowen et al.75 recommend eight areas of focus to assess if a public health intervention is feasible (Table 1).
Addressing each area can help in the assessment of the likelihood of an intervention being implemented
as part of routine health care and as a future commissioned service. Their recommendations for areas of
focus in feasibility studies share similarities with frameworks designed to identify public health impact of
health promotion interventions and evaluate the extent to which it is implementable, such as RE-AIM.76
Using this approach, feasibility and pilot work can be carried out to provide information that can be used
to modify an intervention to enhance its future implementation, as well as inform decisions about whether
or not it is sensible, from an implementation perspective, to progress to a large-scale trial.
Another reason for conducting feasibility and pilot work is to evaluate trial methodology. Thabane et al.77
propose four primary purposes for conducting pilot studies (Table 2). Although these key reasons were
initially identified to guide the conduct of drug pilot trials, they have recently been adapted and used to
guide the conduct of a rehabilitation intervention pilot trial.78 Addressing these four areas will give some
indication of the chances of a large-scale trial being successfully conducted.
TABLE 1 Bowen et al.’s75 areas of focus for evaluating intervention feasibility
Area of focus The feasibility study asks . . .
Acceptability To what extent is a new idea, program, process or measure judged as suitable, satisfying, or attractive
to program deliverers? To program recipients?
Demand To what extent is a new idea, program, process, or measure likely to be used (i.e., how much demand
is likely to exist)?
Implementation To what extent can a new idea, program, process, or measure be successfully delivered to intended
participants in some defined, but not fully controlled, context?
Practicality To what extent can an idea, program, process, or measure be carried out with intended participants
using existing means, resources, and circumstances and without outside intervention?
Adaptation To what extent does an existing idea, program, process, or measure perform when changes are made
for a new format or with a different population?
Integration To what extent can a new idea, program, process, or measure be integrated within an existing system?
Expansion To what extent can a previously tested program, process, approach, or system be expanded to provide
a new program or service?
Limited efficacy Does the new idea, program, process, or measure show promise of being successful with the intended
population, even in a highly controlled setting?
Reproduced from American Journal of Preventive Medicine, vol. 36, Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L,
Linnan L, Weiner D, et al. How we design feasibility studies, pp. 452–7, © 2009, with permission from Elsevier.75
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It is recommended that threshold criteria for claiming future success of a large-scale trial are established
before feasibility and pilot work commences.77,78 The criteria should be based on the primary feasibility
objectives.77 Examples include the acceptable proportion of participants being eligible, consenting and
completing the intervention. Using these criteria, the outcome of a pilot study will be one of the following:
1. stop – main study not feasible
2. continue, but modify protocol – feasible with modifications
3. continue without modifications, but monitor closely – feasible with close monitoring
4. continue without modifications – feasible as is.
Using this approach, pilot and feasibility studies provide critical information for planning and designing
large-scale trials and justification for whether or not to allocate large sums of money to such a trial.
It is generally recommended that feasibility and pilot studies descriptively evaluate a trial’s feasibility,
acceptability and safety rather than test the effectiveness of the hypotheses of the planned main
large-scale trial.74,77,79,80 This is because the small number of effect data available in feasibility and pilot
studies mean the degree of uncertainty is such that the chance of reaching inaccurate conclusions about
intervention effect is high. Feasibility and acceptability assessments of trial components may also be
misleading if only a limited number of highly motivated sites are included in a pilot study because these sites
are unlikely to be representative of the multitude of sites involved in a large-scale trial.80 Event rates such
as recruitment and willingness to be randomised cannot be accurately estimated from small pilots and
estimates of variance of the outcome variable to calculate sample size from small pilot studies are also likely
to suffer from imprecision.78–80 How many total participants are required to estimate a standard deviation
(SD) for a sample size calculation is unclear, with suggestions ranging from 24,81 to 30,82 to 5083 and to 70.84
Good trial design requires the magnitude of the clinically important effect size to be stated in advance, and
at least some indication of the efficacy of the proposed intervention is often required to justify to funders
that it is worth the effort and expense in conducting a large-scale trial. One strategy for reporting outcomes
from pilot work is to declare ‘potential efficacy’ if the CI around the estimated effect of the intervention on
a clinically important outcome includes a predefined minimal important difference and, conversely, to
declare ‘potential harm’ if the harm effect lies outside the upper confidence limit for safety.79 This approach
acknowledges the limited power of pilot trials to confirm the benefits and/or harms of treatment, while at
the same time minimises the likelihood of the abandonment of a large-scale trial on the basis of negative
or positive results.74 Nevertheless, conducting analyses to glean information about efficacy from pilot trials,
although tempting, is misleading and unreliable.76,78 As a consequence, any observed potential patient
benefit ought to be reported extremely cautiously or not at all; robust and rigorous assessment of an
intervention’s therapeutic implications must await adequately sized definitive pivotal trials.80
TABLE 2 Thabane et al.’s77 four reasons for conducting pilot studies
Process This assesses the feasibility of the processes that are key to the success of the main study
Resources This deals with assessing time and resource problems that can occur during the main study
Management This covers potential human and data management problems
Scientific This deals with the assessment of treatment safety, dose, response, effect and variance of the effect
© Thabane et al.; licensee BioMed Central Ltd 2010. Reproduced open access under the terms of the Creative Commons
Attribution Licence (http://creativecommons.org/licenses/by/2.0).
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Study aims
The CRIB (Cardiac Rehabilitation In Bowel cancer) study was funded by the NIHR Health Services and
Delivery Research programme. The overall aims of the CRIB study were to assess whether or not using
phase 3 cardiac rehabilitation is a feasible and acceptable model of rehabilitation to aid the recovery
of CRC survivors (i.e. examine intervention implementation potential) and to test the feasibility and
acceptability of the protocol design (i.e. examine methodological standard). Thus, the overall purpose of
the study was to assess whether or not it is appropriate to progress to a larger-scale trial and, if so,
to optimise the design and conduct of any such trial.
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Chapter 2 Study design and governance
In this chapter, the study design, research questions and objectives are presented. The details aboutethics committee and research management approvals are also provided. Finally, the trial registration
information is reported.
Study design
The CRIB study was set up to evaluate the feasibility and acceptability of an innovative approach to aid the
post-treatment recovery of people with CRC available in the NHS. Specifically, this involved an intervention
study to test the feasibility and acceptability of the referral of people who had recently had surgery for
CRC, who may or may not have been receiving adjuvant therapy, to cardiac rehabilitation. We undertook
a phased programme of work comprising intervention testing and feasibility work (phase 1) and a pilot
RCT (phase 2). The pilot trial was supplemented by a preliminary economic evaluation to consider the
cost-effectiveness of providing the intervention compared with usual care. There was also a qualitative
component to explore the views and experiences of patients and clinicians involved in the study.
A description of the study protocol has already been published.85
In phase 1, we sought to answer the following research questions:
1. What modifications, if any, are required to be made to existing cardiac rehabilitation (the intervention)
to make it more relevant and acceptable to CRC patients and clinicians?
2. What modifications, if any, are required to be made to the training and support provided by the
cancer-exercise specialist to make it more relevant and acceptable to cardiac physiotherapists running
the cardiac rehabilitation exercise classes?
3. What modifications, if any, are required to be made to the proposed trial procedures to make the trial
more feasible to conduct and to make the trial procedures more acceptable to CRC patients
and clinicians?
In phase 2, we sought to answer the following research questions:
1. Are participating centres likely to recruit a sufficient number of patients to deliver a large-scale trial?
2. What are the likely eligibility, consent, recruitment, adherence and completion rates and speed of
recruitment for a future large-scale trial and how can these be optimised?
3. Are patients allocated to the control group also increasing levels of physical activity (i.e. contamination)?
4. What are the likely completion rates at baseline and follow-up for the proposed outcome and process
measures for a future large-scale trial and how can these be optimised?
5. What sample size is required to power a future large-scale trial?
6. Have practitioners delivering the intervention delivered it as intended and in accordance with the study
protocol and how can intervention fidelity be optimised for a future large-scale trial?
7. What are the enablers and barriers that clinicians experience in delivering rehabilitation for patients and
in conducting the trial?
8. What are the enablers and barriers that cancer patients experience in participating in the
rehabilitation programme?
9. Can costs and health and outcomes be measured for this group using the patient-reported outcome
tools for use in the economic evaluation?
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Objectives
Phase 1: feasibility study objectives
1. To assess the feasibility of delivering rehabilitation to people with CRC within a cardiac
rehabilitation setting.
2. To assess the acceptability of the intervention for patients and clinicians (cancer and cardiac).
3. To assess the acceptability and adequacy of the training and support provided by a cancer-exercise
specialist for cardiac physiotherapists running the rehabilitation exercise classes.
4. To assess the feasibility and acceptability of the main trial components (e.g. recruitment procedures,
rehabilitation referral procedures and proposed outcomes and process measurement tools) and
proposed tools for measuring impacts on outcomes and costs.
Phase 2: pilot study objectives
1. To determine eligibility, consent, recruitment and retention rates and speed of recruitment.
2. To determine completion rates for proposed effect outcomes measurement tools at baseline and
follow-up.
3. To determine likely contamination across trial arms (contamination occurs when controls reach exercise
intervention goals. Contamination dilutes treatment effect and therefore increases the risk of
false-negative conclusions).
4. To provide data for sample size calculations for a definitive RCT.
5. To assess intervention fidelity according to study protocol.
6. To assess the extent to which intervention and trial procedures can be integrated into routine
clinical practice.
7. To conduct a preliminary economic evaluation of the cancer rehabilitation programme.
Ethics approval and research governance
An application for NHS ethics approval for the CRIB study was submitted using the electronic Integrated
Research Application System. A submission was made on 20 January 2013, received by the NHS ethics
committee on 25 January 2013 and reviewed by the committee at a meeting on 14 February 2013 [Research
Ethics Committee reference 13/NS/0004; Integrated Research Application System project identification (ID)
121757]. The committee requested further information and submission of revised documentation. Hence,
revised documentation was submitted to the chairperson of the ethics committee on 21 February 2013
and a favourable ethics opinion was given on 22 February 2013.
Applications for NHS Research Management approval, an additional approval required in the UK for
research involving NHS patients, staff or premises, were made to the research and development office in
each of the three health boards in which the study was conducted. Approval was given on the
following dates:
l site 1: 5 March 2013
l site 2: 17 December 2013
l site 3: 14 January 2014.
Trial registration
The trial was registered with the International Standard Randomised Controlled Trial Registry under the
reference number ISRCTN63510637; and also with the UK Clinical Research Network Portal under the
reference number 14092.
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Chapter 3 Phase 1 methods
The purpose of phase 1 was to evaluate the feasibility and acceptability of the main trial proceduresplanned for phase 2 and also the feasibility and acceptability of delivering the intervention. The aim
was to use the results of phase 1 to modify the methods and the intervention as appropriate for further
testing in phase 2.
This chapter describes the phase 1 study design, participants, recruitment and consent procedures,
intervention description, primary and secondary end points and methods for analysis.
Phase 1 design
Phase 1 was a before-and-after study; this is a rigorous design in which dependent variables are measured
before and after an intervention has been delivered.86 This design is suitable for assessing the feasibility of
delivering an intervention and main trial procedures.
Participants
Colorectal cancer patients
The study sought to recruit people who had recently had surgery for CRC from an acute general hospital
in Scotland.
Inclusion criteria
Patients were considered for inclusion if they:
l were aged ≥ 18 years and had been diagnosed with primary CRC and were in the recovery period
post surgery
l were/were not receiving adjuvant chemotherapy/radiotherapy (note to reduce risk of infection,
patients would have to wait 48 hours after each chemotherapy session before attending cardiac
rehabilitation classes).10
Exclusion criteria
The study excluded anyone:
l with advanced disease
l with failed clinical/risk assessment for rehabilitation and who were deemed unsafe to participate in
exercise classes; for example, according to recent guidelines, those with severe anaemia should
delay exercise and patients with compromised immune function should avoid public gyms and
exercise classes10
l with severe cognitive impairment and therefore are unable to give informed consent to participate in
the study
l unable to communicate in English, as this is the language used in the delivery of cardiac rehabilitation.
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Clinicians
Cancer nurses involved in screening patients for eligibility and giving out study information or delivering
the intervention (i.e. cardiac rehabilitation physiotherapists) were approached by an investigator and invited
to attend a semistructured face-to-face interview about their experiences of the main trial procedures and
the intervention.
Recruitment procedures
Recruitment took place over 5 months. The first participant was recruited on 12 August 2013 and the last
participant was recruited on 26 November 2013.
The following recruitment procedures for phase 1 were employed.
A CRC clinical nurse specialist assessed all CRC patients admitted for surgery to determine their eligibility
for the study. At a follow-up appointment, the nurse gave eligible patients an information sheet
(see Appendix 1) about the study, talked them through it, and completed a screening and recruitment form
(see Appendix 2) for all eligible patients. This form included, for instance, information about a patient’s
demographic characteristics (e.g. age and gender), cancer diagnosis (e.g. rectal or colon), date and type of
surgery (e.g. open surgery or laparoscopic), and neo-adjuvant and adjuvant therapies. The patient signed this
form if they were willing to participate in the study and agreed to have their contact details forwarded to an
investigator. If the patient agreed to participate, the nurse then referred the patient to cardiac rehabilitation
by e-mail, fax or letter, and used a referral form (see Appendix 3) to advise cardiac rehabilitation services that
the patient would be participating. Patients who, having read the study information, declined to participate
were asked if they were willing to give their reasons for declining, which were recorded by the nurse on the
‘reasons for not participating’ form, and the patient was asked to sign a non-participation patient consent
form (see Appendix 4) if they were willing to have information about them (e.g. age, gender, diagnosis,
treatment) used by the investigators to assess if participants were representative of the study population.
An investigator contacted the patients who had signed the screening and recruitment form, agreeing to
participate, and arranged a time for them to sign a consent form, which meant that they had formally
consented, in writing, to participation in the study (see Appendix 5). Baseline assessments were conducted
for consenting participants.
Once a CRC patient had consented to the study, a member of the cardiac multidisciplinary team
(e.g. cardiac physiotherapist or nurse) contacted them and invited them to attend a cardiac rehabilitation
clinical/risk stratification assessment to determine whether or not, from a cardiac clinical perspective, they
were able to exercise safely; the team member also planned physical activity goals tailored to the individual
patient’s needs. Patients deemed safe to exercise were invited to attend cardiac rehabilitation classes.
A flow chart outlining CRIB phase 1 recruitment and follow-up procedures is given in Figure 2.
PHASE 1 METHODS
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Informed consent
Informed consent for patients with CRC was obtained at two stages of the recruitment process.
First, nurses obtained written consent to forward a patient’s contact details to an investigator if trial
eligibility was established. The patient signed a screening and recruitment form (see Appendix 2). Second,
an investigator obtained written consent before undertaking the baseline assessment. The patient signed a
consent form (see Appendix 5). The original signed and dated consent forms were held securely as part
of the trial site file, with a copy in the clinical notes held securely at the hospital.
Thus, all participants gave written consent to participate in the study. Informed consent discussions for
participants took place face to face with a nurse and an investigator, with the opportunity given for
participants to ask questions. Patients were informed that they had no obligation to participate and their
care would not be affected if they declined to participate. They were made aware that the results of the
study would not directly give rise to changes in rehabilitation provision for CRC patients; rather, it would
determine whether or not large-scale trials, which may give rise to change in rehabilitation, were feasible.
If a patient’s consent to participate in the study was declined or terminated at any stage, that patient then
entered usual follow-up care.
Nurse screens patients for eligibility, completes screening
and recruitment form for all eligible patients and
gives study information sheet to eligible patients
Patient agrees to participate and
have contact details forwarded 
to the investigator. Nurse 
sends referral form to CR team
Patient declines to participate
and, if willing, completes a 
declining to participate form
Investigator contacts patients
 to arrange consenting and 
baseline assessment
Patient withdraws and,
 if willing, completes a declining
to participate form
CR contacts patients to
 arrange CR assessment
Patients attends CR
 (i.e. intervention)
Investigator contacts patients to 
arrange follow-up assessment 
If assessed as unsafe to 
attend CR, patient is withdrawn 
from study by investigator
FIGURE 2 Flow chart outlining phase 1 recruitment and follow-up procedures. CR, cardiac rehabilitation.
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Participants had the right to withdraw from the study at any time for any reason, and without giving a
reason. The investigator also had the right to withdraw patients from the study intervention if this was
considered in the patient’s best interests. There were two withdrawal options:
1. complete withdrawal from both the study intervention (i.e. cardiac rehabilitation) and the provision
of data
2. partial withdrawal, when the patient withdrew from participating in cardiac rehabilitation but continued
to provide data.
Consent was sought from participants choosing option 1 to retain data collected up to the point of
withdrawal. Participants were also asked if they would be willing to give their reasons for their decision to
withdraw so that these could be recorded, as this would help to improve acceptability of the study in a
large-scale trial. We also gathered data about patients with CRC who declined to participate in the study
to explore their reasons for not giving consent, thereby helping us to make the study more acceptable to
patients in a large-scale trial.
Intervention
Cardiac rehabilitation
The intervention was phase 3 cardiac rehabilitation (see Chapter 1 for a brief introduction to cardiac
rehabilitation as practised in the UK). The cardiac physiotherapist contacted the patient and invited them to
attend a cardiac rehabilitation clinical/risk stratification assessment, to determine whether or not, from a
cardiac clinical perspective, the patient was able to exercise safely, and also planned physical activity
goals tailored to individual patient needs. Patients deemed safe to exercise were given a date to attend
cardiac rehabilitation sessions alongside cardiac patients. The participants were expected to attend once
per week for 10 weeks. The weekly session consisted of approximately 60 minutes of aerobic and strength
training delivered by a senior physiotherapist and physiotherapy assistant, followed by an educational
session delivered by a range of clinicians for patients with CHD. Educational sessions included general risk
factor advice for better health and some cardiac-specific sessions (e.g. medications and sessions with a
cardiologist). Cardiac physiotherapists reinforced health behaviour theories by, for instance, discussing
barriers to engaging in physical activity with patients and goal setting, in line with current behaviour
change theory87–90 and cardiac rehabilitation guidance.61 We have used the Template for Intervention
Description and Replication (TIDieR)91 to describe, in more detail, cardiac rehabilitation in this site (Table 3).
TIDieR is used to describe reasons for, and goals of, the intervention (why), materials and procedures used
(what), personnel delivering the intervention (who), how the intervention is delivered (how), where the
intervention is delivered (where), when the intervention is delivered and for how long (when and how
much), if the intervention differs from one individual to the next (tailoring) and whether or not any
changes were made to the original design (modifications).
In addition, education sessions about cancer, delivered by a cancer nurse specialist (CNS), were planned to
supplement the education sessions for cardiac patients. This was the only alteration to routine cardiac
rehabilitation planned for the study. Education sessions were to be delivered either face to face to a group
of CRC survivors or individually by telephone.
Cancer and exercise training
As described in Chapter 1, a multidisciplinary team, which includes qualified physiotherapists and nurses,
delivers cardiac rehabilitation. Physiotherapists are registered with the Health and Care Professions Council
(HCPC) and will have successfully completed a HCPC-approved programme in physiotherapy (offered as
3- or 4-year undergraduate degrees and 2-year postgraduate levels at various UK universities). The training
involves both periods of theory and clinical experience gained by meeting and working with patients.
The theory part of the course covers anatomy, physiology, physics and pathology. Cardiac rehabilitation
physiotherapists are experienced in prescribing exercise for patients with a range of conditions. There are
PHASE 1 METHODS
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TABLE 3 A description of cardiac rehabilitation at site 191
Item
number Item
Brief name
1 Provide the name or a phrase that
describes the intervention
Referral to a cardiac rehabilitation programme
Why
2 Describe any rationale, theory, or
goal of the elements essential to
the intervention
RATIONALE
Physical activity in CRC patients has shown improvement in cancer-
specific mortality and general mortality. Five recent systematic reviews
of controlled trials indicate that physical activity interventions can help
address the physiological and psychosocial effects of cancer and
associated treatments in adult patients with cancer
Cardiac rehabilitation may be an appropriate form of rehabilitation for
patients with CRC because many of their needs post treatment are
similar to those of individuals living with CHD. Studies on patients’
experiences of needs after CABG and patients with CRC indicate that
patients with cardiac issues and cancer experience similar problems,
including pain, fatigue, anxiety and depression, worry, appetite loss,
sexual problems, sleep disturbance, and work and financial-related
difficulties, and express a need for information about medication and
self-management
THEORY
No one model best explains exercise behaviour, but the theory of
planned behaviour is used most frequently in the research and
literature. This proposes that patient behaviour is predicted by
behavioural intent, and that their actions are based on that person’s
intention to perform that behaviour: in this case, cardiac rehabilitation.
Intentions are based on three factors: attitudes towards the behaviour;
beliefs of friends/relatives about the behaviour; and level of control
over their actions and behaviour. Health behaviour is, therefore,
determined by a combination of these factors, and barriers to change
What
3 Materials: describe any physical or
informational materials used in the
intervention, including those
provided to participants or used in
intervention delivery or in training
of intervention providers. Provide
information on where the materials
can be accessed (e.g. online
appendix, URL)
Patients attending classes have access to an array of information
booklets on behaviour change for smoking, diet, healthy living, physical
activity and more. The majority of these can be accessed at www.bhf.
org.uk/healthcare-professionals/resources-for-patients.aspx. There is
also a folder with local information on exercise classes, walking groups,
walking routes and other appropriate clubs and groups
For intervention delivery, the cardiac rehabilitation team follows the
BACPR core components and standards, available at www.bacpr.com/
resources/46C_BACPR_Standards_and_Core_Components_2012.pdf
A key component of cardiac rehabilitation is an exercise class (see
section 4). Patients are talked through the circuit stations by staff, and
each station has an illustration with varying degrees of difficulty to suit
each participants needs during the class. Patients are also offered
material to take home to continue their progress at home. These are
individually tailored by the physiotherapist at the centre
continued
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TABLE 3 A description of cardiac rehabilitation at site 191 (continued )
Item
number Item
4 Procedures: describe each of the
procedures, activities, and/or
processes used in the intervention,
including any enabling or support
activities
A patient will attend for an initial consultation with the cardiac
physiotherapist. This involves confirming details received on referral
(past medical history, current medications), and includes an Incremental
Shuttle Walk Test to establish fitness levels and suitability for patient to
attend the exercise classes
Once the patient is accepted into the intervention, they attend class
once per week for 10 weeks, where they are put into a group of the
most suitable level for their abilities; this includes a lower-level group
who do activities at a lower intensity than the standard groups, to
allow as many patients as possible to benefit from the intervention.
Lower-level classes are run according to demand
Standard cardiac rehabilitation sessions involve a 15-minute warm-up
session involving range of motion exercises and pulse-raising exercises
to gently prepare the body for the session. The main component
involves a variety of exercise ‘stations’, which includes CV stations
(e.g. shuttle walking, cycling) and strength stations, also known as
‘active recovery’ stations (e.g. exercise ball; dumbbell exercises;
theraband movements). The main sessions lasts around 20 minutes,
which consists of completing the circuit twice (2 × 10 minutes).
Each station in the class has three varying levels of intensity, identified
by an illustration at the station itself. This is followed by a 15-minute
cool-down, in which feet are kept moving to maintain blood return to
the heart, and to allow the heart rate to gradually reduce to resting, or
near resting, values. A period of stretching exercises follows, and some
sessions incorporate some relaxation techniques, if time allows
Weekly information sessions are held for participants on a variety of
behaviour change topics. Current classes are cardiac misconceptions,
relaxation, consultant questions, healthy heart workshop, psychological
health and a session on moving on
Who provided
5 For each category of intervention
provider (e.g. psychologist, nursing
assistant), describe their expertise,
background and any specific
training given
Cardiac physiotherapist is a band 7 NHS specialist physiotherapist with
extensive experience working in cardiac rehabilitation
Physiotherapy assistant is a band 3 NHS support member
Cardiac rehabilitation co-ordinator is a band 6 NHS member with a
background in cardiac nursing in a cardiac care unit
How
6 Describe the modes of delivery
(e.g. face to face or by some other
mechanism, such as internet or
telephone) of the intervention and
whether it was provided individually
or in a group
Intervention is provided face to face by the cardiac rehabilitation
team specified above. This is provided in a hospital gym in a group
environment, with numbers at around 15–20 per class depending on
demand. Initial consultations are given on a one-to-one basis with the
specialist physiotherapist
Where
7 Describe the type(s) of location(s)
where the intervention occurred,
including any necessary
infrastructure or relevant features
Patients will attend their local hospital and perform their exercises in
the Heartbeat centre, with its specialist cardiac rehabilitation gym with
sprung flooring and temperature control. The hospital is the only
district general hospital in the trust, providing care for 320,000 people
over 32,500 km2
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TABLE 3 A description of cardiac rehabilitation at site 191 (continued )
Item
number Item
When and how much
8 Describe the number of times the
intervention was delivered and over
what period of time including the
number of sessions, their schedule,
and their duration, intensity or dose
Patients will attend once per week for 10 weeks, plus an initial
assessment appointment, for sessions that last between 60 and
75 minutes. Intensity of sessions is individualised to each patient by the
physiotherapist. RPE scales are used to assess intensity, and heart rate
monitors are used for checking pulses, not for intensity
The class uses RPE Borg 6–20 scale, and asks participants to work at
the range of 12–14 during classes. Patients are given information and
explanations of the intensity required using the RPE scale
Tailoring
9 If the intervention was planned to
be personalised, titrated or
adapted, then describe what, why,
when and how
Each patient is given targets that are agreed by the patient and the
physiotherapist. These targets are individualised but will normally
include attending as many sessions as possible, working at the agreed
intensity, doing the exercises properly and achieving activity goals
outside the classes. Goals are set with discussion with the patient and
physiotherapist, but time allocation for this varies depending on other
time pressures, so there is no standardised procedure. Ideally, patients
see the physiotherapist after approximately 5 weeks to discuss how
goals are going, but, again, this is time-dependent and not always
achievable
Modifications
10 If the intervention was modified
during the course of the study,
describe the changes (what, why,
when, and how)
The intervention is likely to remain constant throughout the study
period. As the cardiac rehabilitation intervention is an existing service,
there is no opportunity during this pilot study to make changes to the
intervention, unless done so by the staff running the programme
How well (planned): If intervention
adherence or fidelity was assessed,
describe how and by whom, and if
strategies were used to maintain or
improve fidelity, describe them
Intervention adherence will be assessed using attendance at cardiac
rehabilitation classes, giving a percentage attendance figure. This will
be monitored by the cardiac rehabilitation team
How well (actual): If intervention
was assessed, describe the extent
to which the intervention was
delivered as planned
Average attendance over 10 sessions will be calculated. Of the patients
allocated to the intervention group, we will calculate how many
attended the programme, and the percentage of those who completed
the programme
BACPR, British Association of Cardiovascular Prevention and Rehabilitation; CV, cardiovascular; RPE, Rating of
Perceived Exertion.
© 2015 BMJ Publishing Group Ltd.
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specialist physiotherapy areas, including cardiology, care of the elderly, rheumatology and women’s health.
Given cardiac rehabilitation physiotherapists’ level of expertise, 1-day training in cancer and exercise was
deemed to be sufficient to deliver the intervention for this study.
Cancer and exercise training sessions were delivered to clinicians in the phase 1 site and the two other
sites that would be involved in phase 2. These sessions were delivered to clinicians (CRC nurses and cardiac
rehabilitation team) by the director of CanRehab (www.canrehab.co.uk), a Skills Active-validated provider
of Level 4 Cancer Exercise Rehabilitation training courses for fitness instructors and clinicians. The training
session was delivered in 1 day, face to face in sites 1 and 2 and by video conferencing in site 3. The main
aim was to provide cardiac rehabilitation clinicians with the appropriate evidence-based knowledge on
current guidelines and contraindications in order to deliver safe effective and appropriate exercise classes
to patients with cancer in a cardiac rehabilitation setting.
The content of the 1-day training included:
l evidence of the benefits of exercise during and after CRC treatment
l principles and guidelines of exercise prescription for cancer survivors
l assessment tools for screening and monitoring CRC patients prior to and during exercise programme
l contraindications, red flags and issues to monitor before and during exercise programme
l examples of different types of exercise and FITT (frequency, intensity, time, type) principles
l practical examples of circuit-based exercises, working at different levels of intensity
l practical examples of seated exercise options
l principles of exercise motivation and facilitating health behaviour change
l methods of implementing the information in a cardiac rehabilitation circuit class.
Each attendee was given a report, produced by CanRehab, offering guidance about cancer and
physical activity.
In phase 1, there was no control group.
Measures
The primary objective of a future large-scale RCT will be to test if cardiac rehabilitation is clinically
beneficial for CRC survivors and cost-effective. As we have explained in Chapter 1, there is evidence that
physical activity is associated with improved survival and quality of life, and with reduced anxiety,
depression and fatigue. At the time of designing this study, the proposed primary outcome for a future
large-scale trial would be the difference in measures of physical activity (e.g. minutes per week, MET hours
per week, time spent sedentary and in moderate-intensity activity) between the intervention and usual care
(control) groups, measured by accelerometer. The proposed secondary outcomes were self-reported
measures of quality of life, anxiety, depression and fatigue. In phase 1, we assessed the feasibility and
acceptability of data collection instruments for these proposed outcomes. The results of phase 1 informed
decisions about which data collection instruments would be tested further in phase 2 (i.e. pilot RCT) or
replaced. An economic evaluation was also planned for any future large-scale trial, and so questions for
this economic evaluation were also assessed for feasibility and acceptability during phases 1 and 2 of
this study.
The following accelerometer and patient-reported outcome measures were taken at baseline (T0) and
approximately 2 weeks post intervention (T1). Information about the validity and scoring of each measure
is provided below.
PHASE 1 METHODS
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Proposed primary outcome
The proposed primary outcome is change in amount of weekly physical activity. This is based on the
research described in Chapter 1, which shows health benefits (e.g. improved survival and quality of life)
associated with increasing post-diagnosis physical activity.
Amount of physical activity
The amount of physical activity was assessed using the Actigraph GT3X+ triaxial accelerometer (Actigraph
LLC, Pensacola, FL, USA).92–94 It is designed to be worn around the waist and measures activity counts,
steps, inclinometer, and light and moderate to very vigorous physical activity. Accelerometers record
movement in such a way that it can be translated into a number of different outputs, for example total
step count, bouts of physical activity at specified intensities or energy expenditure. Accelerometers were
chosen because they are a robust method for identifying movement. A video-recorded study of 12 healthy
adults wearing triaxial accelerometers found that the accelerometers demonstrated high validity, with
sensitivity and positive predictive values of > 85% for sitting and lying and > 90% for walking and
jogging.95 Compared with self-report, accelerometers are also likely to provide a more accurate and
objective assessment of physical activity in patients with cancer,96 including those diagnosed with CRC.97
A recent study of 176 colon cancer survivors found that the total mean minutes per day spent in moderate
to vigorous physical activity was 12 minutes based on accelerometer data and 26 minutes based on
self-reported data (p< 0.01) and the proportion of participants meeting physical activity guidelines based
on self-reported data and accelerometer data was 37.6 and 24.3%, respectively; agreement between the
methods on this measure was poor (kappa= 0.32) with self-report overestimating level of physical
activity.97 Thus, participants in this study wore an accelerometer to provide an objective measure of the
amount of physical activity undertaken. Every participant was offered an accelerometer to wear during
waking hours for 7 consecutive days per week. At the end of the 7-day period, participants returned the
monitors to the research team.
Initialisation of device
Accelerometer devices were initialised as follows:
l Device recording of physical activity and sedentary behaviour was set for 10 days maximum, with the
intention to gain at least 4 usable days of data for each participant (4 days is standard practice).
l The date and time when the participant was scheduled to wear the device were set.
l The sample rate was set to 30 Hz.
l The unique participant ID was added to the specific device.
Device download
Once the device was returned by a participant, Actigraph software was used to download data, as follows:
l The unit of measurement was set at 60-second epochs so that the data were automatically converted
to minutes for analysis.
l The ‘# of axis’ setting was set to 3, and ‘steps’, ‘lux’, ‘inclinometer’ and ‘low frequency extension’
were all selected.
l The ‘limb’ setting was set to ‘waist’ and the ‘side’ setting was set to ‘right’.
Wear-time validation
The validation parameters and cut-off points described below have been used in cross-sectional40,97,98 and
intervention studies49 that have measured physical activity and sedentary behaviour among people with
CRC. Actigraph software wear-time validation was set to meet the following criteria:
l Minimum number of valid days required= 4.
l Non-wear-time was set at > 60 minutes of consecutive zeros.
l Minimum number of wear hours per day required was set at > 10 hours (600 minutes).
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In addition, each suggested non-wear-time was checked manually by an investigator to ensure that we
minimised the chance of removing a sedentary period, which can be confused with a non-wear period,
particularly among a population who have a high rate of sedentary behaviour, such as some
clinical populations.
Cut-off points
Commonly accepted cut-off points for adults were used to differentiate activity intensity using Freedson
et al.92 adult cut-off criteria:
l sedentary: < 100 counts per minute
l light: 100–1951 counts per minute
l moderate: 1952–5724 counts per minute
l vigorous: > 5725 counts per minute.
In addition, a sedentary bout was set at 10 minutes.
Type of physical activity
Type of physical activity was assessed using the International Physical Activity Questionnaire (IPAQ) long
self-report version. This is a 27-item questionnaire used to establish levels of physical activity using 7-day
recall. This was used in conjunction with the accelerometer to further explain the type of physical activity,
which the accelerometer cannot pick up.99 Activities are split into low, moderate and vigorous level of
activity. The items in the IPAQ are structured to provide separate scores for walking, moderate in intensity
and vigorous in intensity activity in each of the four domains (work-related, home and garden, recreation
and transportation). The self-administered IPAQ (long version) has acceptable validity when establishing
activity levels in healthy adults, and the scale ranks similarly to other self-report options, and produced
repeatable data in adults in diverse settings.100
Scoring
The ‘score’ can be calculated either in minutes per week in each intensity of activity or as a continuous
variable in MET minutes per week. Total time spent in physical activity during the past 7 days can be
obtained by multiplying the number of days of the activity by the amount of time spent in each activity
and then summed according to the intensity of the physical activity.
Proposed secondary outcomes
Quality of life
The European Quality of Life-5 Dimensions (EQ-5D) instrument and SF-36 were chosen as measures of
quality of life because they have strong evidence of reliability, validity, responsiveness and acceptability.101
Both EQ-5D and SF-36 are used in health economics as a variable in the quality-adjusted life-year
calculation to determine the cost-effectiveness of an intervention.
European Quality of Life-5 Dimensions
The EQ-5D is measure of health-related quality of life divided into two sections: the EQ-5D index and the
EQ thermometer.102 The EQ-5D index assesses health across five domains: mobility, self-care, usual
activities, pain/discomfort and anxiety/depression. The EQ thermometer is a single 20 cm vertical visual
analogue scales with a range of 0 to 100, where 0 is the worst and 100 is the best imaginable health, and
is completed by the user for their current health. A 2007 review shows a substantial and growing body of
literature using the EQ-5D in cancer, and draws the conclusion that it is a valid and reliable instrument.103
A 2010 review of patient-reported outcome measures for patients with CRC favourably summarises the
EQ-5D and recommends its use for measurement of comprehensive general health status.101
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Scoring
Descriptive data from the five dimensions of the EQ-5D part 1 can be used to generate a health-related
quality-of-life profile for the subject, created from the 1–5 scale for each question. This can be further
divided into those reporting ‘problems’ or ‘no problems’, combining some of the subscales. Part 2 is scored
from 0 (worst health state imaginable) to 100 (best health state imaginable). The score from part 2 can be
used to track changes in health, on an individual or group level, over time.104
Short Form Health Survey-36 items
The SF-36105 was also used to measure quality of life. The Medical Outcomes Study SF-36 is intended for
application in a wide range of conditions and with the general population. The SF-36 is a validated health
survey consisting of 36 questions that measure eight health concepts: physical functioning, role limitations
due to physical problems, bodily pain, general health, vitality, social functioning, role limitations secondary
to emotional problems, and mental health. The content validity of the SF-36 has been compared
favourably with that of other widely used generic health surveys.106
Scoring
Two scores are available from the SF-36 results: a physical component and a mental component.
The physical component score is derived from physical functioning, role limitations due to physical
problems, bodily pain and general health. The mental component score is derived from the remaining
four scales: vitality, social functioning, role limitations due to emotional problems, and mental health.
For each participant, a number obtained from the responses indicates each health concept. A higher score
indicates an improved level of function; for example, a high score in the pain category indicates low
pain/improved pain.
Anxiety and depression
The Hospital Anxiety and Depression Scale (HADS), which consists of 14 questions, seven for anxiety and
seven for depression, was used to measure anxiety and depression.107 Test–retest scores for the anxiety
subscale were reported as 0.84 at up to 2 weeks, 0.73 at 2–6 weeks and 0.70 at > 6 weeks, and for
the depression subscale were reported as 0.85, 0.76 and 0.70 at the same intervals.108 The scale has
also demonstrated excellent internal consistency in both subscales using Cronbach’s alpha values
(anxiety= 0.93; depression= 0.90) in a study of 568 cancer patients.109 A meta-analysis suggests that
HADS is sufficiently sensitive for identifying depression and anxiety in patients with cancer.110
Scoring
Each variable is scored on individual subscales, with a maximum score of 21 on each scale. A higher score
indicates higher levels of anxiety or depression. Six out of the 14 items on the scale are reverse scored,
four of which are items related to the participant’s ratings of anxiety and the remaining two of which are
measures of depression. Scores from 0 to 7 are considered normal, scores between 8 and 10 indicate
borderline clinical disorder and scores of ≥ 11 represent possible clinical disorders.
Fatigue
Cancer-related fatigue was measured using the 13-item Fatigue Scale of the Functional Assessment of
Chronic Illness Therapy (FACIT) measurement system.111 The FACIT measurement system is considered
appropriate for use with patients with any form of cancer and, importantly, has been shown to be
responsive to change in clinical and observational studies.111 A 2008 systematic review of the scales used for
the measurement of cancer-related fatigue shows that there is no accepted definition of cancer-related
fatigue and no agreement on how it should be measured.112 Nevertheless, the review recommends the use
of FACIT questionnaires for measuring fatigue. The FACIT Fatigue Scale has been successfully used in studies
investigating physical activity interventions for people with CRC.38,44,49 In addition, FACIT questionnaires to
measure fatigue have also been successfully used in a longitudinal study of 291 participants with early-stage
CRC, 72 participants with metastatic disease and 72 healthy controls.113 The study found that fatigue was
self-reported by 52% of early-stage patients and 26% of healthy controls (p< 0.0001).113
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
25
Scoring
Questionnaire responses are given on a Likert scale (0–4), with two items being reversed, giving a score
range of 0–52. The higher the score, the better the quality of life; a score of < 30 indicates fatigue.
Proposed process variables
Self-efficacy and risk perception were measured to assess if they were predictive of cardiac rehabilitation
attendance and of changes in health outcomes arising from the intervention.
Self-efficacy
Self-efficacy is predictive of both the adoption and the maintenance of physical activity.114–116 Furthermore,
there is experimental evidence that changes in self-efficacy can mediate the effects of behaviour change
interventions on increases in objective measured physical activity behaviour.117 General self-efficacy, which
is the belief that one can perform difficult tasks or cope with adversity, was measured using a 10-item
scale.118 Physical exercise self-efficacy, which is the belief that one can engage in, and meet, physical
activity goals, was also measured, using a 5-item scale.119 High reliability, stability and construct validity of
the general self-efficacy scale have been confirmed.120,121
Scoring
Likert scoring (1–4 per questions) is used to give a score for self-efficacy (general self-efficacy range from
10 to 40; physical activity self-efficacy range from 5 to 20); the higher the score, the higher the self-efficacy.
Risk perception
According to the behaviour motivation hypothesis,122 perceived risk is positively and directly related to
health behaviours. Risk perception of suffering from diseases has been found to play an important role
in the development of intentions to perform physical activity among older adults123 and in explaining
cancer-related behaviours.124,125 Given lack of consensus about measuring risk perception, we measured
cognitive (beliefs) and affective (feeling) risk perception and perceived severity.126
Scoring
Risk perception was measured by six items and each item had a 5-point Likert scale. The two cognitive risk
perception question scores were summed (‘If I don’t have a healthy lifestyle, my chances of getting
colorectal cancer again at some point in my life are . . .’ and ‘If I have a healthy lifestyle my chances of
getting colorectal cancer again at some point in my life are smaller . . .’). A higher score indicates that a
respondent believed that a healthy lifestyle would have a protective health effect (range 0–10). The two
affective risk perception question scores were summed (‘If I don’t have a healthy lifestyle, I feel . . .’ and
‘If I have a healthy lifestyle, I feel less vulnerable to getting cancer again at some point in my life . . .’).
A higher score indicates that a respondent felt that a healthy lifestyle would have a protective health effect.
The two perceived severity question scores were summed (‘Compared to other forms of disease, the
consequences of bowel cancer are . . .’ and ‘Bowel cancer is more serious than other diseases I know . . .’).
A higher score indicates that a respondent believed that bowel cancer was a more serious disease.
Proposed clinical variables
In addition, the following clinical confounding factors were reported on the screening and recruitment
form (see Appendix 2):
l colon or rectal surgery
l surgical intervention (e.g. laparoscopic or open surgery)
l temporary (a loop ileostomy) or permanent stoma or no stoma
l chemotherapy or no chemotherapy.
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Sample size justification
The sample size was based on two factors: (1) number of patients with CRC that was sufficient to address
phase 1 objectives, that is, test the feasibility and acceptability of the intervention and main trial
components before commencing phase 2 (i.e. a pilot RCT); and (2) estimated number of patients with CRC
who could be recruited within a planned recruitment period of 2 months (the recruitment period was
extended from 2 to 5 months).
As highlighted in Chapter 1, there is no clear guidance for how many participants are necessary for
estimating event rates such as recruitment and willingness to be randomised in pilot RCTs. Similarly, there
is no clear guidance for how many participants are required to assess the feasibility and acceptability of
an intervention and study instruments. Thus, we aimed to recruit 12 patients with CRC, as this is the
number of patients we thought that we could realistically recruit within the given time scale to meet
phase 1 objectives.
Data collection and management
The original plan, as specified in the protocol, was to ask patients to complete the self-report
questionnaires using pen and ink in the presence of an investigator who would guide them through it.
However, all questionnaires were administered online (Bristol Online Survey) to save the time and expense
of entering data.
Outcome measures
Baseline assessment
The investigator conducted baseline assessment at the cardiac rehabilitation facility. The investigator
administered online questionnaires (IPAQ, EQ-5D, SF-36, HADS, FACIT Fatigue Scale, self-efficacy and risk
perception questions) using Bristol Online Survey (http://survey.bris.ac.uk). The majority of questions were
in a closed format, requiring participants to choose one option from a limited selection of discrete
responses. Each question was read out by the investigator and answered by the participant. The
investigator directly input the response to each question. The participant was also invited to wear the
Actigraph GTX3+ accelerometer for 7 consecutive days (beginning the following day). All baseline
assessments were conducted between 16 September 2013 and 26 November 2013.
Follow-up
Follow-up assessment coincided approximately with the end of the intervention delivery period (i.e. after
the participant had attended the final cardiac rehabilitation class). The investigator conducted follow-up
assessment at the cardiac rehabilitation facility. The investigator administered the online questionnaires
that were completed at baseline using the same procedures. The participant was again requested to wear
the Actigraph GTX3+ accelerometer for 7 consecutive days (beginning the following day). All follow-up
data were collected between 27 April 2014 and 29 May 2014.
Process evaluation
Evaluation of cancer and exercise training
Clinicians attending the cancer and exercise training class completed a standard CanRehab evaluation form
(see Appendix 6). The form included 18 questions covering pre-course information, course content, course
venue and facilities. Questions were a combination of scaled questions (1–5: strongly agree 5, strongly
disagree 1) and open-text questions.
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Evaluation of measures and intervention
As described above, each instrument had already been independently tested for validity and reliability.
However, we wanted to assess if completing the batch questionnaires was acceptable to participants.
Immediately after the participant had completed the questionnaire, the investigator recorded any naturally
occurring comments made by the participant as he or she answered questions. The investigator recorded
comments about, for example, repetition (e.g. if the participant felt that questions were similar and he or
she had already answered a similar question), relevance (e.g. if the participant felt that the questions
applied to him or her) comprehension (e.g. if the participant asked the investigator to explain a question)
and burden (e.g. if the participant commented on the length of the questionnaire). This approach is similar
to the ‘think-aloud’ method, which involves the respondent completing the questionnaire and speaking
aloud their thoughts as they reach each instruction and complete each item.127 ‘Think aloud’ allows access
to the participant’s genuine thoughts as they complete the instrument.128
Face-to-face semistructured interviews were conducted with participants at the end of the intervention
delivery period (i.e. after the patient had attended the final cardiac rehabilitation class) about the
acceptability of main trial components and the intervention. Face-to-face semistructured interviews were
also conducted with the three nurses involved in recruitment and the one cardiac physiotherapist delivering
the intervention about the acceptability of main trial components and the intervention. Semistructured
interviews were chosen because they allow flexibility in what sequence questions are asked, and in
whether or not and how particular areas might be followed up and developed with different
interviewees.129 Interview schedules (see Appendix 7) were used to assist the investigator in gathering
responses about the feasibility and acceptability of the intervention and trial procedures.
In addition, a focus group with 1 CRC nurse and 12 cardiac rehabilitation team members (eight
physiotherapists/assistants and four nurses) in one of the other sites that would be involved in phase 2 was
conducted to discuss the results of phase 1. An investigator recorded comments made by the clinicians at
the focus group by making a set of notes. ‘Any group discussion may be called a “focus group” as long as
the researcher is actively encouraging of, and attentive to, the group interaction.’130 A focus group was
chosen because it was a practical method for involving cardiac rehabilitation clinicians in the process of
developing the main trial components for testing in phase 2 and working collaboratively with
the investigators.
Analysis
Descriptive statistics
To address phase 1 objectives (see Chapter 2), descriptive statistics were generated to summarise the main
features of information from the screening and recruitment, declining to participate and evaluation forms
to assess feasibility and acceptability of main trial components and the intervention. In addition, rates of
missing data on the self-report questionnaires completed by patients and the accelerometers were
analysed and reported.
Thematic analysis
Interviews and focus group data were also analysed to assess the feasibility and acceptability of the main
trial components and the intervention. Audio-recorded interviews were transcribed verbatim and analysed
thematically. The Framework approach, which is a rigorous method providing a structure within which
qualitative data are organised and coded and themes are identified, was used to guide the analysis.131 In
brief, first the investigators became familiar with the interviews transcript data by reading and rereading
transcripts and assigning interview and focus group data (sentences and paragraphs) to the two main
themes, which were (1) the feasibility and acceptability of the main trial procedures, and (2) the feasibility
and acceptability of the intervention. Second, subthemes were identified and a narrative summary of
coded data was made under each subtheme. Third, the investigators referred to the original data to ensure
that participant accounts were accurately presented to avoid misinterpretation.
PHASE 1 METHODS
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Adverse events
Although this was not a clinical trial of an investigational medicinal product, the investigators adhered to
Tayside Medical Science Centre standard operating procedure 11: ‘Identifying recording and reporting
adverse events [AEs] for clinical trials of investigational medicinal products’.132 The following serious
adverse event (SAE) protocols were reported within 24 hours of the principal investigator or person
delegated responsibility for recording SAEs becoming aware of them:
A SAE is any AE occurring that results in any of the following outcomes:
l death
l inpatient hospitalisation or prolongation of existing hospitalisation
l persistent or significant disability/incapacity.
The following protocol exclusions applied:
l hospitalisation for assault or accidental injury
l hospitalisation for pre-planned surgery.
The above protocol exclusions were recorded in the AE log (see Appendix 8) for the study and line listings
were reported annually to ethics and the sponsor.
Each hospital, and hence each cardiac rehabilitation programme, also had a reporting system for AEs, and
cardiac rehabilitation operates a system of incident reporting. Thus, AE reporting of study participants by
cardiac rehabilitation were also recorded by an investigator.
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
29

Chapter 4 Phase 1 results
The purpose of phase 1 was to evaluate the feasibility and acceptability of the main trial componentsplanned for use in phase 2 and also the feasibility and acceptability of delivering the intervention in one
site. In this chapter, phase 1 results are reported under two sections. The first section of this chapter
reports the results that address the feasibility and acceptability of the main trial components. Descriptive
statistics were generated to show the recruitment rate, participant and non-participant characteristics,
completion rate and missing data. Findings from the interviews and focus group about the feasibility and
acceptability of main trial components are reported thematically. Table 4 describes participants interviewed
or involved in a focus group during phase 1. The second column of the table lists the key themes
addressing the feasibility and acceptability of the main trial components that are reported in this chapter.
In this chapter, for quotations, ‘CNS’ refers to cancer nurse specialist; ‘CRP’ refers to cardiac rehabilitation
professional; ‘P’ refers to participant, that is, a patient with CRC; and the number, for example, ‘001’, is
given after the letters to uniquely identify the participant for the purposes of the study.
The second section of this chapter reports the results that address the feasibility and acceptability of
delivering the intervention. Descriptive statistics were generated to show the number of clinicians who
attended the cancer and exercise training and the results of the evaluation of this event. Descriptive
statistics were also used to report cardiac rehabilitation attendance patterns of the four CRC patients
who consented to the study. Findings from the interviews and focus group about the feasibility and
acceptability of delivering the intervention are reported thematically. The third column of Table 4 lists the
key themes addressing the feasibility and acceptability of the intervention that are reported in this chapter.
The next chapter (see Chapter 5) presents the modifications made to trial procedures and the intervention
based on phase 1 results for further testing on phase 2.
TABLE 4 Participants and key themes
Participants
Themes addressing feasibility and
acceptability of the main trial
components
Themes addressing feasibility and
acceptability of the intervention
Interviews (site 1)
l Three out of a potential three CRC
nurse specialists
l One out of a potential one cardiac
rehabilitation physiotherapist
l Three CRC patients (i.e. those who
remained in the study)
l Interpretation of eligibility criteria
l Perceived barriers to participation
l Time and place to recruit patients
Referral pathways to cardiac
rehabilitation
Importance of exercise for patients
with CRC
Cancer and cardiac patients
exercising together
Cardiac rehabilitation education
sessions
Focus group (site 2)
l One CRC nurse and 12 cardiac
rehabilitation team members (eight
physiotherapists and physiotherapy
assistants and four nurses)
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Feasibility and acceptability of main trial components
Colorectal cancer patient recruitment rate
Figure 3 presents patient flow through the study. In total, there were 34 new patient admissions. A nurse
gave 24 (70% of all patient admissions) eligible patients a study information sheet. Nurses completed a
screening and recruitment form for 17 (71% of those receiving a study information sheet) of these eligible
patients. Nurses did not complete a screening and recruitment form for seven eligible patients who had
been given study information, because the patient was too unwell, had been discharged or had moved
wards. Ten (58% of completed screening and recruitment forms) patients signed a screening and
recruitment form indicating their willingness to participate in the study and to have contact details
forwarded to an investigator. Six patients who signed a screening and recruitment form indicating their
willingness to participate withdrew from the study before signing a consent form and entering the
intervention owing to ill health (n= 3) or travel problems (n= 2) or because they were subsequently unable
to be contacted (n= 1). Four of these patients signed a consent form and started cardiac rehabilitation
(i.e. the intervention), which is 17% of eligible patients. One of these patients withdrew owing to ill health.
Patient admissions
(n = 34)
Ineligible or missed patients
(n = 10)
Eligible patients given 
study information by nurse
(n = 24)
Screening and 
recruitment forms completed by 
nurse for eligible patients
(n = 17)
Forms not completed 
(n = 7)
Patients signing screening 
and recruitment form indicating 
willingness to participate
(n = 10)
Patients who completed 
screening and recruitment form 
who declined to participate
(n = 7)
Reasons given
• Travel distance, n = 5
• Already physically active, n = 1
• Unknown, n = 1
Signing consent form
 and starting intervention
(n = 4)
Patients withdrew 
(n = 6)
Reasons given
• Travel distance, n = 2
• Health, n = 3
• Unable to be contacted, n = 1
Patients 
completed intervention
(n = 3)
Patients withdrew
(n = 1)
FIGURE 3 Participant flow.
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Participant characteristics
Table 5 summarises the main characteristics of patients who signed a screening and recruitment form
indicating their willingness to participate in the study and to have their contact details forwarded to an
investigator (n= 10). The mean age was 71 years (range 50–89 years); 60% were men. Three patients
were diagnosed with metastatic disease; eight patients had open surgery and two had laparoscopic
surgery; five patients were receiving adjuvant therapy (one radiotherapy and four chemotherapy); and four
patients had a stoma.
Participant and non-participant characteristics
The characteristics of 10 eligible participants who were willing to participate and signed a screening and
recruitment form and the seven eligible participants who declined to participate and signed a declining to
participate form were compared. Differences by age, gender and type of surgery are shown in Table 6.
The age range and the proportion of people diagnosed with colon and rectal cancer in each group were
similar. There were proportionately more men and more people who had open surgery in the willingness
to participate group than in the declining to participate group.
TABLE 5 Characteristics of participants willing to participate (n= 10)
ID
Age
(years) Gender Diagnosis Treatment
Reasons for
withdrawal
1a 77 F Colon cancer Open surgery, adjuvant chemotherapy
2 60 M Upper rectal cancer with
lung and liver metastasis
Open surgery, permanent stoma Travel distance
3a 84 F Caecal adenocarcinoma
with liver metastasis
Laparoscopic surgery, adjuvant
chemotherapy
4 75 F Lower rectal cancer Open surgery, permanent stoma,
adjuvant radiotherapy
Wound healing
5a 89 F Cancer of transverse colon Open surgery
6a 80 M Caecal cancer Open surgery
7 61 M Rectal cancer Open surgery, temporary stoma,
adjuvant radiotherapy
Unable to be contacted
8 69 M Rectal cancer Open surgery, temporary stoma Travel distance
9 62 M Colon cancer, metastatic
disease
Open surgery, adjuvant chemotherapy Having chemotherapy
10 50 M Rectal cancer Laparoscopic surgery More surgery scheduled
F, female; M, male.
a These participants did not withdraw and entered the intervention.
TABLE 6 Characteristics of eligible people with CRC willing and unwilling to participate
Characteristic Willing (n= 10) Unwilling (n= 7)
Age (mean) 71 years (range 50–89 years) 69 years (range 51–90 years)
Gender 60% male 42% male
Diagnosis 50% colon; 50% rectal 57% colon; 43% rectal
Type of surgery 80% open surgery; 20% laparoscopic 57% open surgery; 43% laparoscopic
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Completion rates and missing data
As described in Chapter 3, outcomes and process variables were assessed by accelerometer and
investigator-administered patient-reported outcomes questionnaires at two time points: pre intervention
and post intervention.
Accelerometer
Participants were invited to wear an accelerometer for 7 consecutive days and for as long as possible on
each day. Participants were asked to wear the device for an extra day or two if they felt that they had not
worn it for long enough during the allotted time period, or if they had forgotten to wear the device on
one of the days. Data were classed as valid if the device had been worn for at least 10 hours per day for
4 days (see Chapter 1).133 Table 7 shows that participants wore the accelerometer as requested.
Participants did not report any difficulties wearing the accelerometer.
Investigator: Right, and how did you find it wearing that [accelerometer]?
P005: That was OK.
Investigator: Any problems at all?
P005: No.
P005
Investigator: And how did you find it [wearing the device]?
P001: Fine, no problem.
Investigator: OK . . . em . . .
P001: And I understood why I was wearing it, you know.
P001
Self-report questionnaires
As we pointed out in Chapter 3, the original plan was to ask patients to complete the self-report
questionnaires using pen and ink in the presence of an investigator who would guide them through it.
However, all questionnaires were administered online (Bristol Online Survey) with an investigador present,
to save time and expense entering data. To administer online questionnaires, internet access was required,
and hence permission was successfully obtained from the NHS to access the internet in the hospital where
patients met the investigator to complete the questionnaire.
All items of the questionnaire were completed at baseline and at follow-up for the three patients
completing the intervention. There were no missing data to report from the self-report questionnaires.
TABLE 7 Accelerometer wear-time
Study ID Baseline wear valid
Number of valid
wear-days (out of 7) Follow-up wear valid
Number of valid
wear-days (out of 7)
001 Yes 4 Yes 5
005 Yes 5 Yes 5
006 Yes 7 Yes 6
PHASE 1 RESULTS
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Participants reported that the questionnaire was repetitive. In particular, participants reported that there
were similar questions being asked on a number of occasions about their quality of life (as described in
Chapter 3, the EQ-5D and SF-36 were being used to measure quality of life). In addition, participants
reported that they were not asked specifically about the impact of the cancer and cancer-related
treatments on their quality of life, suggesting that general quality of life measures may not capture key
domains relevant to patients with cancer. Participants reported that some questions about their physical
activity were not relevant (as described in Chapter 3, the IPAQ was being used to measure types of
physical activity). IPAQ included questions about work-related physical activity, and the majority of
participants were not in paid employment. Self-efficacy and risk items were met generally with indifference
and were completed with the only comment that questions were very similar. Participants did not report
any difficulties answering questions about the costs associated with attending cardiac rehabilitation, which
provided data for use in a health economic evaluation.
Clinicians’ experiences and perceptions of recruitment
The themes identified were interpretation of eligibility criteria, perceived barriers to participation, and time
and place to recruit patients.
Interpretation of eligibility criteria
Nurses did not report difficulties applying exclusion and inclusion criteria. However, they used their
personal judgement to exclude patients who they believed should not participate. For example, the
criterion ‘advanced disease’ was not interpreted to refer to all patients with metastatic disease. In addition,
one nurse reported that she did not approach a patient who met the inclusion criteria because she
believed that the patient would be unable to participate.
We use our judgement all the time, like, I mean there is a lady in at the moment but she’s 88 and her
husband’s got dementia, and she doesn’t drive and you think she’s, you know she’s not going to
achieve anything.
CNS 002
Cardiac rehabilitation clinicians at the focus group discussed the challenges of including patients with
metastatic disease in cardiac rehabilitation exercise classes and concluded that it was feasible to include
these patients as long as the CRC clinical team confirmed that it was safe for these patients to exercise.
Perceived barriers to participation
Reasons given by eligible patients for non-participation (n= 7) or withdrawal (n= 6), and that were also
perceived by clinicians as barriers to participation, were as follows:
l travel distance from cardiac rehabilitation facility
l returning to work and therefore unable to attend cardiac rehabilitation
l feeling fit and well and therefore perceiving cardiac rehabilitation as unnecessary
l having ongoing treatment and therefore not feeling well enough to attend cardiac rehabilitation
l poor recovery from surgery (e.g. wound not healing).
Given how remote and rural some parts of the Scottish Highlands are, it was perhaps inevitable that some
patients would decline to be involved in the study or withdraw from the study owing to the distance that
they would have had to travel to attend cardiac rehabilitation.
The distance has been the big, the big stumbling block, but even some people, em, from a long way
away have, have been very keen to take part.
CNS 001
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The cardiac rehabilitation physiotherapist perceived that the main issue regarding the involvement of
patients with CRC was their protracted recovery, which meant that they were not always able to attend
cardiac rehabilitation immediately.
I think the biggest issue is time . . . eh, the effects on the cardiac service. The patients themselves
weren’t a problem in any way. The only thing that we have established is that they don’t have a
straightforward journey which has been the biggest problem . . . and which is probably going to have
the biggest effect on how compliant they can be. But generally once we’ve, once we’ve sort of
assessed the recruitment and screening and you’ve got appropriate patients, they’ve been quite keen.
CRP 001
A stoma was cited as a barrier to participation in cardiac rehabilitation; one nurse described why this might
be the case:
It’s a big confidence issue; em, you know, living with a stoma, worried about whether the bag’s going
to burst. And for them if they were in a class where they were doing a bit of exercise which they had
been doing for a while and the bag was to fill up and you know maybe cause a problem that could be
quite detrimental to their recovery. A disaster, you know, a leak or something, you know, they would
maybe have to have spare clothes with them, em, you know, ensure that there’s toilet facilities so that
they can empty their bag when and if necessary; there’s maybe changing facilities if they did have a
problem, eh, you know, eh, with that. I suppose I mean you, you may get a cardiac patient that feels
nauseous and is sick, so I mean there are different.
CNS 003
Four patients who signed a screening and recruitment form indicating their willingness to participate in the
study had a stoma, suggesting that it was not a barrier to participation for all patients. However, none of
the patients who had a stoma participated in the intervention (i.e. cardiac rehabilitation) because they
decided to withdraw from the study. As Table 5 shows, their reasons for withdrawal were having travel
difficulties (n= 2), being uncontactable (n= 1) and having wound problems (n= 1), suggesting that factors
other than having a stoma were the barriers to participation.
Nurses cited age as a barrier to participation. One nurse, for instance, believed that older people were
probably less likely or willing to change their lifestyle and, therefore, less likely to participate in the study.
And the older the people get they’re maybe not just quite so able or amenable to embracing drastic
changes in their lifestyles.
CNS 002
Nevertheless, the average age of patients who signed a screening and recruitment form indicating their
willingness to participate in the study was 71 years and the oldest patient was aged 89 years. The patient
who was 89 years old participated in the intervention (i.e. cardiac rehabilitation), suggesting that age was
not a barrier to study participation. Cardiac rehabilitation clinicians at the focus group did not perceive age
as a barrier to attending cardiac rehabilitation and referred to the broad age range of people with CHD
attending cardiac rehabilitation classes.
Time and place to recruit patients
Nurses did not believe it appropriate to raise the study with patients when they were being given their
cancer diagnosis.
Not at diagnosis – you have to assess that patient at that time; are they able to take in, on board
anything else that you’re going to say to them.
CNS 002
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However, nurses believed that it was appropriate to give patients information about the study as early as
possible so that they had enough time to think about participating.
I think it’s better to give it to them as early as possible in their diagnosis so that they can be thinking
about it.
CNS 002
The original plan, as stated in the protocol and described in Chapter 3, was for nurses to approach CRC
patients about the study after discharge from hospital, at the first follow-up appointment. This time and
place was initially chosen because it avoided raising the issue of the study during diagnosis, but also was
not too long after the diagnosis. In practice, however, nurses decided to raise the issue on patients’
admission to the surgical ward. Nurses found that this was appropriate because ways to support recovery
from surgery were already being discussed with patients on the surgical ward, pre and post surgery. Thus,
nurses gave patients a study information sheet and discussed participation in the study pre or post surgery
on the ward.
As described in Chapter 3, nurses were expected to complete a screening and recruitment form for all
eligible patients they approached about the study. Nurses said that screening and recruitment did not take
up too much clinical time and the form was easy to complete.
No I think, certainly for the forms that we fill out, I mean it is very simple, it was just a tick box and eh,
you know, it’s easy enough for us to do that.
CNS 003
It’s, it’s maybe 5 minutes per patient really. We’d introduce it and give them the leaflet to read and
then, em, the forms themselves only take a few minutes to fill in, so it wasn’t any, it wasn’t any, eh,
any hardship at all.
CNS 001
Feasibility and acceptability of the intervention
Cancer and exercise training
During phase 1, all clinicians across all three sites involved in phase 2 attended a 1-day cancer and exercise
training course. All clinicians delivering the intervention (i.e. phase 3 cardiac rehabilitation) attended; that
is, 10 cardiac physiotherapists/assistants and four cardiac nurses across all three sites were trained. In
addition, all six CRC nurses involved in recruitment were trained. Fourteen (70%) evaluation forms from
across all three sites were completed and returned; six (30%) forms were not returned.
The results of the evaluation are presented in Table 8. All scaled questions marked highly with a score of
4 or 5, with 5 being the maximum score. Additional free-text comments show that, overall, training was
well received by all attendees who completed the evaluation forms (cancer and cardiac staff). Attendees
reported that the training was excellent and enjoyable.
As described in Chapter 3, all sites received training separately. Two sites received cancer and exercise
training face to face and the third site received training via group video conferencing (skypeTM, Microsoft
Corporation, Redmond, WA, USA). One attendee in the site that received training via video conferencing
wrote on the evaluation form that she would have preferred face-to-face training, whereas two other
attendees reported that video conferencing was an effective method for delivering training.
Attendees reported that the course content was at the appropriate level (mean score of 4.3) and was well
presented (mean score of 4.7). One attendee reported that the booklet about cancer and exercise that was
handed out was ‘great’, and one attendee reported that the content was ‘interesting and stimulating’.
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TABLE 8 Evaluation of cancer and exercise training
Question
Average score (mean) (5: strongly
agree; 1: strongly disagree)
Registration and pre-course information
I received all the necessary information prior to starting the course 4.3
The directions to the venue were helpful and accurate 4.5
Additional comments for those trained via video conference
Effective method of delivering course
Opportunity for asking questions over video link as we went along
No practical session, but did not feel this was necessary
Course content
The content of the course was at the appropriate level 4.3
The course information was well presented 4.6
The content was well presented 4.7
The content of the practical session was well presented 4.7
Additional comments for course content
Great booklet, presenter very knowledgeable and easy to listen to
Very interesting and stimulating
No practical given
Information a little basic
Felt session was more of a presentation than a training session
Course venue and facilities
Course teaching and rooms were of an adequate standard 4.3
The equipment used was of an adequate standard 4.3
The refreshments were of an adequate standard 4.7
The teaching room was set up and prepared 4.6
Each session started and finished on time 4.7
You were provided with sufficient breaks 4.5
Do you have any suggestion on how this course could be improved?
Excellent introduction to exercise and cancer
Needs to be in person rather than teleconference
Would you recommend this course to other colleagues?
Yes – 65%; no – 0%; no response – 35%
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However, one attendee reported that the information was a ‘little basic’ and another attendee reported
that ‘some examples given may have been patronising for staff doing classes for many years’.
One attendee highlighted that she had learnt that many cancer and cardiac risk factors are similar and
therefore patients with CRC would benefit from the education sessions organised for cardiac patients.
Cardiac rehabilitation adherence
Table 9 shows that the average number of days between a patient signing a screening and recruitment
form indicating agreement to participate in the study and starting cardiac rehabilitation was 70.
Participants were expected to attend 10 consecutive cardiac rehabilitation exercise classes. Table 10 shows
that one participant attended 10 cardiac rehabilitation classes over a period of 13 weeks, one participant
attended 6 out of 10 classes over a 14-week period, one participant attended half of all classes over a
7-week period and another was unable to attend any classes owing to ill health.
TABLE 8 Evaluation of cancer and exercise training (continued )
Question
Average score (mean) (5: strongly
agree; 1: strongly disagree)
Please add any additional comments you wish to make
Very enjoyable, great presenter
None, it was excellent
I would like to learn more
Some examples given may have been patronising for staff doing classes for many years
Good to learn that cancer patient risk factors are the same as cardiac so will benefit from most information sessions
Enjoyed the open discussion with colleagues
TABLE 9 Number of consenting patients attending cardiac rehabilitation
ID Screening date First rehabilitation class Time (days)
001 12 August 2013 5 November 2013 54
003 16 August 2013 28 November 2013 69
005 5 September 2013 5 September 2013 84
006 23 September 2013 23 September 2013 73
TABLE 10 Attendance at cardiac rehabilitation
Patient ID First session Last session
Sessions
attended
Number
of weeks
Completion
(%)
Sessions per
week equivalent
001 7 November 2013 19 December 2013 5 7 50 0.7
003 28 November 2013 Unable to attend owing to non-related medical reasons
005 28 November 2013 6 March 2014 6 14 60 0.4
006 5 December 2013 6 March 2014 10 13 100 0.8
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Patients’ and clinicians’ experiences and perceptions of cardiac rehabilitation
The themes were referral pathways to cardiac rehabilitation, importance of exercise for patients with CRC,
cancer and cardiac patients exercising together, and cardiac rehabilitation education sessions.
Referral to cardiac rehabilitation
The cardiac rehabilitation physiotherapist did not find the referral procedures of CRC patients into the
service acceptable and so these were changed. The original plan, as stated in the protocol85 and described
in Chapter 3, was that nurses would refer patients to cardiac rehabilitation. In the absence of a study,
this is how patients would be referred if the intervention were implemented as part of routine care.
In this study, however, the investigator referred patients to cardiac rehabilitation. The reason for this was
to minimise the workload of the cardiac rehabilitation team. If we had kept to the original procedure
(i.e. nurses directly referring patients to cardiac rehabilitation), the onus would have been on the cardiac
rehabilitation team to continuously check with the patient when they felt ready to attend cardiac
rehabilitation. The difficulty was that patients with CRC varied in terms of their recovery and readiness to
start cardiac rehabilitation following surgery, which meant that the time to starting cardiac rehabilitation
after surgery could not be strictly regimented. To save the team repeatedly contacting CRC patients to find
out if they were ready to start the programme, telephone calls by an investigator were introduced instead.
It was only once a CRC patient informed an investigator that he or she was ready to attend cardiac
rehabilitation that an investigator informed the cardiac rehabilitation team about that patient. A member
of the cardiac rehabilitation team could then contact the patient to invite him or her to attend the first
appointment to conduct a risk assessment and discuss the programme. A physiotherapist explained why
the original procedure was problematic.
It was slightly cumbersome, I think with the to-ing and fro-ing between when we wanted to fit them
in, checking with you [the researcher] when you were available [to consent the patient and collect
baseline measures before the patient started cardiac rehabilitation] and regrouping, em, and also time
wasted initially, em, but once we got round to you phoning them in advance it was fine.
CRP 001
The new procedure to be implemented for the purposes of the study was also endorsed by the focus
group. In particular, the cardiac rehabilitation team was concerned about the amount of time required of
them to include CRC patients in their service and so welcomed any procedure that would reduce this.
Nevertheless, all of the clinicians involved in phase 1 reported that direct referrals from the cancer care
team to cardiac rehabilitation would be possible in the future if this model of rehabilitation were to be
implemented as part of routine care. Figure 4 illustrates key differences between referral and enrolment
procedures in the study and the procedures if this model of cardiac rehabilitation were to be rolled out as
part of routine aftercare.
The referral form sent to the cardiac rehabilitation team about a new patient was modified in the light of
interviews and focus group discussions with clinicians. The additional information requested is given in
Table 11.
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CNS gives study
information to patient 
on ward
Research pathway
Patient screened
for eligibility by CNS
Eligible patients referred
to research team by CNS
Researcher assesses
readiness to change
Researcher 
contacts patient for 
baseline measures
Patient is referred to
CR by researcher
On completion, patient
referred back to 
researcher by CR
Practice pathway
CNS gives information
about CR to patients
on ward
CNS refers patients 
to CR
CR screens and does
initial assessment
Patient attends CR
On completion, patient
is discharged from
outpatient CR services
FIGURE 4 Research and practice cardiac rehabilitation referral pathways. CR, cardiac rehabilitation.
TABLE 11 Additional information requested
Information Reason for request
Names and address of GP This was included (with participants’ prior consent) in case it was felt necessary to inform the
GP that a patient on their register was participating in cardiac rehabilitation
Date of surgery This information was included because CRC surgeons suggested that it was safe to exercise
4–6 weeks post laparoscopic surgery and 6–8 weeks post open surgery. Thus, cardiac
rehabilitation practitioners wished to know the date of surgery
Current medication This was included for safety reasons in case the patient became unwell during exercise classes
Relevant past medical
history
This was included for safety reasons so that cardiac physiotherapist could assess whether or
not the patient was safe to attend exercise classes
GP, general practitioner.
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Importance of exercise for patients with colorectal cancer
All three CRC nurses were supportive of cardiac rehabilitation for patients with CRC because it would help
with patient recovery.
The more exercise you do post-op, you do, you have a much better recovery rate.
CNS 001
I like to try and encourage a healthy approach to living anyway so I think it [cardiac rehabilitation]
formalises what I encourage.
CNS 002
Nurses mentioned the benefit of physical activity when recruiting patients to the study.
[The nurse said] it’s good for you, do it.
P005
Nevertheless, patients with CRC reported that they had not been informed about the role of physical
activity to reduce the risk of cancer:
Investigator: Yes. And are you aware of any things that you can do yourself to reduce the risk of the
cancer coming back?
P005: No, I haven’t been told about anything.
P005
Investigator: And, how do you think you can reduce the risk of the cancer coming back, have you
been given any steps that you can take?
P006: No.
P006
Patients with CRC welcomed the opportunity to attend cardiac rehabilitation for three reasons: physical
activity is generally beneficial, it is difficult to exercise independently, and rehabilitation provides an
environment in which patients can learn how to exercise safely. These beliefs in the benefits of cardiac
rehabilitation are likely to have influenced patients’ willingness to participate in the study.
Two patients with CRC said that being physically active would be good for them.
I’m sure that any exercise is good for us . . . em, sitting is maybe the worst thing you can be doing.
P006
You’ve got to be willing to try different things, it’s for your own good really, you want to try as much
as you can.
P001
One patient with CRC said that she was not very good at exercising on her own at home.
P005: . . . I mean, I do know it [exercise] does [help], but I’m not very good at doing it at home by
myself [laughs].
Investigator: Right, right, so you enjoy coming to a class to do it?
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P005: Eh, yes, it’s the getting here isn’t it but yes, it’s OK once I’m here it’s good for me.
P005
One patient with CRC welcomed the opportunity to attend cardiac rehabilitation because he learnt how to
safely pace himself when being physically active.
It lets you know you can safely push yourself a bit.
P006
Cancer and cardiac patients exercising together
The intervention was referral of patients with CRC who had recovered from surgery to cardiac
rehabilitation. Thus, as the physiotherapist pointed out, it is important to explain why this particular model
for rehabilitation for patients with cancer was being researched.
Initially I just thought why involve them with cardiac rehab, why not set up a pilot geared towards
cancer patients?
CRP 001
The physiotherapist found it straightforward to slot patients with CRC into existing classes.
They have come in as normal patients . . . they just slipped in and joined in.
CRP 001
Patients with CRC did not perceive mixing with cardiac patients during rehabilitation as problematic:
Investigator: And how do you feel about it being a mixed group?
P005: Oh, that didn’t bother me at all . . .
Investigator: At all?
P005: No, no.
Investigator: No, OK.
P005: I quite enjoy the various company of people, yes.
P005
Investigator: And what about it being a group with cardiac patients as well?
P001: You do talk to other people . . . most were heart, I think I was the only one with cancer . . .
eh, maybe not.
Investigator: Maybe, OK.
P001: . . . Meeting other people and sitting having a cup of tea helps.
P001
Another patient summarised the mixed groups simply:
You just accept it, and they [cardiac patients] accept you.
P006
Cardiac rehabilitation clinicians attending the focus group also endorsed mixed patient exercise classes.
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
43
Cardiac rehabilitation education sessions
As described in Chapter 3, the intervention comprised a 60-minute exercise session followed by an
education session. These education sessions were designed to provide information useful to cardiac
patients. Nevertheless, according to the cardiac physiotherapist, patients with CRC attended not only the
exercise sessions but also the education sessions.
Investigator: And how do you feel that the patients that have come through have got on generally?
CRP 001: Well, all three of them have fitted in in fact very well, em, in fact, one of them, well they’ve
just gone in to all the cardiac talks regardless.
One of the patients with CRC thought that the education sessions were the most useful part of the
rehabilitation programme. This patient had recently had a stroke and so may have found the education
sessions particularly relevant. However, given increasing comorbidity in older age, education sessions
designed for cardiac patients may be relevant to patients with cancer.
P006: . . . and the lecture is one of the best things about it.
Investigator: Right, so what things, what particular lectures have you found, did you find most helpful?
P006: Eh, drugs and eh, eh, resuscitation, although I knew something about resuscitation. But eh, eh,
just em, the, letting you know about your condition and eh, eh, how to eh be a good boy and take
care of it.
Not all education sessions, however, were regarded as useful. One patient with CRC said that the session on
smoking cessation was not relevant because most patients, including cardiac patients, had given up smoking.
. . . I don’t know whether, it may have applied, most people had given up, there was only one person
who was in the process of giving up and I really felt it wasn’t beneficial to anybody . . .
P005
As described in Chapter 3, it was planned that a CNS would deliver education sessions about cancer to
patients with CRC. However, this did not happen. Thus, the cardiac rehabilitation programme was not
altered in any way to accommodate CRC patients and patients with CRC attended classes alongside
cardiac patients.
However, the cardiac physiotherapist believed that cancer education sessions should be provided:
I feel slightly for them that they’re getting all this cardiac stuff and not really any follow-up . . . there’s
no support from the, from the cancer side as it was mooted about, eh, when we were talking about
the project that, eh, if it was cancer-specific then they would maybe, eh, if it was cardiac-specific talks
then they would maybe get some additional support and there’s just been absolutely nothing.
CRP 001
One patient also expressed a desire for cancer education:
. . . it’s more for heart than for cancer . . . I think that’s where it maybe falls down you know . . . but I
don’t know how you will do that. When push comes to shove, they really didn’t know a lot about the
cancer end of things, even [name of cardiac rehabilitation] said . . . eh . . . em, she didn’t know a lot
about it [cancer].
P001
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Chapter 5 Phase 1 discussion and
recommendations for phase 2
In this chapter the key findings from phase 1 about the feasibility and acceptability of main trialcomponents and intervention are presented. The chapter also describes the changes to improve trial
procedures and the intervention for further testing in phase 2.
Summary of findings
The results for phase 1 are clear:
l Nurses were willing to recruit patients with CRC to the study. The evidence is that nurses gave a study
information sheet to 70% (n= 24) of all surgical CRC patients and completed a screening and
recruitment form for 71% (n= 17) of these patients.
l The majority of eligible patients were willing to participate in the study. The evidence is that 10 out of
17 eligible patients (58%) signed a screening and recruitment form indicating their willingness to
participate in the study and have their contact details forwarded to an investigator.
l The surgical ward, when patients with CRC were admitted or while they were waiting to be discharged
from hospital, was an appropriate time to raise the study with patients with CRC and to give them a study
information sheet. The evidence for this is that 10 out of 17 eligible patients (58%) signed a screening and
recruitment form indicating willingness to participate in the study before being discharged from hospital.
l There were barriers (e.g. travel and poor recovery from surgery) to patients participating in the
intervention (i.e. cardiac rehabilitation), which had a detrimental impact on sample attrition.
The evidence for this is that only 4 out of 10 (40%) patients who signed a screening and recruitment
form then proceeded to start the intervention. These barriers and subsequent loss to the study of six
participants are the main reasons why we did not meet our anticipated target of recruiting 12 patients.
l A good cross-section of patients with CRC were interested in taking part. The evidence is that men and
women from the ages of 50 to 89 years, with and without metastatic disease, having open surgery and
laparoscopic surgery, with and without a stoma, and having and not having adjuvant therapy were
willing to participate in the study (i.e. signed a screening and recruitment form).
l An accelerometer was an acceptable objective method for assessing level of physical activity and sedentary
behaviour. The evidence is that participants wore the accelerometer for a validated period of time.
l Investigator administration of online patient-reported outcomes questionnaires was an acceptable method
for collecting outcomes data and was not perceived as a major burden by participants. The evidence is
that all questions were answered at baseline and follow-up and there were no missing data.
l Some parts of the questionnaire were considered by participants as repetitive and irrelevant. Some
participants found questions about quality of life very similar. Quality of life questions also failed to
capture issues relating to the impact of CRC and treatments.
l A cancer and exercise expert delivering 1-day cancer and exercise training face to face or by video conference
to cancer nurses and cardiac rehabilitation practitioners was feasible and acceptable. The evidence is that the
results of the evaluation of the training were excellent with all attendees, for instance, either agreeing or
strongly agreeing that the information and course content was helpful and well presented.
l Patient readiness to start cardiac rehabilitation varied owing to different rates of recovery and hence
the length of time from date of surgery to the start of cardiac rehabilitation also varied (54–73 days).
l Adherence was suboptimal. The evidence is that participants were expected to attend 10 exercise
classes but the four participants attended 10, 6, 5 and 0 classes, respectively.
l Cardiac rehabilitation for patients with CRC was feasible and acceptable. The evidence is that patients
with CRC attended the exercise and cardiac-specific education sessions. However, it could be improved
by introducing cancer-specific education sessions. In addition, cardiac and cancer clinicians were
supportive of this model of rehabilitation and participated in the study.
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Recommended changes to main trial components
Based on the results of phase 1, the following changes to the main trial components (Table 12) were
recommended for further testing in phase 2.
TABLE 12 Recommended changes to trial components
Procedure Original protocol Recommendation Rationale
Recruitment procedures
Time and place when
patient is first
approached about the
study
A nurse will give eligible
patients at the first
follow-up appointment
post surgery an
information sheet about
the study and talk them
through it
A nurse will give eligible
patients when they are
admitted on the surgical
ward (pre or post surgery)
an information sheet about
the study and talk them
through it
Nurses found that the surgical ward
was an appropriate place to raise
participation in a study about
rehabilitation because ways to support
recovery from surgery were being
discussed with patients on the surgical
ward pre and post surgery
Eligibility criteria
Clarification of
eligibility criteria
The study will exclude
anyone with advanced
disease
Make it clear that
advanced disease refers
only to patients with
metastatic and incurable
disease
‘Advanced disease’ is interpreted in
different ways, with some definitions
including all patients with metastatic
disease and other definitions only
including patients with incurable
metastatic disease.134 The CRC
multidisciplinary team decided that it
was inappropriate to exclude patients
who had metastatic disease but were
expected to fully recover
Measures
Amount of physical
activity
Accelerometer Introduce guidance for
patients on how to wear
the accelerometer
Based on the investigator’s experience
of giving verbal instructions to
patients about wearing the
accelerometer, we decided to also
introduce written guidance for
wearing the accelerometer. Guidance
will include a photograph of how to
wear the accelerometer and
frequently asked questions, such as
whether or not it is necessary to wear
it at night in bed when asleep
Type of physical
activity
IPAQ SPAQ IPAQ contains a large section on
job-related activity, which is not
relevant for the majority of study
participants. In addition, SPAQ is
shorter and therefore burden on
patient significantly reduced but
gathers relevant information135
Quality of life EQ-5D
SF-36
EQ-5D
FACT-C
SF-36 repeats EQ-5D and, compared
with EQ-5D, is relatively expensive to
use (EQ-5D is freely available).
Employing a CRC-specific measure,
such as FACT-C, will mean that we
will be able to assess general
health-related quality of life and a
cancer-specific quality of life
Fatigue FACIT Fatigue Scale No change
Anxiety and
Depression
HADS No change
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Recommended changes to the cardiac rehabilitation
Based on the findings of phase 1, the following changes (Table 13) to the intervention were recommended
for further testing in phase 2.
TABLE 12 Recommended changes to trial components (continued )
Procedure Original protocol Recommendation Rationale
Cancer risk perception 6-item risk perception
questionnaire
No change
Self-efficacy General self-efficacy
(10 items)
Physical activity
self-efficacy (14 items)
12 item-physical activity
self-efficacy questionnaire
The general self-efficacy questions
were too general and therefore
participants did not see the relevance,
especially when the focus is on
physical activity. One of the
coinvestigators is involved in the
ActWell trial,136 which is a feasibility
trial to reduce breast cancer risk
factors by promoting lifestyle changes
including physical activity. ACTWell
includes a 12-item physical activity
self-efficacy questionnaire. We
decided to use this tool, as its
questions were designed specifically to
measure self-efficacy in the context of
delivering a behaviour change
intervention. The added advantage is
that we can directly compare findings
between two similar studies
FACT-C, Functional Assessment of Cancer Therapy – Colorectal; SPAQ, Scottish Physical Activity Questionnaire.
TABLE 13 Recommended changes to intervention
Procedure Original protocol Recommendation Rationale
Cancer and exercise training
None
Cardiac rehabilitation
Referral procedures The nurse will refer
patients who have
agreed to participate in
the study to the cardiac
rehabilitation team who
will then contact the
patient
After the patient is
discharged from hospital
an investigator will contact
them by telephone to find
out if they are ready to
start cardiac rehabilitation.
Only when a patient
informs an investigator that
they were willing and
ready to start will the team
be informed about the
patient by the investigator
Were this model for rehabilitation to
be implemented in routine aftercare,
CRC nurses would refer patients to
cardiac rehabilitation, hence our
original plan
However, the time to start cardiac
rehabilitation after surgery cannot be
strictly regimented for CRC patients.
This is because patients vary in their
recovery and readiness to start
exercise classes following surgery. A
key barrier to patients participating in
cardiac rehabilitation is poor recovery
and so to remove this barrier they
need to be given time to recover
continued
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TABLE 13 Recommended changes to intervention (continued )
Procedure Original protocol Recommendation Rationale
To save the cardiac rehabilitation team
repeatedly contacting CRC patients to
find out if they are willing and ready
to start, telephone calls by an
investigator will be introduced. It is
only once a CRC patient is willing and
ready to attend that the cardiac
rehabilitation team will be informed
about the patient and subsequently
invite the patient to attend the
programme. Changing the time to
refer to cardiac rehabilitation was also
designed to address suboptimal
intervention adherence
Referral form Referral form Include the following
additional information:
Name and address of GP GP information was included in case it
was felt necessary to inform the GP
that a patient on their register was
participating in cardiac rehabilitation
Date of surgery Date of surgery was included because
CRC surgeons suggested that it was
safe to exercise 4–6 weeks post
laparoscopic surgery and 6–8 weeks
post open surgery. Thus, cardiac
rehabilitation practitioners wished to
know date of surgery
Current medication Current medication information was
included for safety reasons in case the
patient became unwell during exercise
classes
Recent past medical history Recent medical history was included
for safety reasons so cardiac
physiotherapist could assess whether
or not the patient was safe to attend
exercise classes
Exercise component Patients with CRC
attend exercise sessions
No change
Education component Patients with CRC
attend cardiac-specific
sessions delivered by
cardiac clinicians and
cancer-specific sessions
delivered by cancer
clinicians
No change but ensure that cancer-specific sessions are, in fact,
delivered
GP, general practitioner.
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Limitations
Phase 1 was a small study. The feasibility and acceptability of trial components and the intervention were
tested on only one site and included fewer than 10 participants. The site was a relatively small hospital
serving a rural and geographically dispersed population. It is not possible to determine if the study is
feasible and acceptable in different contexts, such as large urban hospitals with a relatively large number
of trials simultaneously taking place. It is important, therefore, to test feasibility and acceptability in more
sites with more participants.
Conclusions
The feasibility and acceptability of trial components and the intervention were tested on only one site over a
short period of 6 months, involving a very small number of patients and clinicians. Phase 1 results suggested
that nurses were willing to recruit patients with CRC to the study, the majority of eligible patients indicated
a willingness to participate in the study, the surgical ward was an appropriate place for nurses to give study
information, a good cross-section of patients with CRC were interested in taking part, and no data were
missing from accelerometers or questionnaires. Phase 1 results also highlighted barriers to CRC patient
participation, a suboptimal consent rate (we did not meet our anticipated target of recruiting 12 patients),
repetition and lack of relevance in the self-report questionnaires, a long period of time between CRC
patients indicating a willingness to participate and actually starting cardiac rehabilitation classes, suboptimal
intervention adherence and lack of cancer-specific education sessions and lifestyle advice.
A decision was reached among the research team, funder and advisory group to proceed to phase 2 with
the following main modifications to trial procedures and the intervention.
Trial procedures
l Nurses were requested to approach CRC patients about the study on the surgical ward.
l A quality of life questionnaire was removed to minimise duplication, a physical activity questionnaire
including questions about activity during work was removed and replaced with a more appropriate
questionnaire for this age group, and general self-efficacy questions were removed and replaced with
further physical activity self-efficacy questions.
Intervention
l Referral of CRC patients to cardiac rehabilitation was changed so that a referral was made only when
the patient had informed an investigator that he or she felt ready to begin exercise classes.
l The referral form was changed to include further information about patients being referred, for
example comorbidities, treatments, date of surgery and relevant previous medical history.
l Colorectal cancer nurses were requested to provide cancer-specific education sessions and lifestyle
advice to CRC patients to supplement the cardiac rehabilitation education sessions.
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Chapter 6 Phase 2 methods
In this chapter, the design and methods used in phase 2 are described.
Phase 2 design
Phase 2 was a pilot RCT. As discussed in Chapter 1, and in accordance with the MRC’s framework for the
evaluation of complex interventions,71 pilot work is valuable for helping to optimise study design and study
procedures before proceeding to a large-scale trial. A RCT is also a robust method for reporting any
preliminary effects of the intervention, with the proviso that these results are interpreted with great caution.
Participants
The study sought to recruit patients with CRC from two acute hospitals in Scotland and a large teaching
hospital in Wales. Table 14 summarises characteristics for each hospital.
Inclusion criteria
Patients were considered for inclusion if they:
l were aged ≥ 18 years, had been diagnosed with primary CRC and were in the recovery period
post surgery
l were/were not receiving adjuvant chemotherapy/radiotherapy (patients would have to wait 48 hours
after each chemotherapy session before attending cardiac rehabilitation classes).10
Exclusion criteria
The study excluded anyone:
l with advanced disease (includes patients with curable metastatic disease)
l who failed clinical/risk assessment for rehabilitation and were deemed unsafe to participate in exercise
classes; for example, according to recent guidelines, those with severe anaemia should delay exercise
and patients with compromised immune function should avoid public gyms and exercise classes10
l who had severe cognitive impairment and therefore was unable to give informed consent to participate
in the study
l unable to communicate in English, as this is the language used in the delivery of cardiac rehabilitation.
TABLE 14 Site characteristics
Hospital Classification CRC CNSs Surgeons 2012 CRC surgical admissions
Site 1 Urban and remote and rural 3 4 127
Site 2 Urban and rural 2 6 230
Site 3 Urban and rural 2 7 215
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Recruitment procedures
Recruitment took place over 7 months. The first participant was recruited on 13 January 2014 (site 1) and
the last participant was recruited on 29 July 2014 (site 2).
Based on phase 1 results (see Chapter 4), changes were made to the recruitment procedures and approved
by the NHS Research and Ethics Committee (AM01 12/12/2013). The amended recruitment procedures in
phase 2 were as follows.
A CRC clinical nurse specialist assessed patients admitted for surgery for CRC to determine their eligibility
for the study. Eligible patients were given an information sheet (see Appendix 1) by the nurse (pre or post
surgery) and the details of the study were discussed. If the patient agreed to participate in the study, the
nurse asked them to sign a screening and recruitment form (see Appendix 2), before discharge from
hospital, indicating their willingness and agreement to have their contact details given to an investigator.
Patients who, having read the study information, declined to participate were asked if they would indicate
their reasons for declining to participate on the screening and recruitment form; in addition, the patient
was asked to sign a non-participation consent form (see Appendix 4) if they were willing to have
information about them (e.g. age, gender, diagnosis or treatment) used by the investigators to assess if
participants were representative of the study population.
After discharge from hospital, an investigator contacted patients who agreed to participate in the study, by
telephone, to confirm the patient’s willingness to participate in the study and to establish if he or she was
ready to attend cardiac rehabilitation. If the patient was willing and ready to attend cardiac rehabilitation, a
mutually convenient time for the patient to meet with the investigator was arranged and formal written
consent to participate in the study was sought. If the patient did not feel able to attend cardiac
rehabilitation at this point in time (e.g. owing to poor recovery or transport difficulties) but was still willing
to participate in the study and attend cardiac rehabilitation at some point in the future, then the
investigator agreed to contact the patient again by telephone at a later date. Thus, at the first meeting with
the investigator, eligibility was confirmed and written consent was obtained. If patients declined to give
consent after hearing what the study involved, they were asked if they were willing to give their reason for
no longer wishing to participate. Consented patients had baseline measures taken and were given an
accelerometer to wear for a period of 7 days. They were given a FAQ (frequently asked questions) sheet,
which listed answers to common queries (see Appendix 9). The patient was then randomised to the
intervention or the control group (see Randomisation, concealment and blinding, which describes
randomisation procedures).
Patients randomised to the control group were informed that they would not receive the intervention, but
were given an information leaflet. They were also advised how and when to return their accelerometer to
the investigator. Patients randomised to the intervention group were informed that they would be referred
to cardiac rehabilitation.
The investigator completed a referral form and sent it on to the cardiac rehabilitation service. A member of
the cardiac multidisciplinary team (e.g. a cardiac physiotherapist or nurse) then contacted the patient and
invited them to attend a cardiac rehabilitation clinical/risk stratification assessment to determine whether or
not the patient was able to safely exercise from a cardiac clinical perspective. Physical activity goals tailored
to individual patient needs were also usually discussed at this time. Patients who were deemed safe to
exercise were then given a date to start cardiac rehabilitation.
The recruitment process at site 3 was slightly different because a research nurse carried out all of the tasks
conducted by the nurses and the investigator described above. Research nurses are nurses employed by
PHASE 2 METHODS
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hospitals in the UK to recruit to RCTs and can be working on a large number of trials simultaneously.
Decisions about the use of research nurses for specific projects are decided by research and development
managers in each NHS board. Site 3 had agreed that our study was able to make use of the research
nurse, whereas the other two sites had not.
A flow chart outlining CRIB phase 2 recruitment and follow-up procedures is given in Figure 5.
Nurse screens patients for eligibility, 
completes screening and recruitment form for all 
eligible patients and gives study information 
sheet to eligible patients
Patient agrees to participate 
and have contact details 
forwarded to the investigator
Patient declines to participate 
and, if willing, completes a 
declining to participate form
Investigator contacts patients
 to arrange consenting 
and baseline assessment 
Randomisation
Control Intervention
Patient given information 
leaflet and has usual 
aftercare (number of weeks 
varies by site)
Investigator informs 
CR and CR contacts patient 
to arrange CR assessment
Patient attends CR
 (number of weeks 
varies by site)
Investigator contacts 
patients to arrange first 
follow-up assessment
 (approximately 10–14 weeks 
after baseline)
Investigator contacts patients 
to arrange first follow-up assessment
 (approximately 2 weeks post CR)
Investigator contacts 
patients to arrange second
follow-up assessment
(approximately 3 months after 
first follow-up assessment) 
Investigator contacts patients to 
arrange second follow-up assessment
 (approximately 3 months post CR)
If assessed as unsafe
to attend CR,
patient is withdrawn
from study by
investigator
Patient withdraws and
completes a declining to 
participate form
FIGURE 5 Flow chart outlining phase 2 recruitment and follow-up procedures. CR, cardiac rehabilitation.
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Informed consent
The phase 2 informed consent procedures were identical to those used in phase 1 and are described in
Chapter 3.
Randomisation, concealment and blinding
Eligible and consenting patients were individually randomised at the end of their baseline assessment to
one of two treatment groups: cardiac rehabilitation (i.e. the intervention) or usual care plus a booklet with
information about lifestyle following CRC diagnosis and treatment (see Treatment group allocation).
To conceal the allocation of treatment from those conducting the research, the randomisation of individual
participants to a particular treatment arm was undertaken using an automated online randomisation
system, which was administered remotely and used a computer-generated code. The randomisation service
was provided by Tayside Clinical Trials Unit, a UK Clinical Research Collaboration-registered trials unit.
Once the randomisation procedure had been completed, the outcome and further details about the
allocated treatment were immediately communicated by the investigator to the participant. Because of the
nature of the intervention, it was not possible to blind participants, investigators or the clinicians delivering
the intervention (i.e. cardiac rehabilitation multidisciplinary team) to the treatment allocation.
Randomisation was stratified to take account of the three sites. This was to ensure equal distribution of
intervention and control participants per site.
Treatment group allocation
Usual care
Individuals allocated to the usual care arm of the trial were advised to follow the current advice of their clinical
team about physical activity if any advice was forthcoming. Individuals also received an information leaflet.
Intervention
The intervention was Phase III cardiac rehabilitation, which comprises exercise classes and cardiac-specific
education sessions. Education sessions about cancer delivered by a CNS were planned to supplement the
education sessions for cardiac patients. Education sessions were to be delivered either face to face to a
group of patients with CRC or individually by telephone. This was the only alteration to routine cardiac
rehabilitation planned for the study.
In each of the three sites, a cardiac physiotherapist contacted the patient and invited them to attend a
cardiac rehabilitation clinical/risk stratification assessment to determine whether or not the patient was able
to safely exercise from a cardiac clinical perspective, and also planned physical activity goals tailored to
individual patient needs. Patients who were deemed safe to exercise were given a date to attend cardiac
rehabilitation sessions alongside cardiac patients. We have used the TIDieR91 checklist to describe in more
detail the components of the cardiac rehabilitation intervention in each site (see Table 3; Tables 15 and 16).
Table 17 compares the three sites, highlighting key differences.
In addition, the investigators sought information about behaviour change techniques used by asking
cardiac rehabilitation teams. The cardiac rehabilitation team was requested to complete a behaviour
change technique taxonomy.87 However, none of the sites achieved this because the task proved too
difficult. Indeed, there is training on the use of the taxonomy (www.bct-taxonomy.com), so it was perhaps
unreasonable to request that clinicians completed this task without additional training.
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TABLE 15 Cardiac rehabilitation site 291
Item number Item Description
Brief name
1 Provide the name or a phrase
that describes the intervention
Referral to a cardiac rehabilitation programme
Why
2 Describe any rationale, theory, or
goal of the elements essential to
the intervention
Physical activity in CRC patients has shown improvement in
cancer-specific mortality and general mortality. Eight recent
systematic reviews23,24,28,29,41,45–47 of controlled trials indicate that
physical activity interventions can help address the physiological and
psychosocial effects of cancer and associated treatments in adult
patients with cancer
Cardiac rehabilitation may be an appropriate form of rehabilitation
for patients with CRC because many of their needs post treatment
are similar to those of individuals living with CHD. Studies on
patients’ experiences of needs after CABG and patients with CRC
indicate that patients with cardiac issues and cancer experience
similar problems, including pain, fatigue, anxiety and depression,
worry, appetite loss, sexual problems, sleep disturbance, and work
and financial-related difficulties, and express a need for information
about medication and self-management
THEORY
No one model best explains exercise behaviour, but the theory of
planned behaviour is used most frequently in the research and
literature. This proposes that patient behaviour is predicted by
behavioural intent, and that their actions are based on that person’s
intention to perform that behaviour, in this case cardiac
rehabilitation. Intentions are based on three factors: attitudes
towards the behaviour, beliefs of friends/relatives about the
behaviour and level of control over their actions and behaviour.
Health behaviour is, therefore, determined by a combination of
these factors, and barriers to change
What
3 Materials: describe any physical
or informational materials used in
the intervention, including those
provided to participants or used
in intervention delivery or in
training of intervention providers.
Provide information on where the
materials can be accessed (e.g.
online appendix, URL)
Patients attending cardiac rehabilitation have access to an array of
information on behaviour change for smoking, diet, healthy living,
physical activity and more. The majority of these can be accessed at
British Heart Foundation website (www.bhf.org.uk/healthcare-
professionals/resources-for-patients.aspx) and from Chest, Heart and
Stroke Scotland; however, some refer to very local events and
groups and so will be specific to area (available on request). The
patients are provided with a copy of the Scottish Borg Scale in a
leaflet that also includes information about heart rate and how to
check pulse rate. In addition, there are several wall charts and
posters at each of the five different sections of the circuit with large
photographs demonstrating each exercise. Patients are also given
laminated cards depicting exercises that they can continue to
complete at home between sessions
For intervention delivery, the cardiac rehabilitation team follows local
health board protocols, SIGN guidelines, ESC guidelines and ACPICR
guidelines as well as the BACPR core components and standards,
available at www.bacpr.com/resources/46C_BACPR_Standards_and_
Core_Components_2012.pdf
continued
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TABLE 15 Cardiac rehabilitation site 291 (continued )
Item number Item Description
A key component of cardiac rehabilitation is an exercise class
(see section 4). Patients are also invited to take part in information
sessions on CHD, misconceptions of CHD, exercise, medications,
diet, first aid, stress and relaxation, moving on and a general
question-and-answer session that are provided once a week at the
end of the exercise classes. The talks are done in both low impact
and mainstream classes once a week for 30 minutes. Smoking
cessation seminar is not provided, as patients who require this
information are referred on to smoking cessation services
4 Procedures: describe each of the
procedures, activities, and/or
processes used in the
intervention, including any
enabling or support activities
A patient will attend for an initial consultation prior to the exercise/
education classes with the cardiac physiotherapist or cardiac
specialist nurse. This involves confirming details received on referral
(past medical history, current medications, any changes to
symptoms, physical activity). Once the patient is assessed for the
intervention, they attend class once or twice a week for 12 weeks,
where they are put into a group of the most suitable level for their
abilities; this includes a lower-level group who do activities at a
lower intensity than the standard groups, to allow as many patients
as possible to benefit from the intervention
Standard cardiac rehabilitation sessions involve a 15-minute warm-up
session involving range of motion exercises, and pulse-raising
exercises to gently prepare the body for the session. The main
component involves a variety of exercise ‘stations’ but includes CV
stations (e.g. shuttle walking, cycling, step-ups) and strength
stations, also known as ‘active recovery’ stations (e.g. sit–stand and
dumbbell exercises, including bicep curls, shoulder press and upright
row) and range of motion activities (such as toe backs, knee bends,
shoulder lifts, half-jacks, side-to-side). The main sessions last
approximately 30 minutes, depending on other time pressures. This
is followed by a 10-minute cool-down, where feet are kept moving
to maintain blood return to the heart, and to allow the heart rate to
gradually reduce to resting, or near resting, values. A period of
stretching exercises follows, along with some adapted tai chi
Weekly information sessions are held for participants on a variety of
behaviour change topics. These include CHD, misconceptions of
CHD, exercise, medications, diet, first aid, stress and relaxation,
moving on and a general question and answer session
At the end of the intervention, patients are invited to continue
to maintain their physical activity by moving on to different
maintenance activities (e.g. Local Phase IV programme Healthy
Hearts who have exercise classes, badminton, swimming, walking
groups, aquacise, or Active Stirling, who provide a tailored exercise
programme for the individual)
Who provided
5 For each category of intervention
provider (e.g. psychologist,
nursing assistant), describe their
expertise, background and any
specific training given
Cardiac physiotherapist is a band 7 NHS specialist physiotherapist
with extensive experience working in cardiac rehabilitation
Cardiac specialist nurse with extensive experience working in cardiac
rehabilitation
Band 6 physiotherapist and rotational physiotherapist are also part
of the team
One cardiac physiotherapist and one cardiac nurse always present at
the class
Numbers of staff vary depending on the number of participants.
High-risk group staffing is 1 : 5. Lower-risk class 1 : 10
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TABLE 15 Cardiac rehabilitation site 291 (continued )
Item number Item Description
How
6 Describe the modes of delivery
(e.g. face to face or by some
other mechanism, such as
internet or telephone) of the
intervention and whether it was
provided individually or in a
group
Patients are seen on the ward while an inpatient for initial cardiac
event. Patients recovering from CABG or valve surgery are seen in a
separate hospital, and are referred by tertiary centres rather than
directly from ward staff
Patients who are referred to cardiac rehabilitation are contacted by
telephone to arrange for an initial consultation and the appointment
is confirmed by letter. The initial consultation takes place just
before the first exercise class on a one-to-one basis with the
specialist physiotherapist or cardiac specialist nurse and this lasts
approximately 30 minutes. The intervention is provided face to face
by the cardiac rehabilitation team specified above. This is provided in
either a hospital gym setting or a community sports centre (see
section 7) in a group environment, with numbers around 15–25 per
class depending on demand. Initial consultations are given on a
one-to-one basis with the specialist physiotherapist or nurse
Where
7 Describe the type(s) of location(s)
where the intervention occurred,
including any necessary
infrastructure or relevant features
Patients attend either the main district hospital or the local
community sports centre, depending on where they reside.
The trust provides care for individuals across the Stirlingshire,
Clackmannanshire, Falkirk and Kincardineshire regions
When and how much
8 Describe the number of times the
intervention was delivered and
over what period of time
including the number of sessions,
their schedule, and their
duration, intensity or dose
Patients will attend either once or twice per week for 12 weeks, for
sessions that last 60 minutes. Intensity of sessions is individualised to
each patient by the physiotherapist or nurse. RPE scales are used
to assess intensity
Typical parameters for cardiac patients within a cardiac rehabilitation
class are as follows
RPE – using the 1–10 Borg CR10 scale to work at range 3–4. Staff
use the ‘talk test’ to ensure the patient can speak in sentences; this
is deemed an appropriate workload. Observational skills are also
used by the experienced clinicians (e.g. facial colour; breathing rate;
work intensity and speed)
Tailoring
9 If the intervention was planned
to be personalised, titrated or
adapted, then describe what,
why, when, and how
Each patient is given a file and each week targets are set by the
physiotherapist or nurse. These targets are individualised but will
normally include attending as many sessions as possible, working at
the agreed intensity, doing the exercises properly and achieving
activity goals outside the classes. Goals set follow normal
goal-setting procedure under the SMART principle
continued
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TABLE 15 Cardiac rehabilitation site 291 (continued )
Item number Item Description
Modifications
10 If the intervention was modified
during the course of the study,
describe the changes (what, why,
when, and how)
The intervention is likely to remain constant throughout the study
period. As the cardiac rehabilitation intervention is an existing
service, there is no opportunity during this pilot study to make
changes to the intervention, unless done so by the staff running the
programme
How well (planned): if intervention
adherence or fidelity was assessed,
describe how and by whom, and if
strategies were used to maintain
or improve fidelity, describe them
Intervention adherence will be assessed using attendance at cardiac
rehabilitation classes, giving a percentage attendance figure.
This will be monitored by the cardiac rehabilitation team
How well (actual): if intervention
was assessed, describe the extent
to which the intervention was
delivered as planned
Average attendance over 12 weeks (12 sessions for low impact or
24 sessions for the mainstream participants) will be calculated.
Of the patients allocated to the intervention group, we will calculate
how many attended the programme, and the percentage of those
who completed the programme
ACPICR, Association of Chartered Physiotherapists in Cardiac Rehabilitation; BACPR, British Association of Cardiovascular
Prevention and Rehabilitation; CV, cardiovascular; RPE, Rating of Perceived Exertion; SMART, specific, measurable,
achievable, realistic, time approriate.
© 2015 BMJ Publishing Group Ltd.
TABLE 16 Cardiac rehabilitation site 391
Item number Item
Brief name
1 Provide the name or a phrase
that describes the intervention
Referral to a cardiac rehabilitation programme
Why
2 Describe any rationale, theory, or
goal of the elements essential to
the intervention
Physical activity in CRC patients has shown improvement in
cancer-specific mortality and general mortality. Eight recent
systematic reviews23,24,28,29,41,45–47 of controlled trials indicate that
physical activity interventions can help to address the physiological
and psychosocial effects of cancer and associated treatments in
adult patients with cancer
Cardiac rehabilitation may be an appropriate form of rehabilitation
for patients with CRC because many of their needs post treatment
are similar to those individuals living with CHD. Studies on patients’
experiences of needs after CABG and patients with CRC indicate
that patients with cardiac issues and cancer experience similar
problems, including pain, fatigue, anxiety and depression, worry,
appetite loss, sexual problems, sleep disturbance, and work and
financial-related difficulties, and express a need for information
about medication and self-management
THEORY
No one model best explains exercise behaviour, but the theory of
planned behaviour is used most frequently in the research and
literature. This proposes that patient behaviour is predicted by
behavioural intent, and that their actions are based on that person’s
intention to perform that behaviour, in this case cardiac
rehabilitation. Intentions are based on three factors: attitudes
towards the behaviour, beliefs of friends/relatives about the
behaviour and level of control over their actions and behaviour.
Health behaviour is therefore determined by a combination of these
factors, and barriers to change
PHASE 2 METHODS
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TABLE 16 Cardiac rehabilitation site 391 (continued )
Item number Item
What
3 Materials: describe any physical
or informational materials used in
the intervention, including those
provided to participants or used
in intervention delivery or in
training of intervention providers.
Provide information on where the
materials can be accessed
(e.g. online appendix, URL)
Patients attending cardiac rehabilitation have access to an array of
information on behaviour change for smoking, diet, healthy living,
physical activity and more. The majority of these can be accessed at
www.bhf.org.uk/healthcare-professionals/resources-for-patients.aspx.
A MI and surgery booklet is also given to patients with information
on recovery
Patients are given home exercise sheets, if appropriate
A key component of cardiac rehabilitation is an exercise class
(see section 4)
4 Procedures: describe each of the
procedures, activities, and/or
processes used in the
intervention, including any
enabling or support activities
A patient will attend for an initial consultation with the cardiac
physiotherapist and nurse. This involves confirming details received
on referral (past medical history, current medications, any pending
investigations, risk factor assessment), and includes a 6-minute walk
test to establish fitness levels and suitability for patient to attend the
exercise classes. The 6-minute walk test is repeated at the end of
the programme. Patients are given a score of perceived fitness,
and perceived confidence by the clinician completing the form.
Occupational therapy assessments are also given, if appropriate.
Referral to smoking cessation services is made if necessary
Once the patient is accepted into the intervention, they attend class
twice per week for 12 sessions over 6 weeks
Standard cardiac rehabilitation sessions involve a 15-minute warm-up
session involving range of motion exercises, and pulse-raising
exercises to gently prepare the body for the session. This is followed
by a 20- to 30-minute conditioning phase (10 CV and strengthening
stations at 2 minutes each). Ten minutes are taken for the cool
down. This is all in accordance with the ACPICR standards.
A relaxation session is given once per week
Weekly information sessions are provided with the following topics:
physical activity, healthy eating, stress management and relaxation,
CRC, cancer misconceptions and drug therapy
Who provided
5 For each category of intervention
provider (e.g. psychologist,
nursing assistant), describe their
expertise, background and any
specific training given
Two band 6 cardiac rehabilitation nurses for each class. Nurses
check blood pressure and heart rate before and after each session.
Medical condition is assessed to ensure that the patient is safe to
exercise
Band 7 physiotherapist to lead the exercise and to instruct patients
to ensure that they are exercising safely
How
6 Describe the modes of delivery
(e.g. face to face or by some
other mechanism, such as
internet or telephone) of the
intervention and whether it was
provided individually or in a
group
Intervention is provided face to face by the cardiac rehabilitation team
specified above. The maximum number of patients per class is 15.
Pre-assessments are carried out one to one by a nurse and a
physiotherapist
continued
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TABLE 16 Cardiac rehabilitation site 391 (continued )
Item number Item
Where
7 Describe the type(s) of location(s)
where the intervention occurred,
including any necessary
infrastructure or relevant features
Patients attend the sessions at the local community leisure centre.
The classes take place in the centre dance studio. The centre has
lecture room facilities for the information sessions
When and how much
8 Describe the number of times the
intervention was delivered and
over what period of time
including the number of sessions,
their schedule, and their
duration, intensity or dose
Patients will attend twice per week for 6 weeks, for sessions that
last approximately 75 minutes. The physiotherapist individualises the
intensity of sessions to each patient. Patients are taught the use of
the Borg RPE scale and heart rate monitors are used to assess
exercise intensity. Patients are given a heart rate target range to
work within, and the nurse checks monitors after every exercise
Tailoring
9 If the intervention was planned
to be personalised, titrated or
adapted, then describe what,
why, when and how
Each patient is given a pre-assessment to risk stratify and to
establish fitness levels and suitability for classes. Patients are given
an assessment of health behaviour and offered a treatment plan,
including goal setting for health behaviour change. Regular reviews
of progress are scheduled, and completed when time allows
Modifications
10 If the intervention was modified
during the course of the study,
describe the changes (what, why,
when and how)
The intervention is likely to remain constant throughout the study
period. As the cardiac rehabilitation intervention is an existing
service, there is no opportunity during this pilot study to make
changes to the intervention, unless done so by the staff running the
programme. In this site, efforts have been made to provide
cancer-specific sessions to intervention patients
How well (planned): if
intervention adherence or fidelity
was assessed, describe how and
by whom, and if strategies were
used to maintain or improve
fidelity, describe them
Intervention adherence will be assessed using attendance at cardiac
rehabilitation classes, giving a percentage attendance figure. This
will be monitored by the cardiac rehabilitation team
How well (actual): if intervention
was assessed, describe the extent
to which the intervention was
delivered as planned
Attendance over 12 sessions will be calculated. Of the patients
allocated to the intervention group we will calculate how many
attended the programme, and the percentage attendance and
programme completion
ACPICR, Association of Chartered Physiotherapists in Cardiac Rehabilitation; CV, cardiovascular; MI, myocardial infarction;
RPE, rating of perceived exertion.
© 2015 BMJ Publishing Group Ltd.
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TABLE 17 Comparison of three cardiac rehabilitation sites91
Intervention
component Site 1 Site 2 Site 3
What: materials BHF booklets
Local activities
Home exercises
BHF booklets
Chest, Heart and Stroke
Scotland resources
Local activities
Leaflet on exertion and pacing
Home exercise cards
BHF booklets
A MI and surgery leaflet about
recovery
Home exercise sheets, if
appropriate
What: procedures 1 : 1 initial assessment
Incremental Shuttle Walk Test
Class: 15-minute warm-up;
20-minute stations
(2 × 10 minutes); 15-minute
cool-down
Stretching and relaxation
Weekly information seminars
1 : 1 initial assessment
Class: 15-minute warm-up;
30-minute stations; 10-minute
cool-down
Followed by stretching/tai chi
Weekly information seminars
2 : 1 initial assessment
6-minute walk test and given a
score of perceived fitness and
confidence by HP
Class: 15-minute warm-up;
20-minute stations
(2 × 10 minutes); 10-minute
cool-down
Relaxation session once per
week
Weekly information seminars
Who Cardiac physiotherapist
Physiotherapy assistant
Cardiac rehabilitation
co-ordinator
Cardiac physiotherapist
Cardiac specialist nurse
Additional physiotherapist × 2
Specialist physiotherapist
Two cardiac rehabilitation
nurses
How Group classes (15–20 patients
per class)
Hospital gym
Low-level classes available
Group classes (15–25 patients
per class)
Main district hospital and local
community sports centre
Low-level classes available
Group classes (maximum of
15 patients)
Leisure centre
Dance studio facilities
When and how
much (dose)
Frequency: once per week for
10 weeks (10 sessions)
Frequency: once or twice per
week for 12 weeks
Frequency: twice per week for
6 weeks (12 sessions)
Intensity: 12–14 RPE
(Borg 6–20 RPE scale)
Intensity: 3–4 RPE (Borg CR10
scale). ‘Talk test’ also used.
Observation from health-care
team
Intensity: RPE and heart rate
monitor given, with
patient-specific ranges to work
within
Time: 75-minute sessions
(50-minute exercise
component)
Time: 90 minutes (55-minute
exercise component)
Time: 75 minutes (50-minute
exercise component)
Type: both CV and
resistance/strength stations
Type: both CV and
resistance/strength stations
Type: both CV and
resistance/strength stations
BHF, British Heart Foundation; CV, cardiovascular; HP, health professional; MI, myocardial infarction; RPE, rating of
perceived exertion.
© 2015 BMJ Publishing Group Ltd
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Measures
The primary objective of a future large-scale RCT will be to test if cardiac rehabilitation is clinically
beneficial for CRC patients and also if it is cost-effective. As explained in Chapter 1, there is strong
evidence that physical activity is associated with survival, improved quality of life and reduced levels of
anxiety, depression and fatigue. At the time of designing this study, the proposed primary outcome for a
future large-scale trial would be the difference in measures of physical activity (e.g. MET hours per week;
sedentary and moderate activity) between the intervention and usual care (control) group measured by
accelerometer. The proposed secondary outcomes in a future trial would be self-reported measures of
quality of life, anxiety, depression and fatigue. An economic evaluation would also be conducted.
Based on phase 1 results, some data collection instruments were replaced for testing in phase 2 (see
Chapter 4). All measures used in phase 2 are described below. A summary of outcomes and associated
measures is presented in Table 18.
Proposed primary outcome
Amount of physical activity
Amount of physical activity was assessed using the Actigraph GT3X+ accelerometer (Actigraph LLC,
Pensacola, FL, USA).92–94 Phase 1 (described in Chapter 3) procedures informed the introduction of one
amendment, which was that written guidance for wearing the accelerometer was given to participants.
Guidance included a photograph of how to wear the accelerometer and frequently asked questions, such
as whether or not it is necessary to wear it in bed when asleep (see Appendix 9).
Type of physical activity
Physical activity was assessed subjectively using the Scottish Physical Activity Questionnaire (SPAQ) to
ascertain the types of activities participants engaged in.135 SPAQ was used in phase 2 and replaced the
IPAQ (see Chapter 5 for explanation). SPAQ measures 7-day recall of leisure and occupational physical
activity. Respondents are asked to record the number of minutes for each day of the week spent
undertaking each type of activity; leisure time physical activity, which includes minutes spent ‘walking
outwith work’, ‘manual labour outwith work’, ‘active housework’, ‘dancing’, ‘participating in sport, leisure
activity or training’ and ‘other physical activity’; and ‘physical activity at work’, which includes minutes
spent ‘walking whilst at work’ and ‘manual labour whilst at work.’ The SPAQ was designed to include only
activities classed as moderate to vigorous. Test–retest reliability is strong, with a correlation coefficient of
0.998, showing it to be significant (critical value 0.436, p< 0.01; 32 degrees of freedom).135
Scoring
The sum of the total number of minutes for each type of activity is scored. The total sum of activity, for all
types, is also calculated.
Proposed secondary outcomes
General quality of life
The EQ-5D was used to measure comprehensive general health status. This instrument was also used in
phase 1 and is described in Chapter 3.
Cancer-specific quality of life
The Functional Assessment of Cancer Therapy – Colorectal (FACT-C) was used as a self-report measure of
cancer-specific quality of life and replaced the SF-36 (see Chapter 5 for an explanation). A recent review of
patient-reported outcome measures for patients with CRC summarises FACT-C’s reliability, validity,
responsiveness and acceptability, and recommends its use for measurement of cancer-related health
status.101 FACT-C has been used to measure cancer-related quality of life in trials of physical activity
interventions involving people with CRC.44,48,49 FACT-C137 is a 37-item scale that supplements the general
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TABLE 18 Phase 2 end points
Outcomes Measures
Amount of physical activity
Total mean minutes per day spent:
l sedentary
l light
l moderate
l vigorous
Total minutes per week of moderate and vigorous physical activity
Number of participants meeting ≥ 150 minutes of physical activity per week
Accelerometer
Type of physical activity
Proportion of different types of physical activity (leisure time and at work)
over 1 week
SPAQ
General quality of life
1. Health utility score for all five domains (part 1)
2. Single (separate) analysis of the five domains (part 1)
3. Total score for the thermometer (range 0–100) (part 2)
EQ-5D
Cancer-specific quality of life
Subscale scores for the following subscales (maximum score of 28 for each subscale):
l physical well-being
l social and family well-being
l functional well-being
l CRC subscale
FACT-C
Anxiety and depression
1. Total score for anxiety (maximum score of 21)
2. Total score for depression (maximum score of 21)
HADS
Fatigue
Total score (maximum score of 52)
FACIT Fatigue Scale
Physical activity self-efficacy
Total score (maximum score of 120)
Questionnaire developed by
investigators for the ActWell trial136
Risk perception
1. Total score for cognitive risk perception (maximum score of 10)
2. Total score for affective risk perception (maximum score of 10)
3. Total score for perceived severity (maximum score of 10)
Questionnaire designed by CRIB
investigators
FACT-C, Functional Assessment of Cancer Therapy – Colorectal; SPAQ, Scottish Physical Activity Questionnaire.
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version (FACT-G).138 Patients rate each item on the questionnaire from 0 to 4, where a higher score
denotes a better quality of life. The instrument consists of five subscales: physical well-being, social and
family well-being, emotional well-being, functional well-being and the Colorectal Cancer Subscale.
However, following findings from phase 1 regarding respondent burden due to repetition of questions
(see Chapter 4), we decided to remove the emotional well-being subscale, as this is covered by HADS
and EQ-5D.
Scoring
Scores are produced for each of the subscales. A higher score indicates better quality of life (range 0–28).
Anxiety and depression
The HADS was used to measure anxiety and depression. This instrument was also used in phase 1 and is
described in Chapter 3.
Fatigue
The FACIT Fatigue Scale was used to measure fatigue. This instrument was also used in phase 1 and is
described in Chapter 3.
Proposed process variables
Physical activity self-efficacy
Physical activity self-efficacy was measured using a 12-item questionnaire developed by investigators of the
ActWell trial.136 We chose these questions as they were designed specifically to measure physical activity
self-efficacy in the context of delivering a behaviour change intervention.
Scoring
Participants rate on a scale of 0 to 10 their confidence in being able to be physically active under the
following conditions: when tired, in a bad mood, when they do not have time, during bad weather, during
vacation; their confidence in following directions from an instructor, pacing, performing movements,
checking how hard activity is making them work; their confidence in their ability to exercise regularly,
overcome obstacles; and their confidence to make up times if they have missed regular exercise sessions.
Scores are totalled. A higher score denotes higher physical activity self-efficacy (range 0–120).
Risk perception
Risk perception was measured using the same 6-item scale that was used in phase 1 and is described in
Chapter 3.
Proposed clinical variables
In addition, the following clinical confounding factors were reported on the screening and recruitment form:
l colon or rectal surgery
l surgical intervention (e.g. laparoscopic or open surgery)
l temporary (a loop ileostomy) or permanent stoma or no stoma
l chemotherapy or no chemotherapy.
Sample size justification
The aim of the study was not to provide a definitive estimate of treatment effect, so we did not have a
formal sample size calculation. Rather, the aim was to provide robust estimates of the likely rates of
recruitment and retention, and to yield estimates of the variability of the primary and secondary outcomes
to inform power calculations for a future large-scale effectiveness trial. As highlighted in Chapter 1,
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there is no clear guidance for how many participants are necessary for estimating event rates such as
recruitment and willingness to be randomised in pilot RCTs. Our recruitment estimate for the pilot trial was
based on three factors, which were the estimated:
1. number of patients admitted for surgery
2. number of patients likely to meet inclusion criteria
3. recruitment rates in previous similar studies (e.g. trials of physical activity interventions for people
with cancer).
Based on information provided by the local NHS principal investigators of the number of patient
admissions in the previous year (2012), we expected 250 patients, in total, to be admitted for surgery
across the three sites over a 6-month period. Cancer clinicians involved in the study estimated that
approximately one-third (n= 83) would be ineligible and, based on recruitment to a RCT about physical
activity with patients with cancer in Scotland139 and a trial involving patients with CRC within 3 months of
completing surgery conducted in Canada,44 we estimated that just over one-third of eligible patients
would consent (n= 66) to take part. Thus, for the pilot RCT we estimated that we would recruit around
66 patients (40% of eligible patients). We estimated that sites 2 and 3 would each recruit 26 patients,
and that site 1 would recruit 14 patients, as this site admitted fewer patients for surgery than the other
two sites.
Data collection and management
Trial procedures
In phase 2, particular attention was paid to systematically collecting data about recruitment procedures,
including reporting the number of patients screened and assessed for eligibility, eligibility rate, consent
rate, retention rate, completion rate and intervention compliance. These are fundamental physical activity
intervention metrics that are essential for understanding the effects of the intervention in any future
large-scale trial. It was important, therefore, to evaluate in the pilot RCT if data on these key metrics could
be systematically collected and if outcomes indicated that a large-scale trial was feasible. The following
definitions, calculations and data collection methods were used:
l ‘Assessed for eligibility rate’ was defined as the number of people with CRC who were admitted for
surgery and assessed for eligibility using inclusion/exclusion criteria. Information about all eligible
patients with CRC considered for phase 2, and who were subsequently included or excluded, who
withdrew or who were withdrawn, was recorded by site investigators on screening and recruitment
forms and then entered into the OpenClinica (www.openclinica.com) data management system
developed by Tayside Clinical Trials Unit. In addition, investigators maintained a local site record of all
participants in the study, monitoring withdrawal.
l ‘Eligibility rate’ was calculated by dividing the number of people with CRC admitted for surgery by the
number who met inclusion criteria using data entered into OpenClinica.
l ‘Consent rate’ was calculated by dividing the number of people with CRC who met inclusion criteria
and were, therefore, eligible by the number who consented to participate in the study using data
entered into OpenClinica.
l ‘Retention rate’ was defined as the number of participants who remained in the study, that is, the
number of participants who did not formally drop out of the study, using data entered
into OpenClinica.
l ‘Completion rate’ was defined as the number of participants who completed outcome measures: that
is, the number of participants who completed the self-reported questionnaires and were given an
accelerometer to wear at baseline and at first and second follow-up and who met the validation criteria
for wearing an accelerometer. An investigator calculated accelerometer validity manually.
l ‘Missing data’ were defined as the number of participants not entered into analyses because of invalid
accelerometer data.
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l ‘Intervention adherence’ was measured by the total number of planned physical activity sessions/
consultations attended by participants allocated to the intervention group. Adherence data were
collected from the cardiac rehabilitation register of attendance. In addition, adherence data were
collected by a weekly telephone call to participants allocated to the intervention group. The purpose of
the call was to obtain information about attendance and also about the frequency, duration and type
of exercise that the participant did at the cardiac rehabilitation class (see Appendix 10).
l ‘Intervention fidelity’ was also assessed during the weekly telephone call. In particular, participants
were asked if they have received any lifestyle advice by a CRC nurse specialist as this was the main
recommended change made to the cardiac rehabilitation intervention.
Adverse events
If a research participant experienced an AE or a SAE, the investigator submitted a report to the principal
investigator and then the appropriate body was informed, depending on the nature of the event. Any
event considered to be ‘related’ or ‘unexpected’ was reported to the REC and the study sponsor. These
SAEs involved completion of the appropriate paperwork and submission within 15 days of the principal
investigator becoming aware of the event, as per the National Research Ethics Service.
A SAE is any AE occurring that results in any of the following outcomes:
l death
l inpatient hospitalisation or the prolongation of existing hospitalisation
l persistent or significant disability/incapacity.
The following protocol exclusions applied:
l hospitalisation for assault or accidental injury
l hospitalisation for pre-planned surgery.
The above protocol exclusions were recorded in the AE log (see Appendix 8) for the study and line listings
were reported annually to the ethics committee and the sponsor. Each hospital, and hence each cardiac
rehabilitation programme, also had a reporting system for AEs, and cardiac rehabilitation services operate
incident reporting. Thus, the AE reporting of study participants by was also recorded by site investigators.
Outcome measures
All participants’ questionnaires were administered online (Bristol Online Survey).140
Baseline assessment
The investigator conducted baseline assessment at the academic institution in site 1, at the academic
institution or the participant’s own home depending on patient choice in site 2 and at the hospital in site 3.
The investigator administered online questionnaires (SPAQ, EQ-5D, HADS, FACT-C, FACIT Fatigue Scale,
self-efficacy and risk perception questions) using the Bristol Online Survey.140 The majority of questions
were of a closed format, requiring participants to choose one option from a limited selection of discrete
responses. Each question was read out by the investigator and answered by the participant. The
investigator directly inputted the response to each question. The participant was also invited to wear the
Actigraph GT3x+ accelerometer for 7 consecutive days (beginning the next day). They were given an
information sheet about wearing the accelerometer (see Appendix 9). All baseline assessments were
conducted between 11 March 2014 and 29 September 2014.
Follow-up assessment
The first follow-up assessment coincided approximately with the end of the intervention delivery period,
that is, after the participant had attended the final cardiac rehabilitation class. Follow-up measures were
collected at the academic institution, hospital or participant’s own home. The investigator administered the
online questionnaires that were completed at baseline using the same procedures. The participant was
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again requested to wear the Actigraph GT3x+ accelerometer for 7 consecutive days (beginning the next
day). All first follow-up data were collected between 18 June 2014 and 20 February 2015.
The second follow-up assessment was approximately 3 months after the participant had finished cardiac
rehabilitation. The same procedures as used for first follow-up assessment were adopted. All second
follow-up data were collected between 30 October 2014 and 31 March 2015.
Analysis
Phase 2 had seven objectives. To meet objective 1 (see Chapter 2), descriptive statistics were used to
summarise screening, eligibility, consent, adherence and retention rates. Descriptive data on sample
demographic characteristics were reported as frequencies, means and SDs. Differences in categorical
variables of sociodemographic and clinical characteristics were compared between those who signed a
screening and recruitment form but withdrew from the study and those who signed a consent form and
were randomised to the intervention or control group. The reasons why eligible people with CRC did not
wish to participate or withdrew, for the purpose of analysis, were sorted into one of seven categories:
1. no longer eligible
2. distance/travel
3. stated that they are currently exercising and fit
4. clinical (e.g. poor recovery from surgery, receiving adjuvant therapy, comorbidity)
5. too much of a commitment
6. not/no longer interested
7. no reason given.
To meet objective 2, completion rates and rates of missing data were assessed by counting the number of
missed responses on the self-report questionnaires completed by participants at baseline and at 2- and
12-week follow-ups. In addition, the amount of time that participants wore the accelerometer at baseline
and at 2- and 12-week follow-ups was counted (number of days worn over maximum wear-time of 7 days
and number of hours per day worn).
To meet objectives 3 and 4, inferential statistics were used to assess any differences in outcomes between
baseline and 2- and 12-week follow-up. These analyses are described in full in the statistical analysis plan
(see Appendix 11). If data were normally distributed, outcome measures were assessed by multiple linear
regression, adjusted for baseline variables; when data are measured more than once during the study,
repeated measures analysis was also used. Scoring for outcomes follows the scoring instructions given for
each questionnaire. When no such instruction is present, the following approach was taken: if no more
than 20% of questionnaire items are missing, the missing items will be replaced by the mean of the
remaining items to build a sum score. When more than 20% of the items are missing, the sum score will
be set to missing. Outcomes were analysed as baseline versus end of intervention and baseline versus
3 months after intervention. An intention-to-treat approach was used for these preliminary analyses.
Differences were considered statistically significant at p< 0.05.
To meet objective 5, descriptive statistics were generated of the proportion of CRC participants allocated
to the intervention group who received cancer-specific education sessions or lifestyle advice from the CRC
nurse specialists.
Objective 6 is addressed in Chapter 9, which describes the embedded qualitative study, and objective 7 is
addressed in Chapter 10, which describes the economic evaluation.
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Chapter 7 Phase 2 trial results
This chapter presents the results of phase 2, the pilot RCT. Screening, eligibility and consent rates arereported alongside reasons for non-participation. We have already published our experiences of
recruitment elsewhere.141 Completion rates are also reported alongside results of analyses of the effect of
the intervention on outcomes. These results are presented to inform decisions about conducting a larger
multicentre trial to evaluate effectiveness.
Site recruitment
A total of six cardiac rehabilitation services and CRC clinicians located in the same hospital were initially
approached to participate in the study. Two sites agreed to support the research. The reason why four
sites did not wish to participate was due to cardiac rehabilitation concerns about capacity to include more
patients in their classes. All CRC teams at the six sites were willing to collaborate in the study. Following
contact with the NIHR Colorectal Cancer Clinical Studies Group, two further sites were identified and one
of these sites was invited to participate in the study. Table 14 summarises the characteristic of the three
sites involved in this study.
Flow of participants in the trial
In total, 41 individuals were recruited to the CRIB pilot trial, with 21 allocated to the intervention arm
and 20 allocated to the usual care plus booklet group. Figure 6 presents the flow diagram for the trial and
summarises patient throughput from referral to completion of the 1- and 3-month follow-ups. The
diagram also reports the total numbers of patients who were given study information, did not meet
inclusion criteria (sites 1 and 2 only), withdrew before randomisation, withdrew following randomisation or
were lost to follow-up immediately following the intervention and at 3 months post intervention.
Screening rate
Screening rate was defined as the number of people with CRC who were admitted for surgery and
assessed for eligibility. Across all three sites, there were 198 people admitted to hospital for CRC surgery
and, of these, 156 were assessed for eligibility (79%). Table 19 shows screening rates by site and shows
that the research nurse in site 3 assessed 65% of patients for eligibility, whereas the clinical nurse
specialists at the other two sites reached more patients, assessing 86% and 91% of all patient
admissions, respectively.
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Patient admissions for CRC surgery
(n = 198)
Total number of eligible patients
(n = 133)
Signed consent form
(n = 41)
Randomisation
Baseline measures 
(n = 41)
Agreed to participate and signed screening 
and recruitment form
(n = 74)
Screened for
 eligibility in sites 1 and 2
(n = 116)
Not eligible
(n = 23)
Reasons
• Poor mobility, n = 8
• Clinical reasons, n = 5
• Advanced disease, n = 2
• Unable to give consent, n = 3
• Patient full-time carer, n = 1
• Missing, n = 4
Completion rate 
• Questionnaires (97.5%), n = 40
• Accelerometers (68%), n = 28
   (intervention, n = 14; control 
   group, n = 14)
Follow-up 1
Completion rate
• Questionnaires (75.6%), n = 31 (intervention, n = 15; control, n = 16)
• Accelerometers (56%), n = 23 (intervention, n = 11; control, n = 12)
Follow-up 2
Completion rate
• Questionnaires (61%), n = 25 (intervention, n = 12; control, n = 13)
• Accelerometers (34%), n = 14 (intervention, n = 6; control, n = 8)
Control group 
(n = 20)
• Site 1, n = 7
• Site 2, n = 9
• Site 3, n = 4
Intervention group
(n = 21)
• Site 1, n = 6
• Site 2, n = 9
• Site 3, n = 6
Patients screened for eligibility
(n = 156)
FIGURE 6 Phase 2 total recruitment and sample attrition across all three sites.
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Eligibility rate
Eligibility rate was calculated by dividing the number of people with CRC admitted for surgery by the
number who met the inclusion criteria. Out of 198 patient admissions for CRC surgery, 133 (67%) met the
eligibility criteria. Table 20 shows that the proportion of patient admissions for surgery who were eligible
for the study was almost identical across the three sites (67%, 67% and 65%, respectively).
Reasons for ineligibility
Nurses at sites 1 and 2 recorded the reasons why patients were considered ineligible for the study.
Reporting of reasons for ineligibility was not recorded at site 3; data were missing for 17% of cases in the
other two sites. Table 21 summarises the main reasons why patients were considered to be ineligible.
The table shows that over half (57%) of patients were excluded because of poor mobility or other health
reasons. When these reasons are mapped to the exclusion criteria listed in Chapter 6, the main reason for
ineligibility is shown to be criterion 2, that is, ‘Patients who fail clinical/risk assessment for rehabilitation
and are deemed unsafe to participate in exercise classes’. Only 9% of patients were ineligible because they
had ‘advanced disease’ (criterion 1) and only 13% of patients were ineligible because they were unable to
provide informed consent (criterion 3). One patient was deemed ineligible because he or she was a
full-time carer, although this was not listed as an exclusion criterion.
TABLE 19 Screening rates
Site Actual admissions, N Assessed for eligibility, n (%)
Site 1 58 50 (86)
Site 2 58 53 (91)
Site 3 82 53 (65)
Total 198 156 (79)
TABLE 20 Eligibility rates
Site Admissions, N Eligible, n (%)
Site 1 58 40 (67)
Site 2 58 40 (67)
Site 3 82 53 (65)
Total 198 133 (67)
TABLE 21 Reasons for ineligibility (sites 1 and 2)
Reason given by nurse Number (%) of patientsa Exclusion criterion (1 to 3)
Poor mobility 8 (35) 2
Other health reason 5 (22) 2
Advanced disease 2 (9) 1
Unable to provide consent 3 (13) 3
Patient is a full-time carer 1 (4) N/A
Unknown 4 (17) N/A
N/A, not applicable.
a Percentages are the proportion of ineligible patients at sites 1 and 2, n= 23.
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Consent rate
In total, 74 out of 133 eligible patients signed a screening and recruitment form indicating that they were
interested in participating in the study and willing to be contacted by an investigator (i.e. 56% of the
number of people with CRC who met inclusion criteria).
The consent rate was calculated by dividing the number of people with CRC who met the inclusion criteria
(n= 133) by the number who consented to participate in the study and were randomised. Forty-one
people with CRC consented and were randomised to the intervention or usual care (control) group, which
is a consent rate of 31%. Twenty-one patients were randomised to the intervention group and 20 were
randomised to the control group.
Table 22 shows the difference between total estimated and actual patient admissions, eligibility and
randomisation rates across all three sites.
Figure 7 shows graphically the difference between the total estimated and actual patient admissions at
each stage of the recruitment process. ‘Admissions’ refers to the numbers of estimated and actual patients
admitted to hospital for CRC surgery; ‘assessed for eligibility’ refers to the number of these patients who
were assessed for eligibility for the study; ‘eligible’ refers to the number of patients who met eligibility
criteria; ‘screened’ refers to the number of eligible patients who completed a screening and recruitment
form; ‘consent to approach’ refers to the number of patients who indicated on this screening form that
they were interested in participating in the study and willing to have an investigator contact them about
the study; and ‘randomisation’ refers to the number of patients who signed a consent form and were
randomised to the intervention group or the control group.
The number of actual surgical admissions was lower than the protocol estimate (198 vs. 250). The actual
number of eligible patients was approximately two-thirds of surgical admissions, which was on a par with
the protocol estimate. In total, 133 out of 198 (67%) actual patient admissions were judged as eligible
for the study. Seventy-four eligible patients signed a screening and recruitment form indicating willingness
to participate and 41 of these patients consented and were randomised to the intervention or control
groups. Thus, 31%, as opposed to an estimated 40%, of eligible patients consented and were randomised.
Reasons for non-participation
Table 23 shows the reasons why eligible patients who signed a screening and recruitment form expressing
willingness to participate in the study then withdrew before randomisation. Most commonly, reasons fell
into the clinical category, which included poor recovery from surgery, comorbidity or receiving adjuvant
therapy (15 out of 33; 46%).
TABLE 22 Revised estimated and actual admission, eligibility and consent rates in each site
Variable
Site 1 Site 2 Site 3 All sites
Estimated Actual Estimated Actual Estimated Actual
Original
estimate Actual
Admissions 74 58 134 58 125 82 250 198
Eligible
(% of admissions)
49 (66) 40 (69) 88 (66) 40 (69) 82 (66) 53 (65) 165 (66) 133 (67)
Randomised
(% of eligible patients)
20 (40) 13 (32) 35 (40) 18 (45) 33 (40) 10 (19) 66 (40) 41 (31)
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FIGURE 7 Total differences between estimated and actual admission, eligibility and randomisation rates.
TABLE 23 Reasons for declining to participate (N= 33)
Reason All sites, n (%)
Distance/travel barriers 2 (6)
Return to normal activities 3 (9)
Clinical (e.g. poor recovery from surgery, comorbidity) 9 (28)
Other commitments/time 2 (6)
Adjuvant therapy 6 (18)
Study time limit 3 (9)
Unable to contact 1 (3)
Patient death 1 (3)
Missing 6 (18)
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
73
Retention rate
The retention rate was defined as the number of participants who remained in the study, that is, the
number of participants who did not formally drop out. As indicated above, 41 people with CRC consented
and were therefore identified as study participants. Three (7%) of these participants formally left the study
(two control and one intervention).
Completion rates and missing data
Completion rate was defined as the number of consenting and randomised participants (n= 41) who
completed outcome measures, that is, the number of participants who completed the self-reported
questionnaires and were given an accelerometer to wear. Missing data were defined as the number of
participants who were given an accelerometer but did not provide validated accelerometer data (see
Chapter 6 for definition of validity) at baseline and at first and second follow-up.
Number of participants completing the self-reported questionnaires
A total of 40 (97.5%) (20 intervention and 20 control) out of 41 participants completed the questionnaires
(SPAQ, FACT-C, EQ-5D, FACIT Fatigue Scale, HADS) at baseline and 31 (75.6%) (15 intervention
and 16 control) and 25 (61%) (12 intervention and 13 control) completed the questionnaires at the
follow-up 1 and follow-up 2 time points, respectively.
Number of participants providing valid accelerometer data
Twenty-eight (68%) (14 intervention and 14 control) out of 41 participants provided validated
accelerometer data to measure physical activity and sedentary behaviour at baseline and 23 (11 intervention
and 12 control) (56%) and 14 (six intervention and eight control) (34%) participants provided validated
accelerometer data at the follow-up 1 and follow-up 2 time points, respectively. These figures are broken
down by site in Table 24.
If all 41 participants had provided valid accelerometer data at each time point, there would have been a
total of 123 accelerometer data sets. Sixty-five (53%) accelerometer data sets were provided and, of these,
20 (31%) were removed from analysis because data were invalid, which involved 14 different participants
spread more or less evenly across the intervention and control groups. Table 25 shows reasons for invalid
accelerometer data. The main reasons for invalidity were not wearing the device and not wearing it for a
sufficient number of hours per day to meet the validation criteria.
Figure 8 shows the number of completed questionnaires and valid accelerometer data at each time point.
TABLE 24 Variation in complete data, by site
Site Baseline, n (%) Follow-up 1, n (%) Follow-up 2, n (%)
Site 1 (n= 13) 9 (69) 9 (69) 8 (62)
Site 2 (n= 18) 11 (61) 7 (39) 2 (11)
Site 3 (n= 10) 8 (80) 7 (70) 4 (40)
Total 28 23 14
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Adverse events
In phase 2, no AEs were reported. One participant was unable to start cardiac rehabilitation owing to a
torn knee ligament that was unrelated to the study.
Intervention adherence
As described in Chapter 6, adherence data were collected from the cardiac rehabilitation register of
attendance and by a weekly telephone call to the participant. Adherence rate was calculated in two ways:
1. attendance during the cardiac rehabilitation programme (i.e. site 1: once-weekly for 10 weeks= 10,
site 2: twice-weekly for 12 weeks= 24, site 3: twice-weekly for 6 weeks= 12)
2. attendance from start and end date that participant attended cardiac rehabilitation, including breaks
and absences owing to, for instance, treatment.
Thirteen out of 21 participants (62%) randomised to the intervention group completed the programme as
per protocol. Three participants started but could not complete all classes and five did not begin (38%).
Table 26 shows that the main barrier to starting or dropping out of cardiac rehabilitation was poor physical
health. Table 27 shows that participants who were able to continue with the programme had high levels
of attendance (range 75–142%).
TABLE 25 Reasons for accelerometer data removal from analysis (N= 20)
Reasons invalid Intervention, n (n= 11) Control, n (n= 9) Total, n (%)
Days worn (< 4) 0 3 3 (15)
Hours per day (< 10) 2 3 5 (25)
Not worn at all 5 2 7 (35)
Abnormal activity patterns 4 1 5 (25)
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FIGURE 8 Number of participants completing self-reported questionnaires and valid accelerometer data.
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TABLE 26 Reasons for not completing CRC classes (n= 8)
Study ID Number of sessions Reason for non-completion
Site 1 19 1 Patient unable to complete owing to arthritis problems in his ankle. He was not
suitable to attend the cardiac rehabilitation classes
Site 2 12 0 Discharged by cardiac rehabilitation team owing to high blood pressure
Site 2 22 0 Physically and mentally unfit at cardiac rehabilitation consultation
Site 2 26 2 Further treatment – operation on liver
Site 2 14 6 Found that the sessions were too easy for her and were not challenging enough
Site 3 01 0 Neuropathic pain, other scans awaited. Wanted to follow own exercises at home
Site 3 18 0 Torn knee ligaments
Site 3 20 0 Unwell during follow-up therapies, and no longer wanted to participate in study
TABLE 27 Cardiac rehabilitation attendance (n= 13)
Study ID
Number (%)
of sessions
attended First session attended Last session attended
Number
of weeks
attended
Average number
of sessions
per week
Site 1 16 8 (80) 1 May 2014 15 July 2014 12 0.7
Site 1 11 12 (120) 23 September 2014 9 December 2014 12 1.0
Site 1 02 10 (80) 15 May 2014 17 July 2014 10 1.0
Site 1 13 11 (110) 13 May 2014 26 August 2014 15 0.7
Site 1 26 11 (110) 6 November 2014 5 February 2015 13 0.8
Site 2 19 22 (92) 18 September 2014 16 December 2014 14 1.6
Site 2 06 24 (100) 26 May 2014 14 August 2014 11 2.2
Site 2 15 24 (100) 25 August 2014 8 January 2015 20 1.2
Site 2 04 25 (104) 22 April 2014 15 August 2014 16 1.6
Site 2 04 34 (142) 2 June 2014 4 September 2014 14 2.4
Site 3 07 12 (100) 17 June 2014 24 July 2014 6 2.0
Site 3 30 12 (100) 4 September 2014 23 October 2014 8 1.5
Site 3 29 9 (75) 4 September 2014 21 October 2014 8 1.1
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Participant length of time in the study
Table 28 shows baseline, follow-up 1 and follow-up 2 dates for participants who completed all time points
(intervention, n= 13; control, n= 12). The mean number of days between baseline and follow-up was 86
and 104 for control and intervention group, respectively; between follow-ups 1 and 2 it was 83 and
78 days, respectively. The total mean number of days involved in the study was 169 and 182 for control
and intervention groups, respectively. Thus, there was minimal difference in the number of days between
data collection points between the two groups.
TABLE 28 Data collection dates (n= 25)
Subject ID Date of surgery
Time
(days) Baseline
Time
(days) Follow-up 1
Time
(days) Follow-up 2
Control
Site 1 15 23 January 2014 44 25 March 2014 62 18 June 2014 185 3 March 2015
Site 1 23 17 March 2014 137 23 September 2014 56 9 December 2014 69 13 March 2015
Site 1 32 7 July 2014 58 24 September 2014 85 20 January 2015 47 25 March 2015
Site 2 05 24 January 2014 51 4 April 2014 71 11 July 2014 131 9 January 2015
Site 2 07 18 February 2014 98 3 July 2014 101 20 November 2014 60 11 February 2015
Site 2 08 4 March 2014 121 19 August 2014 134 20 February 2015 26 27 March 2015
Site 2 09 4 March 2014 61 27 May 2014 97 8 October 2014 121 25 March 2015
Site 2 10 4 March 2014 67 4 June 2014 74 15 September 2014 66 15 December 2014
Site 2 16 29 April 2014 47 2 July 2014 105 25 November 2014 60 16 February 2015
Site 2 17 5 May 2014 47 8 July 2014 134 9 January 2015 42 9 March 2015
Site 3 02 11 February 2014 119 26 July 2014 13 13 August 2014 76 26 November 2014
Site 3 09 19 March 2014 31 30 April 2014 99 15 September 2014 144 2 April 2015
Site 3 32 4 August 2014 28 10 September 2014 86 7 January 2015 51 18 March 2015
Intervention
Site 1 02 16 December 2013 66 17 March 2014 118 27 August 2014 114 2 February 2015
Site 1 11 15 January 2014 145 5 August 2014 127 28 January 2015 42 26 March 2015
Site 1 13 19 February 2014 48 25 April 2014 121 10 October 2014 90 12 February 2015
Site 1 16 16 January 2014 51 27 March 2014 106 21 August 2014 139 3 March 2015
Site 1 19 4 March 2014 143 18 September 2014 83 12 January 2015 57 31 March 2015
Site 1 26 20 May 2014 86 16 September 2014 86 13 January 2015 53 26 March 2015
Site 2 02 13 January 2014 88 14 May 2014 87 11 September 2014 84 6 January 2015
Site 2 06 6 February 2014 49 15 April 2014 90 18 August 2014 143 4 March 2015
Site 2 14 15 April 2014 45 20 June 2014 85 16 October 2014 87 13 February 2015
Site 2 15 29 April 2014 53 10 July 2014 156 12 February 2015 32 27 March 2015
Site 2 19 3 June 2014 57 20 August 2014 128 13 February 2015 30 26 March 2015
Site 3 30 25 May 2014 63 20 August 2014 63 14 November 2014 70 19 February 2015
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Comparability of characteristics of consenting and
non-consenting eligible patients
Fifty-four out of 133 eligible patients who did not consent to participate in the study consented to have
their demographic and clinical information used for the purposes of this study. Table 29 shows the
characteristics of eligible consenting and not consenting patients. It shows no significant differences in
age, gender and type of surgery (colon or rectal) between the two groups, but suggests that people with
metastatic disease (T4 and N1 classification), people who have had open surgery and people with a stoma
are more likely not to participate.
TABLE 29 Characteristics of consenting and not eligible patients who consented and did not consent
Characteristic Not consenting, n (%) (N= 54) Randomised, n (%) (N= 41)
Age (years)
n 54 41
Missing 0 0
Mean 65.6 66.0
SD 13.81 11.31
Median 65.5 67.0
Sex
Male 39 (72.2) 27 (65.9)
Female 15 (27.8) 14 (34.1)
Primary tumoura
Missing 13 (24.1) 9 (22.0)
T0 2 (3.7) 1 (2.4)
T1 1 (1.9) 3 (7.3)
T2 8 (14.8) 12 (29.3)
T3 20 (37.0) 11 (26.8)
T4 10 (18.5) 5 (12.2)
Regional lymph nodea
Missing 19 (35.2%) 13 (31.7)
Nx 1 (1.9%) 0
N0 21 (38.9) 22 (53.7)
N1 13 (24.1) 6 (14.6)
Distant metastasisa
Missing 48 (88.9) 36 (87.8)
M0 5 (9.3) 5 (12.2)
M1 1 (1.9) 0
Colon surgery
No 21 (38.9) 16 (39)
Yes 33 (61.1) 25 (61)
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TABLE 29 Characteristics of consenting and not eligible patients who consented and did not consent (continued )
Characteristic Not consenting, n (%) (N= 54) Randomised, n (%) (N= 41)
Rectal surgery
No 35 (64.8) 25 (61)
Yes 19 (35.2) 16 (39)
Laparoscopic surgery
Missing 1 (1.9) 0 (0)
No 37 (68.5) 32 (78)
Yes 16 (29.6) 9 (22)
Open surgery
Missing 1 (1.9) 0
No 21 (38.9) 18 (43.9)
Yes 32 (59.3) 23 (56.1)
Temporary stoma
Missing 3 (5.6) 0
No 39 (72.2) 35 (85.4)
Yes 12 (22.2) 6 (14.6)
Permanent stoma
Missing 3 (5.6) 0 (0)
No 45 (79.6) 34 (82.9)
Yes 8 (14.8) 7 (17.1)
Chemotherapy
Missing 11 (20.4) 7 (17.1)
No 37 (68.5) 27 (65.9)
Yes 6 (11.1) 7 (17.1)
Radiotherapy
Missing 10 (18.5) 7 (17.1)
No 36 (66.7) 29 (70.7)
Yes 8 (14.8) 5 (12.2)
Other treatment
Missing 4 (7.4) 3 (7.3)
No 49 (90.7) 35 (85.4)
Yes 1 (1.9) 3 (7.3)
a TNM stands for tumour, node, metastases. This staging system describes the size of a primary tumour (T), whether or
not any lymph nodes contain cancer cells (N) and whether or not the cancer has spread to another part of the body (M).
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Baseline comparability of demographic and clinical
characteristics of intervention and control group participants
Age and gender
No data about age and gender were missing. Twenty-seven men (65.9%) and 13 (34.1%) women were
recruited to the study. The numbers of men allocated to the intervention and control groups were
13 (61.9%) and 14 (70%), respectively. The mean age of participants was 66 (SD 11.31) years; the youngest
participant was aged 42 years and the oldest was aged 86 years. The mean ages of participants allocated to
the intervention and control groups were 67.9 (SD 11.49) years and 64.2 (SD 11.10) years, respectively.
Colorectal cancer diagnosis
Table 30 shows participants’ CRC diagnosis using the tumour, node and metastases classification system.
The table shows slight differences between participants in the intervention and control groups; for
example, seven (33.3%) participants allocated to the intervention group and four (20%) allocated to the
control group were classified as T3. However, it is difficult to make direct comparisons between the two
groups because of missing data. The table shows that nine (22%) participants had missing information
about tumour size, 13 (31.7%) had missing information about lymph nodes containing cancer cells and
36 (87.8%) had missing information about metastases. The most likely explanation for missing data is that
the tumour, node and metastases classification was not known at the time when diagnosis was recorded
on the screening and recruitment form completed by an investigator.
TABLE 30 Colorectal cancer diagnosis
Variable Intervention, n (%) Control, n (%) Total, N (%)
Primary tumour
Missing 3 (14.3) 6 (30.0) 9 (22.0)
T0 1 (4.8) 0 (0.0) 1 (2.4)
T1 1 (4.8) 2 (10.0) 3 (7.3)
T2 7 (33.3) 5 (25.0) 12 (29.3)
T3 7 (33.3) 4 (20.0) 11 (26.8)
T4 2 (9.5) 3 (15.0) 5 (12.2)
Total 21 (100.0) 20 (100.0) 41 (100.0)
Regional lymph node
Missing 5 (23.8) 8 (40.0) 13 (31.7)
N0 12 (57.1) 10 (50.0) 22 (53.7)
N1 4 (19.0) 2 (10.0) 6 (14.6)
Total 21 (100.0) 20 (100.0) 41 (100.0)
Distant metastasis
Missing 17 (81.0) 19 (95.0) 36 (87.8)
M0 4 (19.0) 1 (5.0) 5 (12.2)
M1 0 (0.0) 0 (0.0) 0 (0.0)
Total 21 (100.0) 20 (100.0) 41 (100.0)
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Type of surgery and stoma
Table 31 shows no missing data about whether participants had colon or rectal surgery and that there was
a near even split between participants allocated to the intervention and control groups who had colon
surgery or rectal surgery.
TABLE 31 Type of surgery and stoma
Variable Intervention, n (%) Control, n (%) Total, N (%)
Colon surgery
No 8 (38.1) 8 (40.0) 16 (39.0)
Yes 13 (61.9) 12 (60.0) 25 (61.0)
Total 21 (100.0) 20 (100.0) 41 (100.0)
Rectal surgery
No 15 (71.4) 10 (50.0) 25 (61.0)
Yes 6 (28.6) 10 (50.0) 16 (39.0)
Total 21(100.0) 20 (100.0) 41 (100.0)
Laparoscopic surgery
No 15 (71.4) 17 (85.0) 32 (78.0)
Yes 6 (28.6) 3 (15.0) 9 (22.0)
Total 21 (100.0) 20 (100.0) 41 (100.0)
Open surgery
No 11 (52.4) 7 (35.0) 18 (43.9)
Yes 10 (47.6) 13 (65.0) 23 (56.1)
Total 21 (100.0) 20 (100.0) 41 (100.0)
Temporary stoma
No 19 (90.5) 16 (80.0) 35 (85.4)
Yes 2 (9.5) 4 (20.0) 6 (14.6)
Total 21 (100.0) 20 (100.0) 41 (100.0)
Permanent stoma
No 19 (90.5) 15 (75.0) 34 (82.9)
Yes 2 (9.5) 5 (25.0) 7 (17.1)
Total 21 (100.0) 20 (100.0) 41 (100.0)
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Table 31 shows that more participants allocated to the intervention group than to the control group had
laparoscopic surgery [n= 6 (28.8%) vs. n= 3 (15%)], whereas more participants allocated to the control
group than to the intervention group had open surgery [n= 13 (65%) vs. n= 10 (47.6%)]. Similarly,
Table 31 shows differences between the two groups for stoma; four (19%) participants allocated to the
intervention group had a temporary stoma or permanent stoma, whereas nine (45%) participants allocated
to the control group had a temporary stoma or permanent stoma.
Treatments
Table 32 shows differences between participants allocated to the intervention and control groups who had
chemotherapy or radiotherapy; for example, five (23.8%) and two (10%) participants allocated to the
intervention and controls, respectively, had chemotherapy. However, it is difficult to make direct
comparisons between the two groups because of missing data; for instance, there were missing data
about chemotherapy for seven (17.1%) participants.
TABLE 32 Treatments
Variable Intervention, n (%) Control, n (%) Total, N (%)
Chemotherapy
Missing 2 (9.5) 5 (25.0) 7 (17.1)
No 14 (66.7) 13 (65.0) 27 (65.9)
Yes 5 (23.8) 2 (10.0) 7 (17.1)
Total 21 (100.0) 20 (100.0) 41 (100.0)
Radiotherapy
Missing 3 (14.3) 4 (20.0) 7 (17.1)
No 15 (71.4) 14 (70.0) 29 (70.7)
Yes 3 (14.3) 2 (10.0) 5 (12.2)
Total 21 (100.0) 20 (100.0) 41 (100.0)
Other treatment
Missing 2 (9.5) 1 (5.0) 3 (7.3)
No 17 (81.0) 18 (90.0) 35 (85.4)
Yes 2 (9.5) 1 (5.0) 3 (7.3)
Total 21 (100.0) 20 (100.0) 41 (100.0)
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Baseline physical activity self-efficacy and risk perception
A higher score indicates a higher level of physical activity self-efficacy (range 0–120). Table 33 shows that
physical activity self-efficacy was high and skewed towards higher scores; at baseline the mean physical
activity self-efficacy was 94.1 and 93.8 for intervention group and control group participants, respectively.
A higher cognitive and affective risk perception score (range 0–10) indicates a greater perception that
lifestyle behaviours have a protective health effect and a higher severity risk perception score (range 0–10)
TABLE 33 Baseline physical activity self-efficacy and risk perception scores
Variable Intervention Control Total
Physical activity self-efficacy total score
n 19 18 37
Missing 1 2 3
Mean 94.1 93.8 93.9
SD 19.43 20.30 19.58
95% CI 84.71 to 103.44 83.68 to 103.86 87.40 to 100.45
Median 93.8 99.5 95.0
Cognitive risk perception
n 20 20 40
Missing 0 0 0
Mean 7.7 6.8 7.2
SD 1.39 2.12 1.82
95% CI 7.00 to 8.30 5.81 to 7.79 6.64 to 7.81
Median 8.0 7.0 8.0
Affective risk perception
n 20 20 40
Missing 0 0 0
Mean 7.7 7.2 7.4
SD 1.27 1.96 1.65
95% CI 7.06 to 8.24 6.28 to 8.12 6.90 to 7.95
Median 8.0 8.0 8.0
Perceived severity score
n 20 20 40
Missing 0 0 0
Mean 6.1 5.6 5.9
SD 1.07 1.70 1.42
95% CI 5.60 to 6.60 4.81 to 6.39 5.39 to 6.31
Median 6.0 6.0 6.0
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indicates a greater perception that CRC is a more serious disease. Risk perception scores were skewed
towards higher scores. Table 33 shows little variation between the intervention and control groups; the
table shows a mean cognitive risk perception score of 7.7 and 6.8, a mean affective risk perception score
of 7.7 and 7.2 and a mean severity risk perception score of 6.1 and 5.6 at baseline for intervention and
control group participants, respectively.
Physical activity and sedentary behaviour
As discussed in Chapter 1, results about the effects of an intervention measured in a pilot study should not
be reported at all or reported only with great caution. As highlighted above, the completion rates for
accelerometer measurement were low. We therefore present descriptive data only for the primary
outcome, physical activity, and for sedentary behaviour; descriptive data for quality of life are presented in
Appendix 12. Inferential statistical analyses are not reported.
Moderate to vigorous physical activity
Per-day physical activity scores were calculated by dividing the total score by number of days worn.
Table 34 shows that participants were meeting or close to meeting the recommended level for moderate to
vigorous physical activity per day (i.e. 30 minutes of moderate physical activity per day). Mean moderate
to vigorous physical activity per day scores were skewed towards lower scores at baseline but normally
distributed at 3 months’ follow-up, indicating that those participants doing less physical activity at baseline
increased their level of physical activity over time.
Sedentary behaviour
Per-day sedentary behaviour scores were calculated by dividing the total sedentary behaviour score by the
number of days worn. Table 35 shows at baseline and follow-up that mean minutes of sedentary time per
day for intervention and control groups was similar, normally distributed and decreased slightly over time.
Change in total sedentary time per day between baseline and 3 months’ follow-up did not correlate with
any demographic (e.g. age or gender), clinical (e.g. chemotherapy, type and location of surgery or stoma)
or psychological (e.g. self-efficacy or risk perception) variables.
Type of physical activity
Table 36 shows that walking was the most common type of physical activity at baseline, followed
by housework.
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TABLE 34 Minutes per day of moderate to vigorous physical activity
Variable Intervention Control Total
Baseline
n 14 14 28
Missing 0 0 0
Mean 21.1 29.0 25.1
SD 11.68 35.90 26.50
95% CI 14.40 to 27.89 8.27 to 49.72 14.80 to 35.34
Median 20.6 10.5 17.8
End of intervention
n 11 12 23
Missing 0 0 0
Mean 25.8 36.7 31.5
SD 17.57 39.00 30.52
95% CI 14.00 to 37.61 11.90 to 61.46 18.28 to 44.68
Median 27.9 18.8 26.8
End of intervention – baseline
n 11 12 23
Missing 0 0 0
Mean 5.6 5.9 5.8
SD 12.35 17.21 14.75
95% CI –2.69 to 13.91 –5.03 to 16.84 –0.62 to 12.14
Median 0.6 3.0 2.8
3 months’ follow-up
n 6 8 14
Missing 0 0 0
Mean 22.5 54.5 40.8
SD 17.41 28.34 28.63
95% CI 4.27 to 40.81 30.85 to 78.24 24.30 to 57.36
Median 23.9 56.3 35.6
3 months’ follow-up – baseline
n 6 7 13
Missing 0 0 0
Mean 1.3 10.5 6.2
SD 15.04 28.37 22.79
95% CI –14.51 to 17.06 –15.74 to 36.73 –7.53 to 20.01
Median 0.3 7.7 4.2
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TABLE 35 Total sedentary time per day in minutes
Variable Intervention Control Total
Baseline
n 14 14 28
Missing 0 0 0
Mean 566.6 579.7 573.1
SD 96.83 80.12 87.46
95% CI 510.68 to 622.50 533.42 to 625.94 539.22 to 607.05
Median 542.9 564.7 546.1
End of intervention
n 11 12 23
Missing 0 0 0
Mean 583.7 521.9 551.5
SD 127.75 99.58 115.63
95% CI 497.86 to 669.51 458.65 to 585.19 501.46 to 601.46
Median 582.3 549.7 551.0
End of intervention – baseline
n 11 12 23
Missing 0 0 0
Mean 14.5 –50.8 –19.6
SD 119.50 81.85 104.66
95% CI –65.78 to 94.78 –102.80 to 1.21 –64.82 to 25.69
Median 44.4 –73.3 –25.4
3 months’ follow-up
n 6 8 14
Missing 0 0 0
Mean 513.4 479.0 493.7
SD 121.60 96.93 105.16
95% CI 385.76 to 640.99 397.95 to 560.02 433.01 to 554.44
Median 513.5 520.6 520.6
3 months’ follow-up – baseline
n 6 7 13
Missing 0 0 0
Mean –54.7 –73.1 –64.6
SD 184.66 86.49 134.31
95% CI –248.49 to 139.08 –153.10 to 6.88 –145.78 to 16.55
Median –7.7 –92.6 –49.7
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Intervention fidelity
All CRC participants allocated to the intervention group reported that they had not received any additional
educational sessions about cancer or lifestyle advice from CRC nurse specialists during the intervention.
TABLE 36 Mean time in minutes over 1 week spent in different types of physical activity (SPAQ)
Group Walking Manual labour Active housework Dancing Sport Other
Intervention 357 142.5 244 0.25 23.7 79
Control 337 73 114 6 44 6
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Chapter 8 Phase 2 discussion
In this chapter, a summary and a discussion of phase 2 results are presented.
Summary
Phase 2 shows that some of the key trial procedures were feasible and acceptable. The evidence for this is
as follows:
l Colorectal cancer nurses screened 79% (n= 156) of all surgical CRC patients for eligibility.
l Sixty-seven per cent (133 out of 198) of all patient admissions for CRC surgery met eligibility criteria.
l Fifty-six per cent (74 out of 133) of eligible patients signed a screening and recruitment form indicating
their willingness to participate in the study and to have their contact details forwarded to an
investigator; 31% (41) were consented and randomised to the intervention or control groups. This was
short of our target of 66 patients.
l A good cross-section of people with CRC were recruited. Men (n= 27; 65.9%) and women from the
ages of 42 to 86 years (mean 66 years, SD 11.31 years), diagnosed with rectal (n= 16; 39%) or colon
cancer (n= 25; 61%), having open surgery (n= 23, 56.1%) or laparoscopic surgery (n= 9; 22%),
with (n= 13; 32%) and without a stoma, participated in the study.
l Only 7% (2 out of 41) of participants formally dropped out of the study.
l Forty (97.5%) out of 41 participants (20 intervention and 20 control) completed the questionnaires
(SPAQ, FACT-C, EQ-5D, FACIT Fatigue Scale and HADS) at baseline, and 31 (75.6%) (15 intervention
and 16 control) and 25 (61%) (12 intervention and 13 control) completed the questionnaires at
follow-up 1 and follow-up 2 time points, respectively.
l No SAEs were reported.
l There was an insignificant difference in the number of days between data collection time points for
participants in the intervention and control groups, and the mean numbers of days in the study were
182 and 169, respectively.
Phase 2 also shows potential threats to the internal and external validity of any future trial. In this chapter,
we therefore make a number of recommendations to manage these threats. The evidence for potential
risks to a future trial is as follows:
l Thirty-three out of 74 (44.5%) of eligible participants who signed a screening and recruitment form
indicating willingness to participate in the study withdrew before randomisation. The main barrier to
going on to actually participate in the study was poor health (e.g. poor recovery from surgery).
l Thirteen out of 21 participants (62%) who were randomised to the intervention group completed the
programme. The main barrier to starting cardiac rehabilitation or stopping once starting to attend was
poor physical health.
l Completion rates for accelerometer devices decreased over time. Sixty-eight per cent (n= 28) of
participants provided validated accelerometer data to measure physical activity and sedentary behaviour
at baseline, and 56% (n= 23) and 34% (n= 14) provided validated accelerometer data at follow-up 1
and follow-up 2 time points, respectively. Across all time points, 31% (n= 20) of accelerometer data
sets were assessed as invalid. The main reason for invalidity was that the device was not worn (35%).
l Information about diagnosis (e.g. tumour size, lymph nodes and metastases) was not available for all
participants, thereby making it difficult to compare diagnosis between intervention and control groups.
l There was recruitment bias; at baseline, participants were meeting or nearly meeting recommended
levels for physical activity (i.e. 30 minutes of moderate physical activity per day), had good self-reported
quality of life and low levels of fatigue and low anxiety and depression, high physical activity
self-efficacy and risk perception.
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l Analyses suggest no intervention effect on outcomes, but given that the study was not designed to
evaluate health outcomes, had a small sample size and poor completion rate for the primary outcome
(i.e. physical activity), this finding is not reliable.
l Intervention fidelity was compromised because no additional cancer-related education sessions were
provided for CRC participants attending cardiac rehabilitation.
Strengths and limitations of phase 2
People with CRC who agreed to participate in this study may be particularly keen to increase their level of
physical activity, which means that the findings from CRIB may not be applicable to people with CRC who
are likely to be less interested in being physically active to aid their recovery and reduce risk of recurrence.
In addition, this pilot trial was small scale, recruiting patients with CRC from only three UK hospitals.
Nonetheless, this is the first time that an already existing rehabilitation service (i.e. cardiac rehabilitation)
has been pilot tested for people with cancer. In this respect, these findings are novel and can be used to
inform future research directions. Importantly, phase 2 highlights ways in which trial procedures can be
improved for a future large-scale trial to measure effectiveness.
Key trial parameters
In this chapter we discuss the CRIB study in relation to similar studies. Thus, Table 37 compares key trial
parameters of physical activity interventions for people with CRC. Although we make comparisons
between studies, CRIB was the only pragmatic trial. We tested an existing NHS service (i.e. cardiac
rehabilitation) in real-world settings, whereas all of the other trials were experimental, with an intervention
specifically designed and controlled by the research team. Studies use different definitions to report rates
and so we applied the following definitions and calculations for the purposes of comparison:
l Design of the study was defined as a RCT, a non-randomised trial or a before-and-after study of
the intervention.
l Mode of the intervention was defined as exercise classes, exercise counselling (telephone or face to face)
or home-based exercise prescription (i.e. participants are given physical activity goals at the start of the
intervention and expected to meet these goals without any or with minimal contact with an instructor).
l Registered patients referred to the pool of people with CRC that potentially eligible participants were
identified from through screening (e.g. in CRIB this was the number of people with CRC admitted to
hospital for surgery).
l Assessed for eligibility was defined as the number of people with CRC who were assessed for eligibility
using study inclusion/exclusion criteria.
l Eligibility rate was calculated by dividing the number of people with CRC who were assessed for eligibility
by the number who met inclusion criteria (note this is different from how we defined eligibility rate in
Chapter 7, which was calculated by dividing the number of people with CRC admitted for surgery by the
number who met eligibility criteria). The calculation was changed for Table 37 because so few studies
report the number of patients potentially eligible; instead, they report the number screened for eligibility,
which is generally a considerably smaller number. Making the change allowed us to compare more studies.
l Consent rate was calculated by dividing the number of people with CRC who met inclusion criteria
(i.e. eligible) by the number who consented to participate in the study.
l Completion rate was calculated by dividing the number of participants who had consented to
participate in the study by the number of participants who completed outcome measures at different
time-points (e.g. baseline and follow-ups).
l Missing data were defined as the number of participants not entered into analyses because of invalid
accelerometer data.
l Intervention adherence was calculated by dividing the number of planned physical activity sessions/
consultations by the number actually attended.
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Eligibility rate
The proportion of people with CRC who were assessed and found eligible in CRIB was 85% and the
proportion of people with CRC who were found eligible from the total number of registered patients was
67%. As Table 37 shows, these figures compare favourably with other studies.
The studies reported in Table 37 have different inclusion and exclusion criteria, which will obviously
influence the proportion of assessed participants who are judged as eligible to participate in a study.
The ways in which these criteria are likely to impact eligibility rates and also likely to influence study bias
and generalisability of results are discussed below.
Table 38 shows that 6 (including CRIB) out of 13 studies specified that only people aged ≥ 18 years were
eligible;49,145,146,148 two studies excluded people who were aged > 75 years143,150 and another excluded
people who were aged > 65 years.142 Given that it is very rare for young people to have a CRC diagnosis,
we can confidently assume that a lower age criterion does not have a decisive influence on eligibility rates.
Nine studies (including CRIB) included language restriction as a criterion,44,49,142,143,145,146,149,150 suggesting a
bias towards people who speak a country’s first language and thereby potentially limiting generalisability
of the study findings to other groups of the population. In CRIB, no patients with CRC were excluded
because they were unable to speak English, suggesting that this criterion did not have any bearing on the
eligibility rate. However, language restriction may impact on eligibility rates in any future multicentred trials
that are likely to include areas in which some people do not have English as their first language.
One inclusion criterion that is likely to influence generalisability of study results is level of physical activity.
As Table 38 shows, two studies were specifically designed for people who were not currently physically
active,48,49 whereas other studies did not apply physical activity behaviour as part of inclusion/exclusion
criteria. Thus, most studies may have included people who were physically active, although as we
highlighted in Chapter 1, evidence suggests that most people with CRC are unlikely to be meeting
recommended levels for physical activity, which makes it probable that most participants in these studies
were not physically active when they started the trial. Nonetheless, our baseline data show that most
participants were already meeting or nearly meeting recommended levels for physical activity, suggesting
that CRIB attracted people who are already physically active and therefore less in need of an intervention
designed to increase people’s level of physical activity associated with health benefits (i.e. 30 minutes per
day of moderate physical activity).
Another inclusion criterion that is likely to influence generalisability of study results is diagnostic inclusion
criteria, which varied across studies. As Table 38 shows, CRIB excluded people with advanced disease but,
as we discussed in Chapter 5, this is an ambiguous term. CRIB did not exclude people with CRC who
had metastatic disease. Six studies specifically mentioned that people with metastatic disease would be
excluded or only people with local disease would be included.49,143,145,146,148–150 Thus, there appears to be a
bias towards people with early-stage disease, thereby limiting generalisability of findings to people with
metastatic disease.
Most studies included only people who had completed active treatment. Only one study was specifically
designed for people who were on active treatment (i.e. receiving adjuvant chemotherapy);148 one
study (CRIB) included people on or off active treatment, seven studies made it clear that people on
active treatment would be excluded,49,142–144,147,149,150 and it was not clear in four studies if people on active
treatment were included or not.44,144–146 We are aware of only one current physical activity intervention trial
for people with CRC on active treatment.151 Thus, there appears to be a bias towards people who have
completed active treatment. Our study suggests that there may well be good reason for only including
people with CRC post treatment; one of the main reasons why participants who were interested in
participating changed their minds was because they felt unable to partake in an exercise class while having
chemotherapy. Thus, for practical reasons alone, a post-treatment trial may be more feasible.
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Virtually all studies had exclusion criteria for contraindications for physical activity, which was the most
common reason for exclusion. As shown in Chapter 7, most people with CRC who were excluded from CRIB
fell into this category because they had a medical problem (46%). Moreover, as described in Chapters 4 and
9, CRC nurses were not approaching some people with CRC about the study because they believed that
they were unable to attend, or would not be interested in attending, cardiac rehabilitation owing to poor
health. The CHALLENGE trial has recently reported that staff did not approach people who ‘do not look like
an exerciser’.152 Similarly, most people who were excluded from a study conducted by Courneya et al.44 fell
into the clinical category (55% excluded owing to a medical condition). It is likely, therefore, that this
particular exclusion criterion explains why most people are excluded from physical activity trials.
This criterion, therefore, ought to be clearly defined and explained to the clinicians and investigators
involved in screening people with CRC for eligibility so that they know what the contraindications for
physical activity are and can apply criteria competently. Training of recruiters is therefore required. Our
study aimed to include people with a stoma, on active treatment and with a cardiac condition, even
though these are known potential, albeit not automatic, contraindications for physical activity. Moreover,
cardiac rehabilitation does accommodate people with poor mobility, wheelchair users and those who are
very frail, and therefore we also did not set out to exclude people with these difficulties. If this exclusion
criterion were to be applied too stringently, then people with CRC who can potentially benefit from the
physical activity intervention would be excluded. As we showed in Chapter 7, our study suggests that
cancer care nurses who screened patients were excluding people with poor mobility, suggesting that
cancer care nurses may require additional information about the ways in which cardiac rehabilitation
accommodates people who face mobility difficulties.
Excluding people from studies, however, is not inherently incorrect; what is important is that it is made clear
which subgroups of the sample population are included and excluded and that reasons are given.
To improve reporting of research and the ability to make reasonable judgements about the relevance of
particular physical activity interventions for subgroups of the sample population, we recommend the
development of standardised inclusion and exclusion criteria. Table 39 presents potential minimum inclusion
and exclusion criteria for future trials of physical activity interventions for people diagnosed with CRC.
TABLE 39 Minimum criteria for trials of physical activity interventions for CRC survivors
Criterion Description
Age Indicate age range for inclusion
Time Provide a time frame for inclusion. Consider the following times as reference points: date of diagnosis,
date of surgery, date of active treatment completion
Diagnosis Recommend use of AJCC system
Treatment Make it explicit if people on active treatment (e.g. adjuvant chemotherapy) are included
Physical activity 1. Make it explicit if people are included by any assessment of level of physical activity/sedentary behaviour
2. Make it explicit if people are excluded by any assessment of readiness to be physically active
(e.g. stage of change)
3. Make it explicit if people are excluded by physical functioning (e.g. poor mobility, use of wheelchair)
Contraindications Recommend use of American College of Sports Medicine exercise guidelines for CRC survivors.153
The following contraindications may be a reason for exclusion or may be used to guide exercise
modifications (e.g. reduced impact, intensity, volume) and hence it should be made explicit if these
subgroups of the sample population are included or excluded:
l fracture risk
l compromised immune function
l cardiac conditions
l stoma (e.g. risk of blow in contact sports and risk of hernia in weight training)
AJCC, American Joint Committee on Cancer.
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Consent rate
Table 37 shows that our study consented 31% of all eligible patients, which is slightly lower than an
average of 40% (range 8–98%). It is also lower than our estimated target of 66 patients across the three
sites. However, if 31% is a proxy for the number of people with CRC likely to take up the offer of cardiac
rehabilitation, should this service be established as part of routine cancer care, then attendance of people
with CRC would be 12% lower than the number of patients with CHD who attended phase 3 cardiac
rehabilitation in 2011–12 (43%).62 Given that cardiac rehabilitation for people with CHD is a
well-established service that has been audited by the British Heart Foundation since 2004, a rate of
31% engenders optimism that uptake among people with CRC would eventually match attendance rates
among people with CHD. Nevertheless, we acknowledge that consent rates for research and for an actual
service are not directly comparable.
Table 37 suggests that consent rates are unrelated to research design or intervention mode. Not all studies
included reasons why eligible participants declined to participate in a study, but, of those that did, ‘medical
conditions’ and ‘not interested’ were the most common reasons given for eligible participants not
consenting. Table 40 shows the reasons why eligible participants did not consent in those studies that
provided these data.
Based on our study and those of others, we anticipate that one of the main barriers to participation in
physical activity interventions is a person’s health. In our study, for instance, some eligible participants were
unwilling to participate because they were receiving adjuvant chemotherapy and did not perceive that they
would feel well enough to attend an exercise class. Some of the health difficulties that people with CRC
experience that may impede involvement in a physical activity intervention are discussed further in the next
chapter, which reports and discusses the findings from our qualitative study.
Of note, many of the barriers that we found are not dissimilar to reasons why people with CHD do not
attend cardiac rehabilitation. A recent audit of UK cardiac rehabilitation, for instance, found that 33% did
not attend because they were not interested, 7% did not attend because of travel difficulties, 9% did not
attend because of physical incapacity and 3% did not attend because they were too ill.62 Addressing some
of the barriers to people attending rehabilitation will, therefore, be relevant to people with CHD as well as
people with CRC.
TABLE 40 Reasons why eligible participants do not consent (%)
Reason CRIB
Lin et al.
2014148
Lee et al.
2013147
Pinto et al.
201349
Courneya
et al. 200344
Sellar et al.
2013149
Hawkes
et al. 2013146
No response 3 5 98 15 5 13
Medical condition 28 26 25 28
Adjuvant therapy 18
Travel 6 9.5 15 7
Not interested 50 20 29.5 21 74
Too busy 6 9.5 1 25 17.5 16
Already active/returned
to normal activities
9 0.5 0.5 5 7
No reason/missing 18 0.5 0.5 5 3
Other 5 2 5 3
Eligible but exceeded
capacity/study time limit
9 44
Deceased 3 10
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Retention, completion rates and missing data
Loss of consenting participants to a study may be due to a combination of factors, including participants
formally dropping out of the study (retention rate), failing to complete outcome measures (completion
rate) or failing to provide valid data (missing data). Loss of participants during trial follow-up can introduce
bias and reduce power, affecting the generalisability, validity and reliability of results.154 Thus, information
about retention and completion rates and missing data is important for assessing bias.155 It has been
estimated that a 20% loss can threaten trial validity.154 Some missing data can be dealt with statistically;
nevertheless, the risk of bias due to missing data can remain156 and, therefore, should be reported
alongside other rates.
Table 37 shows completion rates for CRIB and other studies. Our completion rate was slightly below
average in comparison with other studies. The ongoing CHALLENGE trial has also experienced losses to the
study;152 at first follow-up, 189 out of 250 (75%) randomised participants completed outcomes measures,
and at second follow-up it was 141 out of 250 (56%) randomised participants. Our completion rate for
patient self-reported questionnaires (i.e. most studies used self-report to measure outcomes) at first
follow-up was 31 out of 41 randomised participants (75.6%), whereas other studies’ completion rates
ranged between 79% and 95%. Our completion rate at second follow-up was 25 out of 41 (61%).
This difference may be a reflection of differences between pragmatic and explanatory trials. CRIB was a
pragmatic trial of an already existing service (i.e. cardiac rehabilitation), whereas all of the others were
explanatory trials. In CRIB the intervention was independent of the actual study and it may be that
participants were committed to the service (evidenced by high intervention adherence) but not to the
actual study. Any future trial of CRIB should, therefore, introduce strategies to improve completion rates.
A 2014 systematic review157 of 38 randomised retention trials evaluating six broad types of strategies to
increase questionnaire response and retention in randomised trials concluded that no strategy had a clear
impact on increasing the number of participants returning to sites for follow-up but found that the
following strategies may improve questionnaire response: addition of monetary incentives for return of
postal questionnaires, recorded delivery of questionnaires, and a ‘package’ of postal communication
strategies with reminder letters.157
Accelerometer validation
Our primary outcome was physical activity. Objective measures of physical activity and sedentary behaviour
have been increasingly used to overcome limitations of self-report measures. Research conducted among
the general population suggests that self-reported measures of physical activity and sedentary behaviour
are inaccurate when compared with objective measurement from devices such as accelerometers.158–160
A 2014 study comparing accelerometer-based and self-reported measures of recent moderate- to
vigorous-intensity physical activity (MVPA) and sedentary time in colon cancer survivors found that total
mean minutes per day spent in MVPA was 12 minutes based on accelerometer data and 26 minutes based
on self-reported data (p< 0.01).97 Correlation between the methods was fair (Spearman’s rank-order
correlation= 0.51); however, agreement was poor [intraclass correlation coefficient (ICC)= 0.33]. Mean
daily time spent sedentary was similar in both methods (≈ 8.5 hours); however, both correlation and
agreement were poor (Spearman’s rank-order correlation= 0.19, ICC= 0.16). Pinto et al.49 also found poor
to fair agreement between self-reported and accelerometer-derived physical activity. Our research used
objective (accelerometer) and self-reported measures of physical activity and also found poor agreement
between the two measures.
Despite the advantages of obtaining an objective measure of physical activity and sedentary behaviour,
there are few guidelines for using accelerometers in research161,162 and little guidance on improving
participant compliance.147 Our study shows that 31% of accelerometer data sets were invalid, mainly
because participants did not wear the device. Some of the challenges of using accelerometers in research
involving people with CRC are described in Chapter 9 and include difficulties wearing the device around
the waist after abdominal surgery. Recommended approaches for improving compliance include a daily
monitoring log filled out by participants, reminder telephone calls, adequate education about the monitor
and its proper wear, and the identification of potential barriers to wearing with each participant.163
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Intervention adherence
Intervention adherence refers to the extent to which participants randomised to the intervention group
follow specific treatment therapy instruction as per intervention protocol. Low adherence increases the risk
of policy and service commissioners rejecting physical activity interventions that may actually be effective
should compliance levels be high. Addressing the problem of adherence is, therefore, important. As
reported in Chapter 7, our study shows that 62% of participants randomised to the intervention group
completed cardiac rehabilitation and that the main reason for either not starting cardiac rehabilitation or
stopping it was poor physical health. Table 41 shows adherence rates of physical activity interventions for
people with CRC. It is difficult to draw direct comparisons because studies use different ways of measuring
intervention adherence. Nonetheless, CRIB compares favourably with most studies that use exercise classes
as the intervention mode.
Sample size calculation for a definitive randomised
controlled trial
This study did not set out to measure the effectiveness of the intervention; rather, it was conducted to
find out if cardiac rehabilitation is a feasible and acceptable rehabilitation service for people with CRC and
to gather information to hone trial procedures for a future effectiveness trial. The feasibility work has
provided process information that can inform a future trial but the effect data are insufficient to support
a robust sample size calculation for a future definitive RCT. This is due to a small number of eligible
participants being recruited (n= 41), decreasing completion rates at follow-up (61% at final follow-up),
missing data (31%) and a recruitment bias of physically active and healthy participants.
TABLE 41 Intervention adherence
Study Mode Intervention adherence
CRIB Exercise classes 13 (62%) completed cardiac rehabilitation; attendance was 75–142%
Anderson et al. 2010144 Counselling 18 (90%) had three home visits
Bourke et al. 201148 Exercise classes 90% attendance of sessions
Courneya et al. 200344 Home-based
exercise prescription
76% of exercise group met physical activity target, compared with
46% who met the intervention target in control group
Grimmett et al. 2015145 Counselling 18 (96%) completed all telephone consultations
Hawkes et al. 2013146 Telephone-delivered
health coaching
81.4% of participants received at least 6 of 11 telephone sessions,
whereas 77.3% received at least 8 sessions and 72.2% received all
11 telephone sessions. The median number of sessions was 10
(range 1–11), and median call length for all calls was 31.5 minutes
(range 13.3–59.7 minutes)
Lee et al. 2013147 Home-based
exercise prescription
19 (82.6%) completed intervention
Lin et al. 2014148 Exercise classes 73% of exercise sessions; 52.4% attending at least 75% attendance
sessions
Pinto et al. 201349 Counselling A mean of 11.42 calls (SD= 1.39 calls) were delivered to the
intervention group (maximum 12 calls)
Sellar et al. 2013149 Exercise classes Nine (31%) completed 100% of sessions; 20 (69%) completed
≥ 98% of sessions; 27 (93%) completed ≥ 80% of sessions
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Recommendations for improving trial procedures for a future
effectiveness trial
Phase 2 suggests that it is feasible to conduct a definitive trial. Nonetheless, based on the results of phase 2,
Table 42 presents proposed recommended changes to main trial components and their estimated impact.
TABLE 42 Recommendations for improving trial parameters
Parameter Recommendations Rationale Impact
Screening None Screening rate compares
favourably with those of other
studies; CRC nurses screened
79% (n= 156) of all surgical CRC
patients for eligibility
–
Eligibility Remove language as
exclusion criterion
A multicentred study is likely to
include areas in which English is
not the first language for some
people
We do not envisage a significant
impact on eligibility rate
Exclude people already
meeting recommended
levels of physical activity
People meeting recommended
levels of physical activity will
already be maximising their
chances of obtaining the health
benefits associated with
post-diagnosis physical activity.
It does not seem a good use of
resource, therefore, to include
these people
This change in criteria is likely to
reduce the eligibility rate because
studies suggest that approximately
40% of people with CRC are
meeting recommended levels for
physical activity
In addition, our study shows that
most participants were nearly
meeting or were meeting
recommended levels for physical
activity and therefore greater
efforts will have to be made to
include those who are less active.
To apply this eligibility criterion in
any future study, patients could
be screened using a self-report
physical activity questionnaire to
assess current physical activity
Include people with poor
mobility
The study shows that the main
reason nurses excluded people
with CRC was poor mobility
(35%). However, most cardiac
rehabilitation services
accommodate people with poor
mobility, including people who
use a wheelchair. Cardiac
rehabilitation also accommodates
people with poor physical health
(e.g. a low-intensity class for
people who are in poor physical
health)
This change to criteria should
impact on eligibility rate by
approximately 35%
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TABLE 42 Recommendations for improving trial parameters (continued )
Parameter Recommendations Rationale Impact
Consent Exclude people who are
on active treatment, such
as adjuvant chemotherapy
The study shows that one of the
reasons why people with CRC
who wanted to participate in the
study changed their minds or why
some participants who were
randomised to the intervention
group were unable to attend
cardiac rehabilitation was because
they did not feel able to exercise
while on treatment. Changing the
eligibility criteria should, therefore,
remove this barrier to participation
This change to the criteria should
not impact on eligibility rate but
merely delay when people are
invited to enter the study (i.e. post
treatment). We estimate it will
improve the consent rate by 20%
(18% of those who were
interested in participating
changed their minds because they
were having adjuvant therapy)
and intervention adherence by
25% (25% of participants
randomised to the intervention
group did not complete cardiac
rehabilitation because of ongoing
treatment)
Completion Introduce evidence-based
strategies to improve
completion rates at
follow-up including:
monetary incentive and a
‘package’ of postal
communication strategies
with reminder letters
The study shows that 61% of
participants completed final
follow-up measures
Evidence is lacking about the
actual impact of these strategies
on completion rates. Based on
other studies’ completion rates
(80–90%), we estimate an
improvement of 20–30%
Missing
accelerometer
data
Introduce strategies to
improve accelerometer
wear-time, such as
training investigators to
explain the importance of
these data for the study
to participants and
providing individual
feedback on level of
physical activity recorded
by the device
The study shows that 31% of
accelerometer data sets were
assessed as invalid. The main
reasons were not wearing the
device or not wearing it for long
enough
There was variation across sites
and one site hardly had any
invalid accelerometer data sets.
One possible reason is that the
investigator in site 1 had a sports
science background and therefore
was familiar with measurement of
physical activity and could explain
how to wear these devices
properly. We estimate 10%
invalid accelerometer data sets in
any future trial
Missing diagnostic
information
Ensure that investigators
request this information
once it becomes available
Diagnostic and treatment
information was recorded at
screening and therefore some of
the diagnostic information was
unavailable at this time
We estimate 100% of diagnostic
information will be recorded in
any future trial
Intervention
adherence
None There were genuine health-related
reasons why people were unable
to attend cardiac rehabilitation,
and, of those who did attend,
attendance rates were very good
(range 75–142%)
–
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Chapter 9 Phase 2 qualitative study
This chapter presents the findings of the qualitative study that was nested within the pilot RCT (phase 2).Interviews and focus groups about the feasibility and acceptability of trial procedures and of the
intervention (i.e. the feasibility and acceptability of using cardiac rehabilitation for people with CRC) are
presented and discussed from the perspectives of people with CRC and people with CHD, and cancer and
cardiology clinicians.
Introduction
Qualitative methods are an essential part of a trial’s evaluation and particularly apt for exploring the
feasibility and acceptability of trial components and the intervention as opposed to measuring outcomes.
Qualitative methods in RCTs can be used to understand and improve main trial components, such as
recruitment.164 Qualitative methods can also be used to explore processes, contextual factors or
intervention characteristics and mechanisms that can aid the interpretation of trial outcomes.165
Nevertheless, qualitative studies as an embedded component of RCTs remain uncommon,166 although
there has been a recent growth in use of qualitative methods under the auspices of the MRC
Collaboration and Innovation for Difficult or Complex Randomised Controlled Trials (ConDuCT) Hub.167–170
The phase 2 qualitative study nested within the pilot RCT explored participants’ and clinicians’ views and
experiences of the main components of the trial and the intervention (i.e. cardiac rehabilitation). The
specific aims were to investigate:
l the views and experiences of CRC participants of the main trial procedures (e.g.
recruitment, randomisation)
l the views and experiences of cardiac rehabilitation as a feasible and acceptable rehabilitation
programme for CRC from the perspectives of CRC participants, people with CHD attending cardiac
rehabilitation, and cardiac rehabilitation clinicians and CRC nurse specialists.
We have used the COnsolidated criteria for REporting Qualitative research, a 32-item checklist for
interviews and focus groups,171 to guide the structure of this chapter.
Research team
Four investigators collected qualitative data by interview and focus group. All four investigators attended
a 1-day training course in conducting qualitative interviews organised by the Social Research Association
Scotland and one of the investigators involved in data analysis also attended 1-day training in qualitative
data analysis. None of the investigators conducting interviews and focus groups was involved in providing
patient care. Three were employed on the study as research assistants employed by the University of
Stirling and one was a research nurse employed by the NHS trust.
Study design
Participant selection
Purposive sampling was used to select people for participation in the qualitative study to include people
with CRC and people with CHD, and cancer and cardiac clinicians, across all three sites. In addition, if
a participant with CRC nominated a family member, then that family member was also interviewed.
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People with colorectal cancer
All trial participants (i.e. people with CRC) had provided informed consent at baseline to be approached by
an investigator about being interviewed. All participants (randomised to intervention or control groups)
were contacted by telephone and invited for interview. If a participant was willing to be interviewed,
a mutually convenient time and place was arranged to conduct the interview. To minimise participant
burden, this was often arranged at the same time as a follow-up measure was being assessed. Interviews
were at either the first (i.e. within 2 weeks of the end of the intervention) or the second follow-up
(i.e. approximately 3 months post intervention), depending on what was most convenient for participants.
Face-to-face interviews were conducted with patients with CRC at the end of the intervention delivery
period for those allocated to the intervention group (i.e. after the patient had attended the final cardiac
rehabilitation class) and for participants allocated to the control group at the first or second follow-up.
Interviews were conducted in the cardiac rehabilitation facility in sites 1 and 3 and in the cardiac
rehabilitation facility or the participant’s home in site 2, depending on participant preference. The mean
duration of interviews can be seen in Table 43.
Patients with CRC participating in the trial were requested to nominate a family member to be interviewed
by an investigator about the use of cardiac rehabilitation as a treatment for people with CRC. However,
only one participant nominated a family member. Reasons given by some participants for not nominating
a family member were as follows:
l their partner was deceased
l they had no partner or children
l their partner was unwell
l they did not feel comfortable nominating a family member.
Given that only one family member was nominated and interviewed, the views of family members are not
included in this report.
People with coronary heart disease
Cardiac rehabilitation staff identified people with CHD and approached them about the study, inviting them
to attend a focus group at a specific time and day. The investigator running the focus group consented
those who attended the focus group before conducting the discussion. The focus group took place at the
cardiac rehabilitation facility in each site. The mean duration of focus groups can be seen in Table 43.
Clinicians
An investigator approached CRC nurses involved in recruitment and cardiac rehabilitation physiotherapists
and nurses delivering the intervention and invited them to attend a semistructured face-to-face interview.
The CRC nurses at site 1 who were involved in identifying eligible patients with CRC for the study had
already been interviewed in phase 1 and so were not interviewed a second time for phase 2; the
perspectives of these clinicians about the trial are reported in Chapter 4. We did, however, interview the
TABLE 43 Mean duration of interviews
Interview group Mean duration in minutes (range)
Cardiac rehabilitation clinicians 19 (13–23)
CRC clinicians 24 (17–40)
Intervention patients 41 (18–60)
Control patients 17 (7–30)
Cardiac focus group 14 (11–17)
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cardiac rehabilitation physiotherapist again at site 1. The main reason for conducting a further interview
was because she was involved in actually delivering the intervention and so would have more experience
of including people with CRC in her classes and might have changed her views as a consequence of
further engagement with more people with CRC. No CRC nurses were interviewed at site 3 because none
was involved in the trial; this is because a research nurse was employed instead to conduct recruitment
and collect data at this site.
The face-to-face interviews were conducted with CRC nurses and cardiac rehabilitation clinicians delivering
the intervention about the acceptability of main trial components and the intervention. The interviews
were conducted at the end of the intervention delivery period either in the hospital or at the university.
The mean duration of interviews can be seen in Table 43.
Data collection
All qualitative data were collected between 18 June 2014 and 9 April 2015. Semistructured interviews
were chosen for collecting data from people with CRC and clinicians because they allow flexibility in terms
of the sequence in which questions are asked, and whether or not and how particular areas might be
followed up and developed with different interviewees.129 Focus groups were chosen for collecting data
from patients with CHD because they are a practical method for involving a group of patients.
The interview and focus group schedules were as open-ended as possible to enable participants to raise
issues important to them. Interview schedules (see Appendices 8 and 9) were used to assist the investigator
in gathering responses about the feasibility and acceptability of the intervention and trial procedures.
However, the order of topics covered varied considerably between interviews to ensure that each interview
and focus group was informal and open-ended to suit individual participants. Table 44 summarises the key
topic areas explored with each group. With participants’ permission, interviews and focus groups were
audio-recorded; no participants refused having the interview/focus group audio-recorded.
TABLE 44 Key topic guide explored with each group
Participant group Topic area
Patients with CRC allocated
to intervention group
l Recovery from treatment for CRC (e.g. what do you think can reduce your risk of a
recurrence of cancer?)
l Experiences of attending (e.g. what were you expecting from cardiac rehabilitation?)
l Effect on physical, mental and general health (e.g. did the programme improve your
physical ability to function?)
l Difficulties and challenges of cardiac rehabilitation for people with CRC (what could be
changed to suit the needs of people with cancer?)
l Format and structure (e.g. how did you feel about being part of an exercise class with
people who were not recovering from cancer?)
l Trial design (e.g. what did you think about the questionnaire you were asked
to complete?)
Patients with CRC allocated
to the control group
l Recovery from treatment for CRC (e.g. what do you think can reduce your risk of a
recurrence of cancer?)
l Trial design (e.g. when you were randomised to the control group what were
your thoughts?)
l Cardiac rehabilitation for people with CRC (e.g. what do you think about being part of
an exercise class with people who were not recovering from cancer?)
Patients with CHD l Mixed patient groups
l Difficulties for people with CRC attending cardiac rehabilitation
l Similarities and differences for recovery from CHD and CRC
Cancer and cardiac
rehabilitation clinicians
l Initial thoughts about the study (e.g. what did you think the study might involve for
you and your workload?)
l Patient feedback (e.g. what reactions did you receive from patients when introducing
the intervention?)
l Cardiac rehabilitation (e.g. how helpful do you think it will be for your patients?)
l Study process (e.g. was the paperwork concise and easy to use?)
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Analysis
Thematic analysis – ‘a method for identifying, analysing and reporting patterns within data’172 – was used.
Two investigators analysed qualitative data: one was involved in conducting the interviews and focus
groups and the other was the principal investigator. Audio-recorded interviews were transcribed verbatim
and analysed thematically. The Framework approach, which is a rigorous method providing a structure
within which qualitative data are organised, coded and themes identified, was used to guide the
analysis.173 In brief, the investigators first became familiar with the interviews transcript data by reading
and rereading transcripts and assigning data (sentences and paragraphs) to themes that related to the
study objectives (e.g. barriers to participation in cardiac rehabilitation); second, a narrative summary of
coded data was made under each theme and initial themes were refined; and third, the investigators
referred to the original data to ensure that participant accounts were accurately presented to avoid
misinterpretation. Using this method, participant quotations were summarised in tables. Tables were
produced for each theme and contained summaries of each participant’s views and experiences. Finally,
behaviour change theories and models were drawn on to facilitate interpretation of the data,174 and
associations and patterns between themes were charted and, where relevant, mapped to theories to
explain the findings.
Different investigators completed the qualitative analysis before analysis of the trial data so that the
findings would not bias interpretation of the qualitative and quantitative material and vice versa.
Findings
Number of participants
In total, 38 participants were involved in the qualitative study. Table 45 summarises the number of
participants in each site.
Out of 41 consenting and randomised patients with CRC, 22 (54%) were interviewed, 3 (7%) formally
withdrew from the study, and therefore were not invited for interview, and 16 (39%) declined an
interview. Reasons for non-participation are presented in Table 46. Eight patients with CHD were involved
in a focus group discussion. In total, two CRC nurses at site 2 and six cardiac clinicians across all three sites
were invited for, and participated in, an interview.
For all quotations, letters followed by a unique number are used as participant identifiers; letters indicate
the following:
l CR: cardiac rehabilitation clinician
l CRCN: CRC nurse
l CHDP: patient with CHD attending cardiac rehabilitation
l control: participant allocated to control group
l intervention: participant allocated to intervention group.
TABLE 45 Qualitative participants
Site
Patients with CRC
Patients with CHD CRC nurse Cardiac rehabilitation clinicianIntervention Control
1 6 1 4 0 1
2 3 6 0 2 2
3 3 3 4 0 3
Total 12 10 8 2 6
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Key themes and subthemes
Unsurprisingly, key themes closely matched the interview and focus group topic guides shown in Table 44.
There are five key themes: benefits for people with CRC attending cardiac rehabilitation, barriers for
people with CRC attending cardiac rehabilitation, generic versus disease-specific rehabilitation, key
concerns about including people with cancer in cardiac rehabilitation and barriers to involvement in a study
about cardiac rehabilitation (CRC participants only). Themes and subthemes are presented in Table 47.
Clinician interviews
Benefits for people with colorectal cancer attending cardiac rehabilitation
Clinicians’ perceived main benefits of cardiac rehabilitation were that people with CRC would increase
their level of physical activity, overcome fears about being physically active, gain in confidence and become
more motivated to exercise, access peer support and forge new friendships and obtain psychosocial
support from trained clinicians.
TABLE 47 Themes and subthemes
Themes Subthemes
Benefits for people with CRC attending cardiac rehabilitation l Delivered by health expert
l Benefits of physical activity
l Confidence
l Motivation
l Peer support
l Social skills
Barriers for people with CRC attending cardiac rehabilitation l Travel and distance
l Recovery from treatments
l Stoma
Generic vs. disease-specific rehabilitation
Key concerns about including people with cancer in cardiac rehabilitation l Capacity of cardiac rehabilitation
l Capability of clinicians
Barriers to involvement in a study about cardiac rehabilitation
(CRC participants only)
l Randomisation
l Study information
l Participant burden
¢ Questionnaires
¢ Accelerometers
TABLE 46 Reasons for declining interview
Reason Number (n= 16)
Did not want to talk about cancer 3
Unable to be contacted 3
Not well enough to be interviewed 2
Did not attend 1
Too busy 1
Unable to enter study within study time period 4
Missing 2
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Cardiac rehabilitation clinicians perceived that people with CRC who attended their classes enjoyed them.
Certainly the patients that have attended the programme were very enthusiastic in fact as far as
I know they enjoyed it.
CR 001
I think they’ve benefitted a lot from exercise. They all seemed keen.
CR 005
Delivered by health expert
Cardiac rehabilitation clinicians emphasised that a key advantage for people attending was the quality of
support that they would receive from NHS clinicians.
I think it’s the same with any rehabilitation, it doesn’t matter what condition you have, it’s more that
they’ve got support from NHS professionals. That they’ve got support from peers . . . em, the structure
of the classes is that they had, they know that they’re coming to rehab[ilitation] you know, 2 days a
week. It gives them confidence to go out and do the exercises themselves, and at what levels they can
work at and how hard that they can push themselves. Em, so from that point of view, it’s similar to
your cardiac patents and probably any patients that come for rehab. That early intervention is really,
or short-term benefits are giving them the confidence in how much that they can do, giving them the
advice, giving them, em, the structure about, em, advice about pacing their activities.
CR 003
They have the support obviously. It’s just having someone to ask isn’t it? It’s just having a link I
think sometimes.
CR 005
Colorectal cancer nurses also perceived that a key benefit of this model of rehabilitation was that people
with CRC were being guided and supported by trained clinicians. They were, therefore, completely
reassured that people with CRC would be safely exercising under close supervision of and with support
from qualified clinicians.
Well, it gives them a reason to get out of the house, erm, so it actually gave them a physical resource,
it was good exercise, erm, because it was supervised by physiotherapists. You knew they wouldn’t be
overdoing it, erm, which is quite important because people think they are actually better than they
are, especially within the first few weeks after an operation . . . And there is a physiotherapist there
and if there are any concerns they wouldn’t let them do it.
CRCN 006
Indeed, knowing that patients were being referred to a service delivered by clinicians was one of the
reasons why this model of rehabilitation was attractive to CRC nurses as well as to patients with CRC.
CRC nurses believed that some of the patients would not have attended a gym but were willing to
attend cardiac rehabilitation because clinicians, who were able to offer them a greater degree of safety
and understanding of their illness experiences, delivered it.
I think the thing that sold it was the fact that there was going to be physiotherapists and nursing staff
there with the patients because they worry about hurting themselves and they were all quite happy to
do whatever as long as they were under supervision and I, I got that from all the patients I spoke to.
They would not have gone into a gym without something knowing what they had been through.
And it gave them reassurance from them and that’s why some of them took it on when they were
people who maybe did exercise anyway because they were worried about the wound and the work
that had been done inside and so that, that was definitely a bonus.
CRCN 007
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Benefits of physical activity
Many cardiac rehabilitation and CRC clinicians believed that any increase in physically activity, no matter
how small, was of benefit to patients.
People think you need to be, you know, like be an athlete or really working full pelt to get benefit
from exercise, but you know, absolutely not, wherever you start from and you’re increasing it
gradually, it’s going to benefit.
CR 003
I mean some [patients] are very fit but others, erm, do need a wee bit of help so it’s good to be able
to offer something.
CRCN 007
Additionally, it was pointed out by one CRC nurse that getting fitter was especially important for those
patients who were likely to require further treatment such as further surgery or adjuvant therapy because
their ability to cope and recover from treatment would be likely to be improved if their overall general
health was better.
I suppose I think of the patients that I need to retreat or are involved with their retreatment. If we can
get them their fitness back again it means that we have a healthier bunch of patients if ever in the
future we need to give them chemotherapy or reoperate on people. You know there are people who
are going to get recurrences and some people that won’t, but if they’re fitter it stands them in a
better area to actually have treatment.
CRCN 007
Thus, cardiac rehabilitation was seen as helping patients to recover from past treatment but also preparing
them for any future treatments. Indeed, cancer care clinicians were aware of the benefits of being fit,
which was why they approved this study.
They [CRC surgeons] were all quite happy. We never had any of the surgeons saying, ‘No, don’t
introduce that to my patients’. They were all quite happy that, I mean they wanted their patients fitter.
CRCN 007
Confidence
Cardiac rehabilitation gave people with CRC the confidence to start to become more physically active.
Cardiac rehabilitation reassured them that they could be physically active following cancer diagnosis
and treatment.
I think after any sort of event you’ve been through, it’s all, a lot about confidence isn’t it. And what
our patients tell us they get from the programme the most is confidence.
CR 005
I think just enjoyment and inclusiveness, erm, they found quite helpful and you know, some of the
supporting information, even just pacing and company, erm, was the most, yes, there were quite a
few things that they seem to be, to enjoy about it . . . I think the reassurance, erm, it was actually the
fear factor for exercising is one of the biggest things, erm, again company, hopefully motivating.
CR 001
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Motivation
Cardiac rehabilitation clinicians also believed that their programme would motivate people to start
becoming physically active. Cardiac rehabilitation provided a structure and regular opportunity to exercise,
which was believed to motivate people to engage in physical activity. Moreover, cardiac rehabilitation
motivated people to be physically active because by attending they experienced an improvement in
their recovery.
I think when you’ve got that kind of slot where you must go, it helps to discipline people to do it. And
then they begin to see the difference that it makes and that encourages them to, to do a bit more . . .
when they actually, when they begin to see the improvement it does encourage them and it’s great,
we see huge difference in people here, absolutely.
CR 002
Peer support
Cardiac rehabilitation and CRC clinicians believed that the intervention provided people with CRC with an
opportunity for peer support. The interviews gave a sense that peer support arose from the shared
experience of participating in group-based exercise. Thus, peer support did not emerge as a consequence
of the shared experience of being diagnosed with, and treated for, the same condition (e.g. CHD or CRC),
but was a consequence of the shared experiencing of recovering from illness and using the same
rehabilitation service to aid recovery. Thus, in this sense, cardiac rehabilitation was a social opportunity for
people to tap into support from their peers, as well as an exercise opportunity.
A lot of them get, erm, peer support from the folk round about them, ‘I’ve been through that. I was
anxious like you, terrified to do anything’. And then they see people down the line, you know a lot
better and it kind of gives them a wee bit of hope.
CR 002
I think once you exercise in a class situation you’re getting support inadvertently aren’t you? Even
though they’re not talking about their cancer or their heart they’re working together in an exercise
situation and chatting more generally I suppose rather than about their real condition.
CR 004
I think it’s a fantastic intervention. I think it will be really beneficial for people, not only from an
exercise point of view but just even from a social aspect, getting out there and being social again. If
their surgery, erm, meant that there was huge like body image changes to them that may, erm, it
reinforces the fact that they can do the things that they might have thought that they were unable to
do after their surgery, so I think it’s a very positive thing.
CR 008
I do think, it’s not just exercise that’s offered it’s the social side of it as well which I think is great . . .
it’s certainly something that my own patients [people with CRC] have commented on.
CRCN 007
Furthermore, cardiac rehabilitation provided an arena in which friendships were forged based on mutual
interest, as opposed to based on being diagnosed and treated for the same disease. A cardiac
rehabilitation clinician described the friendship between two golfers attending the classes, one of whom
had CHD and the other had CRC.
He’s going to meet up with one of the patients to play golf so he’s made a friend I suppose. They’re
both keen golfers and they’re going to meet up now.
CR 005
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Barriers for people with colorectal cancer attending cardiac rehabilitation
Colorectal cancer nurses, in particular, believed that cardiac rehabilitation should be available to as wide a
group of patients as possible because of the benefits of physical activity. They perceived, however, that it
might be less suitable for people who were very unfit or wheelchair-bound.
Everyone should have the opportunity to decide for themselves, em, no matter what their level of
ability is, so you treat everyone sort of in the same respect when it comes to CRIB [name of this study]
unless they were very much affected by their mobility, by that I mean wheelchair-bound or, you know,
they’re just so unfit that even surgery was a struggle.
CR 008
There were, however, obstacles and concerns about including all patients, which are described below.
Travel and distance
Cardiac rehabilitation and CRC clinicians pointed out that travel distance acted as a barrier to attending,
and perceived this as a general, as opposed to a disease-specific, barrier. In other words, people with CHD
also encountered travel problems as a barrier to attending cardiac rehabilitation.
It can be difficult because this area covers, it’s wide you know it’s a huge distance for a lot of people
to travel, so for some patients it is, it is a problem and we’ve had cardiac patients that won’t come
because transport is a problem.
CR 002
The vast majority [of patients with CRC] were really interested [in participating in the study] but the
distance was always an issue.
CRCN 006
Recovery from treatments
There were, however, some barriers and concerns that were seen to be unique or particularly prevalent
among people with CRC. People with CRC were seen to experience protracted recoveries from treatment.
As a consequence of protracted recoveries, there was a need for a flexible start date for being referred to,
and attending, cardiac rehabilitation. Thus, the optimum time for people with CRC to start was difficult to
determine. This is in contrast to people with CHD, for whom there is an expected time point following the
cardiac event at which they start their rehabilitation (e.g. post myocardial infarction, 4 weeks; post
angioplasty, 2 weeks; and post CABG surgery, 6 weeks).175
They [people with CRC] were all very keen, very motivated . . . a couple of patients, I think, just with
what they had gone through, were a wee bit hesitant about what they would be able to do. Certainly
one lady that we’ve recently assessed, she’s still ongoing treatment and wound haven’t healed and
things like that, so at her point in her treatment she’d not ready to start rehab but is very keen to
obviously continue with you know the rehab programme when she’s, when she’s fit and able for it.
But no, there was no sort of negative reaction, just, you know, em, initially it’s more, again it’s the
advice that we give all our patients, it, take it at their own pace, don’t do anything that hurts them,
em, and just to let us know if there’s any of the exercises that they wouldn’t be happy about.
CR 003
Colorectal cancer nurses recommended flexibility with regard to people with CRC starting rehabilitation
because of protracted recoveries.
There were some patients who were fit and then something would happen to them and they basically
crashed maybe a couple of, maybe a week or two after surgery. And you introduced them to the
study but you know they were never going to go on it because they had kind of side effects and
would infections and chest infection problems that, erm, it took maybe months, actually to get over.
CRCN 007
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CRC clinicians also felt that a flexible start date was required because they believed that some people with
CRC only realised that they might need help getting active again further on in the recovery process. It
appears that some people need time to mentally adjust to the fact that they may require some help with
their recovery.
I don’t think they realise how much stamina they lose postoperatively. They think they’re just going to go
home and get right back out there and they cannot do it but it takes them a wee while to accept that.
CRCN 007
Chemotherapy was a concern for cardiac rehabilitation clinicians; they expressed uncertainty, for instance,
about whether or not people receiving chemotherapy should be exercising at all.
Investigator: What were your concerns about patients recovering from cancer surgery?
CR 001: I think the biggest issue, I think, to being with, was the timing and chemo[therapy]
and I suppose my main concern would still remain the chemo[therapy].
Investigator: Side effects?
CR 001: You know, the time of them and how it affected them coming or whether they should be here
at all.
CR 001
Investigator: And were you a little anxious about practical issue such as risk infection . . .?
CR 002: The only thing about infection was, I was worried about if someone was maybe coming on
chemotherapy or something like that and it was like the cancer patients that were going to pick up an
infection. But that was all, there was nothing else, no, nothing else.
CR 002
Colorectal cancer nurses were aware that chemotherapy treatment could put people with CRC off being
physically active. Nurses believed that the side effects of chemotherapy varied from one patient to the
next, which was why they did not recommend excluding people undergoing adjuvant chemotherapy from
the study. Indeed, nurses encouraged people on treatment to try to lead as normal a life as possible.
The chemo[therapy] is an issue because it affects people differently, so if you’re, erm, you are going to
be missing with people who are because they are immune suppressed we would worry about that to
some degree, but again, you know, they can’t, you would expect them to still be sort of living as
normal a life as possible, but yeah, it is a concern.
CRCN 006
Despite voicing concerns about people with CRC exercising if they were also undergoing adjuvant
chemotherapy, cardiac rehabilitation clinicians recognised the importance of early intervention if people
with CRC were to gain the most benefit from the programme. This was because physical activity is a key
component in the recovery and rehabilitation process.
I think the intervention for these patients [with CRC] should be sooner . . . should there be a timetable
that, you know, try and get people in that wee bit sooner so that they’re going to get the maximum
benefit from the rehab[ilitation]? So they know exactly you how to pace-up, what they’re doing, what
exercise they can and cannot do . . . When is the best time for them to come to rehab? You know,
obviously, with the cardiac it’s a sort of set times . . . should they [people with CRC] be starting
6 weeks post surgery or is it that it is 3 months down the line?
CR 003
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The CRC nurses confirmed that referral of CRC patients to a cardiac rehabilitation programme should
occur at least 6 weeks following surgery.
It would normally be about 2 months before they feel back to normal anyway or 6 weeks they should
be starting to feel decent. They are not allowed to drive before 6 weeks anyway so that would stop
some people coming, laparoscopic is about a fortnight.
CRCN 006
Stoma
A potential barrier to people with CRC participating in group-based rehabilitation is having a stoma. Two
cardiac rehabilitation clinicians commented that one of the people with CRC in the group who had a
stoma was very conscious about a possible odour, and this impacted on her interactions with others.
I’ve kind of noticed particularly that one of the ladies from the colorectal cancer group, she is just, she
thinks that everybody can smell her . . . you know, she didn’t want to get too near people, erm, she
would kind of change her position over, you know over the room in here because she thought there
would be a smell and if she moved then people wouldn’t see it.
CR 002
A stoma was also a concern for cardiac rehabilitation clinicians because they were not sure what to do if
there was a problem.
Investigator: Did you have any fears looking after these patients?
CR 004: My only fear was if we had one with a stoma and there was a problem with it.
Generic versus disease-specific rehabilitation
Cardiac rehabilitation clinicians recognised that there may be financial incentives in introducing a generic
rehabilitation service for people with long-term conditions other than CHD, but they also perceived the
need for specialist input. Indeed, their experience of including people with cancer led them to conclude
that it was feasible to develop a much broader and more inclusive rehabilitation programme. Moreover,
many programmes were already expanding their client group to include people with heart failure, and so
the seed for including other patient groups had already been planted prior to this study.
This study suggests that all cardiac rehabilitation clinicians recognised that the programme’s exercise
component was generic and applied to all participants regardless of their specific condition. Indeed,
exercise was individually tailored by fitness level and not by the type of disease that a person was
recovering from.
Investigator: Did you tailor the classes for our patients?
CR 004: No, not at all. Absolutely no difference whatsoever in the class. We tailor the exercises
individually but not because they were cancer patients.
Similarly, CRC nurses recognised that offering healthy lifestyle advice was applicable to all patients,
irrespective of the disease they were recovering from.
It doesn’t matter what, what the problem is you know a healthy diet is a healthy diet.
CRCN 007
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There is, perhaps, an inevitable tension between the specialist and generic qualities of a rehabilitation
service. On the one hand, cardiac rehabilitation clinicians recognised that they had the skills and
knowledge that would be used to benefit other patient groups, and on the other hand, they recognised
that specialist knowledge about a particular disease was essential for providing quality care.
CR 001: I think, really, from a financial position, and I know that, erm, from a management point of
view, I think we’re really being pushed toward generic classes.
Investigator: And how do you feel about that?
CR 001: And part of me doesn’t like the idea at all, but I would have to say, well, with this patient
group, it’s not really been any different so it’s not caused problems, so I suppose I’m kind of, erm,
[laughs] . . .
Investigator: Has that reassured you slightly?
CR 001: Yes, I mean, certainly from this group that’s been involved . . . it wasn’t a problem in itself, I
suppose, erm, on your patient group, you know, if you are talking about having pulmonary in there as
well, again, it just involves different expertise . . . which is always just a bit concerning, erm, and that’s
why I’m slightly guarded with that because the you suddenly say, ‘Oh, we’ll just have all the diabetics
and we’ll have this and we’ll have that’, erm, I mean, in fairness, we have a lot of diabetic patients
and they have not generally been an issue either, but I’m not a specialist in diabetes.
Thus, when asked about developing a comprehensive rehabilitation programme for people with a range of
long-term conditions, cardiac rehabilitation clinicians did not dismiss the idea, but they had reservations
because of the need to retain a specialist disease component.
Moreover, alongside this recognition of the need for specialist support, there was reticence among cardiac
rehabilitation clinicians about having to provide support to a group of patients other than people with
CHD, because this was outside their specialist clinical domain. The interviews give the impression that
some cardiac rehabilitation clinicians wished to maintain their ‘cardiology’ identity.
Investigator: Would you be happy to have more patients?
CR 004: Yeah definitely.
CR 004
Investigator: And what are your opinions on mixing classes with different long-term conditions?
CR 002: I really don’t know because my speciality is cardiac I don’t have the knowledge maybe that a
lot maybe like psychological support for cancer patients . . . I’m not a counsellor by any manner of
means but I can answer a lot of questions for folk with cardiac problems. Folk that came from the
bowel cancer thing, I didn’t have that knowledge so I did feel a wee, I know that we can always
phone and ask someone, but it’s quite good if there is somebody, you know, if you do know a wee
bit . . . we do get quite specialists in out our own wee bit so I would be a bit apprehensive, I would
need to look into it a wee bit more.
CR 002
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My specialist area is obviously cardiac. Yes, we can give general advice about pacing and adapting
exercises and things like that but . . . from a specialist support point of view I felt that the support was
lacking from the bowel cancer side of things, you know, some of the issues that we’ve had to deal
with . . . maybe we shouldn’t be having to deal with, you know, because we’re cardiac rather than
bowel cancer . . . Yes, there’s obviously some certain similarities . . . when it comes to exercise and
advice then, yes, you know, that’s something that is very general for everybody, but when it comes to
tailored advice about medications or em, food and things like that, they, erm, then it really needs to
be sort of tailored towards the specialist area.
CR 003
One cardiac rehabilitation clinician suggested that further information could be provided so that he
or she could appropriately signpost people with CRC to specialist support. Thus, rather than providing
psychological support or dietary advice for people outside their specialist area, their role would be to point
the person with CRC in the right direction so that they could access specialist support. Signposting was
something that the clinician already did for people with CHD, and so it was not unfamiliar.
What other resources are available to the bowel cancer patients? What else is available, what
literature, what resources can they tap into as well would be useful for us to know about. You know,
push them in the right direction of what information they needs. Obviously with the cardiac stuff you
know we’ve got the British Heart Foundation, Chest, Heart and Stroke, you know, we know what
websites are.
CR 003
Cardiac rehabilitation includes exercise and information sessions. Cardiac rehabilitation clinicians believed
that some of the information sessions would be relevant to people with CRC as well as to people with
CHD, including sessions about the benefits of exercise, stress management, relaxation and healthy lifestyle.
Cardiac rehabilitation clinicians reported that people with CRC attended most of the information sessions.
They usually ended up coming to them all because they found them very interesting . . . Two of the
cancer patients were on cardiac medications anyway so em, they’ve obviously found it really useful
from that point of view.
CR 005
Nevertheless, the cardiac rehabilitation clinicians noted that they were unable to provide some specialist
information for people with CRC because the information sessions were geared towards people with CHD.
The sessions that we have, em, some of them would be relevant to both. The benefits of exercise is
relevant to both groups, stress relaxation would be relevant to both group. But we do medications,
so we do all the cardiac drugs we do coronary heart disease and treatments, investigations, we do
misconceptions, so there’s a whole chunk of our education that is very geared to folk, you know with
cardiac problems. For folk coming from like a cancer point of view, healthy lifestyle, absolutely, you
know it’s good for everybody, not just folk with health conditions, but there’s probably a lot of issues
there that, you know, are just not relevant to, to folk in that group, and maybe they’ve go other
things that would be more beneficial, you know, that could be covered for them that we’re not
covering in our cardiac programme . . . the bowel cancer nurses maybe could have arranged a
particular session for the with stuff that was relevant for them . . . if they had ileostomies, colostomies,
certain foods that maybe upset them and different things.
CR 002
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As the above quotation illustrates, dietary advice was a key omission in what cardiac rehabilitation was
capable of providing for people with CRC. Another cardiac clinician also highlighted the lack of dietary
advice available for those people with CRC attending the intervention.
We obviously offer dietetic input and a lot of the bowel cancer patients were interested in the dietetic
side of things but they were having issues with the dietician because although it’s general healthy
living, they feel that they need specific dietary advice . . . so that was, you know, a gap that you’re sort
of noticing with the service. It’s maybe that you know they might need some sort of more dietary
input as well to see what they can and cannot eat and what would be beneficial for them.
CR 003
Although CRC nursing teams were encouraged to provide information sessions as part of the cardiac
rehabilitation programme, either on a one-to-one basis or for a group of patients, this did not happen in
any of the sites. One of the reasons is a perception that people with CRC were already given plenty of
information from nursing staff prior to taking part in the cardiac rehabilitation.
Nobody’s actually asked for anything, any more information. I mean, we do give out patients a lot
anyway and it’s probably information overload.
CRCN 007
Key concerns about including people with cancer in cardiac rehabilitation
The key to this model of rehabilitation for people with cancer was the willingness and commitment of
cardiac rehabilitation clinician to accept another group of patients into their care. Their concerns about this
model of rehabilitation are now discussed in more detail.
Capability of clinicians
Cardiac rehabilitation clinicians were concerned that they would not have the relevant knowledge and
skills to support people with cancer because their specialism was cardiology. Clearly, these clinicians
wished to provide a high-quality service for any group of people using their service and, from their
perspective, this meant possessing a level of knowledge and expertise about CRC.
My main concern was not being able to support them properly from a cancer point of view.
CR 001
I felt a wee bit out of my depth because not used to dealing with people, patients in that group
[CRC patients], and I was just worried about are we saying the right things, doing the right things.
CR 002
Cardiac rehabilitation clinicians believed that it was important to obtain the medical history of anyone
attending their service. This was because a good health service was one in which patients could safely
assume that every clinician knew about their medical history, so that patients did not have to keep
repeating their story. This applied equally to people with CHD and to people with CRC. Furthermore,
knowing a person’s medical history equipped the clinician with the necessary information required to
support that individual; one concern that arose, for instance, was being able to competently answer any
questions. Cardiac rehabilitation clinicians articulated why knowing the medical history was important from
their perspective as well as from the patient’s.
I don’t like dealing with patients when you know nothing about them . . . and you know, it’s
important that if somebody is following a journey they don’t at every step of the journey get asked all
the same questions over and over again.
CR 001
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I know that we don’t necessarily need to know what type of tumour and things like that but from our
point of view it’s quite interesting to know actually what these patients have gone through so that we
can deal with any problems arising from that.
CR 003
Because you haven’t got any experience in that area. Just knowing what to expect isn’t it? What
they’ve had done and any problems they might ask you about. That was all I was worried about really
. . . Because otherwise you start off a pre-assessment and it’s a blind really, you don’t know anything
about the patient.
CR 005
Investigator: Anything we could have done differently to help you?
CR 004: Slightly more information on the referral form. There was a couple of times we said,
‘Oh, what operation have you had?’.
However, cardiac rehabilitation clinicians had other concerns regarding cancer patients referrals. For
instance, they wanted to know how they could safely support people to be physically active after
abdominal or rectal surgery.
I was just a bit concerned, you know, will it affect them, are we going to give them something to do,
they going to end up with hernias or something. The exercise is not that strenuous but sometimes,
especially the guys, they come in and they really push themselves and they do more than we would
like them to do.
CR 002
Similarly, they were uncertain about how they could support people with a stoma, or those
having chemotherapy.
Our main concerns, really we thought they would be quite poorly, you know, with stoma, and
because they might be having chemo[therapy] and we wouldn’t be able to answer any questions.
CR 005
The study highlights that cardiac rehabilitation clinicians did not feel that they necessarily had the right
skills to provide psychological support for people with cancer. This suggests that, if cardiac rehabilitation
services were to extend provision to other patient groups, training should not just cover issues relating to
cancer, types of surgery and treatment, and exercise, but also equip cardiac rehabilitation clinicians with an
awareness of the common psychosocial difficulties encountered by people with CRC.
One of the ladies who comes to the class, she was struggling so much with a whole lot of
psychological issues so I did spend a lot of time with her. I don’t know whether it made any
difference, but she was kind of needing, you know, a wee bit extra input, but I didn’t really have the
expertise to give her . . . probably it would be good, you know, if we thought somebody needs a wee
bit more kind of psychological help, if we knew if there was a way to help them.
CR 002
They’ve [people with CRC] obviously got different issues from our cardiac patients and what we’re
finding is that they got a lot of psychological issues now that we’re having to deal with, whereas it
probably would have been more relevant for, you know a specialist nurse in that area or possibly a
physiotherapist in that area that probably could deal with their problems slightly better . . . we’ve got
very minimum skills to do that.
CR 003
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Capacity of cardiac rehabilitation
Alongside voicing concerns regarding their own capabilities to support people with CRC, cardiac
rehabilitation clinicians were also concerned about the capacity to accommodate more patients.
The inclusion of people with CRC inevitably added to the existing workload of the cardiac
rehabilitation team.
At first I was a bit apprehensive because we’ve got quite a big workload, so it was the workload thing,
erm, first of all that was the main concern.
CR 002
The main extra workload highlighted by cardiac rehabilitation clinicians was pre-assessments, which are
routinely conducted prior to any patient attending.
Investigator: Did it [including people with CRC] involve any extra time for you, personally?
CR 001: It involved well, we always had to do the baseline assessments and that was the extra that
was put on the service, erm, we didn’t have large numbers [of CRC referrals] so the perceived idea of
having to run the extra classes never arose.
CR 001
We were having to go and do, you know, a full assessment on these patients ourselves which
obviously takes up a lot of time as well, but obviously we want to make sure that everybody is safe
to exercise.
CR 003
Overall, however, cardiac rehabilitation clinicians noted that the study and the inclusion of people with
CRC did not create undue or impossible demands on their time or the service.
It’s not had a massive impact on our workload.
CR 003
Investigator: In terms of workload was that a concern?
CR 005: No not really because, erm, we were just going to do the same as we do really [with our CHD
patients] . . . going to slot them [people with CRC] in.
Cardiac rehabilitation clinicians raised concerns about service capacity and whether or not including people
with cancer would create a worse service for people with CHD.
Whether it would affect the numbers in the classes, whether we would have to run extra classes and
whether my waiting lists would go up.
CR 001
There was acknowledgement that the referral of a different patient group to an already resource-stretched
cardiac rehabilitation programme could lead to resentment and frustration among staff.
There is a certain group of folk, you know, with cardiac conditions that we don’t see because we
don’t have the resources to see them so that was kind of, I was a wee bit probably protective of my
own corner thinking, that’s not fair, you know, we don’t have resources to see our own folk, erm,
however, that’s life [laughs].
CR 002
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For the purposes of this study, two sites did not use ‘excess treatment costs’ to employ an assistant
physiotherapist to accommodate the additional patients through the study, whereas one site did. A cardiac
rehabilitation clinician from this last site explained how the extra funding made it feasible for them to be
involved in the study.
My very first thought was they were sort of doing the study on the back of our service but then when
we read the actual protocol it made sense then that then there was the funding for it, that’s what
changed the picture because we thought we’d just have to absorb it and we were stretched enough
as it was . . . we all thought it was a really good idea to be involved in something like this.
CR 004
Indeed, the appointed physiotherapist was a welcome addition to the team and meant that people with
CRC could be invited to attend cardiac rehabilitation without it being to the detriment of people with
CHD, which had been an initial concern.
It was really good having a colleague working with me. I enjoyed that very much. And that’s because
you know we had our 12 cardiac patients and our powers that be said we couldn’t deny a cardiac
patient a place.
CR 004
The interviews suggest that one site was not anticipating conducting the cardiac rehabilitation
pre-assessments (e.g. fitness tests) themselves. Instead, they clearly thought that this would be done
elsewhere. Nevertheless, these assessments did not appear to be too onerous a task.
CR 002: At first we thought the patients would have had a kind of more thorough assessment . . .
we really had to do our own assessment . . .
Investigator: The assessment that you had to do, do you think that impacts on your daily workload?
CR 002: We had to do like a half-hour assessment with each patient as though it was from scratch
kind of thing so probably a bit, not a huge amount.
Colorectal cancer participant interviews
Benefits for people with colorectal cancer attending cardiac rehabilitation
Benefits of physical activity
Participants in the control and intervention group believed that rehabilitation was an important part of
their recovery.
Investigator: So if rehabilitation had been offered as part of normal NHS service would you have gone?
Site 1 19 control: Absolutely, you’ve got to give yourself the best chance possible.
There were two main reasons why people with CRC agreed to participate in this study: they believed that
it might help them and/or they believed that it might help others. In particular, some participants
welcomed involvement in a study that was about physical activity because they believed physical activity
was beneficial.
Well, I thought it would help other people and possibly help me too, because you do learn things as
you go along, even about yourself . . . The one that attracted me, well the part that attracted me was
the exercise. I thought that would be, that would have been beneficial. I’ve always been quite active
you know.
Site 2 09 control
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Well you don’t discover things unless you examine them and basically, if I can help by my experiences.
Site 2 17 control
If I can help somebody else erm, I’m happy to do that.
Site 1 23 control
Help others.
Site 1 19 control
If it helps somebody else I was quite willing to do it.
Site 2 07 control
Participants allocated to the intervention group described the exercises that they did during cardiac
rehabilitation and the impact that these had on physical functioning, general health and well-being and
daily living.
Site 3 30 intervention: I was doing something before and I had to hold onto a chair and then suddenly
I realised I didn’t have to, have to do it, so the exercises . . .
Investigator: So they did strengthen then?
Site 3 30 intervention: Yes, yes.
Site 3 30 intervention
When you are out and about you are more physically able, even for things like going and doing your
weekly shop; doing bits and pieces about the house, things that needed done, a bit of decorating.
I do think by doing the exercise programme that happens more quickly, because I reckon I would just
have sort of sat at home and go for little walks round about where I live, but maybe not pushing
myself so much, so getting back to your normal routine would probably have taken longer . . . And I
also think when you come out of the class you’ve got a bit of a buzz . . . then also you see yourself
sort of starting to tone and you think, ‘Oh, I could go out and buy myself something new to wear’, or
go and get my hair done, or whatever, buy some new make-up – whatever it may be – and that again
helps to your overall eh well-being.
Site 2 04 intervention
I mean, I enjoyed it like, but eh, it also helped me get a wee bit back tae [to] my, my fitness before
the, well efter the operation, like ken [know], I sort o’ let things slide sort o’ thing ken, so it got me
back tae being reason, reasonably fit . . . tae me it made me a wee bit mair [more] aware o’ what I
can, what I can actually do like ken, as far as muscle-wise and, and, and eh being flexible.
Site 2 06 intervention
It is clear from some of these accounts that participants’ family members noticed the difference that
cardiac rehabilitation made.
Investigator: What were you expecting from cardiac rehabilitation and how were you hoping it
would help?
Site 1 13 intervention: Well that’s a laugh, ‘cause when I had the first just one-to-one with [name of
physiotherapist] I went home and said, ‘Mmm, I think it’s going to be a bit easy, it sounds you know,
little gentle exercises, we’re not to push ourselves’. And when I came back after the first class,
my husband will never forget this, I was absolutely exhausted, so it was a, a real eye-opener to me,
just how weak I was.
Site 1 13 intervention
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Well, I was hoping that it would improve my activities, you know like – especially walking – and I was
also hoping that eh, I would lose some weight over it, but I didn’t [laughs], but I certainly, after going
to the, to the rehab[ilitation] my walking is greatly improved, and my wife tells me so. I tend, I tend to
be a slow, slower and, you know I’m quite a brisk walker now . . . And there was a, I, I felt there was
a purpose that I was doing it, you know there was . . . I felt, I felt that I needed to do, to do
these exercises.
Site 1 02 intervention
Given the favourable comments made about cardiac rehabilitation by those participants with CRC
allocated to the intervention group, it is perhaps not surprising that the overall impression of cardiac
rehabilitation was that it was very good, and that many participants would have liked to have remained on
the programme for much longer.
Investigator: Was the length of the exercise programme the right time, so your 12 weeks, or could it
have been longer?
Site 1 13 intervention: I could have happily gone on.
Site 1 13 intervention
I would have been very happy if it was 20 weeks [laughs].
Site 1 02 intervention
Confidence
Participants believed that rehabilitation would instil confidence and remove some of the fears about
becoming active again following major surgery for CRC.
I think it’ll stop them from being afraid to do things because it’s a controlled environment they’re
encouraged to do as much as they can without overdoing it . . . so it gives you the confidence when
you do go, you know, you think, ‘I can do this,’ and ‘I can do that’.
Site 2 17 control
Investigator: So what did you get out of it the most do you think?
Site 3 30 intervention: Confidence probably.
Investigator: Confidence that you could exercise?
Site 3 30 intervention: Yes, yes.
I think I was hoping it’d give me the confidence to go and do some physical activity, I think especially
after you’ve had abdominal surgery and you’re not sure what you should and shouldn’t be doing, and
I think they gave me that confidence and, they, they start you off doing things, you think, ‘Oh I
wouldn’t, I wouldn’t have had the confidence to get on a, a spin bike for 5 minutes,’ so yeah I, from
that point of view it’s been a good experience. You’re not really aware that the professionals are
actually watching you, but they are, so you know that if anything goes wrong or you feel unwell that
there’s somebody there on hand you know to help out, whereas I think if you went to a normal
exercise class you wouldn’t feel that level of confidence.
Site 2 04 intervention
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Motivation
Participants cited motivation to be physically active as one of the major benefits arising from attending a
rehabilitation programme. In particular, they believed that a structured physical activity programme would
motivate people to become physically active and help them to do so much quicker than would be the case
if they had no assistance.
I would have enjoyed the exercise and it would have motivated me to do it . . . I mean obviously for
the first couple of months I probably sat here most of the time; (a) I didn’t feel like doing anything and
(b), well you just need that time to recover you know but after that you could, it would maybe help to
get you back quicker.
Site 2 09 control
I’d be confident but just not motivated so I need somebody to give me a kick up the butt and say,
‘Come on, you’ve got to do this,’ and I will do it.
Site 3 02 control
My intentions are always good, and I think I’ve sort o’ mentioned to you before that I would need,
I think I need to be in a, decide I’m going to a class, something that’s structured so that it makes me go.
Site 2 04 intervention
One participant allocated to the intervention group believed that cardiac rehabilitation had given her the
motivation to continue being physically active after rehabilitation had ended.
Motivation, can I quote what I’ve written down, immediately, that I wrote immediately after the
12 sessions? It improved my motivation and discipline to do the exercises actually.
Site 1 13 intervention
Some participants allocated to the intervention group believed that one of the main benefits of cardiac
rehabilitation was being shown exercises that they could do at home.
I, I found it helpful in so much that it, it gave me simple exercises that I, I continued to do at home.
And, and, and there was a lot of em, information available eh, em, and some of it I read and I
continue to, to read and also helpful in meeting the other members of the class and, and eh, how
they were coping, who were all basically cardiac patients.
Site 1 11 intervention
Nevertheless, some of the participants allocated to the control group reported that they had started to
become more active again, in absence of the intervention. The data suggest that many of these
participants, however, were those who had been active before their surgery. This suggests that there may
be a need for a tailored, individualised approach towards attendance at a rehabilitation programme to
promote physical activity following surgery for CRC.
We’ve decided to go swimming . . . taking the [neighbour’s] wee dog out.
Site 2 17 control
My wife and I went on a 5-mile walk just a couple of days ago. I used to do as a regular thing before
the operation . . .
We’re going to book a holiday and start going down the gym or going for long walks or a
combination of the two, but yeah, I do want to get back to where I was.
Site 3 02 control
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Similarly, those who had been typically more physically active before their surgery commented that the
intervention had not made a difference to their level of physical activity post surgery.
Investigator: In terms of the exercise, did you get anything out of it?
Site 3 29 intervention: I don’t think so to be truthful with you. I was already into the golf before
I went there.
Peer support
A key benefit of the rehabilitation programme was peer support. It was clear from interviews with
participants in the intervention group that people attending cardiac rehabilitation provided companionship
and that they encouraged each other to exercise.
And we all fell into the same trap: ‘Oh, did you do your exercises?’ [‘What do you mean, since last
week?’] and, ‘Oh yes, last night’, you know [laughs], but, and then it got better, I got a bit more
disciplined about it. But I’ve, an important point here, is the companionship during the sessions, but
also before the sessions, ‘cause we were encouraged to meet sort of 10 minutes before the class so
we were all there on time.
Site 1 16 intervention
So working in pairs it encouraged you to talk, so you chit-chatted away [laughs] and encouraged, not
encouraged to exceed yourself, but it was an encouragement to say, I mean, I did, with one person
say, ‘Hang on, don’t try and copy me, you know, remember what [name of physiotherapist] said and
don’t push yourself’, and she didn’t.
Site 1 13 intervention
Social skills
Participants believed that cardiac rehabilitation provided an opportunity to meet other people and socialise,
which they saw as important because they had lost confidence in their social skills. Cardiac rehabilitation
provided an excuse to get out of the house, which was an important goal in their recovery.
To focus, get out of the house, see other people. And I mean, post cancer you can sit there and feel
sorry for yourself as long as you like but the more chances you give yourself of opening your mind
the better.
Site 1 19 control
It improves your social skills, because you can become quite, you know, isolated quite quickly, when
you’re not out and about meeting people, so yeah, that was a good side of it as well.
Site 2 04 intervention
I think just by going along there and knowing you’re not the only one in that position and you met a
good group of people and you had a laugh, and it was, you know, and you were getting better, but
you didn’t realise you were getting better, do you know what I mean?
Site 3 07 intervention
So at least it’ll get me out the house twice a week; going somewhere, meeting other people.
Site 3 29 intervention
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Generic versus disease-specific rehabilitation
Participants were asked if they could foresee any difficulties in having mixed patient groups for
rehabilitation. None of the participants in the control group suggested that it would be a problem. Indeed,
one participant did not even think it was worth even giving an opinion about.
I don’t see anything wrong in it.
Site 2 07 control
Investigator: So it wouldn’t matter that they didn’t have stomas and they hadn’t had cancer?
Site 3 02 control: Not in the slightest.
Site 3 02 control
I’ve got no opinion on that at all.
Site 1 19 control
Similarly, none of the participants in the intervention group believed that it was a problem either.
Participants gave the impression that it was irrelevant which disease a person happened to have.
They said, ‘What are you?’ I said, ‘I had cancer’, and that was it.
Site 3 20 intervention
I think when you go to the class everybody is quite open, em, because I remember the first time
somebody, I think it was the first or second class I’d been at, and a gentleman had said to me, ‘Was it
a stent you had put in or . . .?’ and I went, ‘No, actually, no, I’m here because of bowel cancer’, and
he just sort of looked at me, and, you know I, and then I explained to him about the programme as
well, and I don’t know that I would have been quite, quite so open with somebody that I didn’t know
before, but then I thought, well, everybody’s here for a reason, it’s not the same reason as me, but
everybody’s here for a medical reason, so, yeah, probably yeah.
Site 2 04 intervention
Every, everybody mixed very well with me, you know, like when they knew what the, my problem was
like you know, I mean they were surprised . . . like people saying, ‘What are you doing here?’ ‘Well,
the reason I’m here is because I was invited to come here’, you know, and eh, em, that I would
benefit from it, and I did benefit from me being there, yes . . . They asked the question . . . ‘What did
you get? Did you get a stent?’ or whatever.
Site 1 02 intervention
Indeed, one of the advantages of having mixed patient groups was that it enabled one of the participants
allocated to the intervention group to focus on their physical health without it necessarily being dominated
by their cancer diagnosis.
Eh well, well they were’nae [weren’t] bothering aboot [about] me having the cancer, naebody
[nobody] even spoke aboot that, because, as I say it was a heart thing that you were there for, it was
a’ heart cases that were up there for their therapy, so it was right oot [out] ma’ [my] mind [slight
laugh], the cancer.
Site 2 02 intervention
Key concerns about including people with cancer in cardiac rehabilitation
Nevertheless, participants did have some concerns about the use of cardiac rehabilitation for people
with cancer.
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One gap in support from cardiac rehabilitation, noted by a couple of participants, was cancer-specific
advice about, for instance, bowel problems and stoma care.
They would ask how, how have you been, and I would say, ‘Well I’ve not been too great with my
bowels.’ And he went, ‘We don’t have, that’s not our area of expertise’. You know. I didn’t need any
follow-up treatment, but maybe for people who are having to have chemo[therapy] or whatever,
maybe they would need to know a bit more about the medication and the effects of the medication.
Well I don’t know what, what the situation will be going forward, whether they would be offered
some kind of additional training on it or additional insight into em, cancer patients.
Site 2 04 intervention
Because [name of physiotherapist] was very clear with me in the introductory interview that you know
she, she’s not a cancer nurse and she was worried about my stoma bag.
Site 1 13 intervention
Furthermore, participants suggested that they had not been given any advice about how to reduce the risk
of recurrence and would have welcomed guidance on this.
Investigator: And is there anything that you think that you can do to reduce your risk of recurrence
of cancer?
Site 2 09 control: Well it’s something I would like to know if I could [laughs]. No one has said you
know, ‘Don’t do this’, or ‘Do this.’ It would certainly be helpful if there was a guideline, it might help.
Investigator: Do you think there’s anything such as like food groups or anything like that?
Site 2 09 control: Food group, exercise, em, again I think my age is against me because so many
things come with age as opposed to just the cancer but yes I think if there were some guidelines it
would be helpful.
Site 2 09 control
All of them, the consultant and the stoma nurse and my own doctor all said that I was to walk as
much as possible but sensibly . . . but I walk the dog four times a day, every day, rain, hail or shine.
Site 1 23 control
However, other participants said that they had been given advice about what they could do to improve
their health after surgery. Of particular relevance to this study was that some of them had been told by
clinicians to keep physically active.
The consultants said [between diagnosis and surgery], ‘You want to get fit and do lots of walking and
lose a bit of weight’. And so I went walking miles and miles and did lose a little bit of weight but not
a lot and I did get a lot fitter.
Site 3 02 control
Barriers to involvement in a study about cardiac rehabilitation
Randomisation
For some participants, randomisation did not seem to be a major barrier to study participation because
they did not mind which group they were allocated to.
Fine, I had no feelings one way or another. I was quite happy to participate one way or t’other
[the other].
Site 1 23 control
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Other participants, however, expressed disappointment being allocated to the control group.
I would have liked to have done it [physical activity] but I did it anyway but on my own back. It was
my choice to do it, not, I didn’t do it because I was told to do it.
Site 2 17 control
In contrast, some other participants were pleased that they had been allocated to the control group.
I was quite happy in myself that I didn’t have to go through all that.
Site 2 16 control
Some participants were not clear about how randomisation worked and its implications. Furthermore,
the impression given was that some participants allocated to the control group felt abandoned.
I didn’t get that, no . . . it would have seemed to have better to have gone right through with it rather
than just cut me off like that . . . it was disappointing to be left for 12 weeks.
Site 2 07 control
Site 2 09 control: I didn’t understand it to begin with. I thought the exercise was part of the
whole thing.
. . . And I thought the age I am . . . I thought maybe it was, you know, an age thing and that my age
they thought, ‘Well, she wouldn’t be interested in exercise anyway’.
Investigator: Were you a little bit disappointed?
Site 2 09 control: I was because I thought the exercise might help me.
Study information
When participants were asked about study information, most gave a perfunctory response. They either
briefly replied that the information was clear or gave the impression that they could not remember what
they had been given. Thus, although study information was not necessarily a barrier to participation,
neither did it appear to promote participation.
Investigator: Do you feel that all the information you were given was clear?
Site 2 09 control: Yes I’m sure it was . . . I can’t remember reading the booklet. I think it was just
verbal but maybe I should have read the booklet [laughs].
Investigator: Can I ask you what verbal or written information were you given about the study?
Site 2 10 control: I honestly can’t remember.
I got a big form with more information but I haven’t read it [laughs].
Site 2 17 control
I tell you, I would struggle to remember to be honest with you.
Site 1 23 control
Recovery from surgery and adjuvant therapy
None of the participants raised any concerns about being approached about the study on the surgical
ward, either while waiting for surgery or while recovering from surgery and waiting to be discharged.
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Investigator: Was it an appropriate time to discuss the study?
Site 2 17 control: Yeah.
Investigator: There was nothing inappropriate about the timing or insensitive?
Site 2 17 control: Not for me anyway.
Site 2 17 control
I didn’t feel it was an intrusion at any time.
Site 3 02 control
I didn’t see anything wrong in it.
Site 2 07 control
Participants allocated to the intervention group were expected to start cardiac rehabilitation about 6 weeks
after the surgery. Those who were not receiving adjuvant chemotherapy felt that this was a good point at
which to start rehabilitation.
Investigator: OK, and do you feel that [6 weeks] was an appropriate time for somebody to bring it to
your attention?
Site 1 13 intervention: Yes, I think so, because beforehand you’ve got too many other things on your
mind, and going to all these appointments and, whereas you’ve had the operation, you’re now
looking ahead; you’re feeling extremely weak [laughs] so you want to get better as quickly as possible.
Site 1 02 intervention: Oh yes, it came at the right time for me . . .
Investigator: It wasn’t too early or too late?
Site 1 02 intervention: No, no, far from it.
Investigator: You felt it was quite . . .
Site 1 02 intervention: Yes I, I was, I was ready for the classes.
Site 1 02 intervention
No, I think it came at quite a good time for me, because my wound had healed, I was back driving, so
it probably did come at quite a good, quite a good point for me, because I needed to move onto the
next stage of my recovery, which, as I said earlier, wouldn’t, I wouldn’t have had the confidence to do
unless the programme had come along.
Site 2 04 intervention
Because I think after 6 weeks you, you’re fed up of staying in the house after 6 weeks, you’re looking
for something to do and to be honest with you, something to get your out of the house for a change
of scenery.
Site 3 07 intervention
Participants allocated to the intervention group who were receiving adjuvant therapy, however, believed
that the appropriate time for them to start rehabilitation was at the end of adjuvant therapy.
Investigator: Do you think that the class came at the right time for you, or is there a point that you
think it might have fitted in better with your recovery?
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Site 1 23 intervention: No, no I think it, it basically em, had to come after the chemo[therapy]. I, I
know I was still suffering some effects of the chemo/operation; I think if you put it further, any further
back, em, there would be too long a period of time between the operation and, and starting on your
rehab[ilitation]. Oh yeah, I wouldn’t have, no I wouldn’t have been, no, the chemotherapy makes you
very tired.
One participant allocated to the control group described his post-surgical experience as a rollercoaster. His
description of his experience highlights why attending rehabilitation can prove difficult, if not impossible,
for some people, and especially for those receiving adjuvant therapy, which reinforces the need for a
tailored, individualised approach.
Site 3 02 control: It was very much like a rollercoaster from start to finish, it was big highs and big
lows . . . I had the operation . . . then went home for about 3 days, then massive haemorrhage . . . and
they found more cancer . . . it was another operation . . . when I came out the second operation I
accepted the stoma a lot better than I thought . . . I’m finding everything’s affected by the
chemotherapy . . . my whole plumbing system is a bit less predictable . . . I was totally knackered.
Investigator: Any capacity for exercise?
Site 3 02 control: None at all.
Being invited to attend cardiac rehabilitation once all primary treatment (surgery and adjuvant therapy) was
over was seen as fortuitous by some participants because it came at a time when they felt abandoned by
cancer services.
Investigator: And I saw you before the operation . . . so was that about the right time, that would have
been about 5 weeks after your discharge?
Site 3 30 intervention: Yes, yes it was actually, ‘cause it, you felt, you hadn’t been abandoned.
Investigator: And you felt ready to start doing something more . . .
Site 3 30 intervention: Yes
Investigator: Physical, then?
Site 3 30 intervention: Yes, yes. Before that I had been very, very tired.
Participant burden: questionnaires
Some participants did not have any problems with the questionnaire, whereas others felt that it was
perhaps too long and repetitive. Nevertheless, the overall impression given was that the questionnaire was
not a major burden for participants to complete.
I’ve no great shakes about the questionnaires.
Site 3 02 control
Oh they’re fair, the questions are fair, yes, and eh, I mean, there’s nothing that I’m stumbling to
answer, you know, it’s very simple and eh straightforward.
Site 1 02 intervention
Investigator: Did you feel the questionnaire was possibly too long?
Site 2 10 control: No.
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Investigator: Questions that you didn’t understand?
Site 2 10 control: There were certain questions that I didn’t answer but I had no problems with that
either but [name of investigator] said. ‘OK here’s the question, do you want to answer it?’ and I
said ‘No’.
Site 2 10 control
Some participants commented on the length of the questionnaire.
Well, most of it was all right. It was long, I have to say. Em, some of the questions seemed, maybe it
was just to me, em inapplicable. You know, it wasn’t, well, some of them were confusing as well to
me, to be honest, but in general, I mean, they were OK.
Site 2 09 control
A few questions I wondered why they wanted . . . it was a bit lengthy [laughter].
Site 2 07 control
I think they’re quite long . . . Yeah, they were OK to understand.
Site 1 13 intervention
Other participants commented on question repetition.
Fine, no problems . . . Two or three had very similar answers . . . There would be no point having a very
short 5-minute thing. If you want to gain something from it I think it’s got to be at least the length
that you had.
Site 1 23 control
A wee bit long, a wee bit long, I’m saying eh, and, no, eh yae seemed tae be getting the same
question, again and again.
Site 2 02 intervention
Participants were asked to recall how much physical activity they had done for each day of previous week,
and one participant found this a difficult task.
Some of the questions that were asked, you know, how long every day did you do exercise, like
cleaning and I don’t study my life, so I had to stop and think about just what I did.
Site 2 17 control
The interviews suggest that answering these types of questions (e.g. about quality of life) may provide
therapeutic benefit for participants. One participant, for instance, felt that by answering the questions
some of his or her worries had dissipated.
Do you know what. Questions that [name of spouse] and I never ever thought about and we have
answered them and I think it takes it away, a lot of the worry from us as well.
Site 2 16 control
Participant burden: accelerometers
Some participants reported no problems wearing the accelerometer.
Comfortable. I didn’t wear it in the shower, you say you can use it in the shower . . . but eh, that’s the
only time I didn’t use it.
Site 1 02 intervention
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I, I didn’t know I had it on half the, even when I was in work Monday, Tuesday, Wednesday, I didn’t
realise I had it on, I sort of put it down by there.
Site 3 07 intervention
No problem at all.
Site 2 17 control
Easy to use. I think I wore it quite diligently.
Site 1 19 control
Oh no, it didn’t give me any bother.
Site 2 16 control
I knew what it was for and it was easy to put on and I had great fun with it telling everybody what it
was or it wasn’t but that was just a bit of humour.
Site 1 23 control
Other participants reported problems wearing the accelerometer. The device proved particularly
troublesome to wear for those who had a stoma or abdominal wound problems.
I couldn’t wear it because of the operation . . . it just wasn’t comfortable because of the hernia.
Site 2 07 control
The clip design was dreadful and eventually the clip came unglued from the actual accelerometer
itself. The new one that I was given, I was given two, one with a strap round my tum, which I thought
was not very good because I’ve got a bad down there and the other one was slightly better design
clip but the actual accelerometer did fall off a couple of times.
Site 2 10 control
It was almost impossible to get on . . . trying to open it was just impossible. The belt one was
uncomfortable. It would have been initially where my scar one, not my scar but the wound.
Site 2 09 control
Some participants appeared to be self-conscious when wearing the device.
Investigator: Were you a little bit self-conscious of it possibly?
Site 2 09 control: No, not really, eh, I mean, I’ve been wearing sort of loose tops, anyway.
I realised you had to do it [wear accelerometer] but I was putting up with so much with stitches round my
rear end, stitches from here to there like top to bottom on my front, plus the [stoma] bag and all the rest.
Site 3 02 control
One participant forgot to wear the device.
Problem is that sometimes in the morning I would get up and I would go about my business and then
I would go, ‘I forgot to put that on’.
Site 2 04 intervention
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Focus groups with people with coronary heart disease
Generic versus disease-specific rehabilitation
None of the people with CHD said that they minded if people with cancer attended the cardiac
rehabilitation classes.
Investigator: I guess what I want to know is how you lot would feel about having those patients join
you in a class?
Site 3 CHDP1: Oh it’s fine.
Site 3 CHDP2: Yeah.
Site 3 CHDP3: Yes.
Site 3 CHDP3
Investigator: So what are your initial thoughts when I say, ‘Putting cancer patients in your cardiac class’?
Site 1 CHDP1: I don’t see why not, and if they’re just the same, why not?
Site 1 CHDP2: Yeah.
Site 1 CHDP3: The facilities can take it, I don’t see why not.
Site 1 CHDP3
Investigator: What are your thoughts on having cancer patients in a class with you, as a
cardiac patient?
Site 1 CHDP4: I haven’t any problem with that, no.
Investigator: It doesn’t bring anything up?
Site 1 CHDP5: It wouldn’t make any difference.
Site 1 CHDP5
There were three main reasons why participants with CHD did not believe that mixed classes would be
problematic. First, they believed that worries about becoming physically active were similar for both people
with CRC and people with CHD who were recovering from treatment, and that both groups would,
therefore, benefit from cardiac rehabilitation.
Investigator: You have your own anxieties about starting to exercise, or starting to get back after
major surgery, whatever that is, so you know.
Site 3 CHDP1: I think the worries are the same for both.
Second, participants felt that people with CHD were not a homogenous group and that their different
rehabilitation needs may not be too dissimilar to those of people with cancer.
Investigator: Do you think the needs are different for yourselves, as cardiac patients, with people
recovering from cancer surgery?
Site 1 CHDP7: No. There are differences just within us anyway.
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Third, cancer was not an unfamiliar disease for most people with CHD. They believed that many people
attending cardiac rehabilitation would have family and friends who had been diagnosed with cancer,
which meant that they had some understanding of the disease.
Investigator: Do you think it would be difficult talking to these patients?
Site 3 CHDP1: No.
Site 3 CHDP2: Oh not at all.
Site 3 CHDP3: Not at all.
Site 3 CHDP4: No, fine.
Investigator: Some people find cancer difficult to talk about . . .
Site 3 CHDP5: They do, don’t they, yeah.
Site 3 CHDP6: I think so, most people, well not most, but I think a lot of people these days have had
experience of either friends or family.
Barriers for people with colorectal cancer attending cardiac rehabilitation
People with CHD were aware, from their own family and friendship networks, about some of the
difficulties that people with CRC may face attending cardiac rehabilitation, such as having a stoma.
Participants seemed to be particularly aware that a stoma could cause embarrassment.
Site 3 CHDP1: I was only talking to a patient, well a pal of mine who was a patient some years ago,
who again had eh colon cancer . . .
Investigator: Oh really.
Site 3 CHDP1: And eh, he came through it very well, he’s in great form. I have to say, he was very
embarrassed when he had to have the bag put on.
Investigator: Yes.
Site 3 CHDP1: Yeah, and then he didn’t quite know what to do about it, especially when he
was showering.
Site 3 CHDP2: Yeah, I know several people who’ve got one, you don’t, you wouldn’t realise it.
Site 3 CHDP3: No, not at all.
Site 3 CHDP2: You don’t know.
Site 3 CHDP3: Well, it depends on what they’ve had to eat.
[Laughter]
Site 3 CHDP2: [laughs] The bag explodes!
Site 3 CHDP4: My wife has had several bad experiences.
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Investigator: Really?
Site 3 CHDP4: Has she, has she, oh yeah. But she still goes to the gym.
Key concerns about including people with cancer in cardiac rehabilitation
Participants with CHD believed that cardiac rehabilitation classes would probably need to expand should
cardiac rehabilitation become routinely offered to people with cancer.
Investigator: Do you think anything would need to be changed to incorporate my patients?
Site 3 CHDP1: I think the thing you have to be aware of is how big the group gets.
Participants with CHD also believed that specialist input from cancer nurses may be required because
people with CRC and people with CHD would be likely to ask different types of questions.
Site 3 CHDP1: Sometimes when we have this talk it does overrun quite often and if there’s, if there’s
more sets of questions to be asked relating to different issues [i.e. cancer], it may pull it back
even further.
Site 3 CHDP2: Yeah.
Investigator: Yes, that’s true.
Site 3 CHDP3: Will they have their own nurse then at all?
Discussion
Strengths and limitations
It is possible that some of the perceptions presented here represent those of a select cohort of people with
CRC who were already motivated about, and interested in, being part of an intervention such as a cardiac
rehabilitation programme. They may, for example, already have held positive views towards behaviour
change, and, in particular, change in physical activity as a core component of their recovery. As
demonstrated, however, we did uncover a broad spectrum of views, both positive and negative. In
addition, the interviews were conducted by the same investigators involved in collecting baseline and
follow-up measures from people with CRC, which might have influenced the extent to which participants
were willing to criticise trial procedures. Nevertheless, these investigators were not involved in the direct
care of participants, and, in particular, they were not involved in delivering the intervention (i.e. cardiac
rehabilitation), and so participants might have been more candid about their views about the intervention
itself. The generalisability of our findings, however, is limited, because the pilot was small scale, involving
only 3 out of a possible 312 cardiac rehabilitation programmes throughout the UK62,63 and only small
numbers of cardiac rehabilitation and CRC clinicians and people with CRC and CHD. The findings,
nonetheless, provide valuable insights and a starting point for informing future research.
Feasibility and acceptability of cardiac rehabilitation for people with
colorectal cancer
This qualitative study suggests that cardiac rehabilitation is an intervention that can motivate people with
CRC to engage in physical activity. Clinicians perceived the main benefits of cardiac rehabilitation to be
that people with CRC would increase their level of physical activity, overcome any fears about being
physically active, gain in confidence and become more motivated to exercise. This was positive because
they believed that physical activity was an important part of this patient group’s recovery. Similarly,
participants with CRC believed that one of the main benefits of attending cardiac rehabilitation was that it
would motivate people to get physically active following surgery. Motivation is a key construct in theories
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of behaviour change, including self-determination theory, and has been found to be associated with
higher levels of physical activity among CRC survivors.176 Motivation is, therefore, of particular interest to
researchers and clinicians who are developing interventions to increase the level of physical activity among
this group of the population.
This qualitative study indicates that cardiac rehabilitation gave participants the motivation to continue
being physically active at home and once rehabilitation had ended. Whether motivation to be physically
active is transitory or is maintained post rehabilitation requires further investigation. Being referred to
rehabilitation may engender a feeling of ‘having to be’ rather than ‘wanting to be’ physically active.177
There is a danger, therefore, that once rehabilitation stops, physical activity will also come to a halt. To
sustain and maintain physical activity beyond rehabilitation, people would need to engage in physical
activity because of its inherent satisfaction (e.g. because they enjoy it) and because they identify with the
outcome (e.g. because it will improve personal health).178 This suggests the need for a tailored and
individualised approach to assessment of people’s physical activity needs and goals and their attendance at
a rehabilitation programme.
According to self-determination theory, internalisation of the value (the benefits) of the outcomes of
physical activity is likely to lead to greater persistence in being physically active.179 This qualitative study,
however, suggests that many participants were not informed of the benefits of being physically active.
Indeed, recent studies indicate that provision of lifestyle advice from cancer care clinicians is low.151,180–182
Yet clinicians are likely to play an important role in developing motivation because they can inform people
with CRC about the associations between physical activity and health (see Chapter 1 for evidence about
the benefits of physical activity for people with CRC). Developing this type of motivation may not prove to
be too difficult because our qualitative study suggests that many participants with CRC were already aware
of the benefits of adopting a healthy lifestyle. In addition, this study suggests that many cancer nurses
were aware of the benefits of a healthy lifestyle for recovery. Diet appeared to be the main lifestyle
behaviour that participants with CRC valued and associated with health benefit, suggesting that there is a
need for greater promotion and awareness of the benefits of physical activity (see Chapter 1 for a
summary of the benefits of physical activity for people with CRC).
None of the participants with CRC or participants with CHD had an issue with mixed CRC and CHD
patient rehabilitation classes. Participants with CRC believed peer support to be a benefit of rehabilitation,
a view that seemed to be expressed by people with CHD as well as people with CRC attending cardiac
rehabilitation. The study shows that cardiac rehabilitation provided an arena for peer support from other
people who had recently been diagnosed and treated with a life-threatening disease (CRC or CHD).
Traditionally, peer support has been defined as support provided by people with the same disease.183
Shared experience of the disease and experiential empathy is seen as crucial to the giving and receiving of
support.183,184 This study challenges the assumption that peer support for people with cancer can arise only
from shared experience of the same disease.185 Rather, our study suggests that people with CRC can
obtain peer support from people with CHD in the context of rehabilitation. That peer support is not
disease dependent opens up the possibilities of rehabilitation for mixed-disease patient groups. Moreover,
our study raises the prospect of redefining peer support so that it is not confined exclusively to the shared
experience of a specific disease.
A barrier to participation in cardiac rehabilitation was travel distance, which clinicians believed applied to
people with CHD as well as to people with CRC. Clinicians believed that cardiac rehabilitation should be
available to as many people with CRC as possible, but felt that those who had severe mobility difficulties
may be unable to attend. Clinicians also recognised that recovery from CRC and its associated treatments
was protracted and less straightforward than the recovery and rehabilitation pathway for people with
CHD. Both clinicians and participants with CRC alike saw ongoing treatment, and, in particular, adjuvant
chemotherapy, as a barrier to being physically active. A stoma was also felt to be a potential barrier, as
well as a cause of embarrassment; steps would need to be taken to assure people with a stoma that
cardiac rehabilitation was an environment in which they would be supported.
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Clinicians understood that it was important for people with CRC to begin rehabilitation as early as possible
if they were to reap and maximise the health benefits of cardiac rehabilitation. Early intervention fits with
the enhanced recovery from surgery protocols developed by the Association of Surgeons of Great Britain
and Ireland, which recommend ‘early and structured post-operative mobilisation’ for people undergoing
surgery for CRC:186
A structured mobilisation plan should be in place. Patients should be helped to sit out in a chair on the
evening of surgery and definitely by the first post-operative day. This should be followed by gentle
assisted mobilisation either the same day or the next day.
p.14.186 Reproduced with permission from the Association of Surgeons of Great Britain and Ireland
Early rehabilitation for patients with CRC also fits with the recommendations for patients with CHD.187 This
qualitative study suggests that cardiac rehabilitation provided a safe environment for people with CRC to
increase their level of physical activity, and participants felt that they benefited from rehabilitation. On this
basis, cardiac rehabilitation is an appropriate model of rehabilitation for people with CRC. The impression
given was that clinicians delivering cardiac rehabilitation were able not only to support people to be
physically active but, because of their professional training, also to provide a level of psychosocial support.
This belief that clinicians should deliver rehabilitation aligns with patient views: people with cancer prefer
to receive information about cancer from health-care providers. This model of rehabilitation to aid recovery
may, therefore, be more acceptable to clinicians and people with CRC than, for instance, exercise referral
to fitness centres.
Colorectal cancer nurses were enthusiastic about the prospect of integrating this model of rehabilitation
within the cancer pathway. They believed that the surgical ward was a good place to talk to people with
CRC about rehabilitation because at that point patients were already beginning to think about their recovery.
However, there was a degree of reticence about expanding cardiac rehabilitation to accept cancer patient
referrals. Cardiac rehabilitation clinicians had two key concerns about including people with CRC in their
service. They were concerned about their own capabilities for supporting people with CRC and also the
capacity of cardiac rehabilitation to accommodate more patients. In particular, they were concerned that
they would not have the relevant specialist knowledge and skills to support people with cancer because
their specialism was cardiology. To improve their knowledge they wanted the full medical history of
anyone using their service and wanted guidance and training on how people with CRC surgery who may
be receiving adjuvant therapy, and, possibly, have a stoma, can safely exercise. In addition, cardiac
rehabilitation clinicians wanted to know about the common psychosocial difficulties encountered by
people with CRC because they viewed the provision of psychosocial support as part of their role. They also
wanted a list of services for people with CRC so that they could of appropriately refer people with CRC to
the relevant support. Finally, cardiac rehabilitation clinicians believed that a key gap in rehabilitation for
people with CRC that they were unable to address was dietary advice. Thus, if cardiac rehabilitation was to
be become the model of rehabilitation for people with CRC, additional input from CRC experts would
need to be provided and fully integrated as part of the rehabilitation programme.
However, cardiac rehabilitation clinicians and people with CHD were concerned about the capacity of
cardiac rehabilitation to accommodate more patients; their concerns regarded additional workload and
whether or not the inclusion of people with cancer would create a worse service for people with CHD.
Therefore, additional resources should be provided as an incentive for cardiac rehabilitation services to take
cancer patient referrals. Indeed, if cardiac rehabilitation services perceive that the inclusion of other patient
groups will be to the detriment of the service that they currently provide for people with CHD, then they
are likely to withdraw their service for other patient groups, including people with cancer.
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Feasibility and acceptability of trial procedures
Recruitment is critical to the success of a study. Finding out why people with CRC were likely to participate
in this study was, therefore, an important study objective. Two of the main reasons people with CRC
agreed to participate were altruism and personal benefit, echoing previous research findings about why
people agree to participate in health research.188,189 Any future trial should, therefore, consider advertising
the benefits of rehabilitation and, in particular, physical activity for people with CRC in order to encourage
participation and make people feel good about themselves for agreeing to participate because it may
help others.
Randomisation was an issue for some, but not all, participants allocated to the control arm. A previous
study found that about one-fifth of people with cancer who were surveyed about participation in clinical
trials were worried about randomisation.188 Thus, any future large-scale effectiveness trial would need to
factor in the impact of randomisation on attrition rates when estimating the number of people who would
need to be recruited for the study to be powered.
This qualitative study shows that participants either paid little heed to the participant information sheet
(PIS) or could not recall its content. The UK Health Research Authority states that the guidance for
producing PISs:
. . . should be considered as a framework, not a rigid template . . . One size does not fit all . . . The best
way to make sure your consent documentation is fit for purpose is to test it with patient groups or
other members of the public.190
However, in our experience, PISs are often written to satisfy a NHS Research and Ethics Committee, whose
members often request that the PIS includes, for instance, detailed procedures for making a complaint and
a paragraph about how the research will be disseminated, and so on. The upshot of this is a very wordy
and lengthy PIS that is not necessarily user-friendly or memorable. Any future study should, therefore,
consider using different ways of presenting study information for participants so that it is easier to
remember. More imaginative ways of presenting study information should be considered, including the
use of technology (e.g. websites or mobile phone text messages). However, NHS Research and Ethics
Committees would need to be convinced that less information and new approaches to giving information
are ethical.
Our qualitative study suggests that the face-to-face investigator-administered self-report questionnaire
using Bristol Online Survey (i.e. a non-paper-based questionnaire) was feasible to administer and generally
acceptable to participants. Much has been written about the associations between length of questionnaire
and response rates;191–193 some participants in our study found the questionnaire to be too long.
Nevertheless, ‘how long is too long’ is likely to be subjective, and face-to-face administered surveys lasting
over 1 hour have been found to be acceptable in some studies.194 Moreover, a systematic review of
strategies to improve retention rates in trials found that five trials (7277 participants) compared the effect
of short and long questionnaires on postal questionnaire response rates and reported that there is only a
suggestion that short questionnaires may be better (risk ratio 1.04, 95% CI 1.00 to 1.08; p= 0.07); based
on one trial (of 900 participants), there is no clear evidence that long and clear questionnaires are more or
less effective than shorter condensed questionnaires in terms of increasing questionnaire response rates
(risk ratio 1.01, 95% CI 0.95 to 1.07; p= 0.86).157
The repetition of questions, however, was an issue. There is a trade-off between minimising respondent
burden, by the removal of questions, and making full use of a validated questionnaire. In our study, we did
attempt to avoid repetition by removing some questions (see Chapter 5), but a future study should
consider reducing this further if possible. Our qualitative study indicates that responding to questions
yielded therapeutic benefit for some participants, which bears similarities to the findings of a survey about
respondent satisfaction and burden.195
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Accelerometer use in physical activity and cancer research is becoming increasingly popular,96 but
compliance with wearing the device is essential to avoid missing data. There is, however, only minimal
guidance for the use of accelerometers among people diagnosed and living with cancer, and none
specifically for people with CRC.97 In this study, we suggested to participants that they wear the
accelerometer around their waist rather than around their wrist, because wrist-worn accelerometers are
not as accurate as hip-worn accelerometers at classifying activity and sedentary behaviour.196 However, the
interviews suggest that wearing the accelerometer in this way was a burden for some participants,
especially for those with abdominal wound problems or a stoma. Thus, for the purposes of consistency in
measuring the amount of physical activity, all people with CRC should be requested to wear the device on
the wrist in future studies.
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Chapter 10 Economic evaluation
Economic evaluation
The main aims of the economic evaluation component in the CRIB pilot study were to identify the main
resource implications of delivering the rehabilitation programme and the subsequent impact on NHS care
required by the participants; and devise and test approaches and tools to measure these.
To do this, the analysis looked at:
1. response rates to data collection tools
2. the cost of delivery for the rehabilitation groups
3. the health-care costs of participants in both trial arms
4. health-related quality of life through the calculation of utility values using the EQ-5D-5 Levels
(EQ-5D-5L).
Feasibility
The main purpose of the CRIB pilot trial was to prepare the way for a full trial by testing methods of
delivery and trial materials. In this pilot trial, response rates for the Health Resource Use questionnaire and
EQ-5D-5L were high, and it appears that patients did not have problems filling in the questionnaires.
A total of 40 (97.5%) (control, n= 20; intervention, n= 20) out of 41 participants, and 31 (75.6%)
(control, n= 16; intervention, n= 15) and 25 (61%) (control, n= 13; intervention, n= 12) participants
completed the questionnaires at the follow-up 1 and follow-up 2 time points, respectively. Overall, 60.9%
of participants completed the trial.
Cost data
The overall cost of the programme is divided into two main components: the cost of delivery of the
rehabilitation groups and the health-care resource use of all trial participants.
Rehabilitation groups
The content of the rehabilitation groups is described in Chapter 6. The key resources used for each group
were the staff time, equipment and room hire. It was expected that the patients with CRC would attend
existing classes being run for patients with CHD; therefore, the marginal cost per participant was expected
to be negligible. However, each trial site was requested to provide an estimated cost per patient for
running additional classes to accommodate the increased number of patients referred from cancer services.
Table 48 shows the costs of providing cardiac rehabilitation for each site.
TABLE 48 Cost per patient of running rehabilitation group at each trial site
Site 1 Site 2 Site 3
£375.18 £437.21 £198.71
Based on 180 patients Based on 412 patients in 2013 Based on 24 participants
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Sites 1 and 2 could provide only costs related to their usual cardiac rehabilitation team costs and not
specific costs related to this trial. The above costs for these two centres would apply only if they had to set
up a cardiac rehabilitation intervention from scratch. This means that NHS centres provided historical cost
data that related to all costs with standard cardiac intervention. Box 4 presents the costs provided by sites 1
and 2.
Site 3’s cost data were the closest to marginal costs of adding patients with CRC to an existing class.
Site 3 claimed £198 per trial participant to hire a physiotherapy assistant to accommodate additional CRC
patients into the cardiac rehabilitation service. However, it is not clear if these would be recurring costs if
this was an established NHS intervention. For a future larger-scale trial it would be necessary to establish if
patients are being added to existing groups and the associated marginal costs of this or if new groups are
required as this will probably impact on the overall cost-effectiveness of the service.
BOX 4 Cost of cardiac rehabilitation
Site 1 costs
Core staffing.
One administrative assistant: £17,803 pro rata 16 hours per week.
One physiotherapist: £34,876 pro rata 22 hours per week.
One rehabilitation nurse: £29,043 37.5 hours.
One physiotherapy assistant: £17,803 pro rata 22 hours per week.
Total costs: £67,533.
Annual patient numbers= 180.
Site 2 costs
1.0 WTE senior physiotherapist (band 7).
3.6 WTE cardiology specialist nurses (band 6).
0.6 WTE physiotherapist (band 6).
0.3 WTE physiotherapist (band 5).
0.1 WTE support nurse (band 3).
Ad hoc (unquantified) clerical/medical records support.
Total cost per annum= £180,132.
Total number of patients assessed by the cardiac rehabilitation team in 2013= 412.
WTE, whole-time equivalent.
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Health-care resource use
Resources used by the participants were recorded in the outcome questions. Participants were asked to
record health-care resource use for the 3 months prior to the trial beginning to give us an indication of
resource use prior to taking part in the trial (reported in Table 49). It would not generally be necessary to
collect or report these data as we would assume that randomisation of participants would wash out any
larger outliers, but given the small number of participants in the trial, it was important in this study to be
aware of any large differences between the two groups prior to the start of the programmes.
All contacts with NHS services and clinicians in the two follow-up periods, excluding the 3 months before
baseline, are presented in Table 50.
Health-care costs
The information on resource use was combined with the unit cost of each resource to estimate the total
cost of NHS resources used. Health service unit costs were valued using the most recent Department of
Health resource cost data, at 2013–14 UK prices.197 The NHS resources that were included and their unit
costs are shown in Table 51 along with the source of cost information. The cost of drugs consumed by
participants only includes drugs prescribed by participants’ general practitioner (this is not shown in the
table). The British National Formulary200 was consulted for the unit cost of individual drugs prescribed
to participants.
NHS resource use was combined with unit costs. The total mean costs for each trial arm are shown in
Table 52.
NHS resource use and associated costs was similar in the two groups. There were some differences at
baseline, but these were to be expected given the very serious nature of these patients’ condition. For
example, two patients in the control group were admitted to hospital for a combined total of 41 times in
TABLE 49 Frequency of health-care contacts by trial arm across the whole period
Service used Intervention group Control group
GP at surgery 65 111
Nurse at surgery 58 65
GP on the telephone 10 17
Nurse on the telephone 20 29
NHS Direct 15 3
GP at home 7 15
Nurse at home 109 173
Out-of-hours clinic 7 1
A&E visit 2 6
Outpatient department 41 75
Admitted to hospital 11 47
Emergency ambulance 1 3
Allied health professionals 90 20
A&E, accident and emergency; GP, general practitioner.
Data include all patients who participated in follow-up 1 and follow-up 2. There were 15 patients in the intervention group
and 16 patients in the control group at follow-up 1. There were 12 patients in the intervention group and 13 patients in
the control group at follow-up 2.
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TABLE 50 Frequency of health-care contacts by trial arm from baseline to end of intervention and follow-up 2
Service used Rehabilitation group Control group
GP at surgery 51 69
Nurse at surgery 18 36
GP on the telephone 4 7
Nurse on the telephone 14 14
NHS Direct 7 2
GP at home 5 5
Nurse at home 19 47
Out-of-hours clinic 4 0
A&E visit 2 3
Outpatient department 25 35
Admitted to hospital 6 3
Emergency ambulance 0 0
Allied health professionals 76 13
A&E, accident and emergency; GP, general practitioner.
Data include all patients who participated in follow-up 1 and follow-up 2. There were 15 patients in the rehabilitation
group and 16 patients in the control group at follow-up 1. There were 12 patients in the rehabilitation group and
13 patients in the control group at follow-up 2. Data in this table exclude baseline.
TABLE 51 NHS unit costs
Service Unit cost (£) Reference
GP at surgery 45 PSSRU198
Nurse at surgery 16 PSSRU198
GP on the telephone 27 PSSRU198
Nurse on the telephone 5 PSSRU198
NHS Direct 8 Richards et al. (2004)199
GP at home 114 PSSRU198
Nurse at home 47 PSSRU198
Out-of-hours clinic 66 PSSRU198
A&E visit 124 DH reference costs197
Outpatient department 111 DH reference costs197
Admitted to hospital 1542 DH reference costs197
Emergency ambulance 235 DH reference costs197
Allied health professionals 22 DH reference costs197
A&E, accident and emergency; DH, Department of Health; GP, general practitioner; PSSRU, Personal Social Services
Research Unit.
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the 3 months prior to baseline, inflating both resource use and mean costs in that group. At the first
follow-up, resource use dropped in both groups, and it was much lower at follow-up 2, which was due to
an improvement in participants’ health.
As the follow-up period of the study is < 1 year, the costs and outcomes are not discounted.
Patient costs
Information on patients’ out-of-pocket expenses was collected in the questionnaires. Patients were asked
at baseline and follow-ups if they had bought medicines related to their condition. Most patients
responded negatively to this question as they were likely to have received free NHS prescriptions and did
not require extra medications. The patients who bought over-the-counter medicines spent an average of
£5 each on items such as Corsodyl® mouthwash (GlaxoSmithKline, Brentford, UK), DioralyteTM sachets
(Sanofi, Guildford, UK), Bio-Oil® (Pacific World Cosmetics, Aliso Viejo, CA, USA), heat gels, paracetamol,
laxatives, Wind-Eze tablets (Forest Laboratories UK Ltd, Barnstaple, UK), vitamin D tablets, and herbal
cleanse and other constipation-related treatments.
Patients were also asked if they had used any complementary therapies, such as reflexology, acupuncture
or homeopathy. Again, most patients indicated that they had not used any such treatments. Three patients
had acupuncture sessions, spending an average of £250 on these (this high figure was due to one patient
in the control group spending £550 on acupuncture). Three patients had massage sessions, costing an
average of £60. One patient reported having reflexology with no cost.
Questions 44–47 in the patient self-reported questionnaire asked patients if they had incurred costs
specifically related to the cardiac rehabilitation of this trial. This means that these questions applied only to
patients in the treatment group and should have been left blank by patients in the control group. Valid
replies to these questions by patients in the rehabilitation group included the cost of having to purchase
jogging pants, ankle splints and t-shirts, with less than £20 spent on each item. Six patients spent an
average of £50 to travel to the cardiac rehabilitation classes. One patient required two extra gym sessions
per week, costing an extra £4 per week. Finally, one patient had to take time off work to attend the
cardiac rehabilitation classes, a total of 12 hours off.
Looking at the out-of-pocket expenses of patients in the rehabilitation group, it is clear these were not
significant and should not affect costing considerations for this trial. If anything, it appears that patients in
the control group spent more on alternative treatments than patients in the rehabilitation group.
TABLE 52 Mean cost of NHS resource use by trial arm
Rehabilitation group (£) Control group (£)
Mean cost at baseline 1080 (1592) 5206 (11,282)
Mean cost at end of intervention (follow-up 1) 953 (1110) 667 (1148)
Mean cost at follow-up 2 349 (603) 399 (546)
Mean total cost 826 (1217) 2204 (7002)
Total cost excluding baseline 685 (955) 547 (924)
Data include all patients who participated in follow-up 1 and follow-up 2. There were 15 patients in the rehabilitation
group and 16 patients in the control group at follow-up 1. There were 12 patients in the rehabilitation group and
13 patients in the control group at follow-up 2. Two patients in the control group were admitted to hospital for a
combined total of 41 times in the 3 months prior to baseline. SDs are given in parentheses.
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European Quality of Life-5 Dimensions-5 Levels
Data for the EQ-5D-5L were collected at baseline and follow-up. Table 53 reports the mean utility score at
baseline and follow-up by trial arm.
Discussion of economic evaluation findings
Economic evaluation can be defined as a comparison of alternative options in terms of costs and
consequences.201 As such, one can argue that we do not perform a full economic evaluation here as we
mainly present costs and consequences rather than perform a formal comparison between interventions.
Given the limited sample size and no difference in the primary clinical outcome measure and in measured
health gain, as captured by the EQ-5D, between the two groups, we decided not to perform a full
economic analysis in this pilot trial. In a future main trial, a cost-effectiveness analysis will be performed
following methods as outlined by Drummond et al.201 Costs and outcomes for each of the trial participants
will be calculated and the mean incremental cost-effectiveness ratio (ICER) will be estimated as:
E(ICER) = Ei(cost treatment)−Ej(cost control)=Ei(outcome treatment)−Ej(outcome control). (1)
The primary economic outcome in this analysis will be the quality-adjusted life-year, using the EQ-5D-5L,
measured at different time points during the trial, and the economic evaluation will estimate the
incremental cost per quality-adjusted life-year associated with the treatment as stated in the protocol and
shown above. The additional (incremental) costs associated with the treatment, when added to usual care,
will be estimated using resource-use data collected within-trial, and unit costs for resource use from
national published/NHS sources.
Hence, we are pleased to report that in this pilot all trial materials and questionnaires were tested
successfully and proved suitable for economic evaluation purposes. There was a high response rate for
Bristol Online Survey which included EQ-5D and other measures used in the trial. There were no missing
data beyond people who did not participate in the follow-ups. We recognise that recall bias is a problem
when using self-report to measure health service use. For the future we recommend that the larger full
trial will need to clearly establish the ‘true’ costs of health service use using objective measurement and of
the rehabilitation group and whether or not these can absorbed into current practice. It was initially
planned that the CRC participants would enter existing classes, keeping costs at a minimum, so we need
to establish if this is possible. A full economic evaluation during the main trial will require accurate cost
data, so this issue must be addressed. Nevertheless, based on the data reported in this section and
elsewhere in this report, we believe that a full trial is feasible and a full economic evaluation can be
performed if similar materials and methods are employed in a future definite trial.
TABLE 53 Mean EQ-5D-5L scores
Time point Rehabilitation group Control group
Mean EQ-5D baseline 0.860 (0.150) 0.799 (0.232)
Mean EQ-5D follow-up 1 0.855 (0.147) 0.841 (0.254)
Mean EQ-5D follow-up 2 0.840 (0.161) 0.799 (0.155)
Data include all patients who participated in follow-up 1 and follow-up 2. There were 15 patients in the rehabilitation
group and 16 patients in the control group at follow-up 1. There were 12 patients in the rehabilitation group and 13
patients in the control group at follow-up 2. A hypothesis that the means were equal at baseline could not be rejected
(t= 0.90), suggesting that the two groups did not differ at baseline. SDs are given in parentheses.
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Chapter 11 Patient and public involvement
User involvement has been demonstrated to positively impact health research from theconceptualisation of research topic, through to data collection, interpretation and reporting.202 The
NIHR supports and encourages patient and public involvement in all the research that it funds, on the basis
that this can lead to better research that is more focused on the needs of patients and can accelerate the
transfer of research evidence into practice. A handbook for researchers about patient and public
involvement (PPI) has been published by NIHR.203 In addition, INVOLVE (www.invo.org.uk) is funded by the
NIHR to support greater public involvement in NHS, public health and social care research.
Patient and public involvement can take different forms, including:
l prioritisation of studies
l design and management of studies
l data collection and analysis
l dissemination of findings.
In this chapter, we describe the PPI for this particular study.
Involvement of Bowel Cancer UK (Scotland)
The manager of Bowel Cancer UK (Scotland), Emma Anderson, was a member of our project advisory group.
Two patient advisors who were recruited from Bowel Cancer UK (Scotland) also participated in the study.
All three contributed towards the design of the study, advising on, for example, study information sheets
and consent forms. One of the patient advisors moved abroad and so curtailed her involvement in the study.
The other patient advisor, Gillian Sweetman, presented at the NIHR ‘welcome’ event, was a member of
the project advisory group and conducted interviews with three people with CRC during phase 1. She
participated in a 1-day training course so that she could conduct these interviews. Dr Gill Hubbard
(the study’s principal investigator), who organised the event for members of the Service User Research
Partnership of Breast Cancer Care, delivered the training. Gillian Sweetman was invited with agreement
from Breast Cancer Care.
In March 2015, Gillian recounted her overall experience of being involved in the CRIB project (Box 5).
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Discussion and recommendations
In this study, we involved a leading UK CRC charity. We worked particularly closely with a full-time
member of staff and a volunteer who had direct and personal experience of CRC as a patient. Their views
about the study, in terms of its importance for people with CRC, were articulated at research group
meetings, which instilled confidence that the study was worthwhile and would be supported by the charity
at the national level. In addition, Gillian’s involvement demonstrated that, with training and support,
volunteers can work closely with the researchers, helping, for instance, to collect data. This helped to
situate Gillian as one of the team rather than as the patient representative on the team. The difference
between the two approaches may be subtle, but by involving volunteers as co-researchers in this way, we
developed a more inclusive team. Based on our experience, this pilot work can be used as a springboard
for further PPI in any future trial.
BOX 5 Patient involvement comment
I was diagnosed with stage III bowel cancer in July 2008 with a solitary lung secondary. My immediate
goal following bowel surgery was to be fit enough to have the lung surgery . . . and to then be fit enough
for the chemotherapy. During chemotherapy I wanted to be able to have the next cycle on time.
I am a doctor, but it is so different helping patients to experiencing illness 24 hours a day. Getting out and
walking helped me psychologically as well as physically. My background gave me the confidence
to exercise.
Once treatment was complete, I looked around for voluntary work and found that Bowel Cancer UK
needed volunteers to help with the Bowel Cancer awareness programme, and through that I became
involved in the charity. If you are open about your own diagnosis you also start to meet people on a
similar or harder journey with different types of cancer.
Sharing with others, there is a difficult stage when treatment finishes and the immediate link with hospital
and more intensive treatment stops. There is little information given on self-help. I would have been very
rich if I’d taken a pound for every time I was told to take it easy!
I was offered the opportunity to help with the CRIB project and from the proposal I could see immediately
how this programme could fill this information gap and help people exercise with confidence.
I valued being able to help with writing the patient information sheets and with the initial presentation.
I have participated as a member of the steering group. I have also helped with some feedback interviews
from patients. The participants I met were very positive about the programme.
It has been a valuable experience being involved in this project. The intensive surgery and chemotherapy
are very expensive. Rebuilding confidence that has been broken down by the diagnosis and treatment is
important and it is this type of project that will show the best ways to do this. This will be both to the
benefit of individuals and society.
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Chapter 12 Discussion and conclusions
In this chapter we summarise key evidence and draw conclusions about the feasibility and acceptabilityof cardiac rehabilitation for people with CRC and the feasibility of running a future multicentre
definitive trial.
Results
Is cardiac rehabilitation an acceptable and feasible rehabilitation service for
people with colorectal cancer?
Bowen et al.75 recommend eight areas of focus to assess if a public health intervention is feasible. Table 54
presents an assessment of the feasibility of cardiac rehabilitation as a rehabilitation model for people with
CRC against these criteria. Overall, our feasibility work indicates that:
l Cardiac rehabilitation is an acceptable rehabilitation service for people with CRC.
l There is likely to be a demand for this service from people with CRC.
l Cardiac rehabilitation physiotherapists and other members of the team can be trained in cancer and
exercise and to support people with CRC to exercise safely.
l Additional resources (e.g. the appointment of an assistant physiotherapist) are likely to be needed in
order to expand cardiac rehabilitation so that the service can accommodate additional patients.
TABLE 54 Feasibility and acceptability of cardiac rehabilitation for people with CRC
Area of focus The feasibility study asks . . . Evidence for CRIB
Acceptability To what extent is a new idea,
programme, process or measure
judged as suitable, satisfying, or
attractive to programme deliverers?
To programme recipients?
The study shows that cardiac rehabilitation as a rehabilitation
model for people with CRC is attractive and acceptable to the
people with CRC. The study suggests that patients and
clinicians believe that mixed patient rehabilitation classes are a
good idea; nobody (people with CRC, people with CHD, or
cancer and cardiac clinicians) had a problem with mixed
rehabilitation classes for people with CRC and people with
CHD. Physical activity was regarded as a key component in the
recovery and rehabilitation process for people with CRC. The
perceived main benefits of cardiac rehabilitation for people with
CRC were that they would increase their level of physical
activity, overcome fears about being physically active, gain
confidence and become more motivated to exercise, access
peer support and forge new friendships and obtain psychosocial
support from trained clinicians
Demand To what extent is a new idea,
programme, process or measure
likely to be used (i.e. how much
demand is likely to exist?)
The study indicates that demand will be reasonably high
because people with CRC believe there to be a range of
benefits from attending cardiac rehabilitation; they believe that
cardiac rehabilitation will help them to increase their level of
physical activity, overcome fears about being physically active,
gain confidence and become more motivated to exercise, access
peer support and forge new friendships and obtain psychosocial
support from trained clinicians
We recommend, however, that barriers to cardiac rehabilitation
attendance be addressed. In particular, people in poor physical
health or with mobility difficulties should be encouraged to
attend, and we recommend a flexible start date so that people
with protracted recoveries following surgery can also attend.
In addition, we recommend addressing travel difficulties by,
for instance, offering outreach services or virtual classes
continued
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TABLE 54 Feasibility and acceptability of cardiac rehabilitation for people with CRC (continued )
Area of focus The feasibility study asks . . . Evidence for CRIB
Implementation To what extent can a new idea,
programme, process or measure be
successfully delivered to intended
participants in some defined, but not
fully controlled, context?
This study shows that it is possible to train cardiac
physiotherapists and other members of the team in cancer and
exercise so that they can support people with cancer to exercise
safely. The evaluation of the cancer and exercise training was
excellent, with all physiotherapists and nurses agreeing or
strongly agreeing that the information and course content was
helpful and well presented
The study also shows that cardiac rehabilitation can be
successfully delivered to intended participants (i.e. people with
CRC); for instance, cardiac rehabilitation attendance was high,
ranging from 75% to 142% (some people attended more
sessions than planned). Moreover, cardiac rehabilitation is
widely available throughout the UK and our study, conducted in
three sites, suggests that cancer service pathways could be
easily modified so that cancer nurses could refer patients to
cardiac rehabilitation
Practicality To what extent can an idea,
programme, process or measure be
carried out with intended
participants using existing means,
resources, and circumstances and
without outside intervention?
The economic evaluation suggests that the costs of cardiac
rehabilitation for people with cancer will depend on whether it
involves adding people with CRC to an already existing service
or setting up a completely new service. Costs would be
marginal for the former
The study suggests that there are concerns about capacity and
it is likely, therefore, that, were this service to be offered to
people with CRC, additional staff (e.g. a physiotherapy
assistant) would need to be hired. Thus, we recommend the
provision of additional resources so that cardiac rehabilitation
staff can accommodate people with CRC without it having a
detrimental impact on people with CHD
Adaptation To what extent does an existing
idea, programme, process or
measure perform when changes are
made for a new format or with a
different population?
The study shows that existing cardiac rehabilitation can perform
with a different population (i.e. people with CRC)
However, the study suggests that cardiac rehabilitation clinicians
do not feel competent providing specific CRC-related
psychosocial advice and support. We believe that cancer
services rather than the cardiac rehabilitation address gaps in
rehabilitation support, such as stoma care and dietary advice,
because they have the required expertise
Integration To what extent can a new idea,
programme, process or measure be
integrated within an existing system?
This study suggests that referral pathways can be easily
introduced so that CRC nurses can refer people with CRC to
cardiac rehabilitation. In addition, CRC nurses can easily provide
information (e.g. type of treatment, medication, comorbidities)
about patients with CRC to the cardiac rehabilitation team so
that they can support people with CRC to exercise safely
Expansion To what extent can a previously
tested programme, process,
approach or system be expanded to
provide a new programme or
service?
The study shows that cardiac rehabilitation physiotherapists and
other members of the cardiac rehabilitation team are able to
support people with CRC to exercise safely. One AE was
reported that was unrelated to the study, and attendance by
people with CRC was high
Limited efficacy Does the new idea, programme,
process or measure show promise of
being successful with the intended
population, even in a highly
controlled setting?
This pilot study did not set out to test if cardiac rehabilitation
for CRC is effective
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l Cardiac rehabilitation exercise classes do not need to be adapted because physiotherapists are able to
support people with CRC to exercise safely.
l Cancer-specific educational sessions need to supplement the cardiac-specific educational sessions so
that people with cancer attending cardiac rehabilitation have their psychosocial needs addressed.
l Cardiac rehabilitation can be integrated into cancer pathways with minimal disruption.
Are trial procedures acceptable and feasible?
Thabane et al.77 propose four primary purposes for conducting pilot studies. Table 55 presents an
assessment of the feasibility of the main trial components against these set criteria. Our feasibility and pilot
work indicates that some trial procedures worked particularly well, giving us good reasons and a solid
foundation for moving forward. Nonetheless, our work also highlights a major challenge for a future trial;
our recruitment strategy led to a sample of particularly healthy and active people with CRC. This, coupled
with a small sample size, is the most likely reason why we did not find any differences in level of physical
activity between the intervention and control groups at baseline or follow-up, which we could use to
derive a sample size calculation for a future trial. Our recruitment strategy did not recruit people with CRC
who needed it most, that is, those who were inactive and in poor health. We do not know if more
targeted strategies to improve recruitment among people who are inactive or in poor health will work.
Moreover, what this group can achieve may be different from that of an already active group of patients;
it may not be feasible for the former group to reach a target of 150 minutes of moderate physical activity
per week. Thus, perhaps a more achievable, but clinically relevant, end point for this group of patients
would be a reduction in sedentary behaviour. Nevertheless, based on current evidence (presented in
Chapter 1), which shows the health benefits (e.g. survival and quality of life) of increasing post-diagnosis
physical activity, there is a strong argument for retaining change in amount of weekly physical activity as a
primary outcome in future trials of structured physical activity interventions for CRC survivors. A key finding
from phase 2 was the number of missing data from the accelerometers. However, given the limitations of
using self-report to measure change in physical activity (discussed in Chapter 8), objective measurement is
preferable. There are few studies that have used accelerometers with this clinical population and so it is
premature to dismiss this method to measure physical activity. Instead, we believe that it is critical to
develop and evaluate strategies to encourage participants to wear the device according to protocol.
Limitations
This study was conducted to inform design and make decisions for a future full-scale trial of cardiac
rehabilitation for cancer patients, including whether or not a full-scale trial should be done at all. This
requires careful judgements about the limitations of this study and the impact those limitations will have
on the applicability of what we have found to any future full-scale trial. These judgements are part of all
feasibility and pilot studies. Broadly speaking, potential limitations fall into three categories:
1. Design and conduct challenges: challenges and problems encountered in the feasibility and pilot study
that suggest changes are needed if a full-scale trial is to be feasible.
2. Unanticipated conduct failures: a planned part of the feasibility and pilot study was not possible
because of some external event not linked to the intervention under evaluation (e.g. slow approvals,
loss of trial staff).
3. Generalisability of the sites selected for the feasibility and pilot work: whether or not there is reason to
suggest that the sites involved in the feasibility and pilot study are atypical of sites that would be part of
a full-scale trial.
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TABLE 55 Feasibility and acceptability of trial procedures
Area of
focus The feasibility study asks . . . Evidence for CRIB
Process This assesses the feasibility of
the processes that are key to
the success of the main study
This study suggests that a future trial is feasible for the following reasons:
l The proportion of patients screened for eligibility was high (79%)
l The eligibility rate was high (67%)
l A good cross-section (age, gender, diagnosis, type of surgery,
stoma) of people with CRC was recruited
l 56% of eligible people with CRC showed interest in the study and
were planning to participate and 31% of eligible people with CRC
consented and were randomised
l Retention was excellent (93%)
l Cardiac rehabilitation attendance of people randomised to the
intervention group was excellent (75–142%)
l Out-of-pocket expenses for participants randomised to the
intervention group were relatively small (e.g. £20 for clothing and
£50 in total on travel)
Nonetheless, this study highlights threats to the success of the main
study and potential limitations if these risks are not addressed and
managed in a future effectiveness trial:
Improving eligibility rate
The main reason for nurses excluding people with CRC from the study was
poor mobility (35%). However, most cardiac rehabilitation accommodates
people with poor mobility, including people who use a wheelchair.
Cardiac rehabilitation also accommodates people with poor physical
health (e.g. there is a low-intensity class for people who are in poor
physical health). We therefore recommend training clinicians involved in
screening about the viability and importance of including people with poor
mobility and health. We believe that the majority of patients excluded for
poor mobility would, in fact, be candidates for the intervention, meaning
that eligibility could potentially be increased by over 30%
Addressing recruitment bias
There was recruitment bias. At baseline, most participants were meeting
or nearly meeting recommended levels of physical activity (i.e. 30 minutes
of moderate physical activity per day). This is problematic for the NHS and
for triallists. People meeting recommended levels of physical activity will
already be maximising their chances of obtaining the health benefits
associated with post-diagnosis physical activity. There seems little clinical
value in providing a service to people who are already reaping health
benefits arising from being physically active
However, extra efforts will have to be made to recruit people who are
inactive and in poor health because our study suggests that these
people are less likely to wish to participate in a physical activity trial.
Our study suggests that introducing motivational strategies, such as
providing information about the benefits of being active, may help
recruitment. Moreover, reducing the amount of sedentary behaviour
may be a more acceptable and clinically meaningful end point for this
group of patients. This could be achieved by exploring the use of
alternative, emerging technology in the field of activity tracking devices
Improving consent rate
The study shows that 44.5% of eligible patients with CRC who wished
to participate withdrew before randomisation. One of the reasons why
people with CRC (who wanted to participate in the study) changed their
minds was because they did not feel able to exercise while on treatment
(e.g. adjuvant chemotherapy). We recommend, therefore, excluding
people who are on active treatment. This change to the eligibility criteria
should not impact on eligibility rate; it will merely delay when people are
invited to enter the study (i.e. post treatment). Including only people with
CRC post treatment should, however, increase the consent rate by
approximately 20% (18% of those who were interested in participating
changed their minds because they were having adjuvant therapy and did
not wish to or did not feel able to exercise during this time)
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TABLE 55 Feasibility and acceptability of trial procedures (continued )
Area of
focus The feasibility study asks . . . Evidence for CRIB
Improving completion rate
l After randomisation, some people allocated to the control group
reported feeling abandoned. We recommend that participants
allocated to the control group be sent regular updates and
reminders about the study and perhaps given the chance to attend
cardiac rehabilitation once the study is closed
l Completion rates decreased for both intervention and control
groups for the self-reported questionnaires (97.5%, 75% and 61%
at baseline, follow-up 1 and follow-up 2, respectively). We
therefore recommend introducing evidence-based strategies to
improve completion rates at follow-up (e.g. including a monetary
incentive and a ‘package’ of postal communication strategies with
reminder letters). Evidence is lacking about the actual impact of
these strategies on completion rates for a trial of cardiac
rehabilitation for people with CRC. Nevertheless, based on other
physical activity trials’ completion rates, we believe that a future
study could have up to an 80–90% completion rate.
Reducing missing data
Across all time points, 31% (n= 20) of accelerometer data sets were
assessed as invalid. The main reasons were participants not wearing the
device or not wearing it for long enough. There was significant variation
across sites and, importantly, one site had only one invalid accelerometer
data set. The investigator in this site had a sports science background and
was familiar with measuring level of physical activity and already well
versed in the benefits of physical activity for people with CRC. We
therefore recommend introducing strategies to improve accelerometer
wear-time, such as additional training for investigators so that they can
explain to participants the importance of these data for the study. We
also recommend providing individual feedback on the level of physical
activity recorded by the device to each participant so that they can
actually see the data generated from these devices about their level of
physical activity and sedentary behaviour. Evidence is lacking about the
actual impact of these strategies on completion rates but we would
expect positive reinforcement to increase compliance and data acquisition
Improving intervention take-up
Thirteen out of 21 participants (62%) randomised to the intervention
group completed the cardiac rehabilitation programme as per protocol.
Three participants started cardiac rehabilitation but could not complete
all classes and five did not begin (38%). Two of these participants
stopped attending because they did not feel well enough to exercise
while having chemotherapy. As suggested, we therefore recommend
excluding people on active treatment to address this barrier to
attending cardiac rehabilitation (see above)
continued
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Item 1 is what feasibility and pilot studies are chiefly designed to identify: issues that make a full-scale trial
either unfeasible or likely to be unfeasible without modification to what was planned and subsequently
used in the feasibility study. In our study, there were many trial design issues falling into this category,
including suboptimal eligibility, consent and completion rates and missing data. Issues relating to the
intervention – cardiac rehabilitation – falling into this category include barriers to attending cardiac
rehabilitation and the capability of existing cardiac rehabilitation clinicians to support people with cancer.
To address these challenges and study limitations we recommend induction training for staff involved in
recruitment and data collection. The training, for instance, would address suboptimal recruitment by
highlighting to staff the health benefits of cardiac rehabilitation for patients who have poor mobility with
the aim of boosting the recruitment of those patients in relatively poorer health. The training would also
aim to address missing data by increasing researchers’ competence to collect accelerometer data by for
instance, emphasising the importance of these data for the study and showing staff how to explain to
participants how and when to wear the accelerometer device. To improve the consent rate we propose to
remove a major barrier to participation in the study, travel to and distance from cardiac rehabilitation, by
including outreach services in any future trial. Offering cardiac rehabilitation outreach services would also
address a limitation of the intervention, which was that cardiac rehabilitation was too far away for some
people to travel. Another barrier to consenting to the study and also to attending cardiac rehabilitation
TABLE 55 Feasibility and acceptability of trial procedures (continued )
Area of
focus The feasibility study asks . . . Evidence for CRIB
Resources This deals with assessing time
and resource problems that can
occur during the main study
The study highlights the following potential resource problems:
1. The preliminary economic evaluation suggests that the costs of
cardiac rehabilitation for people with cancer will depend on whether
it involves adding people with CRC to an already existing service or
setting up a completely new service. Costs would be marginal for
the former. This study shows that across the three sites people with
CRC were accommodated into an existing service. Nevertheless, the
study shows that the cardiac rehabilitation team was concerned
about capacity. If cardiac rehabilitation reaches capacity, additional
resources (e.g. employment of an assistant physiotherapist) would
have to be found so that people with CRC could use the service.
This cost falls under ‘excess treatment costs’ and therefore would
need to be agreed by each NHS board. In the current financial
climate this may be contentious
2. Research costs will vary depending on whether or not the study
utilises NHS research nurses to recruit people with CRC and collect
data (i.e. no cost to the funder) or whether or not research
assistants are employed for the specific purposes of the study. In a
large multicentre trial, this amounts to a considerable sum of money
Management This covers potential human
and data management
problems
The study involved three sites and a clinical trials unit. No data
management problems were encountered that could not be easily
addressed and the study was conducted according to protocol.
Recruitment rates and the number of missing accelerometer data sets
varied across the three sites and we therefore recommend regular
monitoring of each site in parallel with data validation procedures in
any future trial so that problems can be identified early in the study and
addressed accordingly
Scientific This deals with the assessment
of treatment safety, dose,
response, effect and variance
of the effect
One AE was reported that was unrelated to the study, suggesting that
the intervention and trial procedures are low risk
We did not aim to measure effect on health outcomes because of our
small sample size. That no differences were found between the
intervention and control groups for physical activity and psychosocial
outcomes is, therefore, neither surprising nor unusual for a feasibility
study of this scale
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highlighted by our feasibility and pilot work was poor recovery from surgery and ongoing treatments,
especially adjuvant therapy. Indeed, there was a general reluctance by participants to start exercising
during ongoing treatment. To improve the consent rate and address barriers to participating in the cardiac
rehabilitation programme, we therefore suggest including only patients who are at the end of treatment.
We also recommend adopting a strategy whereby patients are involved in the decision about their start
date for attending cardiac rehabilitation. This is because a limitation of the study design, and also of the
intervention, was that some patients needed more time post surgery to agree to participate than we
provided. Additionally, questionnaire completion rates fell from baseline to first and then second follow
up. To improve completion rates we recommend the adoption of evidence-based strategies such as
monetary incentives to return questionnaires together with regular reminders. Finally, our study found that
cardiac rehabilitation clinicians did not feel competent providing specific cancer-related psychosocial
support to participants with CRC. Hence to address this limitation we propose that cancer clinicians should
continue to provide cancer-specific psychosocial support while cardiac rehabilitation clinicians provide
generic as opposed to disease-specific psychosocial support as well as supporting people to exercise.
Item 2 in the list of limitations differs from item 1, in that the limitation is not necessarily a result of the
trial design, the intervention or its delivery, but of the inability of the study team to make something
happen because of one or more unanticipated problems: generally an external event, such as the loss of a
key member of staff. Whether or not these problems could have been anticipated is a moot point; the key
issue is that they were not anticipated, the impact was substantial and, as a consequence, part of the
study could not be carried out. In our pilot study, we were unable to meet one study objective, which was
to provide data for sample size calculations for a definitive RCT. Our inability to provide data was a
consequence of failing to meet our recruitment target of 66 (the recruitment challenges mentioned above
meant that we recruited 41) and also of recruitment bias. Indeed, a key finding from the feasibility and
pilot work, and also a good illustration of why feasibility and pilot work is important, was recruitment bias;
most participants were already meeting or close to meeting the recommended level of physical activity for
the adult population (i.e. 150 minutes per week of moderate physical activity), which is unusual for this
patient group and, indeed, for the general population.14–19 To address this study limitation we propose in a
future trial to revise the eligibility criteria and exclude patients who are already physically active. This would
also mean that the cardiac rehabilitation would be targeting those patients who need it most, that is,
those who are currently not meeting the recommended level for physical activity associated with health
benefits. This may, of course, extend the recruitment period of any full-scale trial, but this could be
planned for from the start.
Item 3 is a challenge for all feasibility and pilot studies, and perhaps triallists have a tendency to
overestimate the generalisability of findings from small-scale work carried out in a handful of sites to what
might be many tens of sites in a future full-scale trial. There is, of course, a balance to be struck between
the duration and cost of feasibility and pilot work and the duration and cost of a potential full-scale trial.
For example, recruitment is still an important concern for all triallists; a recent study of NIHR- and
MRC-funded trials found that about half of these trials met their targets despite some of the trial teams
having done feasibility and pilot work.204 An earlier study that looked explicitly at the impact of pilot work
on recruitment did not find a clear link between doing pilot work and successful recruitment.205
Our feasibility and pilot work suggests variation in sites regarding recruitment parameters (we have written
about this in detail elsewhere141 as well as in this report) and we therefore anticipate that some sites will
meet recruitment targets and others will not. Which sites are likely to perform well is difficult to judge in
advance. It is for this reason, in particular, that we propose an internal pilot as part of any future multisite
effectiveness trial. The internal pilot should have clearly defined stop–proceed rules based around
recruitment targets. Another limitation of the study is that people with CRC who agreed to participate
might have been particularly keen to increase their level of physical activity, which means that the findings
may not be applicable to those people with CRC likely to be less interested in being physically active to aid
their recovery and reduce risk of recurrence. As discussed above, we are proposing that any future trial
should exclude those who are already physically active. Limitations on the ability to make generalisations
about the intervention are that the costs associated with the referral of cancer patients to cardiac
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rehabilitation is likely to vary by site; the capacity of a cardiac rehabilitation service to take additional
patients is also likely to vary from one site to the next. These variations are likely to be important
information for those who are tasked with commissioning or managing services. Finally, we recommend
embedding a process evaluation in any future trial so that contextual factors impacting the delivery of
cardiac rehabilitation to patients with cancer (including the capacity to take more patient referrals) in each
site are also highlighted. This is important given that there are over 300 cardiac rehabilitation services in
the UK, and this and any future study is likely to include only a fraction of these sites.
In summary, this feasibility and pilot work highlights a range of trial design limitations, including
suboptimal eligibility, consent and completion rates, missing data and recruitment bias. It also highlights
the limitations of cardiac rehabilitation for patients with cancer, including capacity, costs and capability
issues. To make a full trial feasible, we have made a series of recommendations to address the limitations
we have identified, including an internal pilot with clear stop–proceed rules, induction training for staff
and participant incentives. To clarify and aid interpretation of generalisation, we also recommend an
embedded process evaluation so that each site’s contextual factors impacting cardiac rehabilitation for
patients with cancer are illuminated.
Conclusions
Implications for health care
The main novel finding is that cardiac rehabilitation for cancer and cardiac patients together is feasible and
acceptable, thereby challenging disease-specific rehabilitation models.
This feasibility and pilot study suggests that cardiac rehabilitation is, on the whole, an acceptable and
feasible rehabilitation service for people with CRC and their clinical care teams, but there are key concerns
regarding the capacity of cardiac rehabilitation services to accommodate additional patients with cancer
and the capability of cardiac rehabilitation clinicians to provide cancer-specific psychosocial support.
Before UK-wide implementation of the intervention, it is critical to address these concerns and then to find
out if this model of rehabilitation has a health benefit. A major strength of this feasibility and pilot study,
however, is that we evaluated an already widely available existing rehabilitation service, namely cardiac
rehabilitation. The aim of this pragmatic trial was not to attempt to change and adapt cardiac
rehabilitation, but to find out if it is feasible and acceptable to refer people with CRC to this service as
currently configured. We were successful in achieving this aim.
Implications for future research
Research priorities and recommendations
To maximise the success of any future effectiveness trial, research priorities include addressing CRC
patient barriers to attending cardiac rehabilitation and consenting to the study (e.g. travel, poor recovery),
gaps in cardiac rehabilitation provision for cancer patients, such as cancer-specific psychosocial support,
recruitment bias, missing accelerometer data and retention of control group participants, and marginal
costs related to expanding cardiac rehabilitation provision to other patient groups.
To address concerns about capacity, we recommend that additional resources be given to cardiac
rehabilitation services (if required) so that they can take more patients. To address concerns about the
competence of cardiac rehabilitation clinicians to deal with cancer-specific issues, we recommend that
the cancer team address cancer-specific needs and that cardiac rehabilitation attend to generic concerns
of patients. To address travel barriers to attending cardiac rehabilitation, we recommend that outreach
services should be offered. To address recruitment bias, we recommend that induction training should be
provided to cancer clinicians about cardiac rehabilitation so that they refer and offer the service only to
patients who need it most, that is, those who do not currently meet the recommended guidelines for
physical activity. This training will also point out the ability of cardiac rehabilitation services to support
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people who, for instance, have a disability or are immobile, thereby encouraging referral of patients to the
service who are frail, etc. To improve up-take of the service, we recommend that patients are part of
the decision-making process about the start date for attending cardiac rehabilitation. This is so that those
who wish to begin at the end of all active treatment, including adjuvant therapy, can still participate.
If conducting a study, this strategy should also improve the consent rate. To improve completion rates,
especially participants allocated to the control arm, we recommend that incentives are provided to remain
in the study, such as monetary incentives and regular reminders. To reduce missing accelerometer data, we
recommend that researchers are trained so that they communicate to participants the importance of these
data and how to wear the device.
Next steps
A major strength and advantage of pragmatic trials is the testing of already existing services in real-world
settings. It is very different, therefore, from an explanatory trial, in which the intervention is tightly
controlled and managed by the investigating team. This is the first pragmatic pilot trial of a physical activity
intervention for people with CRC. This study has highlighted threats to a future definitive trial and we have
made a series of recommendations to manage these risks. Before proceeding to a full-scale multicentre
trial to evaluate health benefits of cardiac rehabilitation for cancer patients, we recommend an internal
pilot trial be conducted, incorporating the protocol modifications that we have recommended, and that
screening, eligibility and consent rates, in particular, are closely monitored at each site during the pilot.
This internal pilot should have clear ‘stop–proceed’ rules that are formally reviewed before proceeding to
the full-scale trial.
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Appendix 1 Patient information sheet
C R I B 
Cardiac Rehabilitation in Bowel Cancer 
BOWEL CANCER PATIENT INFORMATION SHEET 
Study Title: The use of cardiac rehabilitation services to aid the 
recovery of bowel cancer patients 
You are invited to take part in this rehabilitation programme. This sheet is to provide 
you with the information you need to see if you would like to take part in the study.   
Please ask if you have more questions or need more information. 
What is the purpose of the Study? 
Studies have shown that exercise is likely to reduce the risk of the bowel (colorectal) 
cancer returning and to reduce fatigue and depression. Often patients don’t know if it 
is safe to exercise.  Cardiac rehabilitation, which involves exercise and health advice, 
is already offered to people recovering from a heart attack. Cardiac rehabilitation 
gives people confidence to exercise and improves wellbeing. This study is to see if 
people recovering from bowel cancer can also benefit from this programme.  
Why you? 
You have been asked to join the study as you are recovering from surgery for bowel 
cancer. We have also asked others who have come in for similar surgery. 
Ethical Approval 
The North of Scotland Research Ethics Committee has reviewed the study. There will 
be monitoring from the University of Stirling and NHS Highland that this research 
project is being properly conducted.  
What happens next? 
You will be asked to complete a consent form to confirm your willingness to take part 
in the study.  This will take place in hospital, the rehabilitation facility or your own 
home. A member of the research team will witness your signature. You will then be 
contacted by a rehabilitation physiotherapist, who will meet you and assess if the 
programme is suitable for you.  If the programme is suitable, you will be given an 
appointment for the next available weekly rehabilitation class. 
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We will ask you to come in to answer some questions for us. When we have done 
this, you will be allocated to either take part in the study and attend the rehabilitation 
group, or you will be part of our control group, and will not be required to attend the 
classes.  
Please keep a copy of this information sheet. 
Do I have to take part? 
No.  It is up to you to decide if you want to take part.  If you do decide to join the 
study you can stop at anytime without giving a reason.  If you do stop you may be 
asked if you are willing to give a reason as this may help plan future studies. 
If you do not want to join the study, or leave the study, you will continue with all 
normal follow up care. 
What if I wish to complain about the study? 
You can submit a written complaint about any part of the study to: Feedback Team, 
NHS Highland, PO box 5713, Inverness IV1 9AQ or telephone 01463 705997. 
 
 If you believe you have been harmed by taking part in the study you can make a 
complaint and seek compensation through the University of Stirling (see below).  You 
can also complain through the usual NHS process.  If you are harmed due to 
someone’s negligence you may have grounds for a legal action, but you may have to 
pay your legal costs. The NHS has no legal liability unless the harm is caused by 
someone’s negligence. 
Who do I contact for further information about the study? 
Dr Gill Hubbard is the Principal Investigator for the study.  If you wish independent 
advice please contact Professor Billy Lauder, Head of the School of Nursing, 
Midwifery and Health. 
Dr Gill Hubbard
XXXX
Tel: XXXX 
Email: XXXX 
    Independent contact
  Professor Billy Lauder
  XXXX
  Tel: XXXX
  Email: XXXX  
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 Thank you for taking the time to read this and to consider taking 
part in the study. 
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Appendix 2 Screening form
SCREENING AND RECRUITMENT 
FORM 
 
 
Please complete this form for each patient screened for potential 
recruitment to the study.  Please keep this form in a secure place. Please 
note that all patients who have had surgery for colorectal cancer should 
be screened and have a Screening and Recruitment Form completed. 
  
 
 
Name of clinician completing this form:……………………………………… 
 
 
 
Signature:…………………………………………………….. 
 
 Date:……………………………… 
 
 
 
Please keep this form in a secure place until a researcher collects it. 
 
SECTION A: PLEASE COMPLETE FOR ALL PATIENTS 
 
1. Patient details 
Name  
 
CHI  
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 GP Name and 
Practice 
 
Date of birth  
 
Gender (please )  Male                               Female 
Date of surgery 
(DD/MM/YYYY) 
 
 
 
2. What was the patient’s colorectal cancer diagnosis (if available)? (using AJCC 
- TNM staging system or Dukes) Tick   for each section 
Primary tumour  Regional lymph 
node 
Distant metastasis 
Tx Nx M0 
T0 N0 M1 
T1 N1 No information 
T2 No information  
T3   
T4   
No information   
 
Any additional comments (optional)? 
 
 
 
 
3. What was the patient’s treatment for colorectal cancer? (please ) 
Treatment  
Colon surgery  
Rectal surgery  
Laparoscopic surgery  
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Open surgery  
Temporary stoma (a loop ileostomy)  
Permanent stoma  
Chemotherapy  
Radiotherapy  
Other (briefly describe) 
 
 
 
 
 
 
4. Inclusion and exclusion criteria* 
 
a) Is the patient 18 years old or over? (please ) 
NO  
YES  
 
b) Has the patient been diagnosed with primary colorectal cancer? (please ) 
NO  
YES  
 
c) Is the patient in the recovery period following surgery and may or may not be 
receiving adjuvant chemotherapy? (please ) 
NO  
YES  
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d) Does the patient have advanced disease? (please ) 
NO  
YES  
e) Is there any reason why this patient cannot engage in at least 150 minutes per week 
of moderate intensity or 75 minutes per week of vigorous intensity aerobic physical 
activity**? (please ) 
NO  
YES  
 
If yes, please give reason: 
Reason  
Severe anaemia  
Compromised immune function  
Injury that will be aggravated by exercise 
 
 
Other (briefly describe) 
 
 
 
 
 
f) Does the patient have a severe cognitive impairment? (please ) 
NO  
YES  
 
g) Can the patient communicate in English? (please ) 
NO  
YES  
 
5. Does the patient meet all eligibility criteria? (please ) 
NO  
YES  
 
If yes, continue to Section B. 
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SECTION B: COMPLETE ONLY FOR PATIENTS WHO MEET 
ELIGIBILITY CRITERIA 
 
6. Has the patient been given an information sheet about the study? (please ) 
NO  
YES  
 
7. Has the patient given permission to be approached by a researcher about the study? 
(please ) 
NO  
YES  
 
I give permission to be approached by a researcher about the study. 
 
Patient signature:…………………………………………………………. 
SECTION C: COMPLETE FOR PATIENTS WHO DO NOT WISH TO TAKE 
PART 
8. If no to Question 7, has the patient completed a Non-participation patient consent 
form (Form 3)?  
NO  
YES  
 
9. If yes to Question 8, what is the reason for non-participation (tick one box 
only)?  
Declined to give a reason  
Don’t feel ready to be physically active  
Already physically active  
Transport  
Distance  
Cost  
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
183
Other commitments (work/family)  
Other (please specify) 
 
 
* Inclusion and exclusion criteria 
Cancer patient study participants
Adults who have been, i) diagnosed with primary colorectal cancer, and ii) are in the 
recovery period following surgery and may or may not be receiving adjuvant 
chemotherapy. 
Exclusion criteria 
Adults who i) have advanced disease, or ii) fail clinical/risk assessment for 
rehabilitation and therefore deemed by clinicians as unsafe to participate in exercise 
classes, (e.g. according to recent guidance patients with severe anaemia should delay 
exercise and patients with compromised immune function should avoid public gyms 
and exercise classes [49]), or iii) have a severe cognitive impairment and therefore 
unable to give informed consent to participate in the study, or iv) are unable to 
communicate in English (N.B. if this study shows that the intervention and trial 
procedures are acceptable and feasible then translation service costs will be requested 
in a future large scale trial). 
 
** How do I know if I'm doing moderate or vigorous intensity exercise? 
Moderate-intensity aerobic activity means you're working hard enough to raise your 
heart rate and break a sweat. One way to tell if you're working at a moderate intensity 
is if you can still talk but you can't sing the words to a song. Vigorous-intensity 
aerobic activity means you're breathing hard and fast, and your heart rate has gone up 
quite a bit. If you're working at this level, you won't be able to say more than a few 
words without pausing for a breath. The intensity of different forms of physical 
activity varies between people. The intensity of physical activity depends on an 
individuals previous exercise experience and their relative level of fitness. 
Consequently, the examples given below are provided as a guide only and will vary 
between individuals.  
 
Moderate Intensity: Walking briskly (3 miles per hour or faster, but not race-walking, 
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
184
Water aerobics, Bicycling slower than 10 miles per hour, Tennis (doubles), Ballroom 
dancing, General gardening 
Vigorous Intensity: Race walking, jogging, or running, Swimming laps, Tennis 
(singles), Aerobic dancing, Bicycling 10 miles per hour or faster, Jumping rope, 
Heavy gardening (continuous digging or hoeing), Hiking uphill or with a heavy 
backpack. 
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Appendix 3 Referral form
C R I B 
CARDIAC REHABILITATION 
 REFERRAL FORM 
1. Patient details 
Name  
 
CHI  
Date of birth  
 
Telephone  
 
Address  
 
GP name and practice 
 
 
Date of surgery 
 
 
Relevant PMH  
 
 
Current Medications  
 
 
2. Name of cancer clinician completing this form:……………………… 
 
Signature:……………………………………………………..  
 
Date:……………………………… 
 
Please email/fax/post this form to the cardiac rehabilitation team. 
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Appendix 4 Non-participation consent form
 
C R I B 
Cardiac Rehabilitation in Bowel Cancer 
NON-PARTICIPATION PATIENT CONSENT FORM 
  PLEASE INITIAL 
BOX IF YOU 
AGREE 
1. I agree to have information about my diagnosis, treatment and 
blood test results passed on by the colorectal cancer clinicians to 
the researchers so that they can find out how representative the 
study sample is of all colorectal cancer patients.    
 
I understand that this information from this study will be kept in a 
locked filing cabinet at the University of Stirling and stored in a 
password-protected folder on the University computer hard drive. 
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Appendix 5 Consent form
C R I B 
Cardiac Rehabilitation in Bowel Cancer 
CANCER PATIENT CONSENT FORM 
  PLEASE INITIAL 
BOX IF YOU 
AGREE 
1. I confirm that I have read and understand the information sheet 
(version 2 18Feb 2013) for this study and have had the opportunity 
to ask questions 
 
2. I understand that if I participate in an interview it may be audio-
recorded 
 
3. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason 
 
4. I understand that the research team will hold the information I give 
confidentially and my name will not be mentioned in any reports 
 
5. I understand that all information from this study will be kept in a 
locked filing cabinet at the University of Stirling and stored in a 
password protected folder on the University computer hard drive 
 
6. I understand that if consent to participate in the study is declined 
or terminated at any stage, I will enter normal post treatment 
follow up care 
 
7. If I withdraw from the study at any time, I consent to the retention 
of data collected up to the point of my withdrawal 
 
8. I agree to a letter being sent to my GP informing them that I am 
involved in this study 
 
9. I agree to participate in this study 
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Appendix 6 Training evaluation form
 
 
Evaluation Form 
 
Name:         Date: 
 
Tutor Names:        Venue: 
  
All personal details on this evaluation form will be kept confidentially. Please assess 
the questions using a scale of 1 to 5, where 1=strongly disagree and 5=strongly agree. 
Also provide any additional comments or suggestions which you feel are relevant. 
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 Registration and pre course 
information 
Strongly  
Agree  
5                 4                       3                    2                     
1 
I received all the necessary information 
prior to starting the course 
 
 
The directions to the venue were helpful 
and accurate 
 
 
Additional Comments 
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Course Content Strongly                                                                
Strongly 
Agree                                                                    
Disagree 
5                 4                       3                    2                     
1 
The content of the course was at the 
appropriate level 
 
The course information was well 
presented 
 
The content was well presented  
The content of the practical session was 
well presented 
 
Additional Comments 
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 Course Venue and Facilities Strongly                                                                
Strongly 
Agree                                                                   
Disagree 
5                 4                       3                    2                     
1 
The course teaching and exercise rooms 
were of an adequate standard 
 
The equipment used was of an adequate 
standard 
 
The refreshment facilities were of an 
adequate standard 
 
The teaching rooms set up and prepared 
beforehand 
 
Each session started and ended on time  
You were provided with sufficient breaks  
Course Venue and Facilities Additional 
Comments: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Do you have any suggestions on how this course could be improved? 
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Would you recommend this course to other colleagues?  
 
 
 
 
 
Please add any additional comments you may wish to make: 
 
 
 
 
 
 
 
 
Thank you for your time 
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Appendix 7 Interview guides
Patient interview schedule 
Preamble about purpose of interview, expected length of time, arrangements should they wish to stop 
the interview at any point, purpose of the tape recorder and ensure they are happy for this. 
Perceptions around recovery  
Explain to the participants  
• First set of questions will ask about how they feel having cancer has affected them  
• How they feel about things and the future now that their first line treatment is completed 
• What they think they can do to reduce a risk of recurrence and to help improve their 
general health and wellbeing.  
Evaluation of the programme  
Explain to the participants  
• next set of questions will ask about their experiences and views of the cardiac 
rehabilitation programme that they attended.   
Explain to the participants  
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• next few questions will then ask about whether and how the programme has helped in 
specific ways such as improving physical capacity, general health, emotional wellbeing, 
etc 
• then we will ask participants to specify which parts of the programme they felt helped in 
each of these areas. 
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Explain to the participants that the next few questions will ask about they found difficult or 
challenging with the programme, what they didn’t like, what they found unhelpful and what 
they would change for future patients attending the programme. 
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Evaluation of trial procedures and study design 
Explain to the participants that the next set of questions will ask about their experiences of and 
views on aspects related to the design of the study rather than the programme itself.  The 
questions will ask about the information that participants were given about the study prior to 
taking part, the questionnaires that they are asked to complete before and after attending the 
exercise programme and using the accelerometer.   
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Control patient interview schedule 
Preamble about purpose of interview, expected length of time, arrangements should they wish to stop 
the interview at any point, purpose of the tape recorder and ensure they are happy for this. 
Perceptions around recovery  
Explain to the participants  
• First set of questions will ask about how they feel having cancer has affected them  
• How they feel about things and the future now that their first line treatment is completed 
• What they think they can do to reduce a risk of recurrence and to help improve their 
general health and wellbeing.  
Evaluation of trial procedures and study design 
The next set of questions will ask about their experiences of and views on aspects related to the 
design of the study.   
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 Cardiac rehabilitation for patients with bowel cancer. 
Control patients did not receive rehabilitation but we want to get their thoughts on the 
programme. 
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Cardiac Focus group schedule 
The study we are doing involves looking into exercise for people recovering from bowel 
cancer surgery. The project involves referring these people to the cardiac rehabilitation 
programme and seeing how acceptable that is for both groups of patients. I am here today to 
get your thoughts and ideas as a cardiac group. 
We will go through a few questions about your thoughts on the study, and welcome your 
honest opinions on the topics.  This should last about 15 minutes, and answering the questions 
is voluntary, and you can decide to stop at any point, or not answer specific questions, if you 
wish. If you do wish to stop at any point, please let me know. We will record the interview for 
our research. 
 
Is there anything you would like to ask?  
Are you all happy to be recorded?  
Are you happy to continue with the questions we have for you? 
 
Verbal Consent Documentation For Participation 
The following written consent serves as signed documentation for verbal informed consent for 
the protection of the participants. Informed consent shall be documented by the use of this 
written consent form. 
 
SUBJECT:  Cardiac Rehabilitation in bowel cancer patients 
 
This consent serves as documentation that the required elements of informed consent have 
been presented orally to the participant using the approved telephone consent script. 
Verbal consent to participate in this focus group has been obtained by the below investigator 
on the below date documenting the participant’s willingness to continue with the recorded 
discussion. 
 
Investigator’s Name (Printed) 
 
Investigator’s Signature  
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Welcome the group. Preamble about the purpose of the group, and that we hope to hear 
thoughts from all members, in each area. We are looking for honest thoughts and opinions. 
Remind group that interview will be recorded, ensure they are happy with this. 
Evaluation of the mixed cardiac/cancer programme 
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Clinician interview 
 
Preamble about purpose of interview, expected length of time, arrangements should 
they wish to stop the interview at any point, purpose of the tape recorder and ensure 
they are happy for this. 
Ask clinician to give honest opinion, and to be elaborate in responses, if possible. 
 
• First questions are about your initial thoughts when you first heard of the 
study. 
 
 
 
Initial thoughts on the study 
 
Q1: Can you tell me what your initial thoughts were when the study was first introduced to 
you? 
 Can you explain why? 
 
Q2: What did you think the study might involve for you and your workload? 
Q3: Did you have any thoughts regarding the benefits and or difficulties it might mean for 
your patients? 
Patient feedback 
 
Q4: What reactions did you receive from patients when introducing the cardiac rehabilitation 
intervention? 
 e.g. hesitant; enthusiastic; didn’t need it etc. 
 
Q5: Were patients aware of the potential benefits of taking part in such a study? 
 If not, did you have a chance to introduce this? 
 
Q6: Overall, how helpful do you think the intervention will be? 
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Cardiac Rehabilitation 
 
Q7: What do you think the intervention means for your patients? 
 e.g. long term/short term; self-management; healthy living; behaviour change 
 
Q8: What are your thoughts on referring patients to this type of intervention and what do you 
think should be measured in terms of outcomes? 
 
Q9: Overall, how helpful do you think the intervention will be? 
 
Q10: Did you have any concerns?
 
Q11: Were you aware of what was on offer in terms of activity for your patient? 
 If yes, what were your thoughts on this? 
Cardiac rehabilitation  
 
Q12: Were you aware that the cancer patients would be mixing with cardiac patients within the 
class? 
 
Q13: How do you think this should be approached within the class? 
 e.g. made clear to all patients; no need to mention it?  
 
Q14: Do you think the same social support will be available between patients with different 
long term conditions? 
 
Q15: What are your thoughts on practical issues, such as infection risk etc. for cancer patients? 
 
Q16: Do you think the health behaviour changes for cancer and cardiac patients are similar? 
 
Q17: Overall, what are your opinions on mixing classes with different long term conditions? 
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Explain to the clinician that the next questions refer to being part of the study and 
recruitment process.  
Study process/ Recruitment involvement 
 
Q22: Was your role in the recruitment process made clear when the study was introduced to 
you? 
 
Q23: Was the actual involvement what you expected in terms of workload? 
 
Q24:Did the involvement in the study add extra stress to your day/workload? 
 
Q25: Was the process easy to follow and were you clear on what was expected as part of the 
recruitment? 
 
Q26: Was the paperwork concise and easy to use? 
 
Q27: Is there anything you would change in the processes you were involved in, if the study 
was to be conducted again elsewhere? 
 
Q28: Overall, what were the thoughts of you and your colleagues on the study in general? 
 
Q29: Do you think this would be a feasible service to introduce into your workplace? 
 Yes/No expand on reasons  
Fitness Centre 
Q18: What were your feelings on referring patients to the local fitness centre? 
 
Q19: How do you think patients would feel about attending a fitness centre and exercising 
with the general public after their surgery? 
 
Q20: What are your thoughts on patients exercising unsupervised so soon after surgery?  
 
Q21: Would you have a preference of referring a patient to a fitness centre or cardiac 
rehabilitation? Why? 
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Appendix 8 Adverse event log
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Appendix 9 Accelerometer frequently asked
questions sheet
Accelerometer FAQ’s 
1. What is an accelerometer? 
This is a GTX3 accelerometer. Accelerometers are devices which measure the 
acceleration and movement of your body. It measures movements in three directions 
and has many different uses.  
For this study we are using the device to measure your activity levels for the week 
you are wearing the device. We will ask you to wear it again for a week, when 12 
weeks have passed. This is to see if there are any changes in your activity levels.  
2. How should I wear it? 
For quality control, we would like everyone to wear the device in the same place. This 
is placed round the waistband, and close to the hip bone. The elastic strap can be 
adjusted but should be comfortable but not loose. 
 
3. When should I wear it? 
We would like you to wear the device for a full week. If you forget a day or two, 
please wear for an additional day (or two) at the end of the week. You should remove 
the device when you go to bed and replace first thing on awakening. The device is 
waterproof so is safe for wearing in the shower. 
4. How do I know if it is working? 
The device has a small green light which will be flashing for the entire period it is 
recording data for us.  
5. Do I get to keep the device? 
No, these are expensive pieces of equipment that we need returned. If you are taking 
part in the cardiac rehabilitation classes, please bring the device along to your first 
class and pass it on to the physiotherapist team there. If you are not attending the 
classes please follow the instructions given by the research team at your initial 
appointment.  
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Appendix 10 Weekly intervention log questions
Date: 
 
Patient study ID: 
 
What method of contact was there between the cardiac rehabilitation team/clinician 
and the patient?  
 Face to face 
 Telephone 
 Internet 
 Mailing of written material 
 Other (please specify) 
 
Did the patient attend class this week? 
 Yes 
 No 
 If No, enter the reason for non-attendance 
  Unwell 
  Transport 
  Undergoing treatment 
  Other commitments 
  Issues with stoma 
  Other (please specify) 
 
Is the patient currently undergoing any cancer treatment?  
 Yes 
 No 
 If Yes, what treatment? (select all that apply) 
  Radiotherapy 
  Drug therapy 
  Chemotherapy 
  Other (please specify)  
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Only complete the following if patient attended cardiac rehabilitation this week. 
 
Did the clinician give you any verbal advice? 
 Yes  
 No 
 If Yes, briefly describe 
 
Did the clinician give you any written advice? 
 Yes 
 No 
 If Yes, briefly describe 
 
Did you do any cardiovascular exercise/aerobic exercise? (e.g. walking, running on 
the spot, knee lifts, things that make you breathe faster) 
 Yes 
 No 
 If Yes, did you use any of the following equipment? 
  Treadmill 
  Bicycle 
  Rowing machine 
Cross trainer 
Skipping rope 
Other 
 
Did you do any strength work (e.g weights, exercise bands, wall press ups etc) 
 Yes 
 No 
 If Yes, did you use any of the following? 
  Weights/dumbbells 
  Resistance bands 
  Exercise ball 
  Multi gym 
  Floor mat 
  Other  
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Did you do any flexibility work? (stretching, range of movement exercises) 
 Yes 
 No 
 
Did you do any relaxation this week? 
 Yes 
 No 
 
Topics covered during the intervention (select all that apply) 
 Exercise 
 Diet 
 Stress Management 
Alcohol 
Smoking 
Medications 
Other 
 
Did you use a heart rate monitor during the class? 
 Yes 
 No 
 If Yes, did you work within the range given to you? 
  Yes 
  No 
  Don’t know 
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Did you use the rating of perceived exertion (RPE) scale today? 
 Yes 
 No 
 If Yes, did you work within the range given to you? 
  Yes 
  No 
  Don’t know 
On a scale of 1-10, how hard do you think you worked at this weeks class? 
 
Where did your class take place? 
 
How long was your time at the class in total? 
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Appendix 11 Statistical analysis plan
Statistical Analysis Plan 
 
TRIAL FULL TITLE 
The use of cardiac rehabilitation services to aid the recovery of
colorectal cancer patients: A pilot randomised controlled trial 
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SAP VERSION DATE 12APR2015 
TRIAL STATISTICIAN Petra Rauchhaus 
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Dr. Gill Hubbard 
SAP AUTHOR Petra Rauchhaus 
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Abbreviations and Definitions 
 
AE Adverse Event 
ANCOVA Analysis of Co-Variance 
CI Confidence Interval 
CRF Case Report Form 
EoI End of Intervention 
FACT-C 
Functional Assessment of Cancer Therapy - For patients with 
Colorectal cancer 
FACIT-Fatigue Functional Assessment of Chronic Illness Therapy-Fatigue 
HADS Hospital Anxiety and Depression Scale 
NHS National Health Service 
RCT Randomised Clinical Trial 
SAP Statistical Analysis Plan 
SPAQ Scottish Physical Activity Questionnaire 
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Introduction 
 
Preface 
The research question is: Is using an existing cardiac rehabilitation service delivered 
by a cardiac multi-disciplinary team (e.g. cardiac physiotherapist, cardiac nurse) with 
support from a cancer-exercise specialist, to mixed classes of cancer/cardiac patients 
(with some components tailored to meet cancer patients’ needs and delivered by a 
cancer nurse), an acceptable model of rehabilitation to aid the recovery of colorectal 
cancer patients? Our ultimate aim was to conduct an RCT of the clinical and cost 
effectiveness of utilising an existing cardiac rehabilitation service versus usual care 
(no routine NHS rehabilitation provision) to aid the recovery of colorectal cancer 
patients. Given the uncertainties surrounding such an RCT, we proposed to conduct a 
pilot RCT with embedded feasibility study to inform the design and conduct of a 
larger scale trial for which separate funding would be required.  In this proposed 
preliminary study, we were seeking to undertake a phased programme of work 
comprising of intervention testing and feasibility work (Phase 1) and a pilot trial with 
a process evaluation (Phase 2) within the context of planning a definitive large scale 
RCT. We also piloted an economic evaluation because interventions have a cost 
component that needs to be considered when evaluating the effectiveness of the 
intervention to reduce the burden of a disease. 
Purpose of the analyses 
This SAP describes the analysis of the pilot RCT Phase II data. It will compare 
intervention versus control. to provide data to the planning of a larger RCT, and will 
be included in the clinical study report. 
Objectives and Endpoints 
 
Study Objectives 
• To determine eligibility, consent, recruitment and retention rates and speed of 
recruitment. 
• To determine likely contamination across trial arms. 
• To determine completion rates for proposed outcomes measurement tools at 
baseline and follow up. 
• To provide data for sample size calculation for a definitive RCT. 
• To test intervention fidelity according to study protocol. 
• To assess the extent to which intervention and trial procedures can be integrated 
into routine clinical practice. 
DOI: 10.3310/hsdr04240 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 24
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Hubbard et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
221
• To conduct a preliminary economic evaluation of the cancer rehabilitation 
programme. 
Endpoints 
 
Primary outcome: physical activity  
Physical activity was assessed using the Actigraph GT1M accelerometer (Actigraph 
LLC, Pensacola, Florida). Participants were asked to wear an accelerometer for 7 days 
on 3 occasions (T0 - before patients are randomised to the intervention or control 
group; T1 - at the end of the intervention (data will be collected 12 weeks after 
baseline for patients in the control arm); and T2 - 3 months later). Physical activity 
was also assessed subjectively using the Scottish Physical Activity Questionnaire 
(SPAQ) to ascertain the types of activities participants engaged in. 
Secondary outcomes 
Quality of life: EQ-5D was used to measure quality of life. 
Anxiety and depression: The Hospital Anxiety and Depression Scale (HADS), which 
consists of 14 questions, 7 for anxiety and 7 for depression, was used to measure 
anxiety and depression  
Fatigue: The Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F), 
which is a 13-item fatigue FACT subscale, was used to measure cancer-related 
fatigue.  
Cancer Specific Quality of Life was assessed using the Functional Assessment of 
Cancer Therapy – Colorectal (FACT-C) Questionnaire. 
Physical activity self-efficacy, which is the belief that one can engage in, and meet 
physical activity goals, was also measured. 
According to the behaviour motivation hypothesis, perceived risk is positively and 
directly related to health behaviour. Risk perception of suffering from diseases has 
been found to play an important role in the development of intentions to perform 
physical activity among older adults and in explaining cancer-related behaviours. 
Given the lack of agreement about quality of methods of measuring cancer risk 
perception, we included absolute (i.e. estimation of personal risk) and comparative 
measures (i.e. comparison of personal risk to other people’s risk). We also included 
conditional (i.e. rating the probability that a certain event (e.g. cancer recurrence) will 
occur given their adaptive behaviour (e.g. increasing physical activity) is, or is not, 
performed) and unconditional (i.e. rating the probability that a certain event will occur 
without specifying the adaptive behaviour) measures. 
Study Methods 
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General Study Design and Plan 
The intervention was rehabilitation for colorectal cancer patients in a cardiac 
rehabilitation setting. An 8/12-week (number of weeks depending on research site) 
post-hospital rehabilitation programme was delivered by a member of the cardiac 
multi-disciplinary team (e.g. cardiac physiotherapist, cardiac nurse or dietician) to a 
mixed class of cancer/cardiac patients in a cardiac rehabilitation setting with some 
components specifically tailored for cancer patients and delivered by a cancer nurse. 
Rehabilitation classes were delivered twice weekly or once a week depending on 
research site. The rehabilitation programme comprised of 60/90 minutes (depending 
on research site) of exercise training (aerobic and muscle strengthening) delivered to a 
mixed class of cancer/cardiac patients by a cardiac physiotherapist. 
Participants set individual physical activity goals with advice and support from the 
physiotherapist. 
The exercise class was followed by 30/60 minutes (depending on research site) of 
education (e.g. stress management, diet, drug therapy, smoking cessation, benefits of 
exercise and relaxation). A colorectal cancer nurse delivered some educational 
sessions (e.g. cancer therapies) to cancer patients. These educational sessions were 
either be delivered to a group of cancer patients or one-to-one by telephone  
Patients randomised to the control arm of the pilot received ‘Staying healthy after 
bowel cancer’ booklet by Bowel Cancer UK, which includes a section on ‘staying fit’. 
Outcome and process measures were administered on three occasions: i) T0 - before 
patients were randomised to the intervention or control group, ii) T1 - at the end of the 
intervention (data was collected 12 weeks after baseline for patients in the control 
arm) and iii) T2 - 3 months later. Participants were asked to wear an accelerometer for 
7 days on 3 occasions (T0 - before patients were randomised to the intervention or 
control group; T1 - at the end of the intervention (data was collected 12 weeks after 
baseline for patients in the control arm); and T2 – 3 months later. 
Randomisation and Blinding 
Patients were randomised to the intervention or control group after they consented to 
participating in the study and after baseline primary and secondary measures were 
collected. Randomisation with stratification by centre was conducted by Tayside 
Clinical Trials Unit. Due to the nature of the intervention, the trial was not blinded. 
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Sample Size  
As this is a pilot RCT with embedded feasibility study, a formal power calculation is 
not appropriate; the study is not powered to detect a clinically meaningful difference 
in the primary outcome between the rehabilitation and usual care groups.  
Rather the aim is to provide robust estimates of the likely rates of recruitment and 
retention, and to yield estimates of the variability of the primary and secondary 
outcomes to inform power calculations for a future large-scale trial. We will therefore 
use the pilot trial (Phase 2 of the proposed study) in order to provide a quantitative 
estimate of the intervention impact (relative to control) in order to inform the sample 
size estimation for a definitive trial.  
For the pilot RCT (Phase 2), we believe that over 6 months across the 3 sites we will 
be able to approach 250 patients. From their responses we will be able to determine 
whether it is possible to recruit patients and also estimate eligibility, consent, 
participation and retention rates and speed of recruitment for a future large scale trial. 
We have conservatively estimated that we will recruit approximately 66 patients. 
Cancer clinicians estimate that approximately one third will be ineligible (e.g. have 
advanced disease) and based on recruitment to a RCT about physical activity with 
cancer patients in Scotland (27% recruitment rate) and a trial involving colorectal 
cancer patients within 3 months of completing surgery conducted in Canada (35% 
recruitment rate) we estimate that about a third of eligible patients will consent. Thus, 
we estimate that in Site 2 and 3 26 patients in each site will be recruited (13 
intervention group and 13 control group). In Site 1, we estimate that 14 patients will 
be recruited (7 intervention group and 7 control group).  However, a recruitment rate 
of 71 per cent, which was achieved in a study of a personalised lifestyle programme 
for colorectal cancer survivors in Scotland would provide a total of 118 patients 
General Considerations 
 
Timing of Analyses 
The final analysis will be performed after all data have been entered and the database 
has been locked. 
 
Analysis Populations 
Analysis population will be all available subjects on an intention-to-treat basis for the 
outcome measures. 
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Missing Data 
This is an intention to treat study so all non compliers, withdrawn patients or missing 
data will be analysed by imputation. Missing data will be handled using multiple 
imputation methods, assuming that the assumption of data missing at random is met. 
We will also do a completed cases only analysis. 
Summary of Study Data 
All continuous variables will be summarised using the following descriptive statistics: 
n (non-missing sample size), number of missing records, mean, standard deviation, 
median, maximum and minimum. The frequency and percentages (based on the non-
missing sample size) of observed levels will be reported for all categorical measures. 
In general, all data will be listed, sorted by subject and treatment and where 
appropriate by visit number within subject. 
All summary tables will be structured with a column for each treatment in the order 
(Intervention, Control) and an additional column for the total population relevant to 
that table/treatment, including any missing observations’ 
Demographic and Baseline Variables 
Baseline characteristics for patients are: Age, gender, colorectal cancer diagnosis, 
treatment for colorectal cancer (Colon or rectal surgery; laparoscopic or open surgery; 
Temporary, permanent stoma or no stoma; Chemotherapy or no chemotherapy). 
 
Efficacy Analyses 
Scoring for outcomes follows the scoring instructions given for each questionnaire. 
Where no such instruction is present, the following approach will be taken: 
If no more than 20% of questionnaire items are missing, the missing items will be 
replaced by the mean of the remaining items to build a sum score. Where more than 
20% of the items are missing, the sum score will be set to missing. 
Data for continuous outcome measures will be assessed for normality prior to 
analysis. Transformations of the outcome variables will be used where necessary if 
these are not normally distributed. 
Outcomes will be analysed as baseline versus end of intervention (EoI) and baseline 
versus 3 months after intervention.  
Continuous outcome will be using multiple linear regression (i.e. analysis of 
covariance, ANCOVA).  Intervention effect differences will be reported with 95% 
confidence intervals (CIs) and p-values. The baseline characteristics will be explored 
for meaningful differences between trial arms. Where these are considered 
meaningful and important these variables will be entered into a stepwise selection 
procedure and the primary analysis will be adjusted for these variables if they are 
statistically selected (usual criteria p < 0.05). 
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Outcome measurements across multiple study visits (baseline, EoI, 3 months) will 
also be analysed using mixed effects (repeated measures) regression models. Models 
will include fixed effects for intervention group, time point, and their interaction, plus 
random effects for each subject to account for repeated measures, and will assume a 
general covariance structure. Each model will also include fixed effects for baseline 
values of the outcome, other covariates, in the same way as described above for 
ANCOVA models. 
Ordinal and binary outcomes will be analysed as described above using logistic 
regression. 
 Primary Efficacy Analysis 
The primary outcome is the change in physical activity recorded with accelerometers 
between baseline and EoI. The variables to be analysed are minutes spent each week 
on light moderate and vigorous exercise as well as minutes spent sedentary and will 
be analysed using multiple linear regression.  The model will have outcome as the 
dependent variable with baseline values as a covariate along with intervention group 
(Intervention/Control), and hospital as fixed effects.  
Confounding variables to be assessed for importance are: Cognitive risk perception, 
Affective risk perception, Physical Activity self-efficacy, age, sex, surgery type 
(Colon or rectal surgery), Surgical intervention (e.g. laparoscopic or open surgery); 
stoma (Temporary (a loop ileostomy), permanent stoma or no stoma) and medical 
intervention (Chemotherapy or no chemotherapy). 
 
Secondary Efficacy Analyses 
• SPAQ: All minutes of activity during the previous week will be summed up 
for analysis to provide a total minutes of activity in a week. In addition, the 
activities will be summed up separately for each week and analysed... Where 
no entries were made for a day, it will be assumed that there was no activity (0 
minutes) in this category. 
• FACT-C: The questionnaire consists of 5 subscales (Physical Well-being 
(PWB), Social/Family Well-being (SWB), Emotional Well-being (EWB), 
Functional Well-being (FWB), Additional Concerns (AC)). Composite scales 
are also calculated as described in the guidelines. As emotional well-being 
was not collected in this trial, composite scores including those questions were 
not created. 
• FACIT-F: The questionnaire consists of 13 items and will be calculated as 
described in the guidelines. 
• Activity Self-efficacy: If no more than 20% of the items are missing, a sum 
score will be created from all items in the questionnaire and used for analysis. 
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• EQ-5D: Physical domains will be analysed separately using logistic regression 
as described above. The health state will be analysed using ANCOVA as 
described above. In addition, the health utility score will be created and 
analysed. 
• HADS: Two separate scores for anxiety and depression will be created and 
analysed. 
• Risk perception: Three distinct scores will be created: Cognitive risk 
perception, affective risk perception and perceived severity as a sum of 2 
questions each. Each score will only be created if both items are present. 
Scores will be analysed as described. 
• Service use: This data will be analysed by the health economics team and is 
not part of this SAP. 
Safety Analyses 
 
Adverse Events 
Adverse events (AE) will be coded with MedDRA 16.1. Where more than one 
diagnosis is present in the AE description, the AE will be split with all the descriptors 
kept the same for all diagnosis. Adverse events will be reported by primary System 
Organ Class (SOC) and Preferred Term (PT). 
Subjects will be counted only once when calculating the incidence of AEs. An 
overview table will be created counting the number of adverse events by system organ 
class and preferred term. 
Descriptors for Adverse events will be tabulated separately as described for 
categorical variables in section 8. The total number of AEs will be used as basis for 
tabulation. 
 
 
 
Serious Adverse Events 
Serious Adverse Events (SAE) will be reported with all other AEs as described in 
section 10.1. However, they will be reviewed for the trial report on a case by case 
basis by the PI. 
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Reporting Conventions 
P-values ≥0.001 will be reported to 3 decimal places; p-values less than 0.001 will be 
reported as “<0.001”. The mean, standard deviation, and any other statistics other 
than quantiles, will be reported to one decimal place greater than the original data. 
Quantiles, such as median, or minimum and maximum will use the same number of 
decimal places as the original data. Estimated parameters, not on the same scale as 
raw observations (e.g. regression coefficients) will be reported to 3 significant figures. 
Technical Details 
All analysis will be performed using SAS 9.3. All data, analysis programs and output 
will be kept on the Mackenzie Server and backed up according to the internal IT 
SOPs.  
Analysis programs will be required to run without errors or warnings. The analysis 
programs for outcomes will be reviewed by a second statistician, and any 
irregularities within the programs will be investigated and fixed and date of finalised 
analysis programs will be signed and recorded.  
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Appendix 12 Descriptive data for quality of life
TABLE 56 Functional Assessment of Cancer Therapy – Colorectal: total score
Variable Rehabilitation No rehabilitation Total
Baseline
n 20 20 40
Missing 0 0 0
Mean 58.8 53.3 56.1
SD 11.02 12.88 12.16
95% CI 53.66 to 63.98 47.26 to 59.32 52.17 to 59.94
Minimum 38 23 23
Q1 50.5 49.5 49.9
Median 60.0 57.0 57.5
Q3 68.0 62.0 64.5
Maximum 80 70 80
End of intervention
n 15 16 31
Missing 0 0 0
Mean 63.2 58.2 60.6
SD 8.38 12.60 10.90
95% CI 58.60 to 67.89 51.49 to 64.92 56.65 to 64.64
Minimum 48 26 26
Q1 59.0 55.6 57.2
Median 67.7 61.3 64.0
Q3 70.0 66.8 69.0
Maximum 71 71 71
End of intervention – baseline
n 15 16 31
Missing 5 4 9
Mean 3.6 2.6 3.1
SD 6.66 5.05 5.81
95% CI –0.11 to 7.26 –0.12 to 5.27 0.93 to 5.19
Minimum –9 –4 –9
Q1 –0.3 –0.3 –0.3
Median 3.8 0.3 2.0
Q3 7.0 7.5 7.0
Maximum 18 12 18
continued
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TABLE 56 Functional Assessment of Cancer Therapy – Colorectal: total score (continued )
Variable Rehabilitation No rehabilitation Total
3 months’ follow-up
n 12 13 25
Missing 0 0 0
Mean 62.5 59.1 60.8
SD 9.20 12.98 11.23
95% CI 56.69 to 68.39 51.30 to 66.98 56.14 to 65.41
Minimum 43 26 26
Q1 57.5 57.5 57.5
Median 65.8 63.3 65.5
Q3 68.0 68.0 68.0
Maximum 75 71 75
3 months’ follow-up – baseline
n 12 13 25
Missing 8 7 15
Mean 1.2 5.0 3.2
SD 6.25 5.87 6.23
95% CI –2.77 to 5.17 1.41 to 8.50 0.58 to 5.73
Minimum –9 –4 –9
Q1 –2.9 2.0 –1.2
Median 2.0 3.4 3.0
Q3 6.0 9.0 8.0
Maximum 11 14 14
Q, quarter.
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TABLE 57 Functional Assessment of Chronic Illness Therapy Fatigue Scale: total score
Variable Rehabilitation No rehabilitation Total
Baseline
n 20 20 40
Missing 0 0 0
Mean 39.2 36.9 38.0
SD 11.35 11.75 11.47
95% CI 33.89 to 44.51 31.35 to 42.35 34.3 to 41.69
Minimum 16 14 14
Q1 30.0 26.5 28.0
Median 40.5 39.5 40.5
Q3 49.0 47.5 48.0
Maximum 52 51 52
End of intervention
n 15 16 31
Missing 0 0 0
Mean 44.1 41.5 42.7
SD 8.55 13.31 11.15
95% CI 39.33 to 48.80 34.41 to 48.59 38.65 to 46.83
Minimum 23 9 9
Q1 41.0 33.0 37.0
Median 46.0 47.5 47.0
Q3 49.0 51.0 51.0
Maximum 52 52 52
End of intervention – baseline
n 15 16 31
Missing 5 4 9
Mean 4.7 2.1 3.4
SD 9.45 8.81 9.07
95% CI –0.50 to 9.96 –2.57 to 6.82 0.06 to 6.71
Minimum –10 –23 –23
Q1 –1.0 0.0 0.0
Median 2.0 2.5 2.0
Q3 14.0 4.5 10.0
Maximum 20 20 20
continued
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TABLE 57 Functional Assessment of Chronic Illness Therapy Fatigue Scale: total score (continued )
Variable Rehabilitation No rehabilitation Total
3 months’ follow-up
n 12 13 25
Missing 0 0 0
Mean 43.3 43.5 43.4
SD 10.56 11.18 10.66
95% CI 36.54 to 49.96 36.78 to 50.30 39.00 to 47.80
Minimum 21 15 15
Q1 41.0 41.0 41.0
Median 48.0 48.0 48.0
Q3 50.0 51.0 50.0
Maximum 52 52 52
3 months’ follow-up – baseline
n 12 13 25
Missing 8 7 15
Mean 0.7 4.7 2.8
SD 7.85 10.24 9.22
95% CI –4.32 to 5.66 –1.50 to 10.88 –1.04 to 6.56
Minimum –16 –17 –17
Q1 –4.0 0.0 –1.0
Median 0.5 3.0 3.0
Q3 5.5 10.0 7.0
Maximum 13 24 24
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